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Definition of terms 
activPAL3™ Monitor: Accelerometer-based activity monitor worn on thigh to 
quantify physical activity in four categories: stepping, standing, upright and sitting/ 
lying events (Granat, 2012). 
ACS: Acute coronary syndrome (ACS) is an acute condition characterised by 
chest pain for more than 20 minutes, either with an Electrocardiogram (ECG) 
changes, ST segment elevation or chest pain without ECG changes encompasses 
ST elevation myocardial infarction (STEMI) and non ST elevation myocardial 
infarction (NSTEMI). The main mechanism of ACS initiates through plaque erosion 
of thrombosis (blood clot), and reduction of blood flow to heart muscle caused by 
spasm of vascular smooth muscle (Roffi et al., 2016).  
AMI: Acute myocardial infarction (AMI) or heart attack is necrosis of myocardial 
tissue resulting from lack of blood supply to the myocardium, an atherosclerosis 
results in plaque formation within coronary vessel, if plaque rapture is unstable, 
the immune systems responds with localised inflammation, fibrin and platelets 
aggregate at the site of the plaque and a thrombus (blood clot) forms. This results 
in total occlusion of blood flow in the coronary vessel (Baird, 2015).   
BMI: Body mass index (BMI) describes a particular relationship between an 
individual’s body mass and his or her height, determined by the formula: BMI = 
body mass (in kilograms) / height² (in metres). In lay terms, BMI denotes the 
leanness (low BMI values) or fatness (high BMI values) of an individual (true of the 
general population, however not necessarily true for an athletically trained 
individual). A BMI of 20–25 is considered normal, >25 is overweight and >30 is 
obese (>40 is often termed clinically or morbidly obese) (CDC, 2015 ). 
Body-worn activity monitor: A monitor worn on part of the body, which best 
reflects total body movement. The more the monitor moves the higher the value of 
the counts. It includes two broad approaches to the measurement of physical 
activity and sedentary behaviour those that primarily provide an approximation of 
energy expenditure (volume of movement) and those that primarily attempt to 
classify postures (Granat, 2012). 
  
xv 
 
Cardiac rehabilitation programme: “The sum of activities required to influence 
favourably the underlying cause of the cardiovascular disease, as well as the best 
possible physical, mental and social conditions, so that they may by their own 
efforts preserve or resume when lost, as normal a place as possible in the 
community. Rehabilitation cannot be regarded as an isolated form of therapy but 
must be integrated with the whole treatment of which it forms only one facet” 
(WHO, 1993, p. 1)  
CVD: Cardiovascular Disease (CVD) is a group of disorders of the heart and blood 
vessels and they include: Coronary heart disease, cerebrovascular disease, 
peripheral arterial disease, rheumatic heart disease, congenital heart disease, 
deep vein thrombosis and pulmonary embolism (WHO, 2015a).   
CHD: Coronary Heart Disease (CHD) is characterized by episodes of reversible 
myocardial demand/supply mismatch, related to a narrowing of coronary arteries 
through a gradual build-up of plaques (atherosclerosis) within coronary vessels 
walls, which are usually inducible by exercise, emotion or other stress and 
reproducible and may also be occurring spontaneously (Montalescot et al., 2013).  
Exercise: A subcategory of physical activity that is planned, structured, repetitive 
and purposeful in the sense that the improvement or maintenance of one or more 
components of physical fitness is the objective (WHO, 2013).  
Physical Activity: (PA) is Any bodily movement produced by skeletal muscles 
that requires energy expenditure PA includes exercise and other activities such as 
aerobic activity, occupation, transportation, housework and social activities (WHO, 
2013). 
PPCI: Primary Percutaneous Coronary Intervention (PPCI) emergent 
percutaneous catheter intervention in the setting of STEMI, without previous 
fibrinolytic treatment—is the preferred reperfusion treatment in patients with 
STEMI. An interventional cardiologist should perform PPCI expeditiously (for 
example within guideline-mandated times). PPCI is considered for clinical 
presentation of STEMI patients within 12 hours of symptom onset and with 
persistent ST-segment elevation (Steg et al., 2012, p. 2581)   
xvi 
 
Recovery phase: Phase during which patients restore physical fitness resume 
daily activities and reduce risk of re-infarction, it depends on many physiological 
and psychological factors, early recovery phase last up to six weeks. In order to 
facilitate the early recovery, patients are recommended to engage in cardiac 
rehabilitation programme, which consists of four phases, phase one starts in-
hospital and the remaining phases in cardiac rehabilitation centres (NHS, 2013)   
Reliability: The probability of obtaining the same results with a completely new 
sample of subjects, there are many types of reliability such as internal consistency, 
which is usually measured with Cronbach's alpha, if Cronbach's alpha ≥ 0.7, 
internal consistency is considered acceptable (Polit & Beck, 2012)  
Secondary prevention: Refer to early detection and screening, aiming to 
minimize the burden of diseases and associated risk factors, which improves the 
chances for positive health outcomes. This includes activities such as evidence-
based screening programs for early detection of diseases (WHO, 2016a). 
Sedentary time: A non-upright posture and not simply inactivity, includes sitting 
and lying events times (Granat, 2012). 
Self-efficacy: “Belief in one's capabilities to organise and execute the course of 
action required to produce given attainments” (Bandura, 1997, p. 3).   
Self-management: The individual's ability to manage symptoms, treatment, 
physical and psychosocial consequences, and lifestyle changes inherent to living 
with a chronic vascular condition (Barlow, 2001, p. 178).  
Upright time: An upright posture divided into standing events and stepping events 
 
Validity: An assessment of the degree to which a research tool measures what it 
is intended to measure (Polit & Beck, 2012). There are many different types of 
validity such as, face validity, content validity. 
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Abstract 
Background: Cardiovascular disease is responsible for over 17.1 million deaths 
annually worldwide. Secondary prevention plays a key role in reducing the burden 
of cardiovascular disease. The cardiac rehabilitation programme is an effective 
intervention that supports lifestyle behaviour change after acute myocardial 
infarction. Self-efficacy and regular physical activity are particularly important for 
improving of patients’ health outcomes. No studies have measured both cardiac 
self-efficacy and physical activity levels after acute myocardial infarction during the 
early recovery phase. Aims: To translate and cross-cultural adapt of a cardiac 
self-efficacy questionnaire into Arabic. To use this questionnaire to assess the 
changes in self-reported self-efficacy levels at baseline, after two weeks (T1) and 
after six weeks (T2), to assess changes in physical activity levels and patterns at 
T1 and T2, and to determine whether there is a relationship between self-efficacy 
and physical activity among patients with acute myocardial infarction in the early 
recovery phase. Study design: A descriptive study with a repeated measures 
design. Methods: Phase one: the study used a process recommended by the 
World Health Organisation, to produce an Arabic version of the cardiac self-
efficacy questionnaire. Phase two: the study measured self-efficacy by an Arabic 
version of the self-reported cardiac self-efficacy questionnaire and administered at 
baseline, T1 and T2. Physical activity was objectively measured by body-worn 
activity monitor (activPAL3™) for 24 hours a day for a full seven consecutive days 
at T1 and T2. Sample and Setting: The study recruited a convenience sample of 
100 patients from a single cardiac centre in Amman, Jordan, between February 
and December 2015. Participants did not have access to cardiac rehabilitation. 
Results: The study showed successful translation and cross-cultural adaptation of 
the cardiac self-efficacy questionnaire into Arabic. In addition, the findings showed 
that the Arabic version of the cardiac self-efficacy questionnaire is a valid and 
reliable version with Cronbach’s alpha of 84.6% and Intraclass Correlation 
Coefficient of 92.9%. Self-reported cardiac self-efficacy scores improved 
significantly between baseline and T1, and between T1 and T2 across all 
subscales (p<.05) and specifically for global cardiac self-efficacy (p<.05). There 
was no statistically significant difference in physical activity levels and patterns 
between T1 and T2. There was no statistically significant relationship between 
cardiac self-efficacy and physical activity level at T1 and T2. Conclusion: The 
cardiac self-efficacy questionnaire is suitable for administration to patients with 
coronary heart disease. Study participants had greater amounts of sedentary time 
than levels reported in healthy populations in the UK or the USA. The step count 
was below that recommended in guidelines. The health care system in Jordan 
needs to develop cardiac rehabilitation programmes for patients recovering from 
myocardial infarction to promote physical activity levels and thereby reduce 
sedentary time. In addition, this study showed that the increase in self-efficacy 
levels did not influence physical activity levels. There is a need to further 
investigation to understand the mechanisms that influence physical activity levels 
among patients with acute myocardial infarction in the early recovery phase such 
as socio-cultural context. 
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Chapter One: Introduction 
1.1 Introduction    
This chapter presents an overview of the thesis and a brief description of the 
background to the study. This thesis has two phases. In phase one, the cardiac self-
efficacy questionnaire was translated and cross-culturally adapted guided by the 
World Health Organisation recommendations (WHO, 2014). In phase two, a 
descriptive design, with repeated measures, was used to investigate self-efficacy and 
physical activity levels during early recovery in a sample of post-acute myocardial 
infarction patients; associations between self-efficacy and physical activity levels 
were also investigated. This chapter consists of two sections. Firstly, the burdens of 
Coronary Heart Disease risk factors. Secondly, study objectives and the structure of 
the remainder of the thesis.  
1.2 Background 
Coronary Heart Disease (CHD) is the leading cause of premature death worldwide 
(Piepoli et al., 2016). Across the world, Acute Myocardial Infarction (AMI) causes 
more than seven million deaths per year. Additionally, an estimated 54 million people 
are suffering from CHD, with chest discomfort known as angina pectoris (WHO, 
2015a). The healing process of AMI after receiving treatment depends on two factors: 
first: the size of the infarction. Second: the rate of gradual microvascular reperfusion 
of the damaged area (Minicucci et al., 2014). Consequently, the ejection fraction, 
which is a measure of how well the heart muscle is pumping, will be affected during 
the first three months following infarction (Pride et al., 2010). Since 1964, 
revascularisation techniques such as Percutaneous Coronary Intervention (PCI) or 
Coronary Artery Bypass Graft (CABG) have been deployed in order to improve blood 
flow through the narrowed coronary arteries to the heart muscle (Windecker et al., 
2014). However, these costly interventions do not prevent CHD progression. The only 
way to slow the progression of CHD is through cardio-protective medication and the 
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modification of coronary risk factors. This can occur through lifestyle change and 
compliance with medication, which are the foundation of secondary prevention, and 
can effectively reduce future risk of cardiac events. Indeed, it has been estimated that 
75% of all Cardiovascular Disease (CVD) mortality can be prevented with adequate 
changes in lifestyle (Windecker et al., 2014). 
During the recovery phase, patients recovering from AMI have to restore physical 
fitness and resume daily activities (NHS, 2016). The success of their recovery 
depends on many physiological and psychological factors (NHS, 2016), such as self-
efficacy, depression, and stress (Maeda, Shen, Schwarz, Farrell, & Mallon, 2013; 
Neylon et al., 2013). Therefore, to extend the existing literature further investigation of 
patients with AMI during their early recovery phase is required.   
The recovery phase for patients with AMI starts during their stay in hospital and lasts 
for several-months, depend on the amount of damage to the heart muscle. The early 
recovery phase is a short period of up to six weeks after hospitalisation (NHS, 2016), 
and is a temporary and transient period, where the heart function undergoes a 
dynamic healing process. During the early recovery phase, patients with AMI should 
demonstrate changes in lifestyle after hospital discharge. Making lifestyle changes in 
the early recovery phase is a very difficult and complex challenge for patients 
experiencing AMI as they have different needs (Smith & Liles, 2007) and experiences 
(Petriček, Buljan, Prljević, Owens, & Vrcić-Keglević, 2015). Therefore, it is 
recommended that patients recovering from AMI should participate in the second 
phase of cardiac rehabilitation within ten days of leaving a hospital in order to 
enhance self-management practices and promote a healthy lifestyle, such as healthy 
eating habits, regular physical activity (PA) and adherence to cardio-protective 
medications regimes (NHS, 2016; NICE, 2013c). It is recommended that patients 
resume their usual daily activities such as driving, sexual activity and returning to 
work after four to six weeks (NHS, 2016; NICE, 2013c).  
Cardiac rehabilitation is considered one of the most effective interventions for 
secondary prevention among cardiac patients (Dalal, Doherty, & Taylor, 2015; 
Mampuy, 2012). Cardiac rehabilitation is a complex intervention, where a 
 3 
 
multidisciplinary team provides the required skills to patients with CHD (Dalal et al., 
2015). It includes exercise/aerobic PA training, education and counselling services as 
well as psychological intervention, such as stress management (BACPR, 2012). 
Patients are also educated about cardiac disease complications and healthy lifestyle, 
weight management, medication compliance, healthy diet and smoking cessation 
(Dalal et al., 2015). Cardiac rehabilitation programmes are designed as a 
comprehensive intervention to meet patients’ needs. However, many developing 
countries such as, Jordan do not have cardiac rehabilitation programmes. Further, 
there is no effective structured education programmes provided for patient with CHD 
(Eshah, 2013) which make self-management of lifestyle and medicines among 
patients with AMI a great challenge.   
The development of self-management skills is essential after revascularisation 
treatment for AMI. Self-management refers to “the individual's ability to manage 
symptoms, treatment, physical and psychosocial consequences, and lifestyle 
changes inherent to living with a chronic vascular condition” (Barlow, 2001, p. 178). 
However, self-management is a major challenge for patients recovering from AMI. A 
previous systematic review demonstrates that self-management programmes are 
associated with many factors such as improved self-management skills related to 
increased self-efficacy levels among patients with CVD (Katch, 2010). In this regard, 
increasing self-efficacy level brings about favourable outcomes in term of 
improvement to self-management skills.  
Self-efficacy is defined by Bandura (1997) as “beliefs in one's capabilities to organise 
and execute the course of action required to produce given attainments'’ (Bandura, 
1997, p. 3), which means that individuals with strong self-efficacy set higher goals 
and show better motivation and commitment to accomplishing them. Particularly for 
patients diagnosed with AMI, high level of self-efficacy improves self-management 
skills (Katch, 2010). 
An increase in self-efficacy is one of the outcomes of the cardiac rehabilitation 
programmes, and this has been proven to improve adherence to a healthy 
cardiovascular lifestyle (Sol, Graaf, Petersen, & Visseren, 2011). Moreover, low levels 
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of self-efficacy have been found to be associated with frequent re-hospitalisation, 
reduced quality of life and increased mortality among patients with CHD(Sarkar, Ali, & 
Whooley, 2007). Over and above this, self-efficacy predicts adverse outcomes after 
cardiac events (O’Neil, Berk, Davis, & Stafford, 2013).  
Psychological factors such as anxiety, depression and stress have been extensively 
examined during the early recovery phase among patients recovering from AMI 
(Dickens et al., 2013; Gustad, Laugsand, Janszky, Dalen, & Bjerkeset, 2014). 
However, there are few studies addressing other factors crucial to the improvement of 
health outcomes, such as self-efficacy and PA in the early recovery phase for AMI 
patients. Particularly, in Arabic-speaking countries, where there is no in Arabic 
language tool available to measure self-efficacy among focuses on cardiac patients.  
PA is considered a cost effective self-management practice which has many positive 
impacts on health outcomes of patients with AMI (WHO, 2013). Improving PA level is 
an important cardiac rehabilitation outcome (Dalal et al., 2015). International PA 
guidelines for healthy adults published by the World Health Organisation (WHO, 2013) 
and the European Society of Cardiology (ESC) (Piepoli et al., 2016) recommend that 
individuals do one of the following combination of exercise regimes; either 2.5 to 5 
hours per week of moderate intensity PA, or aerobic exercise training. Alternatively, 1 
to 1.5 hours per week of vigorous PA, or aerobic exercise training. An equivalent 
combination of moderate intensity and vigorous intensity PA/aerobic exercise training. 
The longer the total duration of PA or aerobic exercise training performed over the 
week, the greater the observed beneﬁts (Piepoli et al., 2016; WHO, 2013). In addition, 
average objective measurements of sedentary time among healthy adults during 
waking time range from 55–69% (Colley et al., 2011; Matthews et al., 2008). Hence, 
the upright time represents 30% of the healthy adult’s time. More recently, the 
negative impact of a sedentary lifestyle as a major negative impact on CVD patients 
has been highlighted (Warren et al., 2010). Accordingly, the sixth joint task force of 
the ESC on CVD prevention guidelines recognises regular PA as a vital non-
pharmacological factor for primary and secondary cardiovascular disease prevention 
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(Piepoli et al., 2016). For this, increasing PA to reduce coronary risk after AMI is 
highly recommended following coronary revascularisation.  
Unfortunately, the proportion of patients with CHD who successfully achieve the 
recommended PA level is low. The ESC report, published in 2016, showed that 
among patients with CHD in Europe, only 34 % reach the recommended PA levels 
(Piepoli et al., 2016). In the UK, 46 % of patients with AMI participate in an outpatient 
cardiac rehabilitation programme after hospital discharge (NICE, 2013c). Further, 
patients with AMI usually wait an average of 53 days to start an outpatient cardiac 
rehabilitation programme in the UK after hospital discharge (NICE, 2013c). 
There are still no cardiac rehabilitation programmes or disease management 
programmes accessible to patients with AMI in the Middle East (Turk-Adawi & Grace, 
2014), where a high prevalence of CVD risk factors has been found to be higher in 
the Middle East than other countries (Gehani et al., 2014; Motlagh, O'Donnell, & 
Yusuf, 2009). Moreover, there is no structured, effective education programme for 
patients with CHD (Eshah, 2011). In consequence, CHD risk factors continue to rise 
mainly due to inadequate preventive measures (WHO, 2015c). Consequently, 
patients with AMI and their families are required to take sole responsibility for 
developing their own self-management skills.  
There is currently no evidence regarding changes in self-reported self-efficacy levels 
and changes in PA levels among patients with AMI after receiving treatment in the 
early recovery phase. In addition, no previous studies have focused upon 
connections between cardiac self-efficacy and PA levels among patients with AMI, 
after receiving treatment in the early recovery phase. Moreover, there is no available 
data regarding PA level for patients with CHD in Jordan. Thus, this study is the first 
study to address changes in and the relationship between self-efficacy and PA 
among patients with AMI in the early recovery phase. Furthermore, to the best of my 
knowledge, this is first time that use has been made of a body-posture classification 
device- the activPAL3™ monitor (PAL Technologies.Ltd. Glasgow. Scotland) in the 
Middle Eastern countries. 
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1.3 Study Objectives 
The overarching aim of the study is implementing the WHO process in order to 
translate and adapt the Cardiac Self-Efficacy Questionnaire (CSEQ) to Arabic. In 
addition, it aims to assess the changes in self-efficacy and PA level and pattern 
among patients with AMI in the early recovery phase and explore whether there is a 
relationship between self-efficacy and PA. The researcher undertook two key 
approaches in order to achieve the study aim. First, in order to measure cardiac self-
efficacy among patients with AMI, the researcher documented the process of 
translation and cross-cultural adaptation of the CSEQ into Arabic. Second: The 
researcher has used a quantitative method, a repeated measures design to collect 
data from a convenience sample of Jordanian patients, two weeks and six weeks 
after discharge. In addition, Bandura’s self-efficacy theory guided this study.  
Implications of the study provide clear evidence regarding self-efficacy levels and PA 
behaviour in relation to patients with AMI, which will help healthcare professionals 
and policymakers to promote PA and establish cardiac rehabilitation centres or 
cardiac disease management programmes. This aims to address the following four 
objectives: 
1. Translate, adapt and validate an Arabic version of the Cardiac Self Efficacy 
Questionnaire 
2. Assess self-reported cardiac self-efficacy levels among patients recovering 
from acute myocardial infarction using a validated tool at three time points. 
Baseline, Time 1 (T1: 2 weeks after hospital discharge) and Time 2 (T2: 6 
weeks after hospital discharge).  
3. Determine the PA levels and patterns of patients with AMI using a body-worn 
activity monitor for a full seven days at Time 1 (2 weeks) and Time 2 (6 weeks) 
after hospital discharge.  
4. Explore whether there is any relationship between changes in self-reported 
cardiac self-efficacy levels and changes in PA levels among patients with AMI 
in the early recovery phase.  
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1.4 Study Hypotheses 
1. There will be an increase in self-efficacy levels among patients with AMI 
between (time1) 2 weeks after hospital discharge) and (Time 2) 6 weeks after 
hospital discharge. 
2. There will be an increase in the PA levels between Time 1 and Time 2 among 
patients with AMI, after hospital discharge. 
3. There is a relationship between self-reported cardiac self-efficacy levels and 
changes in PA levels in the early recovery phase among patients with AMI.  
1.5 Structure of the Thesis 
This thesis consists of seven chapters, including the current introduction chapter. An 
outline of chapters 2-7 as listed below: 
Chapter 2: Literature review 
This chapter begins with an overview of AMI definitions and treatment, and a 
description of the impact of secondary prevention, cardiac rehabilitation, and self-
efficacy on CHD. Following that, the chapter explores the importance of the effects of 
PA on the health outcomes of patients with AMI, alongside the methods of 
measurement to quantify PA behaviour. The literature shifts to focus on synthesis of 
research evidence by carrying out a systematic literature review. This review focused 
upon PA and self-efficacy among patients with CHD after hospitalisation. 
Implementation of search strategy, an appraisal and quality review of the evidence on 
the studies included. Further, the review identifies the existing body of research, 
addresses the research problem, and clarifies the gaps in knowledge that require 
further investigation. Finally, the chapter expands upon and generates a rationale for 
the proposed research, its significance and the overarching objectives of this study. 
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Chapter 3:  Self-Efficacy  
This chapter presents an overview of the self-efficacy, and related behavioural 
change theories. In addition, it provides the rationale for the selection of the 
theoretical framework that underpins the thesis. Next, the chapter provides an 
explanation of different types of self-efficacy questionnaire, and then, describes the 
process undertaken to translate and adapt the CSEQ, based on WHO guidelines for 
translation and cross-cultural adaptation (WHO, 2014). Following this, the chapter 
outlines objectives and the method of the translation and cross-cultural adaptation of 
the CSEQ. The study found that the translation and cross-cultural adaptation of the 
Arabic version of the CSEQ was successful, and demonstrated good validity and 
reliability outcomes. 
Chapter 4: Methodology and Method 
This presents the study methodology and the research paradigm. In addition, detail 
about the study setting, cultural context of the thesis, sampling methods, and 
information on the data collection tools such as questionnaires and body-worn activity 
monitors is described along with the data collection procedure and an outline of the 
pilot study. With reference to data management, the chapter presents ethical 
considerations, issues including managing missing data, accuracy of input, quality 
assessment protocols of data, and statistical tests used for data analysis, with the 
rationale for the choices made.   
Chapter 5: Findings  
This chapter presents the pilot study results, along with the patients’ 
sociodemographic characteristics, and then, the chapter provides the results of the 
self-efficacy and PA volume and pattern assessments. A summary of findings 
completes the chapter. 
Chapter 6: Discussion  
This chapter of the thesis brings together the key research findings and generates 
discussion in the context of the wider existing literature. It provides a comprehensive 
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discussion, a detailed argument regarding the changes and the relationship between 
self-efficacy and PA levels after hospitalisation, and a potential explanation based on 
the existing literature for the four study objectives: CSEQ translation and cross-
cultural adaptation process, self-efficacy levels and changes, PA levels and patterns, 
and then, the relationship between self-efficacy and PA level.   
Chapter 7: Conclusion 
The final chapter presents the conclusion with the suggestions for Health policy 
changes, study limitations, implications and suggestions for future research.   
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Chapter Two: Literature Review 
2.1 Introduction 
This chapter presents background information concerning the definition of AMI, its 
pathology, diagnosis, and treatment modalities. It then reviews the existing work on 
secondary prevention of AMI, PA behaviour, and its impact on health outcomes after 
cardiac rehabilitation among patients with CHD. Moreover, the chapter provides a 
systematic literature review in order to form a synthesis of research evidence. The 
purpose of this section is to find the relevant studies that address self-efficacy and PA 
among patients with AMI after hospitalisation. This informed and directed the 
emerging study aims. Finally, the chapter presents an explanation of the significance 
of the proposed study on this topic. 
2.2 Coronary Heart Disease and Secondary Prevention 
Acute Coronary Syndrome (ACS) refer to any group of clinical symptoms compatible 
with acute myocardial ischemia and covers the spectrum of clinical conditions ranging 
from unstable angina to AMI (Timmis, 2015). AMI is classified according to 
electrocardiographic (ECG) changes as Non-ST-Elevation Myocardial Infarction 
(NSTEMI) and ST-Elevation Myocardial Infarction (STEMI) (Timmis, 2015). The 
British Heart Foundation (BHF) reports that ACS remains one of the major causes of 
premature death in men and women in the UK (Bhatnagar, Wickramasinghe, Williams, 
Rayner, & Townsend, 2015). The clinical presentation of ACS diagnosis is variable, 
including many symptoms combined with activation of the autonomic nervous system 
as listed in Table 2.1 
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Table 2.1  
Signs and Symptoms of AMI (Adopted from (Timmis, 2015, p. 8))  
Signs and Symptoms Mechanisms 
 
Severe myocardial ischaemia:  
Chest pain Ischaemia 
Fourth heart sound Forceful filling of non-compliant left 
ventricle 
Low grade fever Inflammation 
Leucocytosis and increased levels 
of inflammatory markers 
Inflammation 
Increase in troponin levels Leakage of protein from injured 
cardiac myocytes 
Activation of autonomic nervous 
system: 
 
Tachycardia and sweating Sympathetic activation 
Bradycardia, nausea, and vomiting Vagal activation (especially in inferior 
acute myocardial infarction) 
 
AMI remains one of the most dramatic presentations of CHD (NICE, 2013b). Every 
seventh women and every sixth men dies because of AMI in Europe (Thygesen et al., 
2012). Atherosclerosis (narrowing of the coronary artery) is the foremost cause of 
CVD mortality and disability (Reiner et al., 2011). Atherosclerosis occurs when lipid 
metabolism is disturbed. This can be done in different ways, leading to changes in 
plasma lipoprotein function and the levels thereof, interaction with CVD risk factors 
may affect the development of atherosclerosis (Reiner et al., 2011). Atherosclerosis 
develops by the formation of plaques due to damage to the endothelial lining of the 
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vessels. Macrophages attach themselves and infiltrate the damaged cell. After that, 
the macrophages digest Low Density Lipoproteins infiltrate, resulting in the formation 
of foam cells, in which collections of fats, cholesterol, platelets, and cellular debris 
accumulate. Then, a protective fibrous cap covers plaques. When the fibrous capsule 
tears and the contents come into contact with blood, through the secretion of 
proteolytic enzymes by plaques, the low molecular weight glycoproteins in the cells 
subsequently initiate clotting (LeMone, Peate, Nair, Hemming, & Wild, 2012).  
AMI occurs when blood flow in coronary circulation is completely blocked by a 
thrombus causing, if occlusion lasts more than 30 minutes, irreversible damage to the 
myocardium (heart muscle) tissue, leading to the occurrence of necrosis of the 
myocardium in that area (LeMone et al., 2012). The affected tissue will degenerate 
and create a non-functional area. The myocardium loses some of its strength, based 
on the location and size of the infarcted area. In addition, an infarction may interrupt 
the conduction system of the cardiac muscle and cause sudden death (Tortora & 
Derrickson, 2015). In 2012, a universal pathological classification of AMI recognized 
five types: first: spontaneous AMI. Second: AMI secondary to oxygen imbalance 
between supply and demand of myocardial muscle. Third: AMI because of cardiac 
death, four: AMI related to PCI or stent thrombosis, and five: AMI related to CABG 
(Thygesen et al., 2012).  
With spontaneous AMI (AMI Type 1) atherosclerotic plaque rupture ulceration occurs 
in the lumen of the coronary artery, leading to decreased blood flow to the myocardial 
muscle and distal platelet emboli with ensuing myocyte necrosis (Thygesen et al., 
2012). AMI type 2, AMI secondary to an ischaemic imbalance, occurs among patients 
with non-CHD, such as coronary spasm, bradycardia or tachycardia arrhythmias and 
respiratory failure. This leads to increased demand on the myocardium tissue, which 
causes an oxygen imbalance between the myocardial tissue supply and demand. The 
third type of AMI occurs when a patient suffers from sudden cardiac death because of 
AMI without any available biomarkers. In these cases, it is common for patients to die 
suddenly with the clinical features of an AMI or myocardial ischemia (combined with 
new ischemic ECG changes, but without biomarker values) before it is possible to 
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collect blood to use in a blood sample as a biomarker. The fourth and fifth types 
associated with mechanical revascularization procedure (periprocedural myocardial 
injury or infarction). The fourth type of AMI associated with PCI procedure. Various 
insults may occur that can lead to myocardial injury with necrosis. Finally, the fifth 
type of AMI occurs after implementation of the CABG operation (Thygesen et al., 
2012).  
AMI diagnosis is determined based on patients history, signs and symptoms, 
changes in the 12 lead ECG (related leads), along with, increases in biomarkers such 
as troponin T or I (Troponin consists of proteins which are released into the blood 
when heart muscle has been damaged) (Thygesen et al., 2012). A clinical 
presentation of CHD includes silent ischemia, unstable and stable angina, AMI and 
heart failure and sudden cardiac death (Hamm et al., 2011). According to the clinical 
features criteria of AMI, myocardial necrosis occurs when the patient has an increase 
in levels of the biomarker cardiac enzyme, Troponin I or T (NICE, 2014). Troponin 
levels can take 10–12 hours after AMI to rise, so serial troponin tests are needed 10–
12 hours apart to observe trends (NICE, 2014). After the onset of myocardial 
ischaemia, histological cell death is not immediate. However, it takes a limited period 
of time to develop complete necrosis of myocardial cells at risk requires at least 2 to 4 
hours, or longer. It depends on the presence of collateral circulation to the ischaemic 
area, persistent or intermittent coronary arterial occlusion, the sensitivity of the 
myocytes to ischaemia, pre-conditioning, and individual demand for oxygen and 
nutrients. The entire process leading to a healed infarction usually takes at least 5–6 
weeks (NICE, 2014). 
However, many conditions other than acute AMI that may cause troponin levels to be 
raised, such as myocarditis, congestive heart failure, severe infections, 
musculoskeletal conditions and renal disease (NICE, 2014). Therefore, the Troponin 
test should be considered with at least one of the following changes to confirm AMI: 
new changes in ECG such as, new significant ST-segment elevation or new left 
bundle branch block, pathological Q-wave, new loss of myocardial viability evidenced 
through imaging, and thrombus formation in the coronary arteries confirmed by 
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coronary angiography (Thygesen et al., 2012). Moreover, non-invasive imaging plays 
several important roles in the diagnosis and characterisation of AMI among patients 
with known or suspected AMI, those commonly used including radionuclide 
ventriculography, magnetic resonance imaging and X-ray computed tomography 
(Thygesen et al., 2012). 
AMI is part of ACS, which includes STEMI, NSTEMI, and unstable angina (Thygesen 
et al., 2012). These conditions are associated with common symptoms but have 
different underlying pathologies. STEMI is usually associated with a relatively large 
amount of damage to the myocardium caused by a major blockage in the coronary 
artery, such as, the Left Anterior Descending Artery (LAD) or the Right Coronary 
Artery (RCA). In this case, full thickness damage of the myocardium will occur, 
resulting in ST-elevation on ECG (Thygesen et al., 2012). By comparison, NSTEMI is 
often associated with relatively less damage to the myocardium. This is caused by 
either partial blockage of the coronary artery or blockage of a smaller artery, and here 
only partial thickness damage of the myocardium will occur, this does not produce 
ST-elevation on ECG (Thygesen et al., 2012). Angina occurs because of narrowing of 
the coronary arteries, and a consequent mismatch in supply and demand of 
oxygenated blood to the heart. Angina is unstable when rest or the medications used, 
do not relieve the chest pain of stable angina (Thygesen et al., 2012).  
2.2.1 Treatment of Patients with AMI Diagnosis 
In last few decades, advances in the management of AMI have occurred. This has 
led to the development of specific revascularisation approaches including 
thrombolytic drugs and of more invasive treatments such as angioplasty, depending 
on the type of AMI (Thygesen et al., 2012). The section presents a detailed 
discussion of the treatment modalities and the main health outcomes after receiving 
treatment for both patients with STEMI and patients with NSTEMI.  
2.2.1.1 Treatment of Patients Diagnosed with STEMI   
In the case of Primary-PCI (PPCI) capable centres, the most recent evidence 
suggests that treatment for STEMI should be given immediately and within 90 
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minutes of symptom onset (Windecker et al., 2014). If PPCI cannot be performed 
within this time period, due to delayed presentation at hospital, or where there is no 
PPCI capable centre within 90 minutes’ travel. Then, thrombolytic agents as the first-
line reperfusion treatment and involve PPCI within 120 minutes (Windecker et al., 
2014). NICE (2013a) recommends implementation of PPCI within 120 minutes of the 
time when it is feasible to give fibrinolysis. In case of non-capable PPCI centre, if the 
fibrinolysis therapy is successful, an experienced team implements coronary 
angiography within 3 to 24 hours. If the fibrinolysis therapy is not successful, a rescue 
PCI should be implemented (Windecker et al., 2014), as shown in Figure 2.1.  
According to Steg et al. (2012, p. 2581) PPCI can be defined as:  
“An emergent percutaneous catheter intervention in the setting of STEMI, 
without previous fibrinolytic treatment—is the preferred reperfusion strategy in 
patients with STEMI, provided it can be performed expeditiously (for example 
within guideline-mandated times), by an experienced team, and regardless of 
whether the patient presents to a PCI-capable hospital”. 
In order to implement coronary angiography with either a stent or a balloon, patients 
with AMI should be admitted to the cardiac intervention centre straight away (Amit, 
Cafri, Gilutz, Ilia, & Zahger, 2007). Thrombolytic treatment involves the administration 
of fibrolysis intravenously and aims to dissolve the blood clot formed in the coronary 
artery. Thrombolytic agents act by promoting the activity of circulating plasminogen, 
in which their enzyme degrades the fibrin leading to break down of the thrombus so 
that the blood flow to the heart muscle can be restored to prevent further damage and 
assist the healing process (NICE, 2014). An experienced team should give 
thrombolytic treatment for eligible patients as early as possible in the pre-hospital 
setting, emergency unit, or coronary unit. Bleeding complications are the main risks 
associated with thrombolysis (NICE, 2014).  
The total ischaemic time between symptom on-set and provision of reperfusion 
therapy, either starting thrombolytic agent or mechanical reperfusion by PPCI, is the 
most important factor. Therefore, the delay time to diagnosis of the patients with AMI 
when they first arrive at the hospital should be less than 10 minutes (Steg et al., 
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2012), as shown in Figure 2.2. In addition, control of delays in the timely 
implementation of reperfusion therapy is vital in the management of AMI, as shown in 
Figure 2.2 
Previous studies have shown that PPCI is a more effective treatment than 
thrombolytic therapy as it reduces the risk of bleeding, re-myocardial infarction, 
mortality and improve maintenance of coronary artery patency (Keeley, Boura, & 
Grines, 2003; Nielsen et al., 2010), and the length of hospitalization  period (Berger et 
al., 2008).  
2.2.1.2 Treatment of Patients Diagnosed with NSTEMI   
According to the ESC guidelines for myocardial revascularization, the treatment of 
patients with NSTEMI consists of three agents. First: use of anticoagulant agents, 
such as heparin and low molecular weight heparin; to inhibit thrombin generation and 
activity, thereby reducing thrombus formation (Figure 2.3). Anticoagulation is effective 
in addition to platelet inhibition and the combination of the two is more effective than 
either treatment alone (Hamm et al., 2011). Second: Antiplatelet therapy, three 
classes of drugs can inhibit platelets aggregation, each of which has a distinct 
mechanism of action. A: Aspirin (acetylsalicylic acid) targets cyclo-oxygenase (COX-
1), inhibiting thromboxane A2 formation and inducing a functional permanent 
inhibition in platelets B: Glycoprotein IIb/IIIa receptor inhibitors (abciximab, eptifibatide 
and tirofiban) C: P2Y12 receptor inhibitors (Clopidogrel), as shown in Figure 2.3. 
Third: Anti-ischaemic to decrease myocardial oxygen demand by decreasing heart 
rate, lowering blood pressure and increase myocardial oxygen supply by inducing 
coronary vasodilatation (Hamm et al., 2011). 
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Figure 2.1 STEMI patient treatment with ideal time interval for interventions, adopted 
from European society of cardiology guideline for myocardial revascularisation 
(Windecker et al., 2014, p. 2564).  
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Figure 2.2 Patients with AMI and ideal time interval for intervention, adopted from 
European society of cardiology, Guidelines for the management of acute myocardial 
infarction in patients presenting with ST-segment elevation (Steg et al., 2012, p. 
2577).  
 
Neither thrombolytic therapy nor PPCI is indicated as an appropriate treatment for 
patients presenting with NSTEMI (Hamm et al., 2011). In addition, the primary 
treatment of patients with NSTEMI is focused predominantly on monitoring ECG 
changes, cardiac biomarkers, cardiac enzymes and symptoms alleviation (Hamm et 
al., 2011). It is recommended that coronary angiography and related cardiac 
intervention be performed where suitable with patients with NSTEMI (Hamm et al., 
2011).  
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Figure 2.3 Targets for antithrombotic drugs (Hamm et al., 2011, p. 3022)  
 
The timing of coronary angiography and intervention implementation are based on 
the risk categories of NSTEMI patients (Windecker et al., 2014). Health care 
professionals use tools for risk assessment such as the Global Registry of Acute 
Cardiac Events (GRACE) to offer a scoring system to assess and categorise the risk 
of future adverse cardiovascular events, predicting 6-month mortality (Table 2.2). 
GRACE is important for determining early management strategies and allows the 
benefits of treatment to be balanced against the risks of treatment-related adverse 
events (Windecker et al., 2014).  
 
Coronary angiography should be implemented within 96 hours of first admission to 
hospital to patients who have an intermediate or higher risk of adverse cardiovascular 
events (predicted 6-month mortality above 3.0%) if they have no contraindications to 
angiography such as active bleeding (NICE, 2010). In addition, the interventional 
cardiologist should implement coronary angiography as soon as possible for patients 
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who are clinically unstable or at high ischaemic risk. It is recommended that this take 
place within two hours for the higher risk group, within 24 hours for the moderate risk 
group, and within 72 hours, and before hospital discharge, for the low risk group 
(Windecker et al., 2014).  
Despite the improvements in treatment modalities of patients with AMI and advanced 
diagnostics and imaging technology in the last few years, up to 50% of patients with 
AMI die within 30 days of the event (NICE, 2014). The Myocardial Ischaemia National 
Audit Project reported data from 2012 showing that 41% of AMI cases categorised as 
STEMI and 59% were categorised as NSTEMI (NICE, 2014). Patients diagnosed with 
NSTEMI had a higher rate of in-hospital mortality (13%) than patients with STEMI 
(9.6%). In addition, patients with NSTEMI had higher mortality (27%)  than patients 
with STEMI (19%)  at follow up of 10 months (Nikus et al., 2007). These findings 
highlight the importance of secondary prevention along with treatment for patients 
with AMI in order to avoid further AMI and other manifestations of vascular disease.   
Table 2.2  
GRACE Risk Assessment Categories, Adopted from (Windecker et al., 2014)  
Predicted 6-month mortality 
(Percentage)  
Risk of future adverse 
cardiovascular events  
1.5 or below Lowest 
>1.5 to 3.0 Low 
>3.0 to 6.0 Intermediate 
>6.0 to 9.0 High 
Over 9.0 Highest 
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2.2.2 Secondary Prevention of AMI 
AMI is a marker of chronic disease, but presents with acute symptoms. It is 
necessary to reduce the risk of recurrence by modifying the coronary risk factors. The 
risk factors associated with CVDs can be categorised into three groups. Firstly, there 
are behavioural risk factors linked to lifestyle choices, such as tobacco use, unhealthy 
diet and physical inactivity. Secondly, there are metabolic and biological risk factors, 
such as DM, HTN, and hypercholesterolemia. Thirdly, there are psychosocial risk 
factors, such as socioeconomic status and psychological conditions such as 
depression (WHO, 2015c). 
The literature has extensively discussed secondary prevention. Detels, McEwen, 
Beaglehole, and Tanaka (2011) categorised disease prevention into three types: 
primary prevention which aims to lower the occurrence rate of the event in question. 
For example, the incidence rate of the disease. Secondary prevention which aims to 
lower the occurrence of the more severe, later stages of the disease, this can be 
done by identifying the disease at a curable stage. Finally, tertiary prevention aims to 
reduce the social consequences: after an acute case of cardiac disease, cardiac 
patients need more attention to improve their quality of life and maintain functional 
capacity. In addition, they require counselling and support to create a medication plan 
and encourage the adoption of a healthy lifestyle in order to prevent event recurrence 
(Piepoli et al., 2010).  
The importance of secondary prevention programmes for CHD patients’ recovery is 
well established in the literature (Clark, Hartling, Vandermeer, Lissel, & McAlister, 
2007). Secondary prevention along with treatment reduced the 30-day mortality of 
AMI to great effect, from 13% in 2004 to 8% in 2012 (NICE, 2013d). The latest ESC 
guidelines (2016) recommend smoking cessation immediately after AMI, adherence 
to cardio-protective medications and a Mediterranean-style diet. In addition, the 
patient would benefit from having a Low Density Lipoprotein of less than 100 mg/dl. 
The target Body Mass Index (BMI) is between 20 to 25, and blood pressure at less 
than 140/90 mmhg. Moderate-intensity PA is recommended ranging from 2.5 to 5 
hours weekly or performing 1 to1.5 hours a week of vigorous-intensity PA or an 
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equivalent combination. The total PA volume per week can be measured by 
calculating daily bouts of exercise, each lasting more than 10 minutes, this total PA 
should be distributed over most days of the week (Piepoli et al., 2016).  
There is clear evidence that secondary prevention practices decrease both mortality 
and morbidity among patients diagnosed with AMI. For example, smoking cessation 
reduces by 18% the mortality risk after AMI (Gerber, Rosen, Goldbourt, Benyamini, & 
Drory, 2009). In addition, failure to control risk factors, for instance 
hypercholesterolemia, was found to be related to angina post-AMI and elevated blood 
pressure, which is significantly associated with early mortality after AMI (Vega, 
Martínez, Jiménez, Navarro, & Bernad, 2007). High levels of PA in patients with AMI 
has been found to have a significant relation to a decrease in morbidity and mortality 
rates, controlling AMI risk factors after treatment and improving quality of life 
(Gassner, Dunn, & Piller, 2003). 
Many previous studies have proven that secondary prevention strategies have a 
beneficial impact on the patient, encouraging a healthy lifestyle and decreasing AMI 
risk factors after treatment (Back, Cider, Gillstrom, & Herlitz, 2013; Bakker, Nijkamp, 
Sloot, Berndt, & Bolman, 2014; Milligan, 2012). Educational programs have been 
shown to improve and maintain the blood lipids profile (Luszczynska, Scholz, & 
Sutton, 2007), encourage smoking cessation, enhance healthy eating behaviours 
(Holtrop et al., 2006), enhance compliance with prescribed medication and improve 
PA level, (McKee, Bannon, Kerins, & FitzGerald, 2007), and decrease mortality 
(Rogers et al., 2007).  
Educational programs for patients with AMI should provide detailed information about 
their disease, its complications, treatment and prevention. One qualitative study, 
conducted by Astin, Closs, McLenachan, Hunter, and Priestley (2008) explored the 
information needs among patients with AMI treated with primary angioplasty. It shows 
that more specific information is needed regarding the risk of AMI recurrence, 
proportion of heart muscle damage, discharge medications, appropriate levels of PA 
and healthy diet guidance.  
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Cardiac rehabilitation is one secondary prevention strategies. Recently a meta-
analysis and systematic review to investigate the effectiveness and the cost 
effectiveness of cardiac rehabilitation from 2009 to 2014 showed that cardiac 
rehabilitation reduces CVD’s mortality and hospital re-admission, and is thus a cost 
effective intervention (Anderson, Thompson, et al., 2016). In addition, the ESC and 
the American Heart Association (AHA) recommend cardiac rehabilitation with the 
highest level of scientific evidence-class (I), after the treatment of patients with CHD 
(Piepoli et al., 2010).  
To summarise, involving patients with AMI in secondary prevention programmes such 
as health education programmes and cardiac rehabilitation can potentially lead to 
beneficial health outcomes. Cardiac rehabilitation is an effective secondary 
prevention intervention that restores both functional capacity and psychological well-
being.  
2.2.3 Cardiac Rehabilitation Programme  
The development of cardiac rehabilitation has its origins in early work by Hellerstein, 
Wenger and Zohman who in the 1960s, showed that progressive regular exercise 
after an AMI is beneficial for both physiological and psychological recovery (Certo, 
1985). This effectively outlined that regular exercise after a cardiac event, AMI or 
cardiac surgery re-establishes and enhances a patient’s health status (Hellerstein, 
1968). This pioneering research formed the foundation of cardiac rehabilitation, which 
is now an internationally established intervention for those with CHD. The WHO 
definition of cardiac rehabilitation is: 
 
“The sum of activities required to influence favourably the underlying cause of 
the disease, as well as the best possible physical, mental and social conditions, 
so that they may, by their own efforts preserve or resume when lost, as normal 
a place as possible in the community. Rehabilitation cannot be regarded as an 
isolated form of therapy but must be integrated with the whole treatment of 
which it forms only one facet” (WHO, 1993, p. 1). 
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Cardiac rehabilitation programme consists of three phases: phase one starts in 
hospital, phase two is viewed as the early post-discharge phase and usually lasts 
from 2 to 16 weeks after hospital discharge, and phase three is considered a long-
term maintenance programme, this phase is a continuation period from the previous 
phase with less intensive supervision (Bjarnason-Wehrens et al., 2010). In the UK, 
after involving patients in phase one of cardiac rehabilitation programme in hospital, 
the patients continue in the second phase from 2 to 4 weeks after AMI, and 4 to 6 
weeks after cardiac surgery (Dalal et al., 2015). Though the early recovery phase is a 
relatively short period, it is a critical one in which patients with AMI leave to their 
homes and return to work or normal life. In this period, patients with AMI should 
adhere to a healthy lifestyle in order to improve health outcomes and reduce the 
likelihood of future complications. However, there is lack of knowledge about self-
efficacy and PA among patients with AMI in the early recovery phase.   
According to the National Institute for Health and Care Excellence (NICE), patients 
with CHD should receive comprehensive cardiac rehabilitation with a tailored exercise 
programme and health education and recommendations for a healthy lifestyle. This 
includes a Mediterranean-style diet, weight control, PA levels, maintaining regular 
exercise, reducing or cessation of smoking and alcohol consumption, in addition to 
psychological or social and cultural support. Therefore, the overall aim is to support 
those with CHD to reduce the risk of subsequent cardiac events and enable patients 
to return to normal active life and develop self-management skills  (NICE, 2013c). 
A cardiac rehabilitation programme emphasises secondary prevention strategies, 
including multidisciplinary programmes such as educational intervention, PA sessions 
and patient counselling, it has been found to have a significant influence on prognosis 
of patients with AMI after receiving treatment (Piepoli et al., 2016). Additionally, many 
international associations, such as the ESC and AHA provide clear guidelines on 
secondary prevention and explaining the benefit of attending cardiac rehabilitation 
(Anderson et al., 2013).  
In a previous multicentre controlled trial intervention study among 3,241 patients with 
AMI. The control group was given usual treatment without attending cardiac 
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rehabilitation, whereas the intervention group received usual care and also attended 
cardiac rehabilitation, the study’s findings revealed that cardiac rehabilitation 
decreased the recurrence rate of AMI,  and rates of stroke and mortality among the 
intervention group (Anderson, Dall, Nguyen, Burgess, & Taylor, 2016; Giannuzzi et al., 
2008). Moreover, the same studies indicated that the intervention group of patients 
with AMI had more adherences to change in their lifestyle, such as PA, control of 
body weight, diet management and stress control. In addition, much research 
evidence demonstrates that the benefits of the cardiac rehabilitation programme 
include reduced hospital admissions, improved PA, increased time and tolerance of 
exercise, reduced anxiety and depression levels, improved quality of life and reduced 
overall and cardiovascular mortality (Eshah & Bond, 2009; Heran et al., 2011; 
Yohannes, Doherty, Bundy, & Yalfani, 2010). Therefore, cardiac rehabilitation 
effectively reduces CHD risk factors and decreases the burden of CHD. 
Although there is a necessity for cardiac rehabilitation, the availability of these 
facilities across regions is variable. In Europe, less than one third have access to a 
cardiac rehabilitation programme (Kotseva et al., 2009). Additionally, the European 
cardiac rehabilitation inventory survey by Bjarnason-Wehrens et al. (2010) showed 
that most European countries had phase (I) (in-hospital) cardiac rehabilitation 
programmes but less than 30% of hospitals, across 15 European countries had 
Phase (II) provisions. Moreover, only 46% had national legislation for phase (II) and 
75% had government funding. Regarding cardiac rehabilitation Phase (III), although it 
is available in most European countries, has less emphasis and support. In addition, 
13 European countries reported that cardiac patients covered all costs incurred. This 
data highlights the obstacles to apply cardiac rehabilitation. Therefore, there is a need 
for more legislation, sufficient funding, professional treatment, prevention guidelines, 
and effective health information systems in several European countries (Bjarnason-
Wehrens et al., 2010).  
Additionally, there is disagreement in the literature regarding cardiac rehabilitation 
programmes’ outcomes. For example, some studies show that there is no significant 
difference in PA level, anxiety, depression, health-related quality of life, cardiac 
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events, and mortality between patients with AMI who were involved in a cardiac 
rehabilitation program and those patients with AMI who were not so involved (West, 
Jones, & Henderson, 2011). However, this could be because cardiac rehabilitation is 
a complex and multidisciplinary intervention with many interrelated sessions (Dalal et 
al., 2015). In addition, the implementation of meta-analysis includes older studies, 
meaning that the same benefits as now are unclear, as the treatment has become 
better. In conclusion, although half of patients with AMI globally do not take up 
cardiac rehabilitation, it is a cost-effective secondary prevention; it reduces CHD risk 
factors, decreases mortality and enhances self-management skills among patients 
with AMI. 
2.3 Secondary Prevention and Self-Efficacy 
The previous section provides an overview of secondary prevention and cardiac 
rehabilitation programmes. This section highlights the role of secondary prevention 
and self-efficacy in self-management skills and in reducing CVD risk factors.  
Self-efficacy has attracted much attention as a key factor in improvement of self-
management skills of patients with AMI (Katch, 2010). In addition, self-efficacy is one 
of the most important mechanisms for the promotion of secondary prevention among 
patients with AMI (Lorig & Holman, 2003; Sol et al., 2011; Sullivan, LaCroix, Russo, & 
Katon, 1998). Recovery after AMI focuses on a change in the behaviour of patients, 
based on current general recommendations associated with diagnosis rather than 
being adjusted to each patient´s preferences (Ekman et al., 2011). According to 
Bandura (1997), it is uncommon for people to attempt to carry out a task if the 
outcome is expected to be failure, and this is consistent with prior studies showing 
that the probability of changing a behaviour is weak without belief in the ability to 
improve the health status by accomplishing a behavioural change (Lorig & Holman, 
2003).  
The literature shows that improved self-efficacy levels reduce the risk factors of CVDs. 
For example, in a previous descriptive cohort study of 125 patients with CVD, 
attending a 12 months self-management program was found that improvements in 
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self-efficacy are significantly associated with an enhanced adherence to PA 
behaviour and better food choices (Sol et al., 2011). In addition, a systematic review 
conducted in the United States (US) to investigate the efficacy of disease self-
management programmes among patients with CVD was conducted by Katch (2010). 
The study found that five disease self-management programmes focusing on self-
efficacy showed improved self-efficacy while patients were developing their self-
management skills such as medication adherence, patient’s perceived management 
skills, and improved clinical outcomes, such as, lower blood pressure or reduced 
hospitalisation (Katch, 2010).  
There is growing evidence that self-efficacy plays a central role in improving patient 
outcomes and self-management among patients with CHD, for example, a prior study 
has shown that self-efficacy reduces cravings upon smoking abstinence (Berndt et al., 
2013), and another shows improved adherence to healthy diet (Sharp & Salyer, 2012). 
In addition, enhanced DM treatment and the effect of adverse events (Robertson, 
Amspoker, Cully, Ross, & Naik, 2013; Sirikamonsathian, Sriratanaban, Hiransuthikul, 
& Lertmaharit, 2013). Moreover, self-efficacy can predict adverse health outcomes 
such as re-admission or mental and physical health problems (O’Neil et al., 2013).  
Another study conducted, among elderly patients with CHD aged 65-101 years, to 
measure self-efficacy and readmission rates, disabilities, and morbidity. The study 
presented clear evidence that special attention needs to be paid to increasing self-
efficacy in patients in order to improve self-care among elderly with CHD (Salamah, 
Wahl, & Abriam-Yago, 2002). In addition, Maeda et al. (2013) found that social 
support and depression were associated with treatment adherence and were fully 
mediated by self-efficacy. Therefore, self-efficacy is a key target for intervention in 
order to enhance disease self-management skills. 
Further, self-efficacy and CVD are strongly related to BMI (Ärnlöv, Sundström, 
Ingelsson, & Lind, 2011). A cohort study explored the effect of self-reported self-
efficacy on cardiovascular lifestyle including BMI. A total of 125 patients with CVD (72 
male and 53 female) were assessed, with a mean age of 61 years, most of whom 
(66%) were patients with CHD. The study found that self-efficacy had a significant 
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relationship with weight reduction and improved BMI (Sol et al., 2011). These results 
are consistent with another study from 2013, concerning a convenience sample of 
214 patients with CHD (161 male and 53 female), with a mean age of 60 years. This 
study showed that cardiac self-efficacy levels were significantly influenced by BMI, 
diagnosis, occupation, experience of receiving patient education, and awareness of 
CHD risk factors (Kang & Yang, 2013). However, BMI is not the optimum approach to 
estimate body fat, there are many disadvantages to using BMI as several factors 
such as age, sex, ethnicity, and muscle mass affect the relationship between BMI and 
body fat (Stommel & Schoenborn, 2010). In addition, BMI has many clinical 
limitations due to variation caused by factors such as age, sex, and ethnicity and BMI 
does not separate between excess fat, muscle, or bone mass, nor does it provide any 
indication of the distribution of body fat (CDC, 2015 ). Therefore, BMI has a significant 
association with healthy lifestyle, PA level and self-efficacy level among patients with 
CHD.  
Although the growing interest in self-efficacy has led to the development of a variety 
of self-efficacy measures that can be utilized in secondary prevention outcomes, the 
underlying factors to developing engagement between self-efficacy and secondary 
prevention outcomes are lacking (Yehle & Plake, 2010). In addition, self-efficacy has 
been found to have a limited relationship with PA, a prior study was implemented to 
examine the relationships between barriers and facilitators of personal factors, 
symptom distress, negative well-being, self-efficacy, and positive well-being with self-
reported PA, 6–12 months after cardiac event among 64 cardiac patients. The study 
found a total of 44% of the variance in PA levels explained, age and gender were 
responsible for 14.7% of the variance, with symptom distress and negative well-being 
responsible for an additional 21.6% of the variance. In addition, self-efficacy was 
responsible for the remaining 7.6% of the variance (Yates, Price-Fowlkes, & Agrawal, 
2003).  
In conclusion, this section has shown that self-efficacy has a substantial role in 
secondary prevention among patients with CHD. In addition, the literature provides 
various examples indicating that an increase in self-efficacy is one of the major 
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outcomes of cardiac rehabilitation among patients with CHD. Hence, enhancing self-
efficacy levels may help to change the lifestyles of patients with CHD and overcome 
the challenges of improving adherence to treatment, along with the mediator role 
played by self-efficacy in improving psychological and clinical health outcomes 
related to secondary prevention and cardiac rehabilitation programmes.  
2.4 Coronary Heart Diseases and Healthcare Provision in Jordan  
The previous section gives an overview of the role of self-efficacy in secondary 
prevention in order to reduce CHD risk factors. This section highlights CHD risk 
factors in the Middle East, particularly Jordan.  
The prevalence of CHD has increased in Middle Eastern countries due to a high 
prevalence of smoking, Hypertension (HTN), dyslipidemia, Diabetes Mellitus (DM), 
and sedentary lifestyles (Almahmeed et al., 2012). In 2014, an INTERHEART study, 
administered to 1,364 first time patients with AMI from eight Middle Eastern countries, 
revealed that AMI occurs at a younger age in the Middle East than in other regions, at 
the age of 51.2 ± 10.3 years. Across the whole INTERHEART study population, as 
opposed to the UK, an average age for a first AMI 65 years for men, while women 
had their first AMI at 73 years (NICE, 2013b). For  the overall population, the 
attributable risk for the nine risk factors (smoking, exercise, alcohol, HTN, DM, waist 
to hip ratio, psychosocial factors, fruits and vegetables,  and Apo B/Apo A1 ratio) was 
higher in the Middle East (97.5%) than in the rest of the world (90.4%) (Gehani et al., 
2014).  
Another study, published in 2015, investigated cardio-metabolic disease attributable 
to dietary intake in the Middle East; it found that systolic blood pressure was the 
leading risk factor for cardio-metabolic disease deaths in the eight countries, reaching 
68% in Libya and 45% in Bahrain. Additionally, fasting plasma glucose and non-
optimal BMI were the third and fourth leading risk factors for cardio-metabolic disease 
mortality in most of the Middle Eastern countries. Moreover, the Jordanian population 
displayed the lowest intake of fruit, at only 8% (Afshin et al., 2015).  
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The 2012 WHO report showed that the Middle East has lower rates of PA than other 
regions, approximately a third of men and 50% of women are physically inactive. In 
the same WHO report, it was estimated that DM, heart disease and stroke would 
reduce gross domestic product by up to 5% in most low and middle income-countries 
in 2015 (WHO, 2015b).  
Sayegh, Van Der Walt, and Al-Kuwari (2016) conducted a longitudinal PA 
assessment study in the Middle East among 549 female Qatari adults, aged between 
18 to 64 years, whose mean age was 37.4±11.7 years, and whose mean BMI was 
28.8 kg/m². The study revealed that daily steps for the overall population ranged from 
3,505 steps per day to 10,010 steps per day, with a median of 6,008 steps/day. 
44.1% females were sedentary, 32.4% showed reduced levels of activity, and 23.5% 
were physically active. For this, Qatari females were not meeting the international 
recommendations for PA.   
In Jordan, the prevalence of Non-Communicable Diseases (NCDs) is increasing 
progressively last a few years. Indeed, about 13% of Jordan’s population suffer from 
NCDs (Department of Statistics/ Jordan, 2015). CVDs are the leading cause of 
premature death in Jordan among both men and women, they account for 35% of the 
mortality rate every year (WHO, 2015e). Furthermore, CHD is the main cause of 
death, representing 16.8% of total deaths in Jordan (WHO, 2015e). The behavioural 
and metabolic risk factors of NCDs in Jordan are currently estimated to be daily 
tobacco smoking 27.1%, blood pressure 28.8%, blood glucose 14.4%, being 
overweight 64.1%, obesity 30% and raised cholesterol 46.4 % (MoH, 2014). In 
addition, 39% of patients diagnosed with NCDs have HTN - which represents 11% of 
Jordan’s total population (Department of Statistics/ Jordan, 2015).   
Although CVD is the leading cause of premature death (MoH, 2014), a retrospective 
analysis study was conducted in two major Ministry of Health (MoH) hospitals in 
Jordan to investigate patients with AMI risk factors of CVD among 730 patients with 
AMI, from 2002 until 2005. This study found that 40% were DM, 40% had HTN , 62% 
were smokers, 24% had a previous diagnosis date of CHD and 18% had 
hypercholesterolemia (Sawalha, Al-Zoobiy, & Shamaileh, 2008). A previous similar 
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study in Jordan, conducted among 5,000 patients, revealed similar results: 57% had 
high Triglyceride levels, 67% were smokers, and 47% were diagnosed with DM 
(Hammoudeh et al., 2006).  
Abu-Baker, Haddad, and Mayyas (2010) investigated smoking behaviour among a 
convenience sample of 300 CHD Jordanian patients, their data showed that 60% of 
the patients with CHD were smokers before diagnosis with CHD. After the illness, 
only 30% ceased smoking. In comparison, Kotseva et al. (2009) in a multi-centre 
study of European countries found that 61% were hypertensive, 46.2% had high 
cholesterol levels, 28% were DM and 18.2% were smokers. This shows that CVD risk 
factors rate in Jordan compared to Europe is high. Therefore, efforts to address these 
CVD risk factors are becoming exceedingly important as the CVD burden for these 
diseases is likely responsible for major and growing problems in the Jordanian 
healthcare system. 
Patients with AMI would consider a secondary prevention programme to reduce the 
complications of coronary risk factors. A prior study in Jordan by Eshah (2011) 
showed patients with first-time ACS believed that educational programmes related to 
daily living activities, medications and treatment that were attended during and after 
hospital discharge, were important and effective. Eshah concluded that establishing 
cardiac rehabilitation programmes that offer patients with ACS all of the information 
they need, might encourage them to continue to apply self-management skills and 
comply with secondary prevention after receiving treatment in Jordan (Eshah, 2011). 
Nevertheless, the secondary prevention strategies in Jordan are insufficient. 
Moreover, Eshah implemented a quasi-experimental study in Jordan to examine the 
effect of an education programme on 104 first-time patients with ACS lifestyle 
changes four weeks after discharge. The study showed that there was no statistically 
significant difference in PA levels between the two groups and recommended that 
further support and follow up for Jordanian patients with ACS were needed (Eshah, 
2013). A conclusion which can be drawn from the previous studies is that CVD will 
increase further and that therefore there is need to know how best to manage the 
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patients with AMI, understanding the key CVD risk factors related to lifestyle changes 
and preventing secondary outcomes in Jordan. 
2.5 Physical Activity  
PA refers to “any bodily movement produced by skeletal muscles that requires energy 
expenditure” (WHO, 2013). Exercise is defined as “a subcategory of PA that is 
planned, structured, repetitive and purposeful in the sense that the improvement or 
maintenance of one or more components of physical fitness is the objective” (WHO, 
2013). Hence, PA includes exercise and other activities such as aerobic activity, 
occupation, transportation, housework and social activities. On the other hand, 
sedentary behaviour refers to the activities of sitting and lying (Granat, 2012). 
It has been found that regular PA that meets the international recommendation of PA 
level increases the physiological capability to use oxygen to derive energy for work 
(Fletcher et al., 2013). Maximal oxygen consumption or maximum volume (V) of 
oxygen (O2) kg per ml (VO2) refers to the aerobic physical fitness of the individual, 
and is an important determinant of their endurance capacity during prolonged 
exercise (Hall, 2015). The average healthy male VO2 max is about 35–40 ml/ (kg per 
minute). The average healthy female VO2 max is about 27–31 ml/ (kg per minute) 
(Fletcher et al., 2013). These scores decrease with age and improve with training, 
while PA may double VO2 or correspondingly reduce the heart rate (Fletcher et al., 
2013). 
PA and sedentary behaviour are complex, multi-dimensional constructs (Plasqui & 
Westerterp, 2007), which is mean that difficult to measure and  cannot be described 
by single metric such as PA duration only, because this description will inadequately 
reflect an individual’s PA, as many biologically important dimensions are independent 
and unrelated (Thompson, Peacock, Western, & Batterham, 2015). Recently, Kelly, 
Fitzsimons, and Baker (2016) presented measurement frameworks for PA and 
sedentary behaviour with many facets such as domains, dimensions, and correlates 
or determinants, with many more sub-groups within each (Figure 2.4). Together these 
demonstrate the total volume of activity (Kelly et al., 2016). 
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Figure 2.4 Measurement framework for physical activity and sedentary behaviour 
including domains, dimensions, and correlates and determinants, downloaded from 
(Kelly et al., 2016, p. 3).  
 
The measurements of PA intensity are commonly in Metabolic Equivalents (METs). 
Moderate-Vigorous PA (MVPA) refer to the magnitude of the effort needed to achieve 
PA or exercise (WHO, 2012a). Moderate intensity, approximately 3-6 METs, is the PA 
that requires a moderate amount of effort and noticeably accelerates the heart rate, 
such as brisk walking and gardening. Vigorous-intensity, approximately ≥ 6 METs, 
refers to PA that requires a large amount of effort and causes rapid breathing and 
substantial increase in heart rate such as running, fast swimming, and fast cycling 
(WHO, 2012a).  
The available evidence on PA from epidemiological surveys and intervention studies 
provides guidelines concerning how much activity the population at large should 
undertake in order to maintain and promote health. For example, the WHO guidelines 
and the ESC both recommend PA for patients with CHD, after further assessment 
and considering clinical evaluation such as exercise testing. Patients  with CHD 
should undertake 2.5 - 5 hours per week of moderate intensity PA or at least 1.0 - 1.5 
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hours per week of vigorous intensity PA or an equivalent  combination of moderate 
and vigorous intensity activity, (Figure 2.5) (Piepoli et al., 2010; WHO, 2013). In 
addition, the percentage of time spent in a particular activity per day can provide an 
accurate evaluation of PA. For example, the average sedentary time among healthy 
adults in US and Canada ranges from 55% to 69% of their activities during waking 
hours, so the upright time ranges from 45% to 31% as reported in the literature 
(Colley et al., 2011; Matthews et al., 2008).  
 
 
Figure 2.5 European guidelines on CVD prevention in clinical practice, European 
society of cardiology, 2016 European Guidelines on cardiovascular disease 
prevention in clinical practice (Piepoli et al., 2016, p. 2343) 
 
Another way of evaluating PA is to count the number of steps. This has traditionally 
been accomplished by using a pedometer and a guide to health intervention was 
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developed to classify PA, individuals who take fewer than 5,000 steps per day are 
considered to have a sedentary life and individuals who take more than 10,000 steps 
per day are considered active (Tudor-Locke & Bassett Jr, 2004; Tudor-Locke, Craig, 
Thyfault, & Spence, 2012) as shown in Table 2.3 and Figure 2.6. In addition, Tudor-
Locke et al. (2011) showed that 8,000 steps per/day was representative of the PA 
guideline of special population such as CHD.  
Table 2.3  
Classification of Pedometer-Determined Physical Activity in Healthy Adults 
(Downloaded from (Tudor-Locke & Bassett Jr, 2004) 
PA level Steps counts per day 
Highly active More than 12,500 
Active More than or equals 10,000 
Somewhat active 7,500–9,999 
Low active 5,000–7,499 
Sedentary life Less than 5,000 
 
 
 
Figure 2.6 Step-defined sedentary lifestyle index for healthy adults (downloaded from 
(Tudor-Locke et al., 2012)).  
 36 
 
 
Despite recognised benefits and clear recommendations, previous studies suggest 
that only 15% of the healthy adult population (Colley et al., 2011), and 35% of 
patients with CHD (Perk et al., 2012) actually meet the amount of PA recommended 
in PA guidelines. Moreover, BHF survey, administered in 2015, reported that the 
sedentary time decreases in adults in England as they move into middle age and then 
increases into older age (BHF, 2015). Sixty-seven percent of men in Scotland and 
England reported meeting the recommended levels of PA, compared to 37% of men 
in Wales and 59 % of men in Northern Ireland. On the other hand, women were less 
active than men in all United Kingdom (UK) countries, with 58% reporting that they 
met the recommended levels in Scotland, 55% in England, 23% in Wales and 49% in 
Northern Ireland (BHF, 2015). Thus, the evidence suggests that the amount of PA 
undertaken across the age spectrum is low and well below the level recommended by 
the guidelines in order to maintain the health benefits that exercise can bring. Aspects 
of modern life such as use of cars, television, and computers have meant that most 
people in society have become much less physically active and increasingly 
sedentary (Bassett Jr, Freedson, & Kozey, 2010; Hamilton, Hamilton, & Zderic, 2007; 
Owen, Healy, Matthews, & Dunstan, 2010). Therefore, much evidence recommends 
that improving PA among patients with CHD to achieve the recommended PA level. 
2.5.1 Physical Activity and Cardiovascular Health 
The first study to provide clear evidence of the benefits of PA on CVD among adults 
was that of Morris, Heady, Raffle, Roberts, and Parks (1953), who reported that 
individuals in physically active jobs had less CHD than those whose jobs involved 
sitting for prolonged periods. Since then, studies have continued to define and 
evaluate the health benefits of PA. There is now substantial evidence that PA, 
particularly of moderate to vigorous intensity, can play a significant preventative role 
in a number of important and prevalent contemporary diseases, including CVDs’ risk 
factors, obesity, cancer, and DM (Shiroma & Lee, 2010), and PA associated with all-
cause mortality in adults after age 40 with various levels of PA has been studied 
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(Moore et al., 2012). In addition, it increases total life expectancy by 0.4 to 6.9 years 
(Reimers, Knapp, & Reimers, 2012).  
A meta-analysis study from 1980 to 2010, which included 21 studies showed that PA 
level has a beneficial effect by reducing the risk factors of CVDs among men and 
women by 20% to 30% and 10% to 20%, respectively (Li & Siegrist, 2012). In addition, 
PA has a significant role in improving CHD patients’ cardiac risk marker outcomes, 
such as BMI, triglycerides, glucose-tolerance, muscle endurance, and 24-hour heart 
rate (Back et al., 2013).  
PA improves myocardial perfusion, with an increase in the interior diameter of major 
coronary arteries, an augmentation of microcirculation, and an improvement in 
endothelial function (Di Francescomarino, Sciartilli, Di Valerio, Di Baldassarre, & 
Gallina, 2009; Linke, Erbs, & Hambrecht, 2007). Additional reported effects of PA are 
antithrombotic effects that can reduce the risk of coronary occlusion after disruption of 
a vulnerable plaque, such as increased plasma volume, reduced blood viscosity, 
decreased platelet aggregation, and enhanced thrombolytic ability (Lippi & Maffulli, 
2009), and a reduction of arrhythmic risk by a favourable modulation of autonomic 
balance (Billman, 2009). 
Patients with critical illness suffer from impaired physical function during 
hospitalisation. Increased PA, additional to engaging in rehabilitation programmes, 
has demonstrated resultant improved functional independence at hospital discharge, 
according to a descriptive study using the behavioural mapping method was 
conducted by Lay et al. (2015) in order to assess PA levels of patients in the first 
week after AMI. The nurses observed the patients for 1 minute every 10 minutes from 
8 am to 5 pm. At each observation, a nurse recorded data concerning the patient’s 
highest level of PA, location and other people present. The therapists recorded 
details of physiotherapy and occupational therapy sessions and the study revealed 
that patients spent half the day being physically inactive. Time spent being physically 
active was 23% for patients with AMI, which is attributable to walking ability among 
patients with AMI. However, only 19% of patients with AMI participated in physical 
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rehabilitation. Therefore, there is a need to investigate patients with AMI in order to 
understand their PA behaviour.  
Obesity more than doubled between 1980 and 2014 worldwide (WHO, 2016b). Being 
overweight and obesity are defined as having fat that has accumulated in an 
excessive manner, to the extent that it may influence health (WHO, 2016b). PA’s 
relationship with BMI has previously been examined, a previous longitudinal study, 
conducted by Ekelund, Brage, Besson, Sharp, and Wareham (2008), found that 
among 393 healthy adults (176 male and 217 female) with a mean age of 49.7 and 
49.2 for men and women respectively, BMI was significantly correlated with sedentary 
time.  Additionally, in the same study, BMI predicted sedentary time at follow-up after 
adjustment for sex, baseline age, baseline sedentary time, baseline PA level, and 
follow-up time. A few studies have examined the association between BMI and PA, 
measured by accelerometer devices. In 2011, in a cross-sectional study among 168 
adults with DM (65 males and 103 females) with a mean age of 53.4 years, the PA 
was measured by an accelerometer during waking hours for seven days, and it was 
found that total sedentary time, moderate-to-vigorous intensity activity time and 
increased breaks in sedentary time were associated with BMI outcomes (Healy, 
Matthews, Dunstan, Winkler, & Owen, 2011).  
Sattelmair et al. (2011) found a dose-response relation between PA and health, 
reported in a meta-analysis of studies conducted between 1995 and 2009. Of the 
3,194 studies reviewed, thirty-three met the inclusion criteria, the study shows a 
dose-response relation between PA and health and CHD risk. Moreover, benefits 
occur with increased PA. Individuals who engaged in the equivalent of 150 minutes 
per week of moderate-intensity leisure-time PA had a 14% lower CHD risk, compared 
with those reporting no leisure-time PA. Those engaging in the equivalent of 300 
minutes per week of moderate-intensity leisure-time PA had a 20% lower CHD risk 
compared to individuals who were physically active below the recommended PA 
guideline. Consequently, the study recommends PA as a primary prevention strategy 
to reduce the risk of developing CHD. PA and exercise programmes provide 
considerable protection in the primary and secondary prevention of AMI, such as 
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lowering psychological factors, behavioural risk factors, and overall CHD mortality 
and morbidity (Swift et al., 2013). Therefore, the previous studies show the 
importance of increasing the adherence of patients with AMI to PA guidelines and 
reducing of sedentary lifestyles in order to prevent risk factors of CVD from 
developing. 
2.5.2 Physical Inactivity and Sedentary Behaviour  
Globally, physical inactivity is considered the fourth leading risk factor for mortality 
(WHO, 2013); it represents 6% of deaths worldwide. About 23% of adults aged 18 
and over were physically inactive, 20% of men and 27% of women globally in 2010. 
This ratio increased in high-income countries, where 26% of men and 35% of women 
were physically inactive, as compared to in low-income countries where the 
corresponding figures were 12% of men and 24% of women (WHO, 2013). 
Physical inactivity has become a major public health concern because it is associated 
with increased risk of morbidity or worsening of many chronic diseases and health 
conditions. Physical inactivity is considered an independent risk factor for diseases 
(Hamilton et al., 2007; Healy et al., 2008), estimated to be responsible for 21% to 
25% of colon and breast cancers, 27% of DM cases and about 30% of the CHD 
burden (WHO, 2013). In addition, a sedentary lifestyle is one of the major risk factors 
for CVDs (Warren et al., 2010). 
Previous studies found sedentary behaviour significantly associated with cardio-
metabolic risk factors among the healthy adult population. Cardio-metabolic risk 
factors, such as HTN, obesity, the dyslipidemia combination of high levels of 
triglyceride and low levels of high-density lipoprotein cholesterol as well as impaired 
glucose tolerance, are known predictors of CHD and Type 2 DM in adults (Carson et 
al., 2014). A meta-analysis of 10 cross-sectional studies, in which only one study 
used a body-worn activity monitor, measured sedentary time in 21,393 adults of 18 
years and above. It examined sedentary behaviour and metabolic risk factors and 
concluded that prolonged time spent in sedentary behaviour was associated with a 
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73% increase in metabolic syndrome risk. However, further longitudinal studies are 
needed to explain and confirm this relationship (Edwardson et al., 2012).  
Previous research, predominantly focused on sedentary behaviour, (Bassett Jr et al., 
2010; Hamilton et al., 2007; Thorp, Owen, Neuhaus, & Dunstan, 2011), has shown 
that sedentary time, involving prolonged sitting time durations, is considered an 
independent risk factor for many health outcomes (Bassett Jr et al., 2010; Hamilton et 
al., 2007). Granat (2012) has classified sedentary behaviour into sitting and lying 
postures. It has also become clear that not all-sedentary behaviour is the same. Apart 
from the total time spent sitting, the occurrence and frequency of breaks in sedentary 
time may also have an influence on a person’s health (Healy et al., 2008). Sedentary 
behaviour includes a wide range of types of behaviours, such as watching television, 
using a computer, sitting in motorised transportation, and sitting in the workplace 
(Owen et al., 2010). The majority of sedentary behaviour studies and guidelines focus 
mainly on screen time, such as television viewing and using a computer, as common 
and important sedentary behaviours (Pate, Mitchell, Byun, & Dowda, 2011). 
Continuing, rapid urbanisation has accompanied social and environmental changes in 
many countries during recent decades. Consequently, awareness of urbanisation ’s 
role in the health risk is vital for health policy makers (Lim et al., 2009). Moreover, 
insufficient participation in PA and passive use of transportation services increasing 
physical inactivity may be attributed to urbanisation, which certainly affects population 
health (WHO, 2013). This shift in research focus from activity to sedentary and then 
sitting behaviour has been assisted by the new opportunities to measure sitting 
behaviour directly and accurately provided by the most recent generation of body-
worn activity monitors. In conclusion, physical inactivity has increased globally, which 
can have serious health implications for health. Therefore, patients should adhere to 
an effective sedentary behaviour reduction strategy to prevent the increasing trend 
towards physical inactivity.  
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2.5.3 Physical Activity in Jordan 
Globally, the Eastern Mediterranean region has the second highest physically inactive 
population (31%) after the Americas (32%) among WHO regions and has the highest 
level for women (WHO, 2010). According to the WHO, the prevalence of insufficient 
PA levels among adult males is low (15.6%) in Jordan, in comparison to other Middle 
Eastern countries(WHO, 2010). The highest levels of insufficient PA are seen in 
Saudi Arabia, Iraq and Kuwait, where over two-thirds (50%) of adults are classified as 
insufficiently active (WHO, 2010). 
Many countries do not support PA or exercise as primary and secondary prevention 
such as low and middle income countries (Amin, Al Khoudair, Al Harbi, & Al Ali, 2012). 
Moreover, high risk groups of patients such as patients with diabetes and those with 
heart problems do not access cardiac rehabilitation (Alsaleh et al., 2016), as part of a 
healthy lifestyle due to cultural reasons, lack of facilities, or lack of resources 
(Barghouti et al., 2015). Further, females are more affected by socio-cultural barriers 
because of their tradition gender role (Amin et al., 2012). In addition, constraints of 
norms and local tradition prevent the females from doing PA in outdoor activities in 
the Middle Eastern countries. Furthermore, there are no physical education classes 
for females in schools in some countries, such as Saudi Arabia (Amin et al., 2012).  
There are no formal education programmes, PA programmes or cardiac rehabilitation 
centres to motivate patients with CHD to maintain PA in Jordan (Alsaleh, Windle, & 
Blake, 2016). A study was implemented among a convenient sample of 98 patients 
with AMI from four governmental hospitals in northern Jordan, and it indicated that 
those developing PA programmes for Jordanian patients with AMI should consider 
culture, socioeconomic status, personal systems, and demographic factors (Al-Ali & 
Haddad, 2004). Recently, perhaps hoping to inspire PA in the country, Jordan won 
the right to host an international women’s football competition, the under-17 Women’s 
World Cup in 2016 (FIFA, 2016), as an example for the Jordanian government to 
motivate PA in the Jordanian community. 
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Another example to attempts encourage PA is that King Abdullah II (The King of 
Jordan) has established “The King Abdullah II Prize for Fitness”. This is a physical 
fitness promotion programme intended to complement the regular physical education 
curriculum for children aged 9–17 years. The main aims of the programme include 
muscular endurance, aerobic exercise, flexibility, agility and speed, to encourage 
students to participate in physical fitness activities and to improve their fitness levels  
(WHO, 2017). 
PA is very important for lifestyle changes among patients with AMI. The previous PA 
surveys showed that healthy adults are physically inactive in Jordan. The culture, 
lifestyle of Jordan and health care system has many barriers to engage in PA. In 
addition, the absence of a cardiac rehabilitation programme is also barrier. Further, 
insufficient health education programme for patients with AMI after discharge. 
There is no previous study measured PA level among patients with AMI in Jordan. In 
coincide with the burden of CVD in Middle Eastern countries including Jordan is now 
progressively increasing. The Middle Eastern countries have a popular saying, “al 
haraka Baraka”, which means, “Movement is a blessing”. This saying indicates that 
there is need for increasing engagement in PA. Therefore, a clear need to take urgent 
action to increase PA in Jordan, as part of their efforts to address risk factors linked to 
CVD and, in particular, physical inactivity. 
2.5.4 Body-Worn Activity Monitor  
PA is complex in nature, because of the use of many terms and definitions to 
describe PA. In addition, there is a lack of a framework and tools to describe and 
explore PA behaviour (Granat, 2012), such as total measurement time or the volume 
and intensity of PA that improve health outcomes. For this reason, the need for 
accurate measures of PA is well documented in the health literature (Ainsworth, 
2009). Improved precision in the measurement of PA has several implications for 
health research, including a more accurate evaluation of intervention effectiveness, 
the ability to make comparisons, and improved monitoring of temporal trends in 
activity behaviour (Ainsworth, 2009).  
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PA assessment tools can be categorised as subjective (indirect) and objective 
(direct). Subjective assessment tools such as diaries and questionnaires have the 
benefits of being easily self-administered and low cost (Ainsworth, 2009). 
Questionnaires are subject to recall bias and fail to provide details about PA patterns 
(Ainsworth, 2009). In addition, the inability of patients to accurately recall relevant PA 
details necessarily leads to several limitations associated with measurement error, 
such as overestimation of PA behaviour (Ainsworth, 2009).  
Objective tools, such as body-worn activity devices: accelerometers and pedometers, 
offer an alternative approach to measuring PA behaviour. With improvements in 
technology over past 20 years, devices have become smaller, movement can be 
recorded continuously for long periods and software has been developed in order to 
analyse and present user-friendly, clinically appealing information (Godfrey, Conway, 
Meagher, & ÓLaighin, 2008). Ainsworth (2009) has concluded objective tools provide 
optimal accuracy and avoid inaccurate recall during self-assessment of PA. In 
addition, objective tools improve precision and provide a complete assessment of all 
forms of PA, irrespective of intensity or where activity occurs (Corder, Ekelund, 
Steele, Wareham, & Brage, 2008). However, accelerometers are expensive (350 
US$) and require a technician to download and interpret the data. Pedometers are 
relatively low cost (20 US$), but data can be lost and cannot be stored data for later 
retrieval (Ainsworth, 2009).    
There are two main categories of body motion data for PA and sedentary behaviour: 
firstly, energy expenditure data, secondly, posture classification data (Granat, 2012). 
Energy expenditure devices determine the volume of activity by quantifying the 
acceleration profile over a specific period. A threshold level is applied to classify 
different energy expenditure levels and distinguish between activity and inactivity 
(Granat, 2012). An energy expenditure device records acceleration signals over a set 
time period (epoch) and assigns values (counts) to represent the magnitude of 
acceleration in that epoch. The device is worn on the part of the body which best 
reflects whole body movement and the more the device moves, the higher the level of 
the counts; then, energy expenditure can be estimated from studies which have 
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related counts to energy expenditure inferred from oxygen uptake (Crouter, Churilla, 
& Bassett, 2006; Freedson, Bowles, Troiano, & Haskell, 2012; Granat, 2012). These 
devices used many regression equations to determine suitable threshold levels for 
different activity intensity levels. However, these monitors classify body motion into 
inactivity and activity based on collected cut-off points from a range of tasks. Then, as 
they are generalized for that population, the threshold for these monitors can be 
considered arbitrary (Granat, 2012). In addition, when using these thresholds it is 
difficult to assess energy expenditure across a range of activities, in addition to which 
they can overestimate low-level activity and underestimate more vigorous activities 
(Crouter et al., 2006). Many body-worn activity monitors comprise several sensors, 
attached to different body segments by a combination of straps and/or harnesses. 
Although technological advances have both increased memory capacity and reduced 
the size of devices, the number of different components can make the monitors a 
burden to wear and limit the use of the devices in the long-term recording of free-
living activity. Hence, the researcher chose not to use an energy expenditure device 
in this study.  
Postural classification devices use body position of one or more body segments to 
distinguish between upright and sedentary posture (Granat, 2012). Posture 
classification devices, such as the activPAL3™ monitor (PAL Technologies.Ltd. 
Glasgow. Scotland), use micro-sensors to determine the inclination of one or more 
body segments and from this data, positional information is derived. The body-
posture classification decision occurs through an algorithm operating upon the signals 
designating the posture at specific points in time. Thus, posture has specific start and 
end times, which can be measured in seconds or even fractions of a second (Granat, 
2012). A particularly important technical development has been the inclusion of 
inclinometers, an example of such a device is the inclinometer-based activity monitor, 
the activPAL3™ monitor, which can classify activity into four categories: sitting, lying, 
standing, and stepping. Therefore, postural classification devices can quantify PA 
patterns. 
 45 
 
The limitations imposed by multiple sensors have been overcome in part by single 
unit monitors, for example the activPAL3™ monitor. The activPAL3™ monitor 
attaches directly to the thigh and posture is inferred from the location of the thigh and 
is classified as sitting/lying, standing, or stepping using proprietary software. This 
offers advantages in that the monitor attaches directly to the body segment (thigh) 
which indicates if the individuals are sitting, standing or stepping. The benefits 
derived from a single attachment may be offset by the output of the monitors as 
complex activities involving the independent movement of limbs cannot be recorded 
and upper limb activity remains undetected (Mathie, Coster, Lovell, & Celler, 2004). 
However, to compensate in part for the reduction in sensors, more complex signal-
processing techniques have been developed (Godfrey et al., 2008). The position of 
the activPAL3™ monitor on the thigh allows the primary postures of sitting, standing 
and stepping to be recorded and the monitor provides direct measures of both PA 
and sedentary behaviour.   
The activPAL3™ has been recognised as the gold standard in the measurement of 
sedentary behaviour and has been validated for all outcomes in a wide range of 
populations (Aguilar-Faríasa, Browna, & Peetersa, 2014). The activPAL3™ monitor is 
a valid and reliable activity monitor for PA measurement (Ryan, Grant, Tigbe, & 
Granat, 2006) that can be used with older adults (Grant, Dall, Mitchell, & Granat, 
2008). It has been used on people with chronic heart failure (Cowie, Thow, Granat, & 
Mitchell, 2011), and has an absolute percentage error of ≤ 1.11 % for number of 
steps and cadence among healthy participants, who walked on a treadmill at five 
different speeds (0.90, 1.12, 1.33, 1.56, and 1.78 m/s) and outdoors at three slow, 
normal, and fast speeds (Ryan et al., 2006). 
The development of activPAL3™ has provided researchers with an objective method 
of examining PA behaviours using postural orientation in free-living populations 
(Chastin & Granat, 2010). To date, studies have found the activPAL3™ monitor to be 
a valid way to measure posture and motion in adults (Godfrey, Culhane, & Lyons, 
2007; Grant, Ryan, Tigbe, & Granat, 2006) and sedentary behaviours in adults 
(Kozey-Keadle, Libertine, Lyden, Staudenmayer, & Freedson, 2011). Also, 
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activPAL3™ was used to measure PA level and pattern among cardiac patients 
(Cowie, Thow, Granat, & Mitchell, 2012). This is consistent with this study’s 
objectives. Additionally, activPAL3™ is an easy to use device and can measure PA 
level and pattern for patients with cardiac disease. For data analysis, activPAL3™ 
data can be collected and saved in an Excel spreadsheet and then transferred for 
analysis.   
In summary, the development of accurate and objective measurements of PA has 
been essential to research in order to evaluate levels of PA and determine the 
effectiveness of PA intervention programmes (Vanhees et al., 2005). In order to 
measure objectively the activity behaviour of patients with AMI it is necessary to 
record both PA, particularly step count, and upright and sedentary postures. In 
reviewing the instruments available, body-worn activity monitors appear to be the 
most feasible devices for recording posture and movement, over prolonged periods. 
To be acceptable to patients with AMI the monitor should be straightforward to use 
and not interfere with activity. From the literature reviewed, the device that most 
closely meets these criteria is the activPAL3™ activity monitor.  
2.6 Physical Activity and Self-Efficacy 
The previous sections provide the background of both PA’s role in CVD health and 
the PA measurement approach. The present section focuses upon the synthesis of 
research evidence related to self-efficacy and PA behaviour among patients with 
CHD. The literature review is synthesised from various quantitative studies, which 
constitute clear evidence for the purpose of identifying the existing body of research, 
addressing the research problem, and clarifying the gaps in knowledge that require 
further investigation. In order to achieve this, three main steps should be 
implemented: browsing, looking for answers and surveying the literature (Greenhalgh, 
2014).   
Brettle and Grant (2004) explain the use of a search strategy in order to find evidence 
to inform professional practice. This includes many stages, beginning with defining 
the key study aims and objectives, setting inclusion and exclusion criteria, identifying 
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relevant resources, identifying keywords and implementing a search process. In 
addition, cleaning the results according to a systematic approach to searching, 
including combined keywords to narrow down the search results, and then reading 
article abstracts to identify the most relevant articles, is required.    
This section presents the strategy employed to search databases and results in the 
systematic literature review of published research. It also highlights key gaps in the 
body of knowledge. In addition, it presents the research objectives and the rationale 
for conducting the study. The review of available study evidence progresses via three 
steps to guide the presentation of evidence within this chapter. Firstly, there is a 
comprehensive search strategy including a database search strategy, database 
keyword strategy, and search results. Secondly, there is an appraisal and quality 
review of the evidence. Thirdly, there is a presentation of a summary of key findings. 
Finally, there is a provision of the significance of the relevant studies on the topic.  
2.6.1 Comprehensive Search Strategy 
A systematic search strategy was developed and employed, using a wide range of 
databases and search engines. In order to cover all topics in this thesis, the 
researcher selected the main electronic databases: CINAHL, PsycINFO-OVID 
MEDLINE, Web of Science and Scopus, to form the main source of literature. In 
addition, the researcher applied and searched other resources such as Google 
Scholar and PubMed in order to find certain AMI, self-efficacy, and PA-related topics. 
Further searching included, reviewing of University of Salford theses and publications 
available on the University of Salford institutional repository website when available 
and, furthermore, searching in local journals in Jordan that publish related studies.  
2.6.2 Database Searching Strategy 
The researcher applied different database searching methods in order to discern the 
most suitable research results. An appropriate thesaurus associated with specific 
database terminology and Boolean operators were utilised (AND, OR but avoiding 
using NOT) to combine concepts, gradually refining the width and depth of the search 
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to capture available evidence. For example, firstly, to increase the options within the 
search words, the “OR” operator was used, such as “Acute myocardial infarction” OR 
“myocardial infarction”. Secondly, to narrow the focus of the search, the researcher 
used “AND” to link search words together, such as “secondary prevention” AND “self-
efficacy”. Thirdly, use of the truncation technique to find syntactical prefix and suffix 
forms for specific words such as acute myocardial infarction or myocardial infarction 
by using the asterisk symbol, such as: “infarct*” instead of “infarction”, improves the 
searching process to include all forms of the term being explored.  
2.6.3 Database Search Keywords   
The researcher used the keywords in the search process mentioned below in order to 
identify the relevant research:  
“Self-Efficacy”, “Acute Myocardial Infarction”, “Myocardial infarction”, “Acute coronary 
syndrome”, “Physical activity”, “Exercise”, “Sedentary”, “Self-management”,” Self-
care”, “Cardiac rehabilitation”, “Secondary prevention”.   
2.6.4 Search Process Criteria 
In order to identify the relevant literature, the researcher discussed the keywords 
used to search the research databases with the thesis supervisors and the University 
of Salford’s librarian for the School of Nursing. In addition, the selection of inclusion 
and exclusion criteria for the identification of relevant literature allows replication in 
further studies (Cronin, Ryan, & Coughlan, 2008). In recent years, remarkable 
progress has occurred in CVDs, most specifically in advanced technology-based 
diagnostic devices, pharmacological and non-pharmacological treatment guidelines, 
and therapeutic procedures, new measurement methods of PA have also come about. 
Consequently, the researcher decided to limit the search in the databases to those 
studies in the ten years up to August 2016. Subsequently, the researcher 
implemented a second search on databases in April 2017, in order to update and 
check whether there were any missing relevant articles in the literature review. The 
researcher read the abstracts of each article, identified through the database search.   
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The inclusion criteria for articles were: 
 Articles published in the English language 
 Articles available as abstract and in full   
 Published between January 2006 and April 2017 
 Available as hard copy or soft copy 
 Studies were relevant to self-efficacy, PA and patients with CHD  
 
The exclusion criterion for articles were: 
 Studies which measured PA by energy expenditure device  
  
2.6.5 Search Results 
After applying the inclusion and exclusion criteria on the four databases, the 
researcher identified 350 articles containing selected keywords in the title and/or the 
abstract. After reading the abstracts of the search results, for those papers where 
clarity was not sufficient, the researcher obtained the full text. Following this, the 
researcher excluded all articles that did not meet the inclusion criteria. There was a 
dearth of studies that addressed both variables- self-efficacy and PA- together in the 
same study. Consequently, if the study addressed at least one of self-efficacy and PA 
variables as an independent outcome then it was included.  
The researcher identified thirteen articles that were relevant to the study. Next, the 
researcher fully reviewed the thirteen articles and then included them. Table 2.4 
shows that search results found 156 articles in the CINAHL database; eight of these 
studies are related to the study topic, hence are included in the study. The PsycINFO-
Ovid database identified 102 articles, seven of which were relevant. After exclusion of 
duplicated articles from other databases, only two of these were included. The Web 
of Science database identified 58 articles, seven of which were relevant. After 
exclusion of duplicated articles from other databases, only two of these were included. 
In addition, the Scopus database contained 34 articles, while six were relevant, only 
one of which was included after exclusion of duplicated articles from other databases. 
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The researcher implemented a further search in Google Scholar and PubMed to 
confirm the searching results, but the search results did not find any new pieces of 
research.  
Table 2.4  
Results of the Database Search 
Database Initial 
Result 
Related to 
the Study 
Duplicated 
Articles 
Total articles 
included 
CINAHL 
 
156 8 ---- 8 
PsycINFO-Ovid 102 7 5 2 
 
Web of Science 
 
58 7 5 2 
Scopus 34 6 5 1 
     
Total 350 28 15 13 
 
2.6.6 Description of the Retrieved Studies 
The researcher retrieved thirteen (13) studies up to April 2017. All of the studies were 
quantitative. The selected studies originated from eight countries: four studies in 
Canada, three in the UK and 1 study in each of US, Netherlands, Poland, New 
Zealand, Japan and Jordan. The majority of the studies (9 out of the 13 studies) were 
conducted after cardiac rehabilitation programmes (Blanchard et al., 2007; Houle et 
al., 2011; Howarter, Bennett, Barber, Gessner, & Clark, 2014; Izawa, Watanabe, Oka, 
Osada, & Omiya, 2006; Luszczynska & Sutton, 2006; Maddison et al., 2014; Reid et 
al., 2006; Van Sluijs, Van Poppel, Twisk, & Van Mechelen, 2006; Yohannes et al., 
2010), three studies were conducted out of cardiac rehabilitation programme 
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(Blanchard et al., 2006; Fitzsimons et al., 2013; Smith et al., 2015), and one study 
was conducted among patients receiving behavioural change intervention and not 
attending a cardiac rehabilitation programme (Alsaleh et al., 2016). 11 out of the13 
studies were conducted among patients with CHD (Alsaleh et al., 2016; Blanchard et 
al., 2006; Blanchard et al., 2007; Houle et al., 2011; Howarter et al., 2014; Izawa et 
al., 2006; Luszczynska & Sutton, 2006; Maddison et al., 2014; Reid et al., 2006; Van 
Sluijs et al., 2006; Yohannes et al., 2010), and two studies were carried out among 
healthy adult participants (Fitzsimons et al., 2013; Smith et al., 2015) (Appendix A).  
2.6.7 Appraisal and Quality Review of the Evidence  
The researcher adopted a systematic approach to quality assessment, with the 
appraisal of every single study against the same criteria, facilitating analysis and the 
scrutiny of study rigour and quality. All research studies were subject to critical 
appraisal to assess the quality of the selected study within a defined framework 
developed by the Health Care Practice Research and Development Unit (HCPRDU 
2002) Evaluation Tool for Quantitative Research Studies (Long, Godfrey, Randall, 
Brettle, & Grant, 2002). The research employed the HCPRDU tool because it is 
simple, clear, and easy to apply. Within the quality appraisal, the researcher focused 
predominantly on five main subjects from HCPRDU 2002: the study’s objectives, 
method and sample, outcome measurements and results (Appendix A). This section 
focused and discussed the examination of the 13 relevant studies, using the evidence 
from these studies to reinforce or challenge findings. The section discussed the 
quality of available evidence within three sections. The first section discusses the 
studies that investigated self-efficacy level after cardiac rehabilitation. The second 
section focuses on the studies that investigated PA level after cardiac rehabilitation. 
Finally, the third section highlights studies that examined the relationship between 
self-efficacy and PA behaviour after cardiac rehabilitation. 
 
Study Aims and Outcomes 
The aims of the 13 studies overlapped with self-efficacy and PA being the central 
focus of the majority of the studies. Eight studies investigated the relationship 
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between changes in self-efficacy and PA in general after cardiac rehabilitation 
programmes (Alsaleh et al., 2016; Blanchard et al., 2006; Blanchard et al., 2007; 
Houle et al., 2011; Izawa et al., 2006; Luszczynska & Sutton, 2006; Maddison et al., 
2014; Van Sluijs et al., 2006). In addition to which four studies discussed  the impact 
of implementing an intervention driven theory including, behavioural change and self-
monitoring approach, socio-cognitive approach and mobile health trial on changes in 
self-efficacy and PA levels among two groups: the control group and the experimental 
group (Alsaleh et al., 2016; Houle et al., 2011; Izawa et al., 2006; Maddison et al., 
2014).   
Two studies aimed to identify the relationship between PA intentions, barriers from 
low self-efficacy, health related benefits and barriers and perceived severity and 
susceptibility either among patients with CHD who did not participate in cardiac 
rehabilitation or compared with patients attending cardiac rehabilitation (Blanchard et 
al., 2006; Blanchard et al., 2007). Further to which Blanchard et al. (2007) compared 
PA self-efficacy trend among patients with CHD who did and did not participate in 
cardiac rehabilitation. In addition, Van Sluijs et al. (2006) studied PA benefits, barriers 
to PA, process of change in health, enjoyment of PA, social support and self-efficacy. 
Howarter et al. (2014) investigated changes in self-efficacy over 2 years following 
cardiac rehabilitation and studied whether the psychological variables affected the 
changes in self-efficacy.    
Two studies aimed to investigate the impact of cardiac rehabilitation on long-term PA 
levels  (Reid et al., 2006; Yohannes et al., 2010), and Yohannes et al. (2010) also 
focused on changes in PA, psychological well-being and quality of life after cardiac 
rehabilitation. In addition, two studies aimed to identify PA level and sedentary time 
among health populations (Fitzsimons et al., 2013; Smith et al., 2015). In addition, 
Smith et al. (2015) determined sitting, standing, stepping time and PA levels for both 
weekends and weekdays.  
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Sample 
Most the study (10 out of the 13) samples were drawn from patients with CHD, CABG 
and ACS (Alsaleh et al., 2016; Blanchard et al., 2006; Blanchard et al., 2007; Houle 
et al., 2011; Howarter et al., 2014; Izawa et al., 2006; Luszczynska & Sutton, 2006; 
Maddison et al., 2014; Reid et al., 2006; Yohannes et al., 2010). One study recruited 
its sample from patients being diagnosed with HTN, DM and hypercholesterolemia 
(Van Sluijs et al., 2006).  Only two studies recruited healthy participants (Fitzsimons 
et al., 2013; Smith et al., 2015). 
Sample size and power calculation was mentioned in only one study (Alsaleh et al., 
2016), three studies refer the calculation of sample size to published previous work 
(Maddison et al., 2014; Smith et al., 2015; Yohannes et al., 2010). The remaining 
studies determined the sample size without providing details on how it was calculated 
(Blanchard et al., 2006; Blanchard et al., 2007; Fitzsimons et al., 2013; Houle et al., 
2011; Howarter et al., 2014; Izawa et al., 2006; Luszczynska & Sutton, 2006; Reid et 
al., 2006; Van Sluijs et al., 2006; Yohannes et al., 2010).  
Almost half of the studies (6) recruited their participants from just one centre 
(Blanchard et al., 2006; Blanchard et al., 2007; Houle et al., 2011; Izawa et al., 2006; 
Luszczynska & Sutton, 2006; Yohannes et al., 2010). Therefore, this is one particular 
limitation of these studies, which can limit the generalisability. Six studies recruited 
participants from more than one centre in their same country (Alsaleh et al., 2016; 
Howarter et al., 2014; Maddison et al., 2014; Reid et al., 2006; Smith et al., 2015; Van 
Sluijs et al., 2006). Only one recruited participants from the non-institutionalised 
population where participants were selected to measure free-living PA (Fitzsimons et 
al., 2013). Only studies making use of Randomised Control Trials (RCTs) showed the 
sampling and sample. The remaining studies did not mention the type of sample such 
as purposive or convenience sample.  
Methods 
The related studies used a range of methodological designs and approaches to 
generate evidence in these studies. A later section covers appraisal of these methods 
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in more detail. Hence, within this review the use of different methods and varied 
samples has limited the ability to compare directly findings across identified studies, 
such as the fact that their methods included administering self-reported 
questionnaires, using a sealed envelope sent by mail, interview, and direct 
observation methods.  
The selected studies used various time frames: five out of the thirteen studies used 
RCT to compare changes in self-efficacy and PA levels between two groups (Alsaleh 
et al., 2016; Houle et al., 2011; Izawa et al., 2006; Maddison et al., 2014; Van Sluijs 
et al., 2006), five studies used repeated measures (Blanchard et al., 2006; Blanchard 
et al., 2007; Howarter et al., 2014; Reid et al., 2006; Yohannes et al., 2010), one 
study used a longitudinal design (Luszczynska & Sutton, 2006), one study used 
cross-sectional study (Smith et al., 2015) and one was a pre-experimental (one group 
pre-test/ post-test) study (Fitzsimons et al., 2013). Study outcomes include an 
assessment of self-efficacy and PA over a period from baseline to 12 months. 
Measurement time points were at baseline, 2 months, 6 months, 8 months and 12 
months after cardiac rehabilitation (Alsaleh et al., 2016; Blanchard et al., 2006; 
Blanchard et al., 2007; Houle et al., 2011; Howarter et al., 2014; Izawa et al., 2006; 
Luszczynska & Sutton, 2006; Maddison et al., 2014; Reid et al., 2006; Van Sluijs et 
al., 2006; Yohannes et al., 2010). Therefore, the included studies focused on self-
efficacy and PA at baseline, on over periods of 2 months, 6 months, 8 months and 12 
months, and no studies measured these variables within 2 months after hospital 
discharge.    
Data Collection 
A range of self-reported self-efficacy questionnaires was used in the 13 studies, 
including self-efficacy for PA (Izawa et al., 2006), perceived self-efficacy, and self-
efficacy barriers and benefits questionnaires (Blanchard et al., 2006). Another study 
used a maintenance and recovery self-efficacy questionnaire, developed by the 
researcher (Luszczynska & Sutton, 2006). Barrier self-efficacy was measured on a 
five-item scale, developed by Plotnikoff and Higginbotham (1998) (Blanchard et al. 
(2007); LaPier, Cleary, & Kidd, 2009). Houle et al. (2011) used Jenkins’ self-efficacy 
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expectation questionnaire, task self-efficacy, barrier efficacy and efficacy strength 
were used (Maddison et al., 2014), likewise the cardiac exercise self-efficacy 
questionnaire (Howarter et al., 2014), and the exercise self-efficacy scale was used 
by (Alsaleh et al., 2016). In addition, two self-efficacy questionnaires were developed, 
one for making time for exercise, resisting relapse, barriers to and benefits of PA, and 
the other for knowledge of PA and health, were used by Van Sluijs et al. (2006). 
Finally, a  Maddison et al. (2014) developed a task self-efficacy questionnaire. Data 
about validity, reliability and the suitability of the self-efficacy questionnaire were 
mentioned (Alsaleh et al., 2016; Blanchard et al., 2006; Blanchard et al., 2007; Houle 
et al., 2011; Howarter et al., 2014; Izawa et al., 2006; Luszczynska & Sutton, 2006; 
Maddison et al., 2014; Van Sluijs et al., 2006). Hence, the authors of the included 
studies used different self-efficacy questionnaires; there is no consensus on using 
one type of self-efficacy questionnaire among the included studies.  
PA level was assessed by many different methods. For example, more than half of 
the studies (8 out of the 13 studies) used self-reported PA questionnaires. Some 
studies used 7-day PA recall telephone interviews (Blanchard et al., 2007; Reid et al., 
2006). Blanchard et al. (2006) measured PA through the Godin Leisure Time 
Exercise Questionnaire, the self-reported PA questionnaire and PA intentions 
questionnaire were used by Luszczynska and Sutton (2006). In addition, a self-
administered questionnaire was used to measure PA energy expenditure, such as 
seven-day recall of activity (Yohannes et al., 2010). In addition, some studies used 
the self-reported international PA questionnaire long form (IPAQ-LF) to assess PA 
levels (Alsaleh et al., 2016; Maddison et al., 2014).  
Other studies used body-worn activity monitors to measure PA, such as the 
activPAL3™ monitor used to measure PA during weekdays and weekends (Smith et 
al., 2015), in addition to Fitzsimons et al. (2013), who measured Sedentary behaviour 
by using the activPAL3™ monitor and also sedentary behaviour was measured 
subjectively using the Sedentary Behaviour Questionnaire 7 consecutive days. Houle 
et al. (2011) used pedometers (Yamax Digiwalker NL-2000, Lees Summit, USA), with 
a 7-day memory. Peak VO² was measured as an index of exercise capacity with 
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assessment of PA by pedometer (Izawa et al., 2006). It is worth noting, in addition, 
that only one study used both self-reported PA questionnaire and pedometer to 
measure PA level, through the use of  Van Sluijs et al. (2006)’s self-reported 
SQUASH questionnaire and the CSA activity monitor (Computer Science Application, 
Inc., model 7164). Using a body-worn activity monitor to measure PA is more 
favourable as it is more accurate and precise than a self-reported PA questionnaire.   
Ethical Considerations 
Obtaining ethical approval from the respective organisations prior to commencing any 
study is not only as good practice, but also in some countries it is essential prior to 
commencing research in the clinical area. The majority of studies (10) obtained 
consent and approval from a recognised ethical authority: university hospital, local 
ethics committee, or directors of related departments and/or organisations (Alsaleh et 
al., 2016; Blanchard et al., 2006; Blanchard et al., 2007; Houle et al., 2011; Howarter 
et al., 2014; Izawa et al., 2006; Reid et al., 2006; Smith et al., 2015; Van Sluijs et al., 
2006; Yohannes et al., 2010). Three studies did not mention how they obtained 
ethical approval to undertake the research (Fitzsimons et al., 2013; Luszczynska & 
Sutton, 2006; Maddison et al., 2014), which affects the research quality of these 
studies.  
Bias in Studies 
In the RCT studies, the researcher or research team gathered data  in five of the 
studies (Alsaleh et al., 2016; Houle et al., 2011; Izawa et al., 2006; Maddison et al., 
2014; Van Sluijs et al., 2006). However, the research team involved people such as 
unit nurses in implementing the intervention and distribution of questionnaires, yet 
there was limited information about whether they trained or not. In addition, there was 
limited data on whether the researcher and the nurses were trained for involvement in 
study interventions such as behavioural change intervention (Alsaleh et al., 2016). 
Moreover, three studies used self-reported PA questionnaires, which participants’ 
recall bias may have occurred (Alsaleh et al., 2016; Maddison et al., 2014; Van Sluijs 
et al., 2006), which in turn affect the resulting recorded of PA level. Researcher bias 
 57 
 
was detected in many studies, and only in one study was it mentioned that the 
participants and the researcher who provided the intervention and assessed the study 
outcomes was not blind (Alsaleh et al., 2016). The remaining RCT studies did not 
mention whether the participants and the researcher who were involved in the study 
interventions and outcomes were blind or not, which is pertinent where the research 
team’s decision may alter how they carry out an intervention and how they record the 
results.  
In the remaining eight studies (Blanchard et al., 2006; Blanchard et al., 2007; 
Fitzsimons et al., 2013; Howarter et al., 2014; Luszczynska & Sutton, 2006; Reid et 
al., 2006; Smith et al., 2015; Yohannes et al., 2010), little or no detail was provided, 
making it difficult to assess possible study bias. In addition, the studies did not 
mention strategies concerning how to minimise the possibility of introducing study 
bias. This is important because failure to provide training for the research team could 
affect how participants respond to the questionnaire.  
Data Analysis 
All of the 13 studies generated results for the purposes of the study by using software 
such as Statistical Package for the Social Sciences (SPSS), Statistical Analysis 
System (SAS) and STATA to manage their data. The common use of using these 
packages indicates that this software is a convenient and standard tool for 
quantitative analysis, with which researchers may already be familiar. The most 
common tests used in these studies for data analysis include chi-square, comparing 
categorical data, t-test, comparing continuous data between two groups, correlation 
for the relationship between individual continuous variables, and Analysis of Variance 
(ANOVA) for more than two groups. 
Key Findings  
The researcher generated three core findings that highlight the key concepts 
extrapolated from the review of the current evidence: changes in self-efficacy level, 
changes in PA level and the relationship between self-efficacy and PA levels. 
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Changes in Self-Efficacy Level 
Increased self-efficacy is important to cardiac rehabilitation outcomes. Indeed, 
interventions based on behavioural change techniques, theory-driven interventions, 
and cardiac rehabilitation programmes improved self-efficacy level among patients 
with CHD (Alsaleh et al., 2016; Houle et al., 2011; Howarter et al., 2014; Izawa et al., 
2006; Luszczynska & Sutton, 2006; Maddison et al., 2014; Reid et al., 2006; Van 
Sluijs et al., 2006). The present review found that there was a difference between 
self-efficacy at baseline and that at subsequent measurement times among different 
populations such as CHD, AMI, ACS and CABG (Alsaleh et al., 2016; Blanchard et al., 
2006; Blanchard et al., 2007; Houle et al., 2011; Howarter et al., 2014; Izawa et al., 
2006; Luszczynska & Sutton, 2006; Reid et al., 2006; Van Sluijs et al., 2006). 
Particularly, self-efficacy increased from two to six months after cardiac rehabilitation. 
However, self-efficacy levels were highest at the initiation of the cardiac rehabilitation 
programme, whereas self-efficacy significantly declined 6 months following cardiac 
rehabilitation, and levelled off over the next 18 months (Howarter et al., 2014).   
No studies investigated self-efficacy levels in the period of 8 weeks following 
treatment. Many different types of phase-specific self-efficacy questionnaire such as 
the recovery and maintain self-efficacy questionnaire, were used for the purpose of 
measuring self-efficacy, some of these were collection of items related to self-efficacy 
developed by the author of the study. In addition, there was no consistency regarding 
the self-efficacy questionnaires used in the relevant studies, which makes 
comparison between the self-efficacy outcomes difficult. Moreover, self-efficacy was 
improved in the cardiac rehabilitation context, only one study showed self-efficacy 
level among patients with CHD not attending cardiac rehabilitation (Blanchard et al., 
2006). The remaining studies found that self-efficacy was improved by the impact of 
intervention or cardiac rehabilitation (Alsaleh et al., 2016; Houle et al., 2011; Howarter 
et al., 2014; Izawa et al., 2006; Luszczynska & Sutton, 2006; Maddison et al., 2014; 
Reid et al., 2006; Van Sluijs et al., 2006). All studies focused on patients with CHD or 
ACS. However, no study focused on measuring self-efficacy among patients with AMI, 
as AMI is a chronic disease of lifelong duration, presenting with acute symptoms, in 
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which patients need to adhere to programmes using their self-management skills 
along with cardio-protective medications to reduce CVD risk factors and improve 
secondary prevention strategies.  
Changes in Physical Activity Level 
In general, PA level increased after cardiac rehabilitation or intervention among 
patients with CHD, there was significant difference in PA levels between experimental 
and control groups. There have been arguments about the influence of psychological 
factors on PA. For example, Reid et al. (2006) found that PA level decreased cardiac 
rehabilitation because of the influences of psychological factors, co-morbidity, gender, 
and education. In contrast, Yohannes et al. (2010) found that PA, depression, anxiety 
and quality of life increased over 12 months. However, both studies (Reid et al., 2006; 
Yohannes et al., 2010) used self-reported PA questionnaire to measure PA levels, in 
which is inherent the risk of recall bias and overestimation. In addition, Reid et al. 
(2006) found that PA had decreased 2 months subsequent to hospitalisation, this 
finding emphasises that specific groups require tailored intervention to promote PA in 
the early recovery phase to maintain PA levels. 
Although, PA is a complex behaviour, self-reported recall PA questionnaires were 
frequently used to measure PA and researchers did not use objective devices to 
measure PA, even in RCTs studies (Alsaleh et al., 2016; Blanchard et al., 2006; 
Blanchard et al., 2007; Luszczynska & Sutton, 2006; Maddison et al., 2014; Reid et 
al., 2006; Yohannes et al., 2010). Therefore, PA behaviour needs more accurate and 
advanced method for its measurement. Hence, a small number of studies used a 
body-worn activity monitor (Fitzsimons et al., 2013; Houle et al., 2011; Izawa et al., 
2006; Smith et al., 2015). Moreover, for improved accuracy, both self-reported PA 
questionnaire and accelerometer device were used to assess PA level (Van Sluijs et 
al., 2006). 
It is noteworthy that measuring step count alone to represent the PA level is not 
sufficient to understand PA behaviour of patients with CHD. Only Fitzsimons et al. 
(2013) and Smith et al. (2015) measured PA behaviours including sedentary time and 
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upright time for healthy adults. Fitzsimons et al. (2013) measured PA level such as 
sitting or lying, standing and stepping among healthy participants, with the activity 
monitor worn for 24 hours per day for seven consecutive days, without including other 
PA behaviour such as step count and upright time. In addition, all participants in 
various different age categories were included. Smith et al. (2015) compared PA level 
by mean of step count, stepping time, standing time and sedentary time on weekdays 
and weekends, among healthy workers, the study did not provide information about 
PA patterns or changes in PA at subsequent times. Therefore, PA is essential self-
management skills for patients with CHD. No study investigated PA in the early 
recovery phase among the included studies. In addition, use of body-worn activity 
monitors for assessment of PA will be more useful to the understanding of PA 
behaviour of patients with CHD than using self-reported self-efficacy questionnaires. 
Moreover, no studies assessed PA behaviour among patients with AMI in the early 
recovery phase after receiving treatment.  
The Relationship between Self-efficacy and Physical Activity Levels  
Of the 13 studies performed, 10 studies assessed PA and self-efficacy of patients 
with CHD after implementing an intervention or a cardiac rehabilitation programme   
(Alsaleh et al., 2016; Blanchard et al., 2007; Houle et al., 2011; Howarter et al., 2014; 
Izawa et al., 2006; Luszczynska & Sutton, 2006; Maddison et al., 2014; Reid et al., 
2006; Van Sluijs et al., 2006; Yohannes et al., 2010) (Appendix A). Only one study 
(Blanchard et al., 2006) was performed to assess the association between self-
efficacy and PA among patients not attending cardiac rehabilitation, two studies 
(Fitzsimons et al., 2013; Smith et al., 2015) assessed PA among a healthy population, 
Only, four studies identified the relationship between self-efficacy and PA (Blanchard 
et al., 2006; Blanchard et al., 2007; Izawa et al., 2006; Luszczynska & Sutton, 2006). 
The present review provides evidence that there is a significant relationship between 
self-efficacy and PA after 2 to 6 months subsequent to AMI (Blanchard et al., 2006; 
Blanchard et al., 2007; Izawa et al., 2006; Luszczynska & Sutton, 2006). No studies 
have investigated the relationship between self-efficacy and PA among patients with 
AMI in the early recovery phase. 
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One study assessed the relationship between self-efficacy and PA among patients 
with CHD not attending cardiac rehabilitation (Blanchard et al., 2006). The study 
revealed that the increase in PA from baseline to 6 months resulted from increases in 
self-efficacy and PA intentions. Furthermore, a reduction in PA from six to twelve 
months resulted from a reduction in health-related benefits and PA intentions. 
Therefore, the associations among these variables within PA were varied after 
hospitalisation (Blanchard et al., 2006). This study is important due to its addressing 
other variables that could influence the relationship between self-efficacy and PA.  
Another study aimed to assess the relationship between barriers to self-efficacy and 
self-reported PA and compare two groups of CHD patients, participants who had 
attended and those that had not attended cardiac rehabilitation, over a 12-month 
period. It found a significant decline in self-reported PA over time. Moreover, the 
association between barrier self-efficacy and PA became weaker over time. This 
result was similar for CHD patients both those who were and those who were not 
involved in cardiac rehabilitation (Blanchard et al., 2007). 
Moreover, phase-specific self-efficacy questionnaires are very useful to predict PA in 
a specific period, for example, maintenance self-efficacy predicted PA in a subgroup 
of participants who maintained regular activity at 8 months after AMI, and recovery 
self-efficacy predicted PA among participants who had relapsed by 8 months after 
AMI (Luszczynska & Sutton, 2006). On the other hand, the RCT studies in the review 
showed that there was a significant difference between intervention and control 
participants. However, they did not examine the relationship between self-efficacy 
and PA after cardiac rehabilitation (Alsaleh et al., 2016; Houle et al., 2011; Izawa et 
al., 2006; Maddison et al., 2014; Van Sluijs et al., 2006).  
2.6.8 Summary of the Key Findings  
The researcher draws a number of issues and findings from the review. These inform 
and raise questions for the development of further study related to self-efficacy and 
PA behaviour. The included studies which examined self-efficacy and cardiac 
rehabilitation or intervention were undertaken in countries where cardiac rehabilitation 
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is available (except for one study which was conducted in Jordan), where the 
respective health care organisations support patients with AMI throughout their 
cardiac rehabilitation programmes. Hence, the majority of the studies assessed self-
efficacy levels after cardiac rehabilitation. The reviews studied investigated the 
changes in self-efficacy and PA by using RCT, cohort and longitudinal studies, 
comparing between two or three groups, with varied studied populations. However, 
no study focused solely on an AMI population.  
The literature shows improved outcomes in self-efficacy level and PA level after 
cardiac rehabilitation or implementation of health education intervention. (Alsaleh et 
al., 2016; Blanchard et al., 2007; Houle et al., 2011; Howarter et al., 2014; Izawa et 
al., 2006; Luszczynska & Sutton, 2006; Maddison et al., 2014; Van Sluijs et al., 2006).  
There is strong evidence proving the relationship between self-efficacy level and PA 
level (Blanchard et al., 2006; Blanchard et al., 2007; Houle et al., 2011; Izawa et al., 
2006; Luszczynska & Sutton, 2006; Van Sluijs et al., 2006). The measurement times 
in the included studies focused on the period from 2 months up to 12 months later, 
which is the critical period the patients with CHD need to adopt a healthy lifestyle for 
their life. There were no studies identified that measured self-efficacy and PA in the 
first 2 months after treatment. In addition, no evidence has been found to reveal the 
changes in self-efficacy and PA out of the cardiac rehabilitation context, and if there 
are other mechanisms which could influence self-efficacy and PA among patients 
with CHD after treatment.   
In this review, many studies used different self-reported self-efficacy questionnaires, 
and there were phase-specific self-efficacy questionnaires such as for task self-
efficacy. However, none of these studies used disease–specific self-efficacy 
questionnaires. There was one study, which used exercise self-efficacy, among 
patients with CHD in Jordan. However, the study did not mention that an Arabic 
version of exercise self-efficacy was available. However, using of the exercise self-
efficacy questionnaire is to measure exercise alone. In addition, the exercise self-
efficacy questionnaire measures continuity in exercise self-efficacy for 40 minutes, 
over 4 weeks and does not measure PA, more detail in section 3.5.2.  
 63 
 
Many studies used frequently self-reported PA questionnaires in order to assess PA 
behaviour. In addition, many studies used step count to represent the PA level of the 
participants rather than using other PA parameters such as stepping time, standing 
time, upright time and sedentary time, which are essential to understand the 
complexity of PA behaviour. A few studies used body-worn activity monitors, which 
are accurate, valid and reliable devices. Moreover, in the review, no studies assessed 
the changes in PA patterns among CHD patients, which are important to understand 
PA behaviour.  
Only one study was conducted among CHD patients who were not participants in 
cardiac rehabilitation (Blanchard et al., 2006), and the study in question showed that 
both self-efficacy and PA increased from baseline to six months and that there was 
no relationship between self-efficacy and PA from six to twelve months after 
hospitalisation. Finally, there is a single study, which was conducted in Jordan 
(Alsaleh et al., 2016), the study focused solely on behavioural’ change intervention 
effect on self-efficacy and PA levels among patients with CHD. Moreover, the study 
used a self-reported PA questionnaire to assess PA level and did not use pedometers 
or accelerometer devices to assess PA level.  
2.7 Significance of the Study 
The review has showed the increasing trend of CHD globally, especially low-middle 
income countries (WHO, 2015b). Much of the available literature showed that 
secondary prevention has many benefits for patients with AMI in order to reduce 
mortality and morbidity and improve their self-management skills after AMI (Dunlay, 
Pack, Thomas, Killian, & Roger, 2014). Indeed, cardiac rehabilitation programmes 
have a crucial role in developing self-management skills (Dalal et al., 2015; Katch, 
2010). In addition, self-efficacy plays a vital role in improving secondary prevention 
and in promoting PA level (Barkley & Fahrenwald, 2013; Poortaghi, Baghernia, 
Golzari, Safayian, & Atri, 2013). There is a lack of knowledge about the self-efficacy 
level of patients with AMI and their PA level and pattern thereof after receiving 
treatment. In addition, there is limited evidence when it comes to establishing whether 
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there is any relationship between self-efficacy level and PA behaviour among patients 
with AMI, who do not participate in cardiac rehabilitation in the early recovery phase.  
Further study is required to extend the current knowledge base regarding the 
changes in self-efficacy level and PA behaviour among patients in their recovery 
phase after experiencing AMI. In addition, this study will add to the limited body of 
knowledge and address the gap in the literature regarding exploration of the 
relationship between self-efficacy level and PA behaviour among patients with AMI 
who have no access to cardiac rehabilitation, after receiving treatment in the early 
recovery phase. 
Although the majority of the studies reviewed focused on the measurement of PA 
behaviour by self-reported recall questionnaire, it is necessary to use a validated and 
reliable body-worn activity monitor in order to measure PA accurately. Additionally, 
this will help reach a better understanding of PA behaviour among patients with AMI 
after treatment.   
Unfortunately, cardiac rehabilitation is not available in many countries present, even 
in those where there is a high prevalence of CVD risk factors, such as Jordan. Indeed, 
one third of the population that dies every year does so as a consequence of CVDs 
(CHD being responsible for 16.8% of total deaths) (WHO, 2015e), and therefore, 
patients with AMI must take complete responsibility for developing their self-
management skills. In addition, to the best of the researcher’s knowledge, there is no 
Arabic version of the self-reported CSEQ. Moreover, this is the first study to use the 
body-worn activity monitor in scientific research in the Middle Eastern countries. 
Consequently, this study presents the healthcare system in Jordan with clear, 
accurate, and comprehensive measures of self-efficacy level and PA behaviour 
among patients with AMI in their early recovery phase. It is a great opportunity to 
direct the efforts to implement the study in Jordan to investigate self-efficacy and PA 
behaviour among Jordanian patients with AMI.  
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2.8 Conclusion  
In sections 1- 6, an introduction to the thesis has been provided and an overview of 
CVD and secondary prevention, healthcare provision in Jordan, self-efficacy and 
secondary prevention, the impact of PA on CVD and the changes and the 
relationship between PA and self-efficacy after hospital discharge have been 
presented. These include a critical review of the research literature on self-efficacy 
and PA. In summary, CVD has been progressively increasing in the last few years, 
particularly in the Middle East. There is no CSEQ in Arabic available for patients with 
AMI in the Middle East. Further, self-efficacy and PA play vital role in reducing burden 
of CVD. Unfortunately, there are no previous studies have been investigated both 
self-efficacy and PA in the early recovery phase among patients with AMI. Therefore, 
the aim of this study is to implement the WHO process in order to translate and adapt 
the CSEQ to Arabic. In addition to assessing the changes in self-efficacy and PA 
level and pattern among patients with AMI in the early recovery phase and exploring 
whether there is a relationship between self-efficacy and PA. 
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Chapter Three: Self-Efficacy 
3.1 Introduction 
Chapter two presents an overview of the burden of CVD and the role of secondary 
prevention in preventing risk factors of CVD, in addition to PA and the measurement 
approach of PA. Moreover, it gives a synthesis of research evidence related to self-
efficacy and PA. This chapter focuses on review of self-efficacy and behavioural 
change, in addition to different types of self-efficacy questionnaires. Following this, it 
describes the WHO process of translation and cross-cultural adaptation of CSEQ, 
including validity and reliability evaluation of the Arabic version of the CSEQ.   
3.2 Self-Efficacy and Behaviour Change  
The self-efficacy construct is based on self-efficacy theory, which was developed 
based on social learning theory (Bandura, 1997). Self-efficacy was defined by 
Bandura (1997) as a person’s belief in their own abilities to effect events that 
influence their lives. Bandura (1997) based his concept of behavioural change on two 
main concepts, self-efficacy and outcome expectations, the latter are the 
expectations about the outcome resulting from performing that behaviour. Both self-
efficacy and outcome expectations play a vital role in the modification of unhealthy 
behaviours, the adoption of healthy habits, and the maintenance of change (Bandura, 
1997).  
Self-efficacy is important for achieving appropriate self-management skills for patients 
with CVD (Katch, 2010). Clear evidence suggests that a predictive link between self-
efficacy and health- related behaviour (Bergström, Börjesson, & Schmidt, 2015; 
O’Neil et al., 2013; Son, Kim, & Park, 2014). Many of the main theories of health 
behaviour, for example the health belief model (Rosenstock, 1974), the theory of 
planned behaviour (Ajzen, 1991) and protection motivation theory (Rogers, 1975) 
include self-efficacy as a significant key factor for motivation, intention and 
accomplishment. In addition, there is clear evidence to show that improved self-
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efficacy beliefs are essential for successful change and maintenance of health 
behaviour, including: stress management, diet, exercise, overcoming alcohol abuse, 
smoking cessation, adherence to treatment and self-management skills (Bandura, 
1997; Maddux, 1995). 
Studies by (Lorig & Holman, 2003; Marks, Allegrante, and Lorig (2005)) have 
demonstrated that self-efficacy is sensitive to modification, interventions and 
enhancements; this is associated with improved health behaviours and clinical 
outcomes. The above findings by Lorig and Holman (2003) also pointed out that self-
efficacy can be improved by involving patients in problem solving and adapting their 
skills to manage their health problems and their particular challenges. For example, 
Behavioural Change Techniques are an effective method to improve self-efficacy 
among various groups of people including the CHD population (Ashford, Edmunds, & 
French, 2010; French, Olander, Chisholm, & Mc Sharry, 2014; Olander et al., 2013). 
On the other hand, changing behaviour is a complex process that involves many 
factors, as described in the Behaviour Change Wheel by (Michie, Atkins & West, 
2014). 
3.3 Behavioural Change Theories  
This section presents an overview of behavioural change theories. Different theories 
and models have been inspected for this research, as the literature presents different 
theories and models that help the researcher to understand the variables affecting an 
individual's behaviour changes to promote health outcomes, including CHD (Lee, 
Arthur, & Avis, 2008). For this study, the researcher has inspected different theories 
and models. These include the theory of planned behaviour (Ajzen, 1991) and 
several others. The transtheoretical model of behaviour change by Prochaska and 
DiClemente (1982) has become progressively common within the area of PA 
behaviour promotion. Self-determination theory by Deci and Ryan (1985) identifies 
that patients are responsible for and control self-management skills such as PA level 
and have an active role in treatment. Self-efficacy theory by Bandura (1997), is 
considered one of the most extensive motivation theories applied in the context of PA 
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studies. Following from this, the researcher selected one of these theories as the 
theoretical framework underpinning this thesis.  
It is essential to use an appropriate theory to guide a study for the purpose of 
maintaining credibility of the findings and creating an important contribution to the 
body of knowledge (Smith & Parker, 2015). The theoretical framework supports 
exploration of the relationships between the study’s concepts (Smith & Parker, 2015). 
In addition, using a theoretical framework improves the study’s strength and simplifies 
information transfer through examining current theories (Rycroft-Malone, 2007). A 
theoretical framework guides the study in each of the key features of the research, 
such as the choice of variables, methodology, and data analysis of the study.  
3.3.1 Theory of Planned Behaviour  
The theory of planned behaviour was developed by Ajzen (1991). The theory was 
designed to predict and explain human behaviour in specific contexts (Ajzen, 1991). 
The key element of the theory of planned behaviour is that an individuals’ intention to 
change their behaviour influences their behaviour. Perceived behaviour together with 
perceived intentions determine behavioural intention. The perceived behaviour 
contributes to a person’s behaviour. Therefore, the more an individual perceives a 
behaviour as being important, the more he or she perceives that they have control 
over it, and the greater the intention to act (Ajzen, 1991). 
Though the theory of planned behaviour suggests a theory of modifying behaviour 
among cardiac patients, the prior studies that used this theory among patients with 
cardiac diseases showed that patients with a higher level of intention and perceived 
behavioural control to change their behaviour were not necessarily more likely to 
change their behaviour, for example by becoming involved in PA (Johnston, Johnston, 
Pollard, Kinmonth, & Mant, 2004; Sniehotta, Schwarzer, Scholz, & Schüz, 2005). 
Therefore, the theory of planned behaviour may present an inadequate explanation 
for the variable used in this study. Because of this, the researcher did not select the 
theory of planned behaviour for use in this study. 
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3.3.2 Transtheoretical Model of Behaviour Change 
The transtheoretical model developed by Prochaska and DiClemente (1982) is an 
integrative model to conceptualise the process of intentional behavior change, in 
which individuals show their readiness for involvement in new healthy behaviours to 
manage illness or promote health (Ruggiero et al., 1997). The application of the 
transtheoretical model was initially to understand how people change their health 
behaviour, such as cessation of smoking and other unhealthy and addictive 
behaviours. Later, the transtheoritical model was applied in exercise behaviour 
studies (Marcus et al., 1992). The transtheoretical model suggests that an individual’s 
behavioural changes progress through a series of stages. These stages include pre-
contemplation, contemplation, preparation, action and maintenance and/or relapse, 
which refer to the process of retreating one stage or more at a time. 
The transtheoritical model of behaviour change is understood as a process rather 
than as an event, so the transtheoretical model intends to explain how behaviour 
change occurs, rather than why (Prochaska & DiClemente, 1982). The model 
proposes that individuals move through a series of stages, instead of changing at 
once, with each single stage being characterised by a temporal component 
associated with the behaviour change. Previous studies reviewed the effectiveness of 
the transtheoritical model, including 37 studies focusing on many target behaviours 
such as smoking cessation, PA, and dietary change. The review showed that there 
was little evidence to support the effectiveness of stage-based interventions as a 
basis for behaviour change or for facilitating stage progression (Bridle et al., 2005). 
Further, Nigg et al. (2011) stated that ordering of behaviour change into a series of 
different stages makes the model difficult to understand as a continuous process and 
obscurity about the use of stage timeframes remains a significant concern. 
Consequently, the transtheoritical model is difficult to apply, with no specific cut-off 
point being evident between stages. Therefore, this model is not appropriate for the 
study’s objectives and design.   
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3.3.3 Self-Determination Theory 
Self-determination theory was initially developed by (Deci and Ryan (2002); Deci & 
Ryan, 1985). It refers to supporting the individual’s intrinsic tendencies to behave 
toward promoting their health. It helps the researcher to understand motivation and 
adherence to health behaviours. The basic principles of this theory are human 
motivation and personality in a social context that distinguishes motivation as 
autonomous and controlled, which promotes long-term behaviour change, implying 
an understanding of the internalisation process. Deci and Ryan (2002) differentiate 
between intrinsic and extrinsic motivation, with intrinsic motivation refers to initiating 
an activity for its own sake because it is interesting and satisfying in itself thereof, and 
extrinsic motivation refers to doing an activity to obtain an external goal. External 
regulation is the least autonomous form of motivation, consisting of individual 
achievement outcomes to avoid punishment and/or to obtain rewards (Deci & Ryan, 
2002; Deci & Ryan, 1985). Self-determination theory explains the individual’s 
motivation to achieve behavioural changes through intrinsic and extrinsic motivation, 
and in addition, the three basic needs: competence, relatedness and autonomy. 
However, there is little evidence about the use of self-determination theory, according 
to a systematic review by Teixeira, Carraça, Markland, Silva, and Ryan (2012) to 
investigate the relationships between key self-determination theory-based constructs 
and exercise and PA behavioural outcomes. The study showed inconsistencies and 
mixed evidence associated with the relationships between self-determination theory 
constructs and exercise. Moreover, there were specific limitations regarding the 
different associations explored when applying of self-determination theory to 
understand exercise and PA promotion. In addition, Mallett (2005) showed that a 
cause-effect relationship cannot be established in an autonomy supportive approach 
in a stressful environment. Consequently, this theory was not able to provide 
sufficient explanation for the variables used in this study. 
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3.3.4 Self-Efficacy Theory  
Bandura developed self-efficacy theory as a part of social cognitive theory, which 
highlights three factors: behavioural, personal, and environmental. These factors 
interact to determine behaviour and motivation (Ashford & LeCroy, 2009). Bandura 
(1997) presents self-efficacy as a kind of self-confidence that plays an essential role 
in behaviour prediction as well as influencing the actions that can affect an 
individual’s life. The basic principle behind Bandura’s self-efficacy theory is that 
individuals are more likely to become involved in activities for which they have a high 
self-efficacy level and less likely to become involved in those for which they have a 
low self-efficacy level.  
Bandura identified four main sources of self-efficacy in a hierarchy of significance, 
which contribute to the development of self-efficacy. The four sources of self-efficacy 
information: First: enactive mastery experience, which is the most effective source of 
self-efficacy. According to Bandura (1997), success builds a robust belief in one’s 
personal efficacy. However, failure with new tasks obviously reduces the self-efficacy 
level for that specific task. If a task has been effectively, accomplished many times, 
unusual failure at the task is unlikely to change self-efficacy for that specific task.  
Second: vicarious experience is also known as modelling in which conducting a 
comparison process effects self-efficacy. People make a comparison between their 
own capability and the capability of others. The modelling effect occurs as the 
observer recognises the ease with which the actor has accomplished a particular task. 
Consequently, the observer develops the perception that they are able to complete 
the same task. Bandura explained that inefficacy influenced an individual’s 
experience and their tendency to perform in ineffectual ways, which leads to 
formulating confirmatory behavioural evidence of failure. On the other hand, the 
vicarious experience can enhance self-efficacy, which weakens the direct experience 
effect of failure by maintaining achievement in the face of failure frequently. 
Third: verbal persuasion, also known as social persuasion, is the third effective 
source of self-efficacy. Verbal persuasion serves to strengthen people’s beliefs that 
they have the capability to achieve their task. For instance, if they doubt their own 
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skills and have a tendency to reflect on personal deficiencies, the verbal persuasive 
effect of a personal trainer will be essential to reduce the self-doubt. Bandura (1997) 
explained verbal persuasion aimed to enhance self-efficacy level based on the 
achievement of realistic objectives. However, unrealistic beliefs may reduce the 
persuader’s credibility in the eyes of the patients. In addition, verbal persuasion alone 
has limited power. However, it is more effective if followed by successful achievement. 
Forth: physiological and affective states constitute one of the four sources that are 
effective for self-efficacy and relate to an individual’s ability to interpret symptoms. 
People judge their capability based on physiological and emotional states. Their 
reaction to a stressful situation such as pain, fatigue or fear can affect their feelings 
about their capability to conduct their daily activity, which can, in turn, alter their self-
efficacy level (Bandura, 1997). For example, there can be pain or difficulty breathing, 
which is signs of forthcoming threat that may lead to beliefs of failure to complete the 
task, such as doing regular PA guidelines. Bandura (1997) proposed that somatic 
arousal creates the fear of inability, which produces further belief in failure that 
worsens somatic arousal and produces fear. 
The physiological state may affect judgements of capability, a person's perception of 
physiological and effective responses related to a specific task, which may influence 
decisions regarding a person's efficacy beliefs (Bandura, 1997). For example, chest 
pain and fatigue could indicate physical dysfunction. Moreover, fear about the 
experience of fatigue whilst engaging in PA may decrease self-efficacy. In this study, 
patients with AMI who usually experience chest pain whilst engaging in PA may begin 
to feel anxious about their capability to maintain PA level, and then begin to decrease 
PA level. Thus, physiological and affective states may adversely affect the patients 
with AMI perception of ability to achieve the recommended level of PA. Therefore, in 
order to improve self-efficacy, emotional arousal levels would be reduced, in order to 
achieve the behaviour changes (Jerusalem & Mittag, 1995). Different assessment 
tools can assess physiological and affective states such as the following: clinical 
evaluation, for example a treadmill test and echocardiogram, and a questionnaire and 
daily chest pain diary, which is an inexpensive and easy to administer tool. In addition, 
 73 
 
there are two kinds of pain diaries that have been employed in researches: specific 
pain assessment and functional pain assessment (Karoly & Jensen, 2013).  
Self-efficacy theory provides a beneficial theoretical framework for understanding and 
predicting adherence to behaviour changes (Shortridge-Bagget, 2002). Self-efficacy 
is important factors for self-management among individuals with AMI (Katch, 2010). 
Self-efficacy theory proposes that individuals’ confidence in their skill to change 
behaviours affects which behaviours they will participate in (Bandura, 1997; Lorig & 
Holman, 2003). In addition, in his review article, Blanchard (2012) concluded that self-
efficacy theory is a useful theory and should be considered when studying the 
correlation between self-efficacy and PA among people with CVDs. Moreover, 
Bandura’s self-efficacy theory is widely applied in the literature, and helps to better 
understand health behaviour and facilitates behavioural change, for example 
increase of PA level (Lee et al., 2008). Bandura’s self-efficacy theory is the most 
applicable theory among the aforementioned theories. 
Hence, Bandura’s self-efficacy theory underpins the research methods used in the 
presented study, including the choice of questionnaire. The researcher selected the 
CSEQ to elicit data on the self-efficacy level of CHD patients, which is one of the 
primary variables in the study’s theoretical framework. This is in addition to the use of 
a body-worn activity monitor to measure PA level in order to identify changes in PA in 
a precise and accurate way. In conclusion, researchers trying to understand patients’ 
motivation for changes in behaviour have used the concept of self-efficacy 
extensively. Bandura’s self-efficacy theory is the appropriate theory to help explain 
the relationship between self-efficacy and PA. For example, patients with a higher 
self-efficacy level set higher goals and demonstrate a greater commitment and 
motivation to achieving higher PA levels. Therefore, Bandura’s self-efficacy theory will 
improve the integration of the study’s findings.  
 
 74 
 
3.4 Types of Self-Efficacy 
Use of self-efficacy is usually as a general concept only. However, there is a growing 
interest in moving towards different types of self-efficacy, such as general self-
efficacy, disease-specific self-efficacy and phase-specific self-efficacy. General self-
efficacy refers to an individual’s belief in their ability to perform in general, across a 
variety of situations (Schwarzer & Jerusalem 1995). In contrast, disease-specific self-
efficacy refers to an individual’s perception of his or her ability to perform the actions 
specific to a situation, such as a belief in the ability to influence the outcome related 
to a specific disease, such as CHD, through achieving several changes (Sullivan et 
al., 1998). Even though general self-efficacy tasks centre around general situations 
and disease-specific self-efficacy tasks centre around dealing with situations related 
to their respective diseases, both concepts are based on self-efficacy, and both types 
of self-efficacy deal with a person’s ability to achieve a desired outcome.  
Maddux (1995) developed the concept of phase-specific self-efficacy in the domain of 
exercise behaviour, McAuley and Mihalko (1998) explained that different kinds of self-
efficacy generally represent one of two main components of the self-efficacy concept: 
a task and a regulatory component. The task component refers to belief in an 
individual’s ability to achieve a specified behaviour, whereas regulatory efficacy refers 
to belief in an individual’s ability to overcome obstacles during the performance of PA.  
Rodgers, Hall, Blanchard, McAuley, and Munroe (2002) distinguished between 
phase-specific self-efficacy beliefs. They found that three types of self-efficacy are 
relevant to the initiation and maintenance of exercise. First: task self-efficacy, which 
refers to an individual’s confidence in performing essential facets of the behaviour 
related to exercise initiation. Second: coping self-efficacy, which refers to an 
individual’s confidence in performing the task in the face of barriers to the 
maintenance of exercise. Third: scheduling self-efficacy, this concerns an individual’s 
confidence in managing the time demands of exercising regularly. Originally 
proposed as a subcategory of coping self-efficacy, this has been the strongest 
predictor of exercise persistence (Rodgers et al., 2002). This separation of task, 
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coping, and scheduling is vital, especially when considering the use of self-efficacy, 
such as its use in cardiac rehabilitation programmes. However, many researchers 
combine these three types of self-efficacy to reflect generalised self-efficacy. 
Moreover, it is proposed that when using different self-efficacy types, different effects 
at different phases of exercise adoption should be considered (Rodgers et al., 2002).  
These phase-specific beliefs have been widely discussed in the literature; a previous 
cohort study, gathered data immediately after completing cardiac rehabilitation and 
again one month later, in order to examine the relationship between the three types 
of self-efficacy to improve the adherence pre-, intra- and post- cardiac rehabilitation. 
The study found that task self-efficacy, for performing elemental aspects of behaviour, 
was the most changed type of self-efficacy during cardiac rehabilitation and was 
associated with self-reported exercise at the end of cardiac rehabilitation. However, 
scheduling self-efficacy, for performing the behaviour regularly, was most strongly 
related to self-reported exercise post- cardiac rehabilitation (Rodgers, Murray, Selzler, 
& Norman, 2013). McAuley, Pena, and Jerome (2001) found that the weak predictive 
role of self-efficacy for long-term maintenance may result from changes in the 
operationalisation of self-efficacy and an absence of correspondence between the 
type and complexity of the measured task and measured beliefs. In conclusion, self-
efficacy is a complex concept. Patients’ health progression and different settings can 
effectively influence self-efficacy. Therefore, developing the proper type of self-
efficacy relevant to each situation in order to measure self-efficacy in each phase is 
important, in order to understand the changes there-within and avoid 
misinterpretation or overestimation of self-efficacy levels.  
3.5 Measuring Self-Reported Self-Efficacy Questionnaire 
The previous sections have described the construct of and different types of self-
efficacy, and highlighted the importance of self-efficacy as a factor that influences 
effective lifestyle change. This section highlights the most commonly used self-
efficacy questionnaires. Self-efficacy has been found to be an important personal 
determinant of human behaviour (Bandura, 1997). As a consequence, many of the 
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available self-efficacy studies show a growing interest in measuring self-efficacy in 
patients with chronic diseases (Frei, Svarin, Steurer-Stey, & Puhan, 2009). Self-
efficacy has been proven to improve long-term self-management skills (Poortaghi et 
al., 2013).  
There are many of self-efficacy questionnaires such as, general self-efficacy, 
exercise self-efficacy and medication adherence self-efficacy questionnaires. 
However, there are two main categories of questionnaire that measure self-efficacy. 
Firstly, those that address a global, general self-efficacy, such as the General Self-
Efficacy Scale by Schwarzer & Jerusalem (1995). Secondly, those designed to 
measure disease-specific self-efficacy, for example the CSEQ by Sullivan et al. 
(1998). According to Schwarzer and Renner (2009), disease-specific self-efficacy 
questionnaires are brief, accurate and able to assess specific situations within the 
context of large-scale health behaviour screening studies. Unfortunately, there is no 
questionnaire in Arabic that measure self-efficacy among patients with CHD. 
Consequently, the need for valid and reliable Arabic version of self-efficacy tools for 
patients with CHD is substantial for establishing self-management program in Arabic-
speaking countries. There are several instruments used to measure self-reported 
self-efficacy. In reviewing these, there are general self-efficacy scale, an exercise 
self-efficacy scale, the self-efficacy for daily PA questionnaire and the cardiac self-
efficacy scale.  
3.5.1 General Self-Efficacy Scale  
The General Self-Efficacy Scale was developed by Schwarzer & Jerusalem (1995), 
and has been translated from the original German version into 31 languages. It is a 
10-item scale designed to assess self-efficacy. The scale aims to assess a general 
sense of perceived self-efficacy with the stated aim of predicting the ability to cope 
with daily obstacles, as well as adaptation after experiencing stressful life events. It is 
a self-administered scale and usually takes two to three minutes to complete. The 
scaled scores for each question range from ‘not at all true’, which scores (1), to 
‘exactly true’, which scores (4). Studies have shown that the General Self-Efficacy 
Scale has high reliability, stability and construct validity. Cronbach’s alpha ranges 
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from 0.75 to 0.94 across a number of different language versions (Luszczynska, 
Gutiérrez‐Doña, & Schwarzer, 2005; Schwarzer, BaBler, Kwiatek, & Schroder, 1997). 
In addition, a short form of the General Self-Efficacy Scale (GSE-6) was developed 
by Romppel et al. (2013) and was demonstrated to be a reliable and valid instrument. 
Cronbach's alpha was between 0.79 and 0.88. The correlations between the GSE 
scale and other social cognitive variables are high and confirm the validity of the 
scale (Luszczynska et al., 2005).  
The General Self-Efficacy Scale aims to assess the general adult population, 
including adolescents. However, the scale measures just one global dimension of 
self-efficacy with Cronbach’s alpha 0.90 (Ebstrup, Eplov, Pisinger, & Jørgensen, 
2011). In general, the General Self-Efficacy Scale does not observe specific 
behavioural changes, and so the CSES cannot measure specific health-related self-
efficacy. Consequently, it cannot obtain sufficiently complete and accurate 
information to meet the present study’s objectives, including measuring the self-
efficacy of patients diagnosed with AMI. 
3.5.2 Exercise Self-Efficacy Scale  
The Exercise Self-Efficacy Scale is a self-administered 8-item scale developed by 
McAuley, Lox, and Duncan (1993). It measures an individual’s belief in their ability to 
maintain periods of continuous exercise, at moderate intensity, for 40 minutes per 
session, three times a week for the following four weeks. For each item, the individual 
indicates their confidence in their ability to perform such tasks on a 100-point 
percentage scale comprising 10-point increments, ranging from not at all confident 
(0%) to highly confident (100%). To measure the total score for each item of self-
efficacy, calculate the confidence ratings and then divide the total by eight, the total 
number of items in the scale, to produce a maximum probable self-efficacy score of 
100. The scale has an excellent Cronbach’s alpha of 0.98 to 0.99 (McAuley et al., 
2011). Previous studies used the Exercise Self-Efficacy Scale to assess the 
maintenance of self-efficacy, physiological condition and PA in different populations. 
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However, previous studies used this scale to measure continuity in exercise self-
efficacy for four weeks and not, per se, PA behaviour. In addition, previous studies 
used it in relation to exercising for 40 minutes without quitting. In addition, the 
Exercise Self Efficacy Scale measures only exercise, which is part of several 
identified classifications of PA behaviour, including but not limited to other physical 
activities, such as recreational activity, occupational activity and social activity. 
Consequently, the Exercise Self Efficacy Scale is not appropriate with a high-risk 
population such as patients with AMI and it is not appropriate to use this scale or, at 
least, it is difficult to modify it to measure PA in the early recovery phase. 
3.5.3 Self-Efficacy for Daily Physical Activity Questionnaire  
The self-efficacy for daily PA questionnaire was developed by Campbell, Gray, Foley, 
Maddison, and Prapavessis (2016) to measure self-efficacy-related tasks in activity 
behavioural domains among a healthy adolescent population. Example of these 
include at home, at school, at work, during leisure time, and for transportation 
purposes. It consists of 39 items: nine items for school activity, 6 items for 
transportation activity, 12 items for leisure time activity, 6 items for household activity, 
and 6 items for occupational activity. It asks how confident individuals are about doing 
10, 30 and 60 minutes of light, moderate and vigorous intensity activity on five or 
more days per week. Participants respond to each item using a 10-point scale 
ranging from 0% (not at all confident) to 100% (completely confident). Calculating a 
cumulative average from all item responses gives participants scores ranging from 
0% to 100%, with a higher score being indicative of greater self-efficacy.  
The questionnaire measures self-efficacy for PA in a free-living condition in healthy 
adults, making it unsuitable among patients with CHD and it has proven difficult to 
modify if for this context. In addition, this scale includes some sections such as school 
or work which are not appropriate to elderly patients. In addition, the questionnaire 
asks the participants to engage in such activity for up to 60 minutes. Therefore, the 
researcher cannot use this questionnaire in this study.  
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3.5.4 Cardiac Self-Efficacy Questionnaire 
Sullivan et al. (1998) developed the CSEQ, its purpose is to examine the role of self-
efficacy in the physical and role functions of patients with coronary heart disease after 
controlling for the effects of anxiety and depression (Sullivan et al., 1998). In addition, 
CSEQ plays a predictive role for cardiac patients, in relation to cardiac function and 
hospital admission following a coronary event (O’Neil et al., 2013).  
The CSEQ is a self-administered questionnaire consisting of 16 items. It has three 
subscales: 1. control of symptoms, eight items, 2. Maintenance of function, consisting 
of five items, 3. three other items related to weight, smoking and diet. Patients are 
asked to rate their confidence in knowing about or acting on each of the 16 
statements on a 5-point Likert scale (zero = not at all confident, one = somewhat 
confident, two = moderately confident, three = very confident and four = completely 
confident). The CSEQ is a valid and reliable questionnaire; Sullivan et al. (1998) 
reported its reliability as 0.90 for the control of symptoms subscale, and 0.87 for the 
maintenance of function subscale. In addition, (Fors, Ulin, Cliffordson, Ekman, and 
Brink (2014); Sarkar, Ali, & Whooley, 2009) concluded that the CSEQ is valid and 
reliable when used with patients diagnosed with AMI.   
In conclusion, the CSEQ is a disease-specific self-efficacy questionnaire, which 
serves to meet the study’s objectives. CSEQ is a validated, reliable tool and widely 
used questionnaire. In addition, it is suitable for the selected age range in the study, 
for example, from 18 to 75 years. Hence, the CSEQ is a suitable questionnaire for 
data collection in the context of this study and meets the study’s objectives. The 
researcher used CSEQ in this study. 
3.6 Translation and Cross-Cultural Adaptation of Cardiac Self-Efficacy 
Questionnaire  
This section highlights  both the original CSEQ as developed by Sullivan et al. (1998) 
and other available versions of the CSEQ. It then describes the process undertaken 
to translate and adapt the CSEQ. The section also presents participants’ 
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characteristics and the results of the validity and reliability tests of the new version of 
the CSEQ. Due to time limitation, the researcher recruited the sample for validity and 
reliability evaluation from patients with CHD. Therefore, they were not recruited for 
the second study phase (measurement of self-efficacy and activPAL3™ among 
patients with AMI). Consequently, this section presents detailed information regarding 
the study phase one- method and data analysis. 
Recently, the CSEQ had been translated into Swedish (Fors et al., 2014). Fors and 
his colleagues translated and cross-cultural adapted the CSEQ for 288 Swedish 
patients with ACS. Construct validity using confirmatory factor analysis, and 
convergent and discriminant validity were tested. The results revealed that the 
Cronbach’s alpha for all items was 0.89, demonstrating the CSEQ to be a valid and 
reliable measure when evaluating self-efficacy in patients with ACS. In addition, the 
CSEQ has been translated into Thai (Saengsiri, Thanasilp, & Preechawong, 2013), 
Saengsiri et al. (2013) translated and cross-cultural adapted the CSEQ for 280 Thai 
patients with CHD. Evaluation of test of the validity and reliability of the CSEQ found 
that the CSEQ is valid and consistent; the Cronbach’s alpha for all items was 0.92.  
Many studies have focused on the prevalence of CHD risk factors in the Middle 
Eastern countries (Eshah, 2013; Gehani et al., 2014; Khattab et al., 2013), yet few 
studies investigate the impact of self-management on CVD risk factors. In fact, to the 
best of the researcher’s knowledge, no previous studies have explored the role of 
self-efficacy in self-management in Arabic-speaking countries. One of the possible 
reasons for this gap in the literature is the lack of a valid and reliable tool to measure 
cardiac self-efficacy for patients with CHD in Arabic-speaking countries. 
Consequently, it was necessary to undertake a rigorous process of translation and 
cross-cultural adaptation of an appropriate tool in order to measure self-efficacy in the 
course of this study. In addition, an Arabic version of CSEQ is now required to 
measure self-efficacy for further studies that focus on self-management skills among 
patients with CHD. 
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The objectives of the translation and cross-cultural adaptation of CSEQ are: 
1. Translation and cross-cultural adaptation of the CSEQ to Arabic language by 
using the WHO guidelines   
2. Evaluation of the psychometric properties validity and reliability- of the Arabic 
version of the CSEQ  
3.6.1 Method  
The researcher adopted the WHO process of translation and cross-cultural 
adaptation of questionnaires to produce the Arabic version of CSEQ. This followed a 
thorough inspection of a variety of translation methods (Beaton, Bombardier, 
Guillemin, & Ferraz, 2000; Eremenco, Cella, & Arnold, 2005; Guillemin, Bombardier, 
& Beaton, 1993). Before applying the process outlined by the WHO for the translation 
and cross-cultural adaptation of questionnaires, the researcher obtained ethical 
approval from the University of Salford, UK (ethical application HSCR14/120) and the 
Jordan University Hospital (JUH), Jordan. Following that, the researcher recruited 
eighty participants diagnosed with and treated for CHD from JUH, in order to 
undertake a validity and reliability test of the CSEQ. The study recruited participants 
with CHD at JUH and were haemodynamically stable. Of these, a sub group of thirty 
participants was involved in face validity testing. The researcher gave the participants 
information about the aim of the translation process and provided written consent. 
The researcher distributed the questionnaire to and collected from patients once they 
were in a stable condition.   
Participants were included if they were diagnosed with CHD, as confirmed by ECG, 
Troponin level test or coronary angiography. All participants spoke Arabic as their first 
language, were being treated in JUH, were 18 years old or over, and had good 
reading and writing skills and were therefore able to understand and complete the 
questionnaire. Those excluded were patients who had a severe comorbidity disease 
such as cancer, had cognitive disabilities and/or had a history of drug or alcohol 
abuse. 
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3.6.2 Process of the WHO Translation and Cross-Cultural Adaptation of 
Questionnaires  
The WHO guidelines provide a clear, comprehensive and systematic process for 
establishing adaptation of a questionnaire as shown below: 
1. Forward translation: One translator, a health professional, familiar with the 
terminology for the area covered by the questionnaire will translate the original 
CSEQ to the Arabic. The translators should aim at the conceptual equivalent of 
a word or phrase, not a literal translation 
2. Expert panel reviewing:  Bilingual translators in English and Arabic convene for 
translation. The expert panel identifies and resolves inadequate expressions or 
any discrepancies between the forward translation and the existing version 
3. Back-translation: An independent translator, who has no prior knowledge of 
the CSEQ, will translate the CSEQ back to English 
4. Pre-testing and cognitive interviewing: Administration of the produced Arabic 
version of the CSEQ to 10 participants, with implementation of interviews, in 
which the researcher will ask the participants about the clarity of the Arabic 
version 
5. Producing final version: After reaching a simple, clear and comprehensible 
translation and resolving any unclear expressions or any discrepancies, a final 
version is ready. 
6. Documentation: Documentation of the previously described translation steps. 
 
The WHO process of translation and cross-cultural adaptation of instruments is a 
well-established method and has been refined in the course of several WHO studies, 
such as the WHO Quality of Life-BREF, ICD-10 Symptom Checklist for Mental 
Disorders (version 1.1) and Severity of Dependence Scale instruments (WHO, 2014). 
The WHO process of adaptation of the CSEQ consists of six steps (WHO, 2014). 
Conceptual equivalence of translation was established through selecting a specific 
method of translation upon which to develop the target version of the questionnaire in 
the study (Beaton et al., 2000). 
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The aim of the translation and cross-cultural adaptation was to produce an alternative 
language version of an original text. Specifically, this process ensured conceptual and 
item equivalence in each target country, each new language version should be 
relevant, acceptable and understandable to the target population (WHO, 2014). In 
addition, paying attention to semantic and conceptual equivalence of the component 
parts in the original English version, indeed to verify the validity and reliability of the 
concepts, the phrasing and terminology with the target sample was a priority (Beaton 
et al., 2000; Eremenco et al., 2005).  
3.6.3 Application of WHO Translation and Cross-Cultural Adaptation of 
Questionnaires Process 
Before beginning the WHO process of translation and cross-cultural adaptation of the 
questionnaire, the researcher sought permission to use and adapt the questionnaire 
from the author of the CSEQ (Appendix B). WHO process of translation and cross-
cultural adaptation of the questionnaire consists of six stages, as shown in Figure 3.1. 
The original English version of the CSEQ is the gold standard from which all other 
translated version of the CSEQ derives. Following this, the study evaluated of the 
validity and reliability of the CSEQ. The analyses of the data such as descriptive 
statistics for participants’ characteristics were made using IBM SPSS, version 22.   
Stage One: Forward Translation 
ln accordance with the WHO Process of translation and cross-cultural adaptation, two 
Jordanian translators implemented a detailed review of the CSEQ. The first translator 
was a native Arabic speaker, a nurse familiar with self-efficacy and the care of 
patients with CVD. The second translator was a professional translator with no 
medical background. Both translators had some knowledge of English-speaking 
culture, and spoke fluent English, but their mother tongue was Arabic. In order to 
produce a more understandable version, it was essential to provide translators with 
instructions on the concepts in the original version of the instrument. The two 
translators compared the two Arabic translations, and then created an initial 
Consensual Arabic Version (CAV 1). Using this approach supported the conceptual 
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equivalence of the forward translation. In addition, it avoided ambiguity of 
terminology. The researcher instructed the translators to use language to be natural, 
simple, clear and acceptable for Arabic people with CHD. 
During the translation stage, the translators used Modern Standard Arabic (Fusha), 
which is a clear, concise, and acceptable language for the broadest audience 
(Khalaila, 2013). The translators sought a conceptual and cultural equivalent of each 
English phrase, rather than conducting a verbatim translation, and took into 
consideration the definitions of the original items, questions, or sentences, in order to 
translate them into the most relevant form. In addition, the translators avoided using 
jargon, colloquialisms, and idioms.  
Maintaining the cultural equivalent of each sentence is an essential issue during the 
process of translation and cross-cultural adaptation. Accordingly, the translators 
placed a great emphasis on preserving the CSEQ adaptation in the cultural context. 
For example, there was one item asking about “maintain sexual relationship with your 
spouse”. The translators changed this item into another expression that was most 
appropriate given the cultural and norms of society in Middle Eastern countries, 
where the Arabic society accepts the sexual relationships within marital context and 
the government and religion accept or support no other sexual relationships such as 
partnership relationships. Finally, they considered issues of gender applicability. For 
example, item 9 of the CSEQ in the maintain function subscale contains the word 
“maintain”, the Arabic translation of the English word “maintain” was “yohafeth,” which 
is used for male and “tohafeth,” which is used for female. Therefore, the panel 
replaced them with the word “mohafethah” which is noun phrase and can be used for 
both male and female.  
Stage Two: Expert Panel – Review of the Forward Translation        
The expert panel consisted of an additional three individuals: a health professional 
and two translators. All panel members were bilingual (Figure 3.1). The aim of this 
step was to identify any unclear expressions, ambiguous concepts or discrepancies, 
and to compare the forward translation with the original CSEQ. The expert panel 
oversaw the translated version of the CSEQ. The expert panel rejected inappropriate 
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items and alternative words suggested. For example, items 1.2.3 and 4 of the CSEQ 
in the control symptoms subscale contains the word “control”, the Arabic translation of 
the English word “control” was “sytara,” which is used to express the power to 
manage in general, but “tahkom,” is used more frequently in medical and scientific 
fields that express the same meaning. Therefore, the panel replaced the word 
“sytara,” with the word “tahkom,” which is more appropriate. Subsequently, the expert 
panel edited (CAV1). Then, the expert panel achieved a consensus on the Arabic 
version of the CSEQ. This became (CAV 2).  
 
Stage Three: Back Translation into English 
Back translation involved translating the Arabic version of the CSEQ back into its 
original language (English), as a means of comparing the two versions (Wild et al., 
2005). Two independent bilingual translators back translated the Arabic translation 
into English. The two bilingual translators, who were not involved in the forward 
translation stage, grew up in an Arabic-speaking country (Jordan) and completed 
graduate level studies in the UK. None of the translators had any prior knowledge or 
experience of the original version of the questionnaire. As in the forward translation 
process, the back translation process focused on conceptual rather than absolute 
linguistic equivalence. Each translator made a back translation of (CAV 2) to create 
English back translation version 1 (EV1) and English back translation version 2 (EV2). 
The back translators then compared the two English versions to create the 
Consensual English back translation Version (CBV). 
It is important to note that there may be some variations in the wording, as not all 
English words easily translate into other languages. For example, in the phrase 
“somewhat confident’’, the word “somewhat” does not translate easily into Arabic. The 
underlying concept of “somewhat” is “fairly”, therefore an Arabic translation should 
reflect this concept rather than search for a literal translation. The back translators 
removed the response option “Non applicable”, as, after explaining at the beginning 
of the questionnaire that participants should select the most appropriate or closest 
answer; all items have an applicable answer. In addition, the issue of gender in 
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Arabic had considered during translation. Hence, the back translators chose words 
and verbs appropriate to both genders. This involved a considerable number of 
changes to many items in order to capture the original concepts. Consequently, the 
back translator used simple and standard Arabic words to make the CSEQ clear and 
understandable, as presented in Table 3.1: 
Table 3.1  
Comparison of the Original English Items and Back Translated Ones  
Original English Items From Arabic back to English  
 
How confident are you that you know or 
can 
How are you confident that you know 
Control your chest pain by changing your 
activity levels 
Control of chest pain by changing your 
activity levels 
Control your breathlessness by changing 
your activity levels 
Control of your difficult breathing by 
changing your PA 
Control your chest pain by taking your 
medications 
Control your chest pain by using own 
medications 
Control your breathlessness by taking your 
medications 
Control of difficulty breathing by having 
own medicine 
When you should call or visit your doctor 
about your heart disease 
When you are calling or visiting your 
doctor about heart disease 
How to make your doctor understand your 
concerns about your heart 
How to make your doctor understand your 
fears about your heart disease 
How to take your cardiac medications How to take your heart medications 
How much PA is good for your health How much of PA improves your health 
How much confident to  How much you are confident to 
Maintain your usual social activities Maintain your usual social activities 
Maintain your usual activities at home with 
your family 
Maintain your usual activities with your 
family at home 
Maintain your usual activities at work Maintain your usual activities at work 
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Maintain your sexual relationship with your 
spouse 
Maintain your sexual relationship with 
your spouse 
Get regular aerobic exercise (work up a 
sweat and increase your heart rate) 
Get regular exercises (working until 
sweating and increasing heart rate) 
How much is good for you to do: How much is good for yourself to do: 
Lose weight (if you are overweight)  Reduce your weight (if you are obese) 
Stop smoking (if you do smoke) Stop smoking (if you are a smoker) 
Change your diet (if your doctor 
recommended this)  
Changing your diet (if your doctor 
recommended that) 
Not at all confident Not confident 
Somewhat confident Confident fairly 
Moderately confident Moderately confident  
Very confident High confident 
Completely confident Confident completely 
 
 
 
Stage Four:  Pre-testing the CSEQ and the implementation of cognitive 
interviewing  
The expert panel oversaw the consensual English back translation version and the 
original CSEQ, to create the final English CSEQ version. Following that, the expert 
panel compared the final English CSEQ version and (CAV 2), resulting in the 
generation of the consensual Arabic version (CAV 3), (Figure 3.2). In accordance with 
the WHO guidelines (WHO, 2014), the (CAV 3) of the CSEQ was administered to 10 
Jordanian patients diagnosed with CHD in a hospital setting. The language used in 
the translated CSEQ was suitable for a 12-year-old child to comprehend, thus making 
it easily comprehensible for the study participants (Beaton et al., 2000).  
Cognitive interviewing, conducted by the researcher, was utilised to understand how 
respondents process and respond to CSEQ items. Cognitive interviewing is defined 
as “general method that developers of such material can use to critically evaluate this 
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transfer of information in which targeted audience understand, mentally process and 
respond to the presented material” (Willis, 2004, p. 5). The researcher interviewed 
each participant who completed the CSEQ, in order to gain their feedback and ensure 
that all questionnaire items were understandable and included all the expected 
concepts. The researcher asked the respondents regarding the meaning of each 
item, in addition to if they perceived any problems with the written language, format or 
scoring scale.    
The cognitive processes included participants completing the translated CSEQ and 
obtaining their feedback on their understanding of individual questions, for example, 
what they thought the question was asking. What came to mind when they heard a 
particular phrase or term. The researcher asked the participants to repeat the 
question in their own words, give associated response options, and verbalise the 
process they had followed when producing their answers. The participants answered 
these questions for each item. If alternative words or expressions existed for an item, 
the respondent suggested selecting the alternative that best represented their usual 
language. The researcher reviewed any comments made by the respondents and 
made any necessary revisions. At the end of the cognitive interviewing process, the 
evaluation of a final translated version was ready. 
Stage Five: Final version of the CSEQ 
Once a linguistically and conceptually equivalent version of the CSEQ became 
available in Arabic (Appendix C), it was subsequent possible to examine validity and 
reliability. This step is important because when translated into other languages, the 
validity and the reliability of the items from the original CSEQ do not always remain 
intact. Therefore, it was necessary to determine validity testing and test-retest 
reliability for the translated CSEQ version. This process involved making minor 
changes to CSEQ items, in order to retain the spirit of the original concepts, and the 
adaptation of simple formal Arabic words to make the questionnaire clear and 
comprehensible (Beaton et al., 2000). 
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Stage Six: Documentation  
The researcher reported the development of the final version of the Arabic CSEQ with 
the review process of the CSEQ translation. All the stages of translation and cross-
cultural adaptation were successfully completed and documented. After completing 
the six steps, the researcher implemented the validity and reliability evaluation for the 
CSEQ, (Figure 3.1).  
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Figure 3.1 Flowchart describing the WHO process used for translation and cross-
cultural adaptation of the CSEQ 
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3.6.4 Key Points to Ensure Rigour 
The more rigorous and inclusive the process of translation, the more likely the 
translation and cross-cultural adaptation will achieve equivalence between cultural 
groups (Hilton & Skrutkowski, 2002). Ensuring rigour starts with the application of a 
well-known method of translation (WHO, 2014), and selecting translators who are 
fluent in both English and Arabic languages and cultures to preserve meanings in the 
translated materials. The translators were familiar with Modern Standard Arabic 
Fusha. The experience of these translators in both Modern Standard Arabic Fusha 
and English helped them to provide more acceptable and understandable versions 
alongside the equivalent meaning of the original version.  
The WHO guidelines state that in the forward translation step, the translator should 
be knowledgeable of English-speaking culture, but his or her first language should be 
the primary language of the Arabic culture. However, in the back translation step, the 
first language of the independent bilingual translator should be English and he should 
be knowledgeable about the questionnaire language. However, due to the shortage 
of bilingual translators having English as their first language, translators for whom 
Arabic is the first language and who are fluent in both English and Arabic were 
considered. Therefore, the researcher contacted Arabic bilingual translators from the 
target country (Jordan) who had been resident in the UK for a number of years and 
were fluent in and familiar with both English and Arabic languages and cultures. 
Therefore, the forward translators’ specialities were nursing and the English language. 
The expert panel’s specialities were nursing, English language and business 
administration, and the back translators had business administration and nursing as 
their specialities. 
3.6.5 Evaluation of Psychometric Properties  
This section presents an evaluation of the psychometric properties of the Arabic 
version of the CSEQ. Due to time limitations, the researcher carried out only face and 
content validity testing, in addition to test-retest reliability for the Arabic version of the 
CSEQ.  
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The researcher recruited a total of 80 patients with CHD for test-retest reliability. The 
participants’ characteristics are presented in Table 3.2. All participants completed the 
CSEQ. Before receiving the completed questionnaires, the researcher checked 
completion of all questionnaires from the respondents. Consequently, there were no 
missing data. Completion of the CSEQ took approximately 10-15 minutes. No items 
were considered confusing, nor were any multiple answers found. This indicates that 
the CSEQ had an excellent acceptability rating.  
Validity  
Achieving successful translation is essential in order to ensure consistency in the 
validity between the original CSEQ and its translation. However, successful 
translation does not ensure that the questionnaire has the same of face and content 
validity as the original CSEQ (Beaton et al., 2000). According to Anthoine, Moret, 
Regnault, Sébille, and Hardouin (2014), a review of published articles describing the 
sample size for validation studies from 2009 to 2011 showed that there is no clear 
method or justification for the determination of sample size for validation testing. 
According to Beaton et al. (2000) guidelines for the process of adaptation of self-
report measures, a total of 30 to 40 subjects is sufficient to test the validity for a pre-
final version of a new questionnaire. Consequently, the researcher tested face validity 
of the Arabic version of the questionnaire on 30 patients with CHD. Due to time 
limitations and the difficulty of collecting the target sample of patients with AMI, the 
researcher decided to evaluate the validity and reliability tests on patients with CHD.  
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Table 3.2 
Demographics and characteristics of patients diagnosed with CHD (study phase one)   
Characteristics Frequency Mean 
 
Age   57.4 ± (6.9) years 
 
Sex    
Male  
Female  
 
55 
25 
 
68.8% 
31.2% 
Education level 
Higher diploma or less 
Bachelor degree 
Postgraduate degree 
 
33 
38 
9 
 
41.3% 
47.5% 
11.3% 
 
Marital status  
Single/Widowed  
Married  
Divorced 
 
14 
58 
8 
 
17.5% 
72.5% 
10% 
 
Employment  
Employed  
Unemployed  
Retired  
Self-employed  
 
17 
11 
30 
22 
 
21.3% 
13.8% 
37.5% 
27.5% 
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In order to implementing face validity, the researcher met the participants in the 
meeting room in JUH. The researcher asked each participant completed the 
questionnaire for their understanding of the meaning of each questionnaire item as 
well as whether or not they had problems with the questionnaire format, instructions 
or response scales. The participants expressed their satisfaction with the 
transparency of the CSEQ and the ease of its completion. The researcher asked 
participants whether they had any comments or suggestions that could make the 
questionnaire more comprehensible. More than two thirds of participants (21 
participants) expressed their satisfaction and they did not suggest or provide 
improving comments. Five participants commented that it would be desirable to 
modify the alternating scoring system and add numbers for each choice. Two 
participants suggested changing the colour to separate each section and make the 
questions in bold font and two participants suggested to a few changes in questions 
number 8 and 13.  
Regarding content validity, a panel of five experts from the school of nursing at the 
University of Jordan evaluated the relevance between the original and Arabic 
versions of the CSEQ by rating the degree of relevance of each item on a four-point 
scale: 1 – irrelevant, 2 – somewhat relevant, 3 – quite relevant, and 4 – highly 
relevant. The ‘relevance rating score’ was calculated based on the number of items 
rated by the experts, and the content validity index (CVI) was computed according to 
the proportion of experts that rated the item’s relevance at either three or 4 on the 
scale. The Scale-level Content Validity Index (S-CVI), was accepted at CVI > 0.80 
(Polit & Beck, 2012). The average degree of relevance for the questionnaire items 
used in this study was 80%, which indicates that the Arabic version of the CSEQ was 
an accurate reflection of the English version. The CVI was found to be 1.0, which also 
indicates an excellent level of content validity for the Arabic version (Polit & Beck, 
2012). 
Reliability  
Using the IBM SPSS application version 22, the researcher evaluated the test-retest 
reliability. A value of more than 0.7 is considered acceptable but more than 0.8 is 
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preferred (Pallant, 2010). Test-retest stability was measured by the Intraclass 
Correlation Coefficient (ICC), which is the proportion of total variation that is between-
subjects variation, ICC is considered acceptable if it is equal to or greater than 0.7 
(Terwee et al., 2007). According to Shoukri, Asyali, and Donner (2004) many factors 
determine the sample size for evaluation of test-rest reliability such as, number of 
raters, number of subjects, confidence interval, cost, and time for data collection. 
Based on the number of raters the planned ICC is between 0.7- 0.9 and to minimize 
the variance of ICC, 50 to 58 participants is sufficient for implementing test-rest 
reliability. Hence, the researcher decided to recruit 80 participants to complete the 
Arabic version of the CSEQ. All participants had been diagnosed with CHD, were 18 
years old or over, and were able to read and write in Arabic. The researcher 
distributed the CSEQ to each participant at two different time points: directly after 
their enrolment in the study, to complete the CSEQ independently after admission to 
the medical unit, and 24-48 hours after receiving the first questionnaire. The 
participants completed and returned the questionnaire after 10-30 minutes. The 
period between the first and second administration of the CSEQ to the participants 
was two days, and the researcher ensured that no interventions were applied that 
might have been able to increase self-efficacy between the two administrations. 
The Cronbach’s alpha score for the Arabic version of the CSEQ was 0.846. This is 
consistent with a similar study of the Thai version of the CSEQ (0.92) (Saengsiri et 
al., 2013), including the original study, 0.90 for the control of symptoms subscale, and 
0.87 for the maintenance of function subscale (Sullivan et al., 1998). The internal 
consistency of all CSEQ items was greater than 0.7. Moreover, the internal 
consistency of the three individual parts of the CSEQ ranged from 0.711 to 0.841. For 
the first subscale, which focuses on controlling symptoms (8 items), Cronbach’s alpha 
was 0.841. For the second subscale, which considers the maintenance of function (5 
items), it was found to be 0.715 and for the third subscale, which comprises three 
items related to a healthy lifestyle, it was calculated as 0.711, (Table 3.4). The 
researcher evaluated the test-retest reliability of the CSEQ by using two-way mixed 
ICC. The ICC score for the Arabic version of the CSEQ was 0.929. The ICC for the 
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three subscales of the CSEQ ranged from 0.835 to 0.895, the ICC values of ≥ 0.5 are 
considered good (Pallant, 2010), (Table 3.3).  
Table 3.3   
The Arabic Version of CSEQ Subscales Test Retest Reliability and Internal 
Consistency  
CSEQ and Subscale Range Cronbach’s 
alpha 
ICC (95% CI) 
CSEQ ( All subscales)  0-64 0.846 0.929 (0.889- 0.954) 
Subscale 1: Control 
symptoms part  
0-32 0.841 0.895 (0.837-0.933) 
Subscale 2: Maintain 
function part  
0-20 0.715 0.845 (0.758- 0.901) 
Subscale 3: Healthy 
lifestyle part  
0-12 0.711 0.835 (0.742- 0.894 ) 
 
3.7 Conclusion  
Self-efficacy has different types of questionnaire, such as general or disease-specific 
questionnaires, in addition to phase-specific self-efficacy questionnaires. CSEQ is 
one of the most widely used disease-specific questionnaires. Therefore, the 
researcher selected the CSEQ for use to measure self-efficacy in the present study. 
However, there is no available Arabic version of CSEQ. Therefore, the researcher 
applied the WHO process of translation to produce an Arabic version of the CSEQ. 
The researcher successfully translated and cross-cultural adapted the Arabic version 
of the CSEQ. Further, the evaluation of the Arabic version of CSEQ showed to be a 
valid and reliable tool.   
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Chapter Four: Methodology and Method  
4.1 Introduction  
The previous chapter presents an overview related to self-efficacy, behaviour change 
theory and measuring self-reported self-efficacy. In addition, a description of the 
translation process of the CSEQ (study phase one) and validity and reliability testing 
were presented. This chapter begins with methodology and research method of the 
study phase two. In addition, the chapter provides a description of a pilot study and 
an explanation of the data collection procedure in chronological order. Finally, the 
chapter presents a section on data management and a summary of the chapter.  
4.2 Methodology  
Research Paradigm     
Both research paradigms and philosophy influence the research methodology. It is 
important to explore them to select and use an appropriate study design and data 
collection procedure. A paradigm has been defined as “the basic beliefs, systems, or 
the world view that guide the investigation, not only in choice of methods, but in 
ontologically and epistemologically fundamental ways” (Denzin & Lincoln, 1994, p. 
105). According to Teddlie and Tashakkori (2009), researchers in the social and 
behavioral sciences use one of three main categories: quantitatively oriented, 
qualitatively oriented, and the mixed methodology. After reviewing these approaches, 
the researcher considered the use of quantitative method was essential to meet the 
study’s objectives. 
Quantitative approaches using positivist research methods include tests and 
experiments, which can be controlled and used in measurements to support a 
hypothesis. If such an approach is included in the research, control involves imposing 
conditions on the research situation so that bias is minimised and precision and 
validity are maximised (Polit & Beck, 2012). In addition, this approach reduces 
research topics as far as possible to simple questions with quantifiable answers. For 
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example, if the researcher is interested in exploring the relationship between diet and 
cardiac disease, quantitative approaches consider many steps to control other 
variables that contribute to cardiac disease, such as stress or smoking. The results 
are analysed to produce quantifiable, statistically significant data. The results of 
quantitative research are intended to be generalisable (Polit & Beck, 2012).   
The study used the quantitative method, as the researcher believes that the analysis 
of the changes in and the relationship between self-efficacy and PA level among 
patients with AMI in the early recovery phase is feasible through using questionnaires 
and body-worn activity monitors. The questionnaires and research tools used in the 
study are valid and reliable for the purposes of collecting the data, and are sufficient 
to meet the study’s aims. Further, there was no need to implement interviews with the 
participants.   
4.3 Method  
The principles of Bandura’s self-efficacy theory underpinned the present study. This 
study used a descriptive repeated measures design. The sample consisted of all 
patients admitted to a Jordanian Coronary Care Unit (CCU) with a confirmed AMI 
after receiving treatment with either PPCI or thrombolytic therapy. The researcher 
used the Arabic version of the CSEQ to measure self-efficacy. The researcher gave 
the CSEQ to patients at three time points: baseline, 2 weeks (Time 1), and 6 weeks 
(Time 2) after hospital discharge. In addition, PA was measured using a body-worn 
activity monitor (activPAL3™ monitor). Patients were asked to attach the activPAL3™ 
monitor to their leg and wear the device for one full week at two different time points 
Time 1 (2 weeks) and Time 2 (6 weeks) after hospital discharge. This study thereby 
supports health policymakers in establishing future cardiac management programmes 
by addressing the importance of self-efficacy and PA among patients with AMI, in 
order to help patients with AMI to increase their adherence to PA after treatment in 
the early recovery phase.  
The activPAL3™ data were downloaded by the activPAL3™ software application 
package version 7.2.32, and the data were then moved to Microsoft Office Excel 
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2010 spreadsheet software. Subsequently, the collected numerical data were 
analysed using IBM SPSS version 22, comparing each group of data at Time 1 and 
Time 2 by using paired t-test, and using repeated measures ANOVA to compare 
more than two groups of data. The researcher used the Pearson or Spearman 
correlation coefficient to determine the relationship between self-efficacy and PA level 
and carried out further analysis using the MATLAB 2015 application for calculating 
PA patterns.  
4.3.1 Study Setting   
The implementation of the study was at JUH, Amman, Jordan. JUH is one of the most 
specialised, advanced technological medical centres in the public sector, and is a 
tertiary hospital with over 500 beds. JUH patients include people who are referred to 
the hospital by the MoH, employees of the University of Jordan and their dependents, 
and the employees of private firms with whom JUH has contractual agreements, as 
well as some independent private patients. JUH receives patients’ referral from 
almost all the cities in Jordan. It holds 5.8% of the total number of hospital beds in 
Jordan and accounts for 4.6% of all hospital admissions (MoH, 2014). JUH has an 
occupancy rate of 77% and employs 2% of the physicians in Jordan (MoH, 2014). 
Therefore, the researcher chose JUH to collect the study data, as it is one of the 
largest hospitals in Jordan and receives patients with AMI referrals from cities across 
the country. 
The CCU consists of 12 beds.  JUH performs more than 4,000 cardiac catheterisation 
procedures annually, including coronary angiography, PCI, PPCI procedures and 
CABG operations. In addition, the JUH includes two cardiac catheterisation 
laboratories and six cardiac outpatient clinics. Once patients with AMI are medically 
stable, they are transferred to - a regular unit- the Medical Cardiac Unit (MCU). The 
MCU consists of 52 beds. In addition, the MCU receives many patients with other 
cardiac conditions, such as heart failure, patients with cardiac arrhythmias and HTN. 
The researcher recruited all patients from the CCU and the MCU. Therefore, the 
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researcher decided to collect the data from JUH, because the JUH could enable the 
research to recruit the sample required for the study. 
 
4.3.2 Background to the Cultural Context of Jordan  
This section aims to provide an overview of the research context, which is Jordan. In 
order to gain an in-depth understanding of the study findings, it is pertinent to explain 
the findings in their socio-cultural context and in relation to the lifestyle in Jordan. 
Thus, this section sheds some light on Jordan's modern history, the demographic 
data and cultural aspects, including the economic and in addition, an explanation of 
the health care system.  
4.3.2.1 Jordan and its Position in the Global Context 
1921 marked the end of Ottoman and the Transjordan Emirates of Jordan was 
established (Al-Ramahi, 2008), Jordan gained its independence from Britain in 1946 
(Cleveland & Bunton, 2016). Tribalism still has a major role in the political, social and 
cultural life of Jordan, in order to protect the norms and traditions of the Jordanian 
community (Al-Ramahi, 2008), such as social activities and marriage. The culture of 
Jordan and its organisation are very similar to those of the Arab world in general.  
Jordan is located in the Middle East with the West Bank to the west, Syria to the north, 
Iraq to the east and Saudi Arabia to the east and the south (Figure 4.1). Jordan is a 
small Arab country in the Middle East, covering 89,318 square kilometres, almost 
equal to an area of Scotland. Administratively it is divided into twelve governorates: 
Ajloun, Aqaba, Balqa, Karak, Mafraq, Amman, Tafila, Zarqa, Irbid, Jerash, Ma’an and 
Madaba (Department of Statistics/ Jordan, 2015).  
Arabic is the predominant spoken language, and Arabs used it extensively in 
conversations and in daily life. Approximately, 430 million people throughout the 
Middle East and North Africa speak Arabic (Roudi-Fahimi & Kent, 2007). In Jordan, 
English is taught to all students and is widely spoken (Department of Statistics/ 
Jordan, 2015).  
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Figure 4.1 Map of Jordan (downloaded from www.emapsworld.com) 
 
4.3.2.2 Population  
2014 statistics show that the total population of Jordan was 6.7 million - 82.6 % of the 
population was classified as urban, with the majority (70%) concentrated in three 
main regions:  Amman - the capital (35% of the country’s population), Zarka, and Irbid, 
whilst the rural population makes up 17.4%. The population density was 7,532 
persons/km2 (Department of Statistics/ Jordan, 2015). The family size is decreasing 
since 1979 to about six members per family. Kinship relationships are patriarchal, and 
extended family ties govern social relationships and tribal organisation (Al-Ramahi, 
2008).  
The population is growing rapidly, at a rate of approximately 2.2% every year, and it 
is a relatively young population, with about 60% aged between 15 and 64 years and 
only 3.2 % of the population being over 65. The percentage of the total population 
who are male is 51.5 % (Department of Statistics/ Jordan, 2015). The birth rate is 28 
per 1000 and the death rate is 6 per 1000 (Department of Statistics/ Jordan, 2015). 
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The life expectancy of the Jordanian population is estimated to be 72.4 years for men 
and 76.7 for women (MoH, 2014), which is less than some other countries, for 
example the UK - 79 years for men, and 82 for women (WHO, 2009).  
Jordan is predominantly an Islamic country. The majority of Jordanians are Muslim 
(92%), with only 6% being Christians (Department of Statistics/ Jordan, 2015). The 
culture of Jordan is based on both Arabic and Islamic elements with significant 
Western influence (Al-Ramahi, 2008). Islamic rules shape most Arabic cultural and 
social values, which then shape most traditional lifestyle values and customs, 
including values associated with communication. Many Jordanian laws such as those 
of a hereditary nature or related to marriage are based on the Quran and the Hadith 
(a collection of Mohammed's sayings). The most important Muslim practices are the 
Five Pillars of Islam. One of the five essential Pillars practiced by Muslims is the 
recitation of prayers five times a day (Salat). Mosques announce calls to prayer 
publicly.  
The month of Ramadan, the ninth month of the Islamic calendar, is a time of fasting 
from sunrise until sunset (The Holy Quran, Sura 2: Versus 183-185). Most public 
restaurants do not open for business until just before sunset. Therefore, during the 
month of Ramadan, the lifestyle changes, and most people are awake at night (during 
which they are permitted to drink and eat) and asleep in the afternoon (during which 
they are fasting from drinking and eating).  
Jordanian people hold traditional opinions regarding the social roles of males and 
females and believe that men are responsible for providing the family income and 
making financial decisions while women's primary role is housework and childcare. 
This patriarchal structure is a cultural lifestyle born of Jordanians' values, beliefs, and 
norms, which therefore justifies male dominance in all social spheres (Al-Ramahi, 
2008). According to this perspective, men's dominance is encouraged in all social 
organisations, especially the families (Khalaf et al., 2010).  
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4.3.2.3 Socio-Economic Development  
The Jordanian individual income is classified falling in the lower-middle income group, 
the country has an income per capita of 5,815 US$ (WHO, 2015d), which is lower 
than many other countries, such as the UK, which sits at 37,340 US$ (WHO, 2012b). 
The retirement age is 60 years, but the early retirement age in Jordan can be 50 
years for both men and women (Social Security Corporation/Jordan, 2014 ). The 
average wage for males is 673 Jordan Dinar and for females, it is 607 Jordan Dinar. 
The percentage of female workers is 23.9%. Unemployment among the Jordanian 
labour force over the age of 15 years runs at 11.9% (males 10.1% and females 
20.7%) (Social Security Corporation/Jordan, 2014 ).  
The climate of Jordan is of the Eastern Mediterranean type, which is characterised by 
being hot and dry in summer, cold and humid in winter, with annual average 
temperatures ranging from 12 to 25°C and summertime highs reaching 40°C in the 
desert regions (United Nations Development Programme, 2013). Jordan’s only 
seaport is Aqaba. Jordan suffers from a shortage of water, and indeed this is the 
gravest environmental challenge that Jordan faces today. Water is the decisive factor 
in the population/resources equation. On a per capita basis, Jordan has one of the 
lowest levels of water resources in the world (United Nations Development 
Programme, 2013).  
The transportation system in Jordan comprises roads, airports, and one port. There 
are conventional buses and extensive fixed-route “servis” (share-taxis, up to five 
passengers) in the main cities. The servis are licensed, with a standard fare scale 
(ranging from 0.3 to 7 US$ for each inter-city trop and 0.2 to 0.5 US$ for intra-city 
travel) (Land Transport Regulatory Commission, 2016), but there are no fixed pick-up 
or set-down points. Buses are the main means of inter-city transport in Jordan (Land 
Transport Regulatory Commission, 2016). There are no longer any scheduled 
passenger trains running in Jordan. 
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4.3.2.4 Healthcare Sector in Jordan 
Jordan has one of the most modern healthcare infrastructures in the Middle East 
(MoH, 2014). The healthcare sector In Jordan consists of 104 hospitals, which are 
divided into four main sectors: MoH (public hospitals), Royal Medical Services 
(military hospitals), university teaching hospitals and the private sector (MoH, 2014).  
MoH is the major single institution financing and providing healthcare services in 
Jordan (Department of Statistics/ Jordan, 2015). The MoH owns and operates 29 
hospitals in 11 governorates, with 3,456 hospital beds, accounting for 37% of total 
hospital beds in Jordan. In terms of utilisation, 43% of inpatient care and 45% of 
outpatient care occurs within its hospitals (Department of Statistics/ Jordan, 2015). 
Second: Royal Medical Services mainly provide secondary and tertiary care services. 
The Services have has 10 hospitals (7 general and 3 specialist), with 1,801 beds, 
representing 19% of the hospital beds in Jordan with an occupancy rate of 79% 
(Department of Statistics/ Jordan, 2015). Third: private sector accounts for 36% of 
hospital beds and 56% of hospitals with an occupancy rate of 46.2% (MoH, 2014). In 
addition, the private sector employs 61.8% of all physicians, 93% of all pharmacists, 
71% of all dentists, and 52% of all nurses. This sector continues to attract significant 
numbers of foreign patients from nearby Arab nations (MoH, 2014). Forth: university 
teaching hospitals include two hospitals: King Abdullah University Hospital. The total 
bed capacity of the hospital is 650 beds (MoH, 2014). The hospital serves as a 
referral hospital for all public sector hospitals in the Northern Region. More than 85% 
of the hospital admissions are for patients referred by the MoH and the Royal Medical 
Services. The second university teaching hospital is JUH. JUH was established in 
1971 under the name of Amman Grand Hospital, and was renamed JUH in 1975 after 
it was affiliated with Jordan University and its medical school (MoH, 2014). Though 
the healthcare system in Jordan consists of these four main sectors, none of these 
sectors has a well-structured cardiac rehabilitation programme (Eshah, 2011). 
The total expenditure on health services per capita in 2014 was around 798 US$, 
7.5% of the gross domestic product, which is considered high. In the UK, for example, 
in 2014 the total expenditure on health services per capita accounted for about 3,377 
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$ US, which was 9.1% of the gross domestic product (WHO, 2015e). The physician 
and nurse ratios per 10,000 heads of population were 30 and 39 respectively 
(Department of Statistics/ Jordan (2015). For comparison, the equivalent UK statistics 
for physician and nurse ratios were 27 and 81 per 10,000 respectively (WHO, 2009). 
Although Jordan has a lower proportion of nurses, then, it has a slightly higher 
proportion of physicians than the UK.  
In conclusion, this section provides an explanation of the context of this study. It is 
vital to be aware of cultural and socio-economic considerations within Jordan, as 
these influence the results and, subsequently, the discussion. Although many factors 
enable individuals to increase PA level such as, religion and weather, other factors, 
such as conservative norms and transportation systems decrease PA levels among 
the Jordanian people. In addition, the health care system needs to face many 
challenges and needs more improvements.  
4.3.3 The Sampling Process and Sample  
Sampling is the process of selecting a portion of the population to represent the entire 
population (Polit & Beck, 2012). A sample is a subset of population elements, and 
sampling design is classified as either probability sampling, which involves random 
selection in choosing the elements and each element in the population has an equal, 
independent chance of being selected, or non-probability sampling, which involves 
non-random selection, and some elements do not have a chance of being included 
(Polit & Beck, 2012). 
There are several approaches to sampling: probability sampling, such as simple 
random sampling, stratified random sampling cluster sampling, and systematic 
sampling, in addition to non-probability sampling such as convenience sampling, 
quota sampling, consecutive sampling, and purposive sampling. Although the JUH 
receives patients with AMI from all cities in Jordan and all patients with AMI have the 
opportunity to participate in the study, convenience sampling was chosen because 
this is used primarily when the participants are conveniently available and accessible 
(Polit & Beck, 2012). Data were collected between March and December 2015. 
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However, consecutive sampling might be considered if the researcher collected the 
data from other major hospitals in Jordan. In conclusion, this study focused on 
particular characteristics among patients with AMI that were of interest according to 
the inclusion and exclusion criteria, which best enabled the researcher to meet the 
research objectives. Hence, the researcher decided to select convenience sampling 
as a sampling method in order to help meet the study objectives.  
Sample Size 
Convenience sampling, a form of non-probability sampling, was utilised in this study. 
The researcher recruited one hundred patients with AMI from JUH for the purpose of 
assessing self-efficacy and measuring PA behaviours. A preliminary power analysis 
was conducted to determine the numbers needed for the proposed analysis in this 
study (Polit & Beck, 2012). 
Based on a similar study of cardiac self-efficacy conducted by Sarkar et al. (2009), 
the mean cardiac self-efficacy score at Time1 would be 30 out of 60 and the 
proposed difference of 5, to give us a mean cardiac self-efficacy score at Time 2 of 
35 out of 60, which would be clinically significant. The standard deviation for this 
measure is 14. Using this power analysis calculation showed that 82 participants 
would be needed for 80% power to show the association between self-efficacy and 
free-living habitual PA variables.  
No previous studies used body-worn activity monitors among cardiac patients in 
Jordan. Therefore, the rationale for the sample size in this study was informed by 
power calculations adopted in previous studies that used body-worn activity monitors 
among cardiac patients (Cowie et al., 2011). From looking at published data, the 
researcher proposed that mean steps per day at Time 1 would be 2,000 and change 
in mean steps per day would be 500 in Time 2. The standard deviation (SD) for this is 
1,000, and a power analysis concluded that 32 participants are required for 80% 
power.  
To account for attrition, the researcher added an additional 20% to the calculated 
sample size. Consequently, 82 patients are enough to form a suitable target sample. 
Therefore, the researcher decided that 100 participants would be an appropriate 
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sample size, as it allowed for dropout. In addition, the power analysis indicated that a 
sample of 100 patients with AMI would be sufficient to show changes in self-efficacy 
and PA behaviours at two time points, Time 1 and Time 2, and to assess the 
relationship between these two variables, with a significant interval of 5% and a 95% 
confidence interval level. 
Inclusion Criteria 
All patients admitted to the CCU of the JUH with a confirmed first diagnosis of AMI, 
using standard ESC criteria (Thygesen et al., 2012), were eligible for the study.  It 
was also necessary that participants were over 18 years old, able to read, 
comprehend and write in Arabic, be medically stable (free of chest pain, 
haemodynamically stable, clear site of catheterisation and transferred to the MCU), 
and willing to give informed consent. 
Exclusion Criteria  
 
The researcher excluded any participants with illness or an injury that might prevent 
them from participating in the regular daily PA, such as joint-replacement surgery less 
than three months previously, lower back pain or surgery or other musculoskeletal 
problems, which might impede free-living PA. The researcher also excluded 
participants if they met any of the following criteria:   
 Patients with AMI with heart failure (ejection fraction of less than 35%) 
(McMurray et al., 2012)  
 Patients with other cardiac disease, such as valvular disease or 
pericarditis  
 Other co-morbidities (life-threatening, infectious, uncontrolled or 
exacerbated by PA) 
 Patients have mental health problems or learning disabilities. 
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4.3.4 Tools for Data Collection     
This section provides a detailed discussion of the research tools used in this study, 
including a demographic data sheet, a medical-record data sheet, a CSEQ, a body-
worn activity monitor, and a daily diary for chest pain.   
Sociodemographic Data Sheet  
A sociodemographic data sheet is a single form designed by the researcher for this 
study (Appendix D). The recruited patients completed the document in order to obtain 
demographic information about their age, gender, marital status, educational level 
and employment status. These data helped the researcher to identify the participants’ 
characteristics. The researcher assessed the homogeneity of the sample in each 
group in the demographic variables. In addition, the research compared the 
difference of the sociodemographic data between the participants of the study and 
the patients with AMI who refused to participate in the study. The researcher 
collected this data once at baseline time only. 
Medical-Record Data  
The researcher recorded medical data, such as the patients’ diagnosis date and type 
of treatment, for example PCI, PPCI, and medical therapy from the patients’ files. The 
researcher upon arrival at the OPD obtained the patients’ BMI. The researcher 
calculated BMI manually. BMI = weight (kg) / [height (m)]2. The researcher calculates 
the BMI through dividing the individual’s weight in kilograms by the square of their 
height in metres. BMI is simple to obtain and has been shown to be a reliable tool for 
assessing overweight compared to other measurements (CDC, 2015 ). The 
researcher used the weight and height scales available in the outpatients’ cardiac 
clinic.  
The Cardiac Self-Efficacy Questionnaire 
Self-efficacy levels were measured by using a validated and reliable self-reporting 
CSEQ with Cronbach’s alpha scores of 0.90 for control symptoms and 0.87 for 
maintenance function themes (Sullivan et al., 1998). CSEQ is used widely in the 
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literature for assessing self-efficacy patients with cardiac disease (Allahverdipour, 
Asgharijafarabadi, Heshmati, & Hashemiparast, 2013; Fors et al., 2015; O’Neil et al., 
2013; Sarkar et al., 2009; Sol et al., 2011). In addition, CSEQ is a disease-specific 
self-efficacy questionnaire that can provide accurate information regarding patients 
with AMI ability when they have to accomplish disease-specific situations.  
After obtaining permission from the Author (Appendix B), the researcher translated 
the self-efficacy questionnaire from the original English version into Arabic, in order to 
make it conceptually equivalent for the targeted sample. Before using the translated 
CSEQ, evaluation of reliability and validity tests showed that, the Arabic version of 
CSEQ is valid and reliable with Cronbach’s alpha scores of 0.85, (see section 3.6.5).  
Daily Diary for Chest Pain 
According to Bandura, physiological and affective states are one of the four sources 
of self-efficacy, as individuals usually rely on their somatic and emotional condition 
when judging their capabilities. The researcher interpreted patients experiencing 
symptoms such as chest pain as a sign of susceptibility to lower performance ability. 
Hence, the researcher developed and used a daily diary for chest pain, which made 
note of factors such as the duration of chest pain, frequency and intensity at Time 1 
and Time 2, as a tool to measure physiological and affective states (Appendix E). The 
researcher asked all participants to complete this daily dairy, and in the event that 
they did not feel pain, to return the daily diary with a blank entry. The participants 
completed the daily diary for chest pain if they felt chest pain. They described the 
pain, such as the pain for 2 minutes, once per day and 2/10 intensity. In order to link 
these data with changes in PA of participants, the daily diary for chest pain was 
returned along with the activPAL3™ monitor and CSEQ. 
Using the activPAL3™         
The activPAL3™ monitor (PAL Technologies.Ltd. Glasgow. Scotland) is a single 
thigh-mounted accelerometer-based device, as shown in Figure 4.2. The activPAL3™   
monitor measures bodily acceleration using a triaxial accelerometer, it also 
incorporates an integrated microprocessor, which performs data reduction and 
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manages data storage. The activPAL3™ monitor is worn at the midpoint of the 
anterior aspect of the thigh; it is lightweight (15 g) and small (53×35×7 mm). The 
activPAL3™ monitor is attached to the skin using a PALstickie™. These are self-
adhesive patented dual layer hydrogels that are recommended for the attachment of 
the activPAL3™ monitor. Participants also use an additional waterproof bag to cover 
the adhesive pad in the case of exposure to water. The activPAL3™ data outcome 
presents the data in different colours, such as red for walking, green for standing and 
yellow for sitting/lying positions across the measurement days and hours (Figure 4.3 
and Figure 4.4).  
 
 
 
Figure 4.2 activPAL3™ body-worn activity monitor downloaded from (Clarke-Moloney 
et al., 2007, p. 489) 
When the monitor was first put on by the researcher, all participants were given 
written and verbal instructions about the fact that the monitor had to be removed 
temporarily during periods of showering, bathing, or swimming. In normal 
circumstances, the activPAL3™ monitor is small and very light and does not interfere 
with normal activity or work. However, occasionally a participant was uncomfortable 
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or unhappy wearing the monitor. If this occurred, the researcher advised the 
participant to take off the monitor for a short period. The participant also had the 
option to take the device off and end data collection. 
The activPAL3™ monitors were used to measure PA in this study. Each participant 
was provided with an activPAL3™ monitor and a detailed demonstration of how to 
wear and remove the device (Appendix F). Participants were instructed to attach the 
activPAL3™ monitor for a full seven days at two time points, two weeks and six 
weeks after hospital discharge, for 24 hours per day (including when sleeping), and 
only to remove the device before swimming or doing any other water-based activities. 
The activPAL3™ monitor instructions and guidelines were given to the participants 
when attaching the activPAL3™ monitor in the outpatient clinic at two weeks and six 
weeks.  
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Figure 4.3 Example of downloaded activPAL3™ monitor data (hourly)  
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Figure 4.4 Example of downloaded activPAL3™ monitor data (daily)  
 
Charging and Programming the activPAL3™     
The activPAL3™ is able to record data for up to 14 consecutive days, powered by an 
internal rechargeable battery. A docking station recharges the device through 
connecting a docking cable from the docking station to a USB port on a computer. 
Then the activPAL3™ device is placed in the docking station, which has slots for 
programming, data transfer, and charging. Complete charging takes around 3 hours. 
An orange light on the device shows when the battery is charging and switches off to 
indicate that the device is fully charged.  
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Prior to use on a participant, a fully charged activPAL3™ is programmed to start 
recording new data. Programming the device requires the use of the activPAL3™ 
software application. The researcher downloaded the activPAL3™ software 
application from the activPAL3™ company website and installed it on a personal 
computer. After installing the software, the programming of the device occurs through 
connecting the device to the computer via a USB port using the station docking cable. 
The researcher starts the activPAL3™ software application, selects “Communicate 
with activPAL3™” from the “File” menu, and presses the “reprogram and clear 
memory” button. After the clearing the memory, the reprogrammed device starts 
recording immediately. A series of rapid flashes indicates that the device is 
programmed and ready for use. The researcher could use the activPAL3™ software 
application to program the device in order to start recording later, according to the 
planned start date and time. Throughout the duration of the device’s recording of a 
participant, a green light flashes every three seconds to indicate that the device is 
active and recording.  
The Placement of the activPAL3™       
Once the activPAL3™ monitor is charged and programmed, the device is attached to 
the patients. The activPAL3™ is placed directly on to a patient’s skin on their mid-
thigh. The researcher then secures the monitor in place with a small hypoallergenic 
adhesive gel patch (hydro gel) “PALstickie™”. The researcher further secured the 
device through applying a transparent sticky film (Tegaderm) over the top. The 
activPAL3™ monitor is then worn continuously for the required duration of monitoring. 
During monitoring, the patient can continue wearing the device while carrying on with 
normal free-living activities during the day and during periods of sleep overnight. 
However, the waterproof bag was not used in this study to protect the activPAL3™ 
monitor. Accordingly, the participants need to remove the monitor during any 
exposure to water-based activity.  
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activPAL3™ Data Download  
The device was then inserted into the docking station and connected via the USB 
cable to the computer on which the activPAL3™ Professional software was installed. 
From the “File” menu, the researcher selected “Communicate with activPAL3™”, and, 
once a connection had been established, pressed the “download stored data” button 
to save the recorded data on to the computer. The data download usually took a few 
seconds to complete. The saved raw activPAL3™ file for each patient was identified 
by an anonymous code for further analysis. 
The activPAL3™ monitor provides step counts and posture classification. The 
activPAL3™ monitor output data classifies body posture as sitting/lying, standing and 
stepping, through determining the inclination of the thigh, whether the wearer’s thigh 
is horizontal, as in sitting or lying, or vertical, as in standing or walking, as shown in 
Figure 4.5. In addition, the activPAL3™ monitor provides an assessment of PA in 
terms of energy expenditure, based on default values of metabolic equivalent. At the 
end of data collection, the activPAL3™ monitor data can be downloaded, via a 
connector to a computer, in the form of daily and hourly activity, which is classified as 
time spent sitting/lying and standing and stepping. Then the data is stored, processed 
and retrieved by special activPAL3™ application software. 
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Figure 4.5 Physical activity behaviour categories (Granat, 2012, p. 1787). 
 
4.3.5 Pilot Study  
The researcher conducted a pilot study for four reasons: first, to evaluating the 
feasibility of the proposed PA study, second, assessing the appropriateness of the 
research design and questionnaires, third, testing the clarity of the Patient Information 
Sheet (PIS) (Appendix G) and consent form (Appendix H). Forth, gaining information 
about the rate of recruitment and identify any barriers to recruitment. The University 
of Salford and JUH in Jordan offered ethical approval permission to start the study.  
The researcher randomly identified a total of 10 patients with AMI from the CCU at 
JUH. According to the same inclusion and exclusion criteria of the study, the 
researcher identified seven of these 10 patients as being eligible for the pilot study 
process. Their ages ranged from 42 to 68 years. Two of these patients were not 
willing to participate in the study. The researcher therefore contacted the remaining 
five patients (3 men and 2 women). After their transferred from the CCU to the MCU, 
the researcher met the participants in the meeting room in the MCU, and the 
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researcher explained the aims and importance of the study, the participants’ role and 
patients’ information confidentiality, the five participants agreed to take part in the 
study and signed the informed consent. All participants completed the questionnaire 
and the activPAL3™ monitor measurements as prescheduled.  
4.3.6 Data Collection 
The researcher implemented the study in the JUH with patients in the early recovery 
phase. Study data were collected via a self-reporting CSEQ, a socio-demographic 
data sheet, medical records and an activPAL3™ monitor. To fulfil the study 
requirements, data collection lasted approximately nine months, excluding the month 
of Ramadan, a month of fasting, when many changes in people’s lifestyle, eating 
habits and physical activities occur. The data collection procedure began in March 
2015 and ended in December 2015.  
The researcher held individual meetings with the head of the cardiology department 
and the JUH director of nursing units to explain the study objectives, design and 
methods, including the health professional team role of introducing the study to 
eligible and willing patients. The researcher then gave informal explanations and an 
outline of the purpose of the study to the CCU and MCU nurses. 
Following research ethics and governance approval, the researcher initially contacted 
the potential participants and the CCU nurses distributed an invitation letter 
(Appendix I). The CCU nurses approached all eligible patients with AMI admitted to 
the CCU about collecting data for the study. The researcher provided verbal and 
written explanations of the study, as well as the PIS and a consent form, once the 
patient gave outright approval. The PIS outlined the study’s purpose, methods, ethical 
approval, the participation’s risks and benefits, information confidentiality, contact 
details of the researcher and explained that participation in the study was voluntary. 
The general objective of the PIS was to confirm that each willing participant 
understood the circumstances of the study before deciding whether or not to 
participate in it (Bateman, 2002). The researcher provided eligible and willing patients 
with 12 hours to reflect before deciding whether to participate or not. Then, the 
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researcher asked willing participants to sign a consent form, thus granting their 
informed and written consent.   
Data Collection Procedure 
Arrangements for the pre-data collection procedure were as follows. All patients 
diagnosed with AMI who were willing to participate were included in the study. Nurses 
working in the CCU approached and identified patients with AMI after admission to 
the CCU between March and December 2015. 
The researcher reassured participants that their participation was entirely voluntary, 
that all information would be confidential, that all participants’ privacy, respect and 
dignity would be carefully considered, and that participants could withdraw from the 
study at any time, without having to give a reason. The researcher also informed 
them that all participants’ information is confidential and kept for three years after the 
study for further analysis.  
Day 1: Admission to CCU: CCU nurses provided all eligible patients diagnosed with 
AMI with a PIS 24 hours after admission, if they were stable. After receiving the PIS, 
the CCU nurse asked patients with an AMI for a decision about participating in the 
study. When the patients with AMI were haemodynamically stable, such as being free 
of chest pain, the CCU nurses transferred the patients with AMI to the MCU, where 
post-PCI patients in a stable health condition can stay. Only if eligible patients with 
AMI were willing to participate did a CCU nurse contact the researcher. 
Days 2 and 3 (after transfer from CCU to MCU), 24 to 48 hours after admission after 
the patients had received the PIS and were willing to proceed, they met with the 
researcher in a prescheduled meeting room in the MCU. The researcher scheduled 
meetings depending on the availability of a meeting room, the patients’ readiness and 
the researcher’s availability. During the meetings, the researcher introduced himself 
and briefly explained the study, its objectives and phases, and the participants’ role. 
At this point, the researcher requested informed consent. Willing participants signed a 
consent form to enrol in the data collection process at both 2 weeks (Time 1) and 6 
weeks (Time 2) after hospital discharge. After patients had signed the informed 
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consent form, the researcher gave the CSEQ and the socio-demographic data sheet 
to the patient whilst they were in-patients of the MCU. The expected time to complete 
the study questionnaire was 15 to 30 minutes. Furthermore, the researcher used 
medical-record data to identify the type of treatment and the diagnosis date of 
participants. Then, the researcher informed participants that the next data collection 
times would be 2 weeks and 6 weeks after discharge, in the cardiac outpatient clinic, 
30 minutes before their scheduled follow-up appointments 
Day 14: (2 weeks after discharge – 1st cardiac outpatient clinic appointment): On the 
first follow-up appointment day, the researcher met the participants in the cardiac 
outpatient clinic. An activPAL3™ monitor was attached, BMI was calculated, and the 
CSEQ and daily diary for chest pain were provided and explained, in addition to an 
envelope to return the completed questionnaire and an activity monitor and a driver 
who was assigned to collect the envelopes from the participants’ residence. At this 
time, the researcher obtained permission from the participants to use their telephone 
number to facilitate ongoing communication. 
 
After a full 7 days had elapsed, the researcher contacted the participants in order to 
arrange collection of the activPAL3™ monitors and CSEQs from their homes. In 
agreement with the University of Salford’s lone working policy code of conduct for off-
site visits (HSC/AC issue 12.05.10 version 2), the researcher considered the following 
points to ensure his safety during the data collection period: firstly, the researcher 
moved between his home and the JUH by public transport to reduce the possibility of 
physical harm of the researcher. Secondly, because the Jordanian postal system is 
not accessible to many citizens, a Jordanian driver with a valid, full driving licence 
and familiarity with places and addresses in Jordan, was assigned to collect the 
activPAL3™ monitors and CSEQ. The driver received the activPAL3™ monitors and 
CSEQ in sealed envelopes that had been given to each of the patients when they 
received a questionnaire and an activity monitor in the OPD. 
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Day 42 (6 weeks after discharge – 2nd cardiac outpatient clinic appointment): The 
researcher repeated the same arrangement with the participants after 6 weeks (T2) in 
order to obtain a second measurement for the CSEQ and the activPAL3™ monitor. 
4.3.7 Ethics and Data Management  
4.3.7.1 Ethical Consideration  
Ethical issues have been considered carefully, as per the principles outlined in the 
Declaration of Helsinki (Declaration of Helsinki, 1964). Key ethical principles were 
taken into consideration, such as protecting anonymity, confidentiality, privacy, 
obtaining informed consent, avoiding deceptive practices, the protection of 
participants, briefing, the patient’s right to withdraw from the study at any time and the 
declaration of any conflict of interests.  
The University of Salford and the JUH granted an ethical approval to the researcher 
(Appendix J and K). All data are anonymous. The researcher kept hard copy data 
(papers such as the questionnaire, consent form and demographic data sheet, and 
medical record data sheet) in a locked filing cabinet. In order to improve handling of 
the information, the researcher assigned a code to each participant. Moreover, the 
researcher saved soft copy data (such as Microsoft Word or Excel spreadsheet files) 
on a password-protected computer, which only the researcher could access.   
According to the University of Salford’s requirements, the researcher and supervisory 
team performed a risk assessment prior to conducting the research. The researcher 
recognised three possible hazards: psychological distress for the involved patients, 
breaches of data confidentiality, and the possibility that using a driver could risk 
patients’ confidentiality about revealing potentially sensitive topics or issues. 
To reduce the participants’ risk of psychological distress in the study, the researcher 
informed the participants that their participation was voluntary and approved by JUH, 
and that they could withdraw from the study at any point. In addition, the researcher 
considered the following precautions:  
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 CCU nurses initially contacted potential participants  
 The researcher provided the PIS to all patients who were eligible and 
expressed an interest in study participation.  
 The researcher invited the patients to complete the questionnaire after their 
transfer from the CCU to MCU. At this point, they were medically stable, such 
as being clear site of cardiac catheterisation, chest pain-free for more than 
eight hours, and haemodynamically stable. 
In order to reduce risks related to data confidentiality, the researcher followed the 
precautions listed below:   
 The researcher kept hard copy data anonymously in a locked and separate 
filing cabinet  
 Each participant was assigned a code in the study which was kept securely in 
locked filing cabinet that could only be accessed by the researcher  
 The researcher kept software data on an encrypted computer, and only the 
researcher had the password.  
In order to reduce the possibility of breaching the patients’ confidentiality through 
using a driver to collect the questionnaires and activPAL3™ monitors, the researcher 
considered the following steps:  
 The researcher gave the driver used to collect the PA monitors the patients’ 
names and addresses only. 
 The researcher gave an empty envelope to each participant to return the 
completed questionnaire.  
 The agreed time to collect the questionnaire and activPAL3™ was a maximum 
of two hours, beginning from when the researcher called the driver, up until 
reaching the participant’s home, and a maximum of two hours from when the 
driver had left the participant’s home and returned to the researcher.  
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4.3.7.2 Data Management  
The following sections explain the procedures for the management of data collected 
for both questionnaires and ActivPAL3™ data during this study, including the 
accuracy of input, activPAL3™ data quality assessment protocol, missing data, 
activPAL3™ monitor data outcome measure and data analysis.  
The researcher checked and stored the completed questionnaires and the 
participants’ consent forms in a separate, locked file cabinet. Then, the researcher 
entered questionnaire data into an SPSS IBM 22 file, which was stored on a 
password-protected computer for the researcher’s use only. 
The researcher downloaded activPAL3™ data from each monitor using the 
activPAL3™ software package. These were stored in coded folders. In addition, the 
stored files did not include the participants’ names on the computer, thus ensuring the 
anonymity of all participants. Then, the researcher saved activPAL3™ data in 
Microsoft Excel 2010 spreadsheet software. 
The researcher inspected the graphical activity profile over seven days for every 
participant and identified all grossly abnormal periods of activity that were out of 
character for the participants. In addition, the researcher inspected of the raw 
acceleration signals from abnormal periods in detail. If the acceleration signal 
remained constant throughout, this meant that the participants attached the monitor 
incorrectly and the researcher therefore excluded these data from the analysis. 
Examples of these abnormal periods included protracted periods of standing during 
the night and prolonged sedentary spells during the daytime in a participant who on 
other days changed position regularly.  
The researcher saved numerical data for each of the seven days in Microsoft Excel 
2010 spreadsheet software. The recorded data showed participants’ activity for 24 
hours from 0100 to 2400 for seven consecutive days. Every hour recorded consisted 
of upright time and/or sedentary time. The researcher extracted the summary data for 
each hour and implemented summation of stepping and standing times to provide 
upright time. The participants were considered to be sedentary when the activPAL3™ 
signal registered sitting/lying. An event refers to each period of continuous upright or 
sedentary posture. All collected data from questionnaires and activPAL3™ were 
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entered and kept together in an SPSS IBM 22 file, then checked for accuracy prior to 
analysis.  
4.3.8 Managing Missing Data 
Questionnaire data: The researcher instructed the participants to complete all items in 
the questionnaires. When contacting the participants to collect their questionnaires, 
the researcher reminded the participants of the necessity to complete the entire 
questionnaire. Upon receiving the returned, completed questionnaires, the researcher 
reviewed the participants’ responses to ensure the minimisation of missing data. 
There was no data found to be missing in the collected data.   
activPAL3™ data: The researcher provided a demonstration of how to correctly apply 
and remove PALstickie™. The participants were instructed to remove the 
activPAL3™ monitor when bathing/showering and advised to renew the PALstickie™ 
when re-applying the activPAL3™ monitor. The participant was asked to wear the 
activPAL3™ monitor at all times with the exception of when bathing. The activPAL3™ 
monitors were attached by the researcher to the participants. Depending upon the 
preference of the participants, the researcher gave the patients the option to put the 
monitor either on the right or on left thigh, in addition to providing written instructions 
and the contact details of the researcher to the participants.  
An appointment was made with the participants to collect the activPAL3™ monitor. 
Before contacting the participants to collect their activPAL3™ monitors, the 
researcher reminded the participants of the necessity to keep activPAL3™ monitors 
on their thigh at all the measurement times. Then, activPAL3™ data was assessed 
and a quality protocol was applied to ensure the data accuracy, where days were 
removed from activPAL3™ data, if the participants removed or were noncompliant 
with the activPAL3™ data quality protocol. 
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Accuracy of Input (Questionnaires and activPAL3™ Data)  
After downloading the data from the activPAL3™ monitors, the data was transferred 
to Microsoft Excel 2010 spreadsheet software. Next, the researcher entered the 
collected data from both the questionnaires and activPAL3™ monitors into SPSS 
software version 22 and kept this data together. To ensure the accuracy of data entry, 
the researcher checked quality assurance of input with different methods at baseline 
and Time 1 and Time 2 points. Firstly, the researcher reviewed the data frequently for 
completeness and accuracy. Secondly, the researcher selected ten full data entries at 
random and compared them with the written questionnaire answers; there were no 
differences between the participants’ responses and data entered. Thirdly, after the 
data-cleaning procedure, descriptive and frequency statistical data were analysed. In 
addition, the researcher examined the lowest and highest scores for each variable in 
order to determine any outliers. 
activPAL3™ Data Quality Assessment Protocol 
Before moving the activPAL3™ data from the Excel 2010 spreadsheet to SPSS, key 
recommendations from (Edwardson et al., 2016), when using the activPAL3™ 
monitor were adopted to apply a quality assessment protocol. Therefore, the 
researcher considered the following points for cleaning the collected data:  
 Sleep or prolonged activPAL3™ removal (non-wear) is commonly represented 
by unchanging sitting/lying periods (if the monitor was placed in a horizontal 
position while removed) or unchanging upright time (if the monitor was placed 
in a vertical position while removed) in the activPAL3™ file.  
If sleep period and prolonged non-wear periods were sitting/lying bouts ≥ 5 hours in a 
24-hour period and coded as sleep, and then combining other sleep periods into the 
sleep bouts using the following guidelines:  
a) If a sedentary period ≥ 3 hours within 15 minutes of sleep, with including any 
movement the researcher considered it as sleep time. 
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b) If sedentary period ≥ 30 minutes within 15 minutes of sleep bout and <20 steps 
in interim plus any movement, these were considered as sleep time.  
c) During sedentary period where the only recorded movement between the 
sleep bout and the sedentary bout was standing, the researcher considered 
this as sleep time. 
 Whole day data were excluded where data suggested that the activPAL3™ 
monitor mainly was removed, the monitor had been positioned upside down, 
detached from the participant or oriented incorrectly, or there was unusual 
activity during the measurement time.  
 The measurement would be for a minimum of 3 days, with at least 13 hours’ 
measurement per day. 
 The researcher identified any disturbances and assessed repetitions or 
regularity on all days by manual inspection of the event files before taking any 
decision.  
 After cleaning the data, the researcher removed the data of any patient with 
less than three complete days from the study. The researcher then recorded 
non-compliance days. 
4.3.9 activPAL3™ Monitor Data Outcome Measure 
Physical Activity Volume 
For each participant, the activPAL3™ outcome measure for the five PA volume 
parameters: steps count, stepping time, standing time, upright time and sedentary 
time, which was the total spent time for every hour of recording, calculated at both 
Time 1 and Time 2, were compared. PA volume was calculated, and each of the PA 
volume parameters such as steps count, stepping time, standing time, upright time 
and sedentary time were calculated by computing total amount of time spent in each 
parameter per day, then the average per hour and average per day was calculated. 
The research did not split the PA parameters into weekends and weekdays as the 
data collection procedure occurred during participants’ sick leave. Subsequently, the 
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researcher has presented the PA volume according to an overall summary for Time 1 
and Time 2, weekdays and 24 hours.  
The activPAL3™ data for all participants were classified as sedentary when the 
activity monitor signal registered sitting/lying. Every hour recorded consisted of 
upright time and/or sedentary time. The sedentary data was a constant 60 minutes 
minus upright time.  
For each participant, the researcher calculated the primary outcome measure through 
measuring the total time spent for the five PA parameters for every hour of recording 
at Time 1 and Time 2, and then comparing the primary outcome measure according 
to measurement time. A significance level of 5% was set for all testing procedures. 
For a complete description of the PA performed by the two-time measurement points, 
the researcher has presented the data in numerical and graphical forms. 
Physical Activity Pattern 
The researcher carried out further assessment of the PA pattern for upright events 
and sedentary events, through calculating the accumulated percentage from the 
duration of percentage for activity time with different cut-off points, and examining the 
differences between Time 1 and Time 2. In terms of assessing the changes in PA 
pattern, the activPAL3™ data files were processed with MATLAB 2015. The 
researcher extracted the PA data of all participants undertaken each day between 
0100 and 2400 hours in this study (Figure 4.6).  
The researcher saved numerical data for each of the 7 days in Excel spreadsheets. 
The researcher extracted the summary data for each hour and summed the stepping 
and standing times to provide the upright time. In addition, the researcher inspected 
individual records for each day. An event refers to each continuous upright or 
sedentary period. During the measurement at the two time points, the length of each 
upright and sedentary event was determined for all participants.  
For both times 1 and 2, the total number of upright events throughout the week was 
calculated and allocated to the appropriate time category (0.5 minutes, 1 minute, 2 
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minutes, 3 minutes, 5 minutes, 10 minutes, 15 minutes, 25 minutes, 30 minutes) and 
percentage category (10%, 20%, 25%, 30%, 40%, 50%, 60%, 70%, 75%, 80% and 
90%). The same process was performed on sedentary events at both times 1 and 2, 
expressed as a duration (5 minutes, 15 minutes, 30 minutes, 60 minutes, 180 
minutes, 300 minutes, 600 minutes, 900 minutes and 1,200 minutes) and a 
percentage (10%, 20%, 25%, 30%, 40%, 50%, 60%, 70%, 75%, 80% and 90%).  
Within each time point, the researcher calculated the duration and the percentage of 
upright and sedentary events for all participants. Then, the researcher statistically 
compared and investigated mean duration and percentage of events between Time 1 
and Time 2.   
 
Figure 4.6 Example of physical activity pattern plot of normalized curve accumulated 
by upright events from shortest to longest. The horizontal line at 75% shows a cut-off 
point to provide outcomes and to characterize the curve. 
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4.3.10 Statistical Data Analysis 
Questionnaires Data Analysis  
The researcher began data analysis by checking the assumptions of the planned 
analysis and evaluation for missing data. The daily diary for chest pain was analysed 
and entered into SPSS in order to link pain assessment data with whether there is 
link between changes in the PA level of participants and feelings of pain. The 
researcher used descriptive and inferential statistical analyses. Before starting data 
analysis, the researcher checked the outliers, and then normality distribution of the 
variables through the Kolmogorov-Smirnov test, a quantile-quantile plot (Q-Q plot) 
and skewness. The researcher used Levene’s Test of Equality of Variance to assess 
the homogeneity of variances.  
The researcher used descriptive statistics to present the participants’ demographic 
characteristics, such as mean, median, standard deviation and frequency, and 
skewedness. The researcher used ANOVA to compare three or more groups. In 
addition, the researcher used the Pearson correlation coefficient (or Spearman’s 
correlation as an alternative test for non-parametric variables) to investigate the 
relationship between two continuous variables such as the relationship between the 
self-efficacy level and BMI. A significance level of 5% was set for all testing 
procedures. For the analysis of the questionnaire data, the researcher used the IBM 
SPSS Statistics version 22. Subsequently, the questionnaire data and the 
activPAL3™ data were kept together in an SPSS file. 
activPAL3™ Data Analysis 
The activPAL3™ data was downloaded using the activPAL3™ analysis software 
package, and then transferred to an Excel 2010 spreadsheet. Following this, the 
activPAL3™ data was transferred to IBM SPSS Statistics version 22. The same data 
analysis steps were repeated for activPAL3™ data. For example, the researcher 
assessed the outliers, normality and homogeneity of variances. Then, the researcher 
undertook descriptive and inferential statistical analyses. 
 129 
 
A paired t-test (or Wilcoxon test, if the assumption as alternative test for non-
parametric variables) was used to compare two related groups such as PA 
parameters at Time 1 and Time 2. Pearson correlation coefficient (or Spearman’s 
correlation, if the assumption as alternative test for non-parametric variables) was 
used to investigate the relationship between two continuous variables such as the PA 
volume and BMI. For further analysis, the researcher used the MATLAB 2015 
application to assess the changes in PA patterns between Time 1 and Time 2. 
4.4 Summary 
This chapter has outlined the study’s methodology and method in order to prepare for 
the description of the findings given in Chapter five. In summary, the reported study 
used a quantitative method and a descriptive repeated measures design. The chapter 
has presented discussion of the pilot study and the data collection procedure. Finally, 
the chapter has provided thoroughly detailed information regarding the ethical 
considerations and data management in the study.  
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Chapter Five: Results  
5.1 Introduction  
The study has two phases, Chapter three presented results from phase one, the 
translation and cross-cultural adaptation of the CSEQ and validity and reliability 
evaluation of the CSEQ. This chapter describes the findings from phase two. The 
chapter begins by presenting pilot study data results for study phase two. In addition, 
the chapter provides a description for statistical analysis of the sample characteristics 
in the study. Following this, the chapter presents findings of the assessment of self-
efficacy and its subscales, in addition to PA levels and patterns at Time 1 and Time 2 
among patients with AMI. Moreover, the chapter provides an assessment of the 
relationship between self-efficacy and PA levels among patients with AMI. It 
concludes with a summary of the findings.  
This chapter presents the results in five sections, as follows: 
I. Pilot data for study phase two 
II. Sample characteristics, demographic data regarding patients with AMI and 
clinical details of the sample 
III. Assessing changes in self-efficacy levels among patients with AMI after 
hospitalisation and the relationship between self-efficacy and clinical details 
among patients with AMI at baseline, Time 1, and Time 2 
IV. Assessing PA levels, pattern changes, and the relationship between PA level 
and clinical details among patients with AMI at Time 1 and Time 2  
V. Examination of the relationship between self-efficacy and PA level at baseline, 
Time 1, and Time 2 among patients with AMI after hospitalisation 
5.2 Pilot Data 
All participants completed the CSEQ questionnaire and assented the placement of 
the activPAL3™ monitor. No participant reported any difficulty with the interpretation 
of the questions or responses and, based on analysing the completed pilot study, the 
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responses given by participants were appropriate and as expected. The researcher 
asked the participants to contact him if they had any enquiries.  
The results of the pilot study indicated that the study design, research method, and 
methodology were feasible and appropriate in this setting. The pilot study provided 
some useful, practical information regarding recruitment to the study, as it seemed 
from an early stage that it would be feasible to recruit the expected sample size, of 
around 12 to 16 participants per month, meaning the researcher could potentially 
recruit 3 to 4 participants per week. The researcher made three changes to the study 
protocol: first, replacing the adhesive tape previously used to attach activPAL3™ with 
Tegaderm, to avoid irritation to participants’ skin. Second, removing of the hair from 
the thigh before attaching the activPAL3™ monitor, to decrease the painful sensation 
upon its removal. Third, emphasising the fact that participants were welcome to 
contact the researcher if they had questions or enquires during the data collection 
period and making participants aware that they could be provided with their results 
three days after the activPAL3™ monitor collection date.  
5.3 Sample Characteristics  
Figure 5.1 shows details of the participants’ recruitment to the study. At the baseline, 
the researcher assessed 324 patients for eligibility. Less than half of the total number 
of assessed patients (136 out of 324 patients) was eligible and recruited to the study. 
The remaining 188 patients did not meet the inclusion criteria. However, 36 
participants refused to participate for personal reasons. Therefore, 100 patients 
participated at Time 1. The response rate was 100 % at Time 1. Subsequently, six 
patients withdrew at Time 2. Thus, the response rate was 94% at Time 2, as shown in 
the CONSORT flow chart in Figure 5.1. Table 5.1 shows the sociodemographic of the 
study participants, such as age, gender, marital status, level of education and 
employment status. Frequency and percentage show the demographic spread of the 
total sample. Further, Table 5.1 shows a descriptive analysis of the clinical variables 
of the participants, such as BMI.  
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Figure 5.1 Study CONSORT flow chart  
 
 
 
Ineligible for the study (n=188) 
 
 
Eligible for the study (n= 136) 
 
Excluded (n= 188),  
Previous MI (n=46), HF (n=44),  
Musculoskeletal Problem (n=39),  
CABG (n=21), Unstable Health 
Condition (Ventilated) (n=20), 
Unable to read or write (n=18), 
  
 
(n= 36)  
Refused to participate  
   
Included (n= 100) Completed the 
questionnaire and PA monitor 
measurement at (T1)  
 
(n=6) Drop out - refused to 
proceed to (T2) for personal 
reasons 
(n= 6) 
 
(n= 94). Completed the questionnaire 
and PA monitor measurement at (T2) 
 
Patient with AMI were assessed 
for eligibility (n= 324) 
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5.4 Study Variables  
The study included 15 variables distributed across four main categories. The first 
category was sociodemographic variables such as age and gender. The second 
category was self-efficacy, which included global self-efficacy and its three subscales. 
The third category was PA volume, which included five parameters: step count, 
stepping time, standing time, upright time and sitting/lying time. Finally, the fourth 
category was clinical variables, which included three variables: CHD diagnosis date, 
BMI and type of treatment (Table 5.2). Before starting data analysis, the outliers of 
the sample were checked, and normality distribution of the variables was assessed 
by the Kolmogorov-Smirnov test, a quantile-quantile plot (Q-Q plot) and skewness 
(Pallant, 2010). The researcher found that all of the variables were normally 
distributed. 
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Table 5.1  
Demographic Characteristics for Eligible Participated Patients with AMI 
Sociodemographic Variables   Frequency 
Age (years) M=54.5, SD= 9.9  ( 36-75)  
Gender  
Male 62 (62%) 
Female 38 (38%) 
Marital Status  
Single / widowed 26 (26%) 
Married 62 (62%) 
Divorced 12 (12%) 
Educational level  
Secondary school or less 33 (33%) 
Higher Diploma or less 21 (21%) 
Bachelor degree 39 (39%) 
Higher education 7 (7%) 
Employment status  
Employed 31 (31%) 
Unemployed 11 (11%) 
Retired 22 (22%) 
Self-employed 36 (36%) 
Clinical Data  
STEMI treated by PPCI 46 (46%) 
THROMB & PCI 22 (22%) 
PCI 32 (32%) 
Diagnosis Date of CHD (months) M=65.28, SD=37.3 (12-216)  
BMI M=25.61, SD= 0.61  (22-28.5)  
Values are numbers (percentages) unless stated otherwise 
 Values are M, SD (Range)   
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Table 5.2  
All Study Variables, Codes and Measurements Level 
No Variable Description Codes Measur
ement 
level 
Basel
ine 
T 1 T 2 
1 Sex  participants’ 
sex 
1= male, 
2 =female 
Nominal     
 
2 Age  participants 
Age in 
months 
Age in years Continu
ous 
   
 
 
3 Education  participants 
education 
level 
1= secondary 
school or less 
2= Higher Diploma 
or less 
3= Bachelor 
degree 
4= Higher 
education 
Nominal     
4 Marital 
status  
Marital status 1= Single/ widow 
2= Married 
3= Divorced 
Nominal     
5 Employm
ent  
Employment 
status 
1= employed 
2=unemployed 
3=self-employed 
4= retired 
Nominal     
6 Global 
CSE 
Cardiac self-
efficacy  total 
score 
Score Range from 
0-64 
Continu
ous 
      
7 CSE 
Control 
symptom
s 
Control 
symptoms 
theme from 
1-8 item 
Score Range from 
0-32 
Continu
ous 
      
8 CSE 
maintain 
function 
maintain 
function 
theme from 
9-13 item 
Score Range from 
0-20 
Continu
ous 
      
9 CSE 
Healthy 
life style 
Life style 
theme from 
14—16 item 
Score Range from 
0-12 
Continu
ous 
      
10 Step 
count 
Number of 
steps/ week 
Mean number of 
steps per day 
Continu
ous 
     
11 Standing Total time in 0-1 Continu      
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time  standing 
position 
ous 
12 Stepping 
time  
Total time 
during 
stepping 
status 
Score Range from 
0-1 
Continu
ous 
     
13 Upright 
time 
Total of 
standing  and 
stepping time 
Score Range from 
0-1 
Continu
ous 
     
14 Sedentar
y time 
Total of 
sitting and 
lying time 
Score Range from 
0-1 
Continu
ous 
     
13 BMI  Body Mass 
Index  = 
Weight in Kg 
÷ Height in 
metres2 
Score in numbers 
according to the 
equation 
Continu
ous 
    
14 CHD 
Diagnosis 
Date  
Start date of 
diagnose as 
CHD patient 
Score in number of 
months of CHD 
diagnosed 
Continu
ous 
    
15 AMI 
Treatmen
t type 
Treatment 
modalities 
used for CHD 
patients 
1= PPCI 
2= THROMB & 
PCI 
3=PCI 
Nominal     
 
5.5 Cardiac Self-Efficacy Measurements  
5.5.1 Self-efficacy levels 
The researcher used a translated, self-reported CSEQ to measure self-efficacy levels 
at baseline, Time 1 and Time 2 among patients with AMI in the early recovery phase. 
The CSEQ includes three subscales: control symptoms, maintain function and a 
healthy lifestyle (section 3.5.4). There is an increase in mean self-efficacy across the 
three measurement times. Table 5.3 presents the mean score of global self-efficacy 
and its subscales at baseline. In turn, Table 5.4 presents the mean score of global 
self-efficacy and its subscales at Time 1 and Table 5.5 presents the mean score of 
global self-efficacy and its subscales at Time 2. The trends in self-efficacy and its 
subscales across the three measurement times show an increase in the global self-
efficacy and its subscales from baseline to Time 1 and between Time 1 and Time 2 
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(Figure 5.2). The three subscales showed a similar increase in self-efficacy mean 
scores from baseline to Time 1. However, the increase in the healthy lifestyle 
subscale mean score was less between Time 1 and Time 2. 
Table 5.3  
The Descriptive Statistics of the Cardiac Self-Efficacy at Baseline   
CSEQ and  the three 
subscales 
N M 
 
SD Minimum Maximum Range 
Global CSEQ  100 22.14  8.26 8 47 39 
Subscale 1: 
Control symptoms  
100 11.10  4.03 1 22 21 
Subscale 2: 
Maintain function 
100 6.89  3.09 2 16 14 
Subscale 3: 
Healthy lifestyle 
100 4.21  2.38 0 10 10 
 
Table 5.4  
The Descriptive Statistics of the Cardiac Self-Efficacy at Time 1  
CSEQ and the three 
subscales 
N  M SD 
 
Minimum  Maximum Range  
Global CSEQ  100 34.75 9.14 17 52 35 
Subscale 1: 
Control symptoms  
100 16.56 4.97 8 28 20 
Subscale 2: 
Maintain function 
100 11.16 3.08 5 20 15 
Subscale 3: 
Healthy lifestyle 
100 7.03 2.12 3 12 9 
Table 5.5  
The Descriptive Statistics of the Cardiac Self-Efficacy at Time 2  
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CSEQ and the three 
subscales 
N M 
 
SD Minimum Maximum Range 
Global CSEQ  94 48.09 8.55 21 60 39 
Subscale 1 
Control symptoms  
94 23.61 4.63 10 30 20 
Subscale 2 
Maintain function 
94 15.56 2.9 6 20 14 
Subscale 3 
Healthy lifestyle 
94 8.85 2.08 3 12 9 
 
 
Figure 5.2 Trends of self-efficacy and the three subscales levels at baseline, Time 1 
and Time 2 
5.5.2 Daily Diary for Chest Pain 
The researcher used a self-administered daily diary to measure chest pain, along with 
the CSEQ at Time 1 and Time 2. However, no participants reported chest pain in the 
daily diary. The participants complained of feelings of pain from the puncture site of 
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catheterisation and they expressed their concerns about fear of recurrent AMI, 
inability to return to normal lifestyle and development of further complications.  
5.5.3 Changes in Self-Efficacy Levels at Baseline, Time 1 and Time 2   
The mean score of self-efficacy increased during the three measurement times. The 
researcher examined the changes in self-efficacy between the baseline, Time 1 and 
Time 2 using one-way repeated measures ANOVA. Before starting the analysis, the 
researcher used Mauchly’s tests to evaluate the assumption of sphericity for global 
self-efficacy and its subscale. Mauchly’s tests indicated that the assumption of the 
sphericity had not been violated for the global self-efficacy (X² (2) = 0.794, p = 0.672), 
Control symptoms subscale (X² (2) = 0.859, p = 0.651), maintain function subscale 
(X² (2) = 0.313, p = 0.855) and healthy lifestyle subscale (X² (2) = 1.413, p = 0.493).  
The repeated measures ANOVA found significant changes between the mean global 
self-efficacy score at baseline, Time 1 and Time 2 (F (2, 92) = 268.5, p ˂ 0.001). The 
findings of ANOVA reported that significant changes in the mean control symptom 
subscale score at baseline, Time 1 and Time 2 (F (2, 92) = 222.6, p ˂ 0.001). Further, 
the analysis showed significant changes between the mean maintain function 
subscale score at baseline, Time 1 and Time 2 (F (2, 92) = 224.5, p ˂ 0.001). Over 
and above this, significant changes between the mean healthy lifestyle subscale 
score were found at baseline, Time 1 and Time 2 (F (2, 92) = 124.6, p ˂ 0.001), as 
illustrated in Table 5.6. 
 
 
 
 
Table 5.6  
Changes in Self-Efficacy Score at Baseline, Time 1 and Time 2 
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 df Sum of 
squares 
Mean 
square  
F  p  
CSEQ self-efficacy 2 31254 15627 268.5 p ˂ 0.001* 
Subscale 1 
Control symptoms 
2 7363 3681 222.6 p ˂ 0.001* 
Subscale 2 
Maintain function 
2 3533 1766 224.5 p ˂ 0.001* 
Subscale 3 
Healthy lifestyle 
2 979 489 124.6 p ˂ 0.001* 
 * Correlation significant at <0.05 level (2-tailed) 
 
5.5.4 Self-Efficacy and Clinical Data Variables  
The study examined the relationship between the mean self-efficacy score and the 
clinical data variables, such as BMI and CHD diagnosis date by using a Pearson 
product-moment correlation coefficient (r) at baseline, Time 1 and Time 2. In addition, 
the study examined the differences in mean self-efficacy score for groups related to 
type of AMI treatment, such as PPCI, THROMB with PCI and PCI using ANOVA test 
at baseline, Time 1 and Time 2. 
At baseline, the researcher used Pearson correlation tests to examine the 
relationship between BMI, diagnosis date of CHD and self-efficacy. The findings 
showed there were no correlations between BMI, diagnosis date of CHD and self-
efficacy and its subscales (p˃0.05), as shown in Table 5.7. In addition, ANOVA tests 
showed that there were significant differences in patients’ global self-efficacy mean 
scores related to types of AMI treatment (F (2,97) = 3.4, p=0.036) and control 
symptoms subscale (F (2, 97) = 3.5, p=0.032). However, there were no significant 
differences in the maintain function and healthy lifestyle subscales among types of 
AMI treatment groups (p˃0.05) at baseline (Table 5.8). A Tukey post-hoc test 
revealed that patients treated with PCI have global self-efficacy scores (M=24, 
SD=9.8) significantly higher than patients treated with THROMB and PCI (M=18.27, 
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SD 6.9), (p=0.034). In addition, patient treated with PCI showed significantly higher 
control symptoms subscale score (M= 12.09, SD =4.8) than patient treated with 
THROMB and PCI (M=9.2, SD=3.3), (p= 0.027). There were no other statistically 
significant differences between types of AMI treatment and global self-efficacy and its 
subscales at baseline (p˃0.05).  
Table 5.7  
The Relationship Clinical Variables with Self-Efficacy at Baseline 
 BMI Diagnosis date of 
CHD 
 
r p r p Analysis Test 
Global CSEQ  0.059 0.562 - 0.113 0.263 Pearson 
correlation 
Control 
symptoms  
0.063 
 
0.531 -0.043 0.671 Pearson 
correlation 
Maintain function -0.023 0.820 -0.130 0.199 Pearson 
correlation 
Healthy lifestyle 0.127 0.209 -0.143 0.155 Pearson 
correlation 
* Correlation significant at <0.05 level (2-tailed) 
 
 
 
 
 
 
 
 
 
 
Table 5.8  
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The Difference in Self-Efficacy Score at Baseline According to Type of AMI Treatment  
  df Sum of 
squares 
Mean 
square 
F p 
Global CSEQ Between group  2 448 224 3.452 0.036* 
 Within group  97 6307 65   
 Total  99 66756    
Control symptoms  Between group  2 110 55 3.568 0.032* 
 Within group  97 1504 15   
 Total  99 1615    
Maintain function 
 
Between group  2 36 18 1.956 0.147 
 Within group  97 310 9.3   
 Total  99 946    
Healthy lifestyle Between group  2 22 11.3 2.031 0.137 
 Within group  97 541 5.5   
 Total  99 564    
* Correlation significant at <0.05 level (2-tailed) 
At Time 1, the findings showed that BMI had no relationship with self-efficacy level or 
any of its subscales (p˃0.05), Table 5.9. The there was a small negative correlation 
between diagnosis date of CHD and global self-efficacy level (r =-0.226, p = 0.024) 
and a small negative correlation between diagnosis date of CHD and the control 
symptoms subscale (r =-0.224, p = 0.025) at Time 1 (Table 5.9). In addition, ANOVA 
tests showed that there were no significant differences in the mean scores for global 
self-efficacy or the subscale mean scores among the type of AMI treatment groups (p 
˃0.05), as shown in Table 5.10.  
Table 5.9  
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The Relationship between Clinical Variables with Self-Efficacy at Time 1 
 BMI Diagnosis date of 
CHD 
 
r p r p Analysis Test 
Global CSEQ  0.123 0.224 -0.226* 0.024 Pearson 
correlation 
Control 
symptoms  
0.119 0.238 -0.224* 0.025 Pearson 
correlation 
Maintain function 0.059 0.559 -0.180 0.073 Pearson 
correlation 
Healthy lifestyle 0.163 
 
0.105 -0.187 0.062 Pearson 
correlation 
* Correlation significant at <0.05 level (2-tailed) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5.10  
The Difference in Self-Efficacy Score at Time 1 According to Type of AMI Treatment  
 df Sum of Mean F p 
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squares square 
Global CSEQ Between group  2 224 112 1.351 0.264 
 Within group  97 8050 82   
 Total  99 8274    
Control symptoms  Between group  2 111 55 2.301 0.106 
 Within group  97 932 24   
 Total  99 934    
Maintain function 
 
Between group  2 11 5.5 0.582 0.561 
 Within group  97 932 9.6   
 Total  99 943    
Healthy lifestyle Between group  2 4.3 2.1 0.481 0.620 
 Within group  97 442 4.5   
 Total  99 446    
* Correlation significant at <0.05 level (2-tailed) 
 
At Time 2, the findings showed that there was only one significant small positive 
correlation between BMI (M=25.6, SD=1.61) and the healthy lifestyle subscale 
(M=8.85, SD=2) (r = 0.222, p = 0.032). There was no correlation between diagnosis 
date of CHD and self-efficacy (p˃0.05), as shown in Table 5.11. In addition, ANOVA 
tests showed there were no significant differences between self-efficacy and its 
subscales and types of AMI treatment as shown in Table 5.12.  
 
 
 
Table 5.11 
The Relationship between Clinical Variables with Self-Efficacy at Time 2 
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 BMI Diagnosis date of 
CHD 
 
r p r p Analysis Test 
Global CSEQ 0.189 0.068 -0.084 0.419 Pearson 
correlation 
Control 
symptoms 
0.130 0.212 -0.105 0.312 Pearson 
correlation 
Maintain function 0.168 0.105 -0.001 0.996 Pearson 
correlation 
Healthy lifestyle 0.222* 0.032 -0.121 0.247 Pearson 
correlation 
* Correlation significant at <0.05 level (2-tailed) 
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Table 5.12  
The Difference in Self-Efficacy Score at Time 2 According to AMI Type of Treatment  
 df Sum of 
squares 
Mean 
square 
F p 
Global CSEQ Between group  2 1.5 0.7 0.110 0.990 
 Within group  91 6805 74   
 Total  93 6807    
Control symptoms  Between group  2 3 1.5 0.070 0.932 
 Within group  91 1997 21.9   
 Total  93 2000    
Maintain function 
 
Between group  2 3 1.5 0.179 0.836 
 Within group  91 780 8.5   
 Total  93 783    
Healthy lifestyle Between group  2 6.4 3.2 0.739 0.481 
 Within group  91 399 4.3   
 Total  93 405    
* Correlation significant at <0.05 level (2-tailed) 
5.6 Measurements of Physical Activity 
This section presents data analysis for both PA volume and PA patterns at Time 1 
and Time 2. At Time 1, the study recorded a complete set of data (7 days) from 45 
participants and recorded the remaining set of data (3-6 days) from 46 participants. At 
Time 2, the study recorded a complete set of data from 60 participants and recorded 
the remaining set of data (3-6 days) from 23 participants (Table 5.13). The minimum 
number of days accepted for inclusion was three days according to the activPAL3™ 
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data quality assessment protocol (section 4.3.8). At Time 1, the excluded data was 
144 days, 11 participants had odd and irregular data and 77 days were removed for 
noncompliance with the activPAL3™ data protocol, representing 20% of the data. At 
Time 2, the excluded data was 118 days, 11 participants had odd and irregular data 
and 41 days were removed for noncompliance with the activPAL3™ data protocol, 
representing 18% of the data.  
The researcher used an activPAL3™ monitor to measure PA behaviour at Time 1 
and Time 2 in the early recovery phase. After application of the activPAL3™ data 
quality protocol, and removal of non-worn activPAL3™ time, the study included 556 
days for Time 1 and 540 days for Time 2. The study measured PA for seven days 
consecutively for 100 participants at Time 1 and for 94 participants at Time 2. The 
study presents the measurement of PA behaviour in two parts: PA volume and PA 
pattern.   
Table 5.13  
Summary of activPAL3™ Data Included for Analysis  
activPAL3™  
included data   
Number of 
participants at Time 1 
Number of 
participants at Time 2 
7 Days 45 60 
6 Days 27 13 
5 Days 12 4 
4 Days 3 4 
3 Days 4 2 
 
5.6.1 Physical Activity Volume  
This section describes the PA data at the Time 1 and Time 2 measurements. The 
section presents the data through first: overall summary for Time 1 and Time 2 and 
comparison of PA measurement parameters between Time 1 and Time 2. As to the 
means of step count, stepping time, standing time, upright time (stepping time and 
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standing time) and sedentary time (sitting/lying time). Second: according to the day of 
the week, third: according to hour.   
5.6.1.1 Primary Outcome Measure- Step Count  
5.6.1.1.1 Overall Step Count for Time 1 and Time 2 
The mean daily step count for all participants was calculated. The population mean 
steps at Time 1 were 6,981 steps and at Time 2 were 7,149. There was considerable 
variation in mean daily steps per day for both Time 1 and Time 2 as indicated by the 
large standard deviation (2,800) and range of step count 11,704 at Time 1 and 
standard deviation (2,575) and range of step count 10,919 at Time 2 (Table 5.14). 
The minimum daily step recorded on a single day in Time 1 was 1,795 steps and the 
maximum daily step count was 13,499. The minimum daily step recorded in Time 2 
was 2,273 steps and the maximum daily step count was 13,192. Figure 5.3 shows the 
mean and standard deviation of the population in a boxplot format. There was no 
significant change in mean daily step count between Time 1 and Time 2 (paired t-test, 
t (74) = -0.673, p = 0.503).  
Table 5.14  
Summary Overall- Mean Daily Step Count in Time 1 and Time 2 
 Number of  steps per day 
Measurement 
time 
M 
(step/ 
day) 
SD 
(step) 
Range  
(step) 
Minimum 
(step) 
Maximum 
(step) 
 
paired t- 
Test / p 
value 
Time 1 6,981 2,800 11,704 1,795 13,499 0.503 
Time 2 7,149 2,575 10,919 2,273 13,192 
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 Figure 5.3 Boxplot of mean daily steps of all participants at Time 1 and Time 2 
  
5.6.1.1.2 Step Count across the Week 
The researcher calculated the mean number of steps per day for each participant for 
each day for Time 1 and Time 2. At Time 1, the mean values indicated that there 
were relatively large variation differences of 1,884 steps between the least active day, 
which was Friday (5,661 steps) and the most active day, which was Tuesday (7,505 
steps), (Appendix L). Figure 5.4 shows a relatively large standard deviation, indicating 
a considerable variation in step count of the participants. At Time 2, the mean number 
of steps per day values indicated that there was considerable variation of (1,893 
steps) between the least active day, which was Friday (5,965 steps) and the most 
active day, which was Monday (7,804), (Appendix L). Figure 5.5 shows relatively 
large standard deviation, indicating a considerable variation in step count of the 
participants.  
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Figure 5.4 Mean step count according to day at Time 1(error bars represent ± SD) 
 
 
Figure 5.5 Mean step count according to day at Time 2 (error bars represent ± SD) 
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5.6.1.1.3 Step Count Over a 24-Hour Period  
The mean step count for each hour across all participants was calculated and this as 
shown in Figure 5.10 for Time 1 and in Figure 5.11 for Time 2. For each participant, 
the researcher computed total step count for each hour, taking an average over the 
included days, which gave a mean step count for each hour of the day. An averaging 
of individuals gave the mean step count, and standard deviations (Figures 5.6 and 
5.7), the Figures showed there were few steps per hour during the night. In Time 1, 
number of steps increased sharply from 06:00 to 14:00. Then, decreased gradually in 
the afternoon and evening (Figure 5.6). Relatively large standard deviations indicate 
that there were considerable variations between individuals in mean step count 
throughout the entire day (Appendix M). These variations were less evident through 
the night between the hours 01:00-06:00.  
In Time 2, the mean step count was small between from 12:00 until 05:00 (Figure 5.7). 
Mean hourly step count increased gradually at 06:00 until 13:00 (615 steps). After 
that, mean step count started decreasing to 338 steps at 16:00, and subsequently 
dropped from 17:00 to 161 steps at 24:00. (Appendix N). Figures 5.6 and 5.7 showed 
the comparison of the hourly pattern of Time 1 and Time 2. Mean step count per hour 
was greater at Time 2 through the morning and afternoon. However, at Time 2, the 
step count was slightly higher than at Time 1. However, there are relatively low levels 
of mean step count throughout the day at both times.   
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Figure 5.6 Mean step counts according to hour at Time 1 (error bars represent ± SD) 
 
 
Figure 5.7 Mean step counts according to hour at Time 2 (error bars represent ± SD) 
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5.6.1.2 Primary Outcome Measure- Stepping Time 
5.6.1.2.1 Overall Stepping Time for Time 1 and Time 2  
The researcher calculated the mean stepping time per day for all participants. The 
population mean stepping time per day at Time 1 was 94.2 minutes and at Time 2 
was 97.2 minutes. There was considerable variation in stepping time at Time 1 and 
Time 2 as indicated by the large standard deviation 37.8 minutes and range of 168 
minutes at Time 1 and standard deviation 32.4 minutes and range of 156 minutes at 
Time 2 (Table 5.15). The minimum stepping time recorded on a single day at Time 1 
was 25.2 minutes and the maximum stepping time was 193 minutes, and the 
minimum stepping time per day recorded at Time 2 was 39.6 minutes and the 
maximum stepping time was 195.6 minutes (Table 5.15). Figure 5.8 shows the mean 
and standard deviation of the population in a boxplot format. There was no significant 
change in mean stepping time per day between Time 1 and Time 2 (paired t-test, t 
(74) =-0.480, p = 0.633). 
Table 5.15  
Summary Overall- Mean Daily Stepping Time in Time 1 and Time 2 
 Mean stepping time per day 
Measurement 
time 
M 
(mins/ 
day) 
SD 
(mins) 
 
Range 
(mins) 
Minimum 
(mins) 
Maximum 
(mins) 
 
paired t- 
Test / p 
value 
Time 1 94.2 37.8 168.2 25.2 193.8 0.633 
Time 2 97.2 32.4 156 39.6 195.6 
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Figure 5.8 Boxplot of mean daily stepping time in Time 1 and Time 2  
5.6.1.2.2 Variations of Stepping Time over a Week 
The researcher calculated the mean stepping time per day for each day of the week 
by averaging the stepping time of the participants for both Time 1 and Time 2. The 
mean daily stepping time was generally lower at Time 1 except for Wednesday 
(Figure 5.9 and 5.10). There was little difference between days but the greatest mean 
daily stepping time for both Time 1 and Time 2 occurred on Friday and Saturday, with 
the smallest mean daily stepping time occurring on Friday 80.69 minutes at Time 1 
and 86.39 minutes at Time 2, which are the weekend and an official holiday in Middle 
Eastern countries. The greatest mean daily stepping time was similar for Time 1 and 
Time 2.  The participants had the greatest mean daily stepping time on Tuesday 
100.73 minutes at Time 1 and 106.12 minutes at Time 2 (Appendix O). However, the 
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comparatively large standard deviation indicates considerable variation within the 
times, particularly Time 1.  
 
Figure 5.9 Mean stepping time according to day at Time 1(error bars represent ± SD) 
 
Figure 5.10 Mean stepping time according to day at Time 2 (error bars represent ± 
SD) 
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5.6.1.2.3 Stepping Time over a 24-Hour Period 
Figure 5.11 shows the mean hourly stepping time across all participants at Time 1. 
From 05:00, the mean hourly stepping time increased from a level of about 0.5 
minutes to 07.32 minutes at 13:00. There were small fluctuations in mean hourly 
stepping time through afternoon with two small peaks in mean hourly stepping time, 
at 17:00 and 20:00. After 20:00, the hourly stepping time fell sharply to a night-time 
level of about 2.2 minutes per hour (Appendix P). In Time 2, mean hourly stepping 
time was small from 12:00 until 05:00 (Appendix Q). The mean hourly stepping time 
then increased gradually at 06:00 until (8.6 minutes) at 13:00. After that, mean hourly 
stepping time decreased to 4.74 minutes at 16:00, and following that, at 17:00, the 
mean hourly stepping time starts decreasing until it reaches 2.4 minutes at 24:00 
(Figure 5.12). The hourly pattern of the stepping time at Time 1 and Time 2 can be 
compared (Figures 5.11 and 5.12). Mean hourly stepping time was greater at Time 2 
throughout the entire day. However, there are relatively low levels of activity 
throughout the day at both times.   
 
 
Figure 5.11 Mean stepping time according to hour at Time 1(error bars represent ± 
SD) 
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Figure 5.12 Mean stepping time according to hour at Time 2 (error bars represent ± 
SD) 
5.6.1.3 Primary outcome measure- Standing Time 
5.6.1.3.1 Overall Standing Time for Time 1 and Time 2 
The mean standing time per day for all participants was calculated. The population 
mean daily standing time at Time 1 was 238.8 minutes and at Time 2 was 231.6 
minutes. There was considerable variation in standing time at Time 1 and Time 2 as 
indicated by the large standard deviation 99 minutes and range of 423 minutes at 
Time 1 and standard deviation 87 minutes and range of 439.8 minutes at Time 2 
(Table 5.16). The minimum daily standing time recorded on a single day at Time 1 
was 69 minutes and the maximum daily standing time was 492 minutes, while the 
minimum daily standing time recorded in Time 2 was 48 minutes and the maximum 
daily standing time was 487 minutes (Table 5.16). Figure 5.13 shows the mean and 
standard deviation of the population in a boxplot format. There was no significant 
change in mean daily standing time between Time 1 and Time 2 (paired t-test, t (74) 
=1.079, p = 0.284). 
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Table 5.16  
Summary Overall- Standing Time at Time 1 and Time 2 
 
 Mean standing time per day 
 
Measurement 
time 
M 
(mins/ 
day) 
SD 
(mins) 
 
Range 
(mins) 
Minimum 
(mins) 
Maximum 
(mins) 
 
paired t- 
Test / p 
value 
Time 1 238.8 99 423 69 492 0.284 
Time 2 231.6 87 439.8 48 487.8 
 
 
 
 
 
Figure 5.13 Boxplot of mean daily standing time in Time 1 and Time 2  
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5.6.1.3.2 Variation of Standing Time over a Week 
The researcher calculated the mean standing time per day for each day of the week 
by averaging the stepping time of the participants for both Time 1 and Time 2. At 
Time 1, there was little difference between days but the smallest mean standing time 
per day was Friday 199.8 minutes, and the greatest mean standing time per day was 
Tuesday 249.6 minutes. The mean daily standing time on Monday, Tuesday and 
Friday was generally lower at Time 1. However, it was higher on Sunday, Wednesday, 
Thursday and Saturday. Figure 5.14 shows relatively large standard deviation, 
indicating a considerable variation in mean standing time per day of the participants 
(Appendix R). At Time 2, there was little difference between days but the smallest 
mean standing time per day was Friday 217.47 minutes, and the greatest mean 
standing time per day was Tuesday 257.36 minutes. Figure 5.15 shows relatively 
large standard deviation, indicating a considerable variation in mean standing time 
per day of the participants (Appendix R).   
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Figure 5.14 Mean standing time according to day at Time 1 (error bars represent ± 
SD) 
 
 
Figure 5.15 Mean standing time according to day at Time 2 (error bars represent ± 
SD) 
5.6.1.3.3 Standing Time over a 24 Hour Period   
Figure 5.16 shows the mean hourly standing time across all participants at Time 1. 
From 05:00, the mean hourly standing time increased from a level of about 3.02 
minutes to 17.10 minutes at 13:00. There were small fluctuations in the mean hourly 
standing time through the day, with one small peak in activity at 13:00. After 13:00, 
the standing time starts decreasing until it reaches 12.22 minutes at 16:00. There was 
a stable phase in mean hourly standing time between 16:00 and 20:00. After 20:00, 
mean hourly standing time fell sharply to a night-time level of approximately 6.1 
minutes per hour (Appendix S).  
Figure 5.17 shows at Time 2, the mean hourly standing time across all participants. 
From 05:00, the mean hourly standing time increased from a level of about 3.07 
minutes to 17.97 minutes at 13:00. There were small fluctuations in the mean hourly 
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standing time after noon at 13:00. After 20:00, the mean hourly standing time started 
decreasing gradually from 11.35 minutes to 05.26 minutes at 24:00 (Appendix T). The 
hourly pattern of the mean hourly standing time at Time 1 and Time 2 can be 
compared (Figures 5.16 and 5.17). The mean hourly standing time was greater at 
Time 1 throughout the entire day, particularly in the afternoon. However, there were 
relatively low levels of the mean hourly standing time throughout the day at both 
times.   
 
Figure 5.16 Mean standing time according to hour at Time 1(error bars represent ± 
SD) 
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Figure 5.17 Mean standing time according to hour at Time 2 (error bars represent ± 
SD) 
5.6.1.4 Primary outcome measure- Upright Time 
5.6.1.4.1 Overall Upright Time for Time 1 and Time 2 
The researcher calculated the mean upright time per day across all participants. The 
population mean upright time per day at Time 1 was 333 minutes and at Time 2 was 
327 minutes. There was considerable variation in upright time at Time 1 and Time 2 
as indicated by the large standard deviation 123.6 minutes and range of 542 minutes 
at Time 1 and standard deviation 104.4 minutes and range of 479.4 minutes at Time 
2 (Table 5.17). The minimum upright time recorded on a single day at Time 1 was 
123.6 minutes and the maximum upright time was 666 minutes, and the minimum 
upright time recorded in Time 2 was 106.2 minutes and the maximum upright time 
was 585.6 (Table 5.17). Figure 5.18 shows the mean and standard deviation of the 
population in a boxplot format. There was no significant change in mean daily upright 
time between Time 1 and Time 2 (paired t-test, t (74) =0.910, p = 0.366). 
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Table 5.17  
Summary Overall- Mean Daily Upright Time in Time 1 and Time 2 
 Mean upright time per day 
Measurement 
time 
M 
(mins/ 
day ) 
SD 
(mins) 
 
Range 
(mins) 
Minimum 
(mins) 
Maximum 
(mins) 
 
paired t- 
Test / p 
value 
Time 1 333 123.6 542.4 123.6 666 0.366 
Time 2 327.6 104.4 479.4 106.2 585.6 
 
 
 
Figure 5.18 Boxplot of mean daily upright time in Time 1 and Time 2  
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5.6.1.4.2 Variation of Upright Time over a Week 
The researcher calculated the mean upright time per day by averaging the upright 
time of the participants for both Time 1 and Time 2. At Time 1, the mean daily upright 
time was generally lower at Time 2. There was little difference between days but the 
smallest mean daily upright time occurred on Friday 280.5 minutes and the greatest 
mean daily upright time day occurred on Tuesday 354.86 minutes at Time 1 
(Appendix U). The mean daily upright time was generally lower on Sunday, Monday, 
Tuesday and Friday at Time 1. Figure 5.19 shows relatively large standard deviation, 
indicating a considerable variation in upright time of the participants at Time 1. At 
Time 2, the smallest mean daily upright time occurred on Friday 303.86 minutes and 
the greatest mean daily upright time day occurred on Tuesday 363.47 minutes 
(Figure 5.20). There was a relatively large standard deviation, indicating a 
considerable variation in mean daily upright time of the participants (Appendix U).   
 
Figure 5.19 Mean upright time according to day at Time 1(error bars represent ± SD) 
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Figure 5.20 Mean upright time according to day at Time 2(error bars represent ± SD) 
5.6.1.4.3 Upright Time over a 24-Hour Period  
Figure 5.21 shows the mean hourly upright time across all participants at Time 1. 
From 05:00, the mean hourly upright time increased from a level of about 3.53 
minutes to 24.41 minutes at 13:00. After 13:00, the mean hourly upright time started 
decreasing to 18 minutes. There was a stable phase from 16:00 to 20:00. After 20:00, 
the mean hourly upright time fell sharply to a night-time level of about 8.34 minutes 
per hour (Appendix V). 
Figure 5.22 shows the mean hourly upright time across all participants at Time 2. 
From 05:00, the mean hourly upright time increased from a level of about 3.78 
minutes to 26.50 minutes at 13:00. After 13:00, the mean hourly upright time 
decreased to 14.84 minutes at 16.00. At 17:00, the mean hourly upright time started 
to increase gradually to 17.17 minutes at 18.00. After 20.00, the mean hourly upright 
time fell sharply to a night-time level of approximately 7.76 minutes per hour 
(Appendix W). The hourly pattern of the mean hourly upright time at Time 1 and Time 
2 can be compared (Figures 5.21 and 5.22). Mean hourly upright time was greater at 
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Time 1 throughout the entire day, except 11:00 to 15:00. However, there were 
relatively low levels of activity throughout the day at both times.  
 
Figure 5.21 Upright time according to hour at Time 1(error bars represent ± SD) 
 
Figure 5.22 Mean upright time according to hour at Time 2 (error bars represent ± SD) 
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5.6.1.5 Primary outcome measure- Sedentary Time 
5.6.1.5.1 Overall Sedentary Time for Time 1 and Time 2 
The researcher calculated the mean sedentary time per day across all participants. 
The population mean sedentary time per day at Time 1 was 1,107 minutes and at 
Time 2 was 1,112 minutes. There was considerable variation in sedentary time at 
Time 1 and Time 2 as indicated by the large standard deviation 123.6 minutes and 
range of 542.4 minutes at Time 1, and large standard deviation 104.4 minutes and 
range of 480 minutes at Time 2 (Table 5.18). The minimum sedentary time recorded 
on a single day at Time 1 was 773.4 minutes and the maximum sedentary time was 
1,316 minutes, while the minimum sedentary time recorded in Time 2 was 853.8 
minutes and the maximum sedentary time was 1,334 minutes (Table 5.18). Figure 
5.23 shows the mean and standard deviation of the population in a boxplot format. 
There was no significant change in mean daily sedentary time between Time 1 and 
Time 2 (paired t-test, t (74) =-0.884, p = 0.380). 
 
Table 5.18  
Summary Overall- Sedentary Time at Time 1 and Time 2 
 Mean sedentary time per day 
 
Measurement 
time 
M 
(mins/ 
day) 
SD 
(mins) 
 
Range 
(mins) 
Minimum 
(mins) 
Maximum 
(mins) 
 
paired t- 
Test / p 
value 
Time 1 1,107 123.6 542.4 773.4 1,316 0.380 
Time 2 1,112 104.4 480 853.8 1,334 
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Figure 5.23 Boxplot of mean daily sedentary time in Time 1 and Time 2  
 
5.6.1.5.2 Variation of Sedentary Time over a Week 
The researcher calculated the mean sedentary time for each day by averaging the 
sedentary time of the participants for both Time 1 and Time 2. There was little 
difference between days but the smallest mean sedentary time per day occurred on 
Tuesday 1,089.7 minutes and the greatest mean sedentary time per day occurred on 
Friday 1,159 minutes at Time 1 (Appendix X). Figure 5.24 shows relatively large 
standard deviation, indicating considerable variation in mean sedentary time per day 
of the participants. At Time 2, there was little difference between days but the 
greatest mean sedentary time per day occurred on Friday 1,136 minutes and the 
smallest mean sedentary time per day occurring on Tuesday 1,076 minutes 
(Appendix X). Figure 5.25 shows relatively large standard deviation, indicating 
considerable variation in mean sedentary time per day of the participants. The 
comparison of the mean sedentary time per day at Time 1 and Time 2 showed that 
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the mean sedentary time per day was generally lower at Time 2 except on 
Wednesday and Thursday.  
 
Figure 5.24 Mean sedentary time according to day at Time 1 (error bars represent 
±SD) 
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Figure 5.25 Mean sedentary time according to day at Time 2 (error bars represent ± 
SD) 
5.6.1.5.3 Sedentary Time over a 24-Hour Period  
Figure 5.26 shows the mean hourly sedentary time across all participants at Time 1. 
From 05:00, the mean hourly sedentary time decreased from a level of about 56.54 
minutes to 35.60 minutes at 13:00. There were very small fluctuations in mean hourly 
sedentary time throughout the entire day with stable phase in activity from 16:00 to 
20:00. After 20:00, the mean hourly sedentary time increased gradually to a night-
time level of about 51.66 minutes per hour (Appendix Y).  
Figure 5.27 shows the mean hourly sedentary time across all participants at Time 2. 
From 06:00, the mean hourly sedentary time decreased from a level of about 53.22 
minutes to 32.49 minutes at 13:00. There were small fluctuations in mean hourly 
sedentary time throughout the afternoon. After 20:00, mean hourly sedentary time 
started increasing gradually to a night-time level of about 52.33 minutes per hour 
(Appendix Z). Figures 5.26 and 5.27 showed the comparison between the hourly 
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pattern of the sedentary time at Time 1 and Time 2. The mean hourly sedentary time 
was greater at Time 2 throughout the entire day. However, there were relatively 
prolonged periods of sedentary time per hour throughout the day at both times. 
 
 
 
Figure 5.26 Mean sedentary time according to hour at Time 1(error bars represent ± 
SD) 
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Figure 5.27  Mean sedentary time according to hour at Time 2 (error bars represent ± 
SD) 
5.6.2 Physical Activity Patterns  
This section presents a full description of PA patterns for both Time 1 and Time 2. 
The study assessed the pattern of both upright events (a combination of stepping and 
standing time) and sedentary events (sitting/lying time) for all participants for both 
Time 1 and Time 2. The length of events was categorised according to specific 
percentage cut-off points. In addition, the percentage of events spent in particular 
fashion was categorised according to specific period cut-off points at both Time 1 and 
Time 2. Then, the study compared and statistically examined both PA events’ results.  
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5.6.2.1 Pattern of Upright Events  
Figure 5.28 shows all the accumulated upright events, sorted from shortest to longest 
at Time 1 and Time 2, for all events from all participants. At Time 1, 25% of the total 
accumulated upright times for all participants were less than 5.82 minutes. Fifty 
percent of their total accumulated upright times were less than 14.64 minutes and 
75% of their total accumulated upright time were less than 33.84 minutes. At Time 2, 
25% of their total accumulated upright time in less than 5.7 minutes, 50% of their total 
accumulated upright time in less than 13.68 minutes and 75% of accumulated upright 
time were less than 32.7 minutes. Comparing the upright events in Time 1 and Time 
2, the accumulated total upright events for all three cut-off points are slightly greater 
at Time 1 than at Time 2. The study calculated the 25%, 50% and 75% cut-off points 
separately for each individual at both time points. Paired t-tests showed there was no 
significant differences in accumulated upright events between the cut-off points of 
25% at Time 1 (M= 6.49, SD= 3.43) and the cut-off points of 25% at Time 2 (M= 5.9, 
SD=2.61) t (74) =1.432, p = 0.156. The cut-off points of 50% and 75% were not 
normally distributed. Therefore, the researcher used an alternative test for 
nonparametric variables (the Wilcoxon Signed-Rank Test) to examine the difference 
in accumulated upright events between Time 1 and Time 2. The Wilcoxon Test 
showed that were no significant differences in accumulated upright events between 
Time 1 and Time 2 for both the cut-off point of 50% (Z = 1.6, p = 0.106) and the cut-
off point of 75% (Z = 0.937, p = 0.349), (Table 5.19). 
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Figure 5.28 Plot of normalized cumulative upright time accumulated by upright events 
from shortest to longest, at Time 1 and Time 2. 
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Table 5.19  
Length of Upright Events Length According to Percentage Cut-off Points 
 Upright events 
 
 
 
  
Percentage 
of the  
events 
Time 1 Time 2 
M 
(mins) 
SD 
(mins) 
Median 
(mins) 
 
Mean 
(mins) 
SD 
(mins) 
Median 
(mins) 
Statistical test 
25 6.49 3.4  5.94 2.61  Paired t-test  
(p= 0.156) 
50 18.71 31.6 14.08 13.69 6.64 13.01 Wilcoxon test 
(p=0.106) 
75 39.34 72.9 28.49 29.7 16.42 26.26 Wilcoxon test  
(p= 0.349) 
 
Figure 5.29 shows the percentage of the upright events accumulated at the three cut-
off points, at 0.5 hour, 1 hour and 1.5 hours. Both times showed similar percentage 
values, for example, at Time 1, 24% of the total accumulated upright events for all 
participants were less than 5 minutes.  54.7% of their accumulated total upright times 
were less than 15 minutes and 74% of their total accumulated upright times were less 
than 30 minutes. At Time 2, 25.3% of their total accumulated upright time was in less 
than 5 minutes, 57.8% of their total accumulated upright time was less than 15 
minutes and 76.8% of accumulated upright events were less than 30 minutes. 
Comparing Time 1 and Time 2, the accumulated total upright events for all three cut-
off points are slightly greater at Time 2 than at Time 1. The study calculated the 5-
minute, 15-minute and 30-minute cut-off points separately for each individual at both 
time points. Paired t-tests showed there were no significant differences in these 
values between Time 1 and Time 2 for the three cut-off points of 5-minutes, t (74) = -
1.024, p = 0.309, 15-minutes, t (74) = -1.596, p = 0.115 and 30-minutes t (74) = -
1.366, p = 0.176, (Table 5.20).  
Table 5.20 shows the values of the three cut-off points of 5, 15 and 30 minutes at 
Time 1 and Time 2. The values of the three cut-off points 5, 15 and 30 minutes were 
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similar for both times, although there was very little variation at Time 2 as 
demonstrated by slightly smaller standard deviations. In Table 5.21, the data for 
percentage accumulated upright events sorted from shortest to longest are similar at 
both times. Over 40% of the participants’ upright events were accumulated in less 
than 10 minutes at both times, and the upright events decreased gradually with 
increased periods of time such as between 10-20, and then, 20-30 minutes, as 
illustrated in Table 5.21. 
 
Figure 5.29 Plot of normalized cumulative upright time accumulated by upright events 
from shortest to longest, at Time 1 and Time 2.  
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Table 5.20  
Percentage of Upright Events According to Length of Events Cut-off Points 
 Upright events 
 
 
 Time 1 
 
Time 2 
 
 
Length of 
events (mins) 
M 
 (percentage) 
 
SD 
 
M 
(percentage) 
SD 
 
 
Statistical test 
5 24.09 12.1 25.35 11.9 Paired t-test 
(p=0.309) 
15 54.72 17.71 57.81 17.5 Paired t-test 
(p=0.115) 
30 74.1 15.85 76.75 14.87 Paired t-test 
(p=0.176) 
 
 
Table 5.21 
The Difference of Mean of Upright Time Percentage between Time 1 and Time 2 at 
the Period Cut-off Points  
 Time 1 Time 2 
Period cut-off 
points (mins) 
Difference of mean upright 
events (percentage) 
Difference of mean upright 
events (percentage) 
0-10 42.2 44.56 
10- 20 21.44 22.28 
20-30 10.87 9.91 
 
 
5.6.2.2 Pattern of Sedentary Events  
Figure 5.30 shows the accumulated sedentary events sorted from shortest to longest 
at Time 1 and Time 2 for all sedentary events for all participants.  At Time 1, 25% of 
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the total accumulated sedentary time for all participants was in less than 0.47 hours. 
Fifty percent of their total accumulated sedentary time was in less than 1.6 hours and 
75% of their accumulated total sedentary time was in less than 5.2 hours. At Time 2, 
25% of their total accumulated sedentary time was in less than 0.46 hours, 50% of 
their total accumulated sedentary time was in less than 1.74 hours and 75% of 
accumulated sedentary events were in less than 5.7 hours. For comparison, at Time 
1 and Time 2, the accumulated total sedentary events for all three cut-off points are 
slightly greater at Time 2 than at Time 1.  
The study calculated the 25%, 50% and 75% cut-off points separately for each 
individual at both time points. Because 25% and 50% were not normally distributed, 
the researcher used the Wilcoxon test to examine the difference in sedentary events 
between Time 1 and Time 2. Wilcoxon tests showed there were no significant 
differences in these values between Time 1 and Time 2 for the cut-off points of 25% 
(Z = -0.651, p=0.515) and 50% (Z = -1.16, p=0.246). Because the cut-off point of 75% 
was normally distributed, the researcher used paired t-test. This showed that there 
was no difference in sedentary events between Time 1 and Time 2 t (74) = -1.176, 
p=0.243 (Table 5.22). 
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Figure 5.30 Plot of normalized cumulative sedentary time accumulated by sedentary 
events from shortest to longest. 
Table 5.22  
Length of Sedentary Events Length According to Percentage Cut-off Points 
 Sedentary events 
 
 
 
 
 
 
 
Percenta
ge of the  
events 
Time 1 Time 2 
M  
(Hours) 
SD 
(Hours) 
 
Median 
(Hours) 
M  
(Hours) 
SD 
(Hours) 
Median 
(Hours) 
 
 
Statistical test 
25 0.45 0.37 0.5 0.48 0.17 0.5 Wilcoxon test 
(p= 0.515) 
50 1.82 1.57 1.5 1.71 0.63 1.6 Wilcoxon test 
(p=0.246) 
75 4.94 2.18  5.27 1.91  Paired t-test 
(p= 0.243) 
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Figure 5.31 shows the percentage of sedentary events accumulated at three- time 
cut-off points, at 30 minutes, 60 minutes and 90 minutes. Both times shows similar 
percentage values. For example, at Time 1, 26.2% of the accumulation of total 
sedentary behaviour for all participants was in less than 30 minutes. 40.5% of the 
accumulation of their total sedentary time was in less than 60 minutes and 48.3% of 
accumulation of their total sedentary time was in less than 90 minutes. At Time 2, 
26.5% the of accumulation of their total sedentary time was in less than 30 minutes, 
39.5% of the accumulation their total sedentary time was in less than 60 minutes and 
47.5% of their accumulated sedentary events was in less than 90 minutes. 
Comparing Time 1 and Time 2, the accumulated total sedentary events for all three 
cut-off points are slightly greater at Time 1 than at Time 2.  
The study calculated the 30-minute, 60 minute and 90-minute cut-off points 
separately for each individual at both time points. Paired t-tests showed there were 
no significant differences in these values between Time 1 and Time 2 for the three 
cut-off points of 30-minutes t (74) = -0.269, p=0.789, 60-minutest t (74) = 0.795, 
p=0.429 and 90-minutes’ t (74) = 0.622, p=0.536 (Table 5.23). In addition, Table 5.23 
shows the values of the three cut-off points of 30, 60 and 90 minutes at Time 1 and 
Time 2. The values of the three cut-off points of 30, 60 and 90 minutes were similar 
for both times, although there was very little variation at Time 2 as demonstrated by 
slightly smaller standard deviations. 
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Figure 5.31 Plot of normalized cumulative sedentary time accumulated by sedentary 
events from shortest to longest. 
 
Table 5.23  
Percentage of Sedentary Events According to Length of Events Cut-off Point 
 Sedentary events 
 
 
 
 
 
Statistical 
test 
 Time 1 Time 2 
Length of 
events 
(mins) 
M  
(percentage) 
 SD 
(percentage) 
M 
 (percentage) 
SD 
(percentage) 
30 26.21 6.55 26.46 6.05 Paired t- test 
p=0.789 
60 40.51 8.66 39.55 6.85 Paired t-test 
p=0.429 
90 48.34 9.72 47.51 6.82 Paired t-test 
p=0.536 
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In Table 5.24, the data for percentage accumulated by sedentary events sorted from 
shortest to longest are similar at both times. Over 25% of the participants’ 
accumulated sedentary events were in less than 30 minutes at both times 1 and 2, 
and the sedentary events decreased gradually with increased period, such as 
between 30-60, then 60-90 minutes, as illustrated in Table 5.24. 
 
Table 5.24  
The Difference of Mean of Sedentary Time Percentage between Time 1 and Time 2 
at the Period Cut-off Points 
 Time 1 Time 2 
Period cut-off 
points (mins) 
Difference of mean  sedentary 
events (percentage) 
Difference of mean  sedentary 
events (percentage) 
0-30 26.2 26.4 
30- 60 14.3 13.1 
60-90 7.8 8 
 
 
5.6.2.3 Physical Activity Level and Clinical Data Variables at Time 1 and Time 2  
The researcher used Pearson correlation tests to assess the relationship between PA 
level (including step count, stepping time, standing time, upright time and sedentary 
time) and BMI and diagnosis date of CHD. The researcher used one-way ANOVA to 
examine the difference in PA level among patients treated with three categories of 
AMI treatment.  
At Time 1, Pearson correlation showed that there were a negative correlations 
between BMI and step count (r = -0.264, p = 0.012) and BMI and stepping time (r = -
0.230, p = 0.030), which were statistically significant. In addition, there were negative 
correlations between diagnosis date of CHD and step count (r = -0.377, p ˂ 0.001), 
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and diagnosis date of CHD and stepping time (r = -0.368, p ˂ 0.001) (Table 5.25). 
One-way ANOVA showed there were significant differences in step count among 
types of AMI treatment groups (F (2, 87) = 6.105, p=0.003). There was a significant 
difference in stepping time among types of in AMI treatment groups (F (2, 87) = 6.226, 
p=0.003) at Time 1, Table 5.26. Tukey post-hoc tests revealed that patients treated 
with PPCI have mean step count (M=7516, SD=2829) significantly higher than 
patients treated with THROMB and PCI (M=4911, SD=2125), p = 0.002. In addition, 
patients treated with PCI have mean step count (M=7069, SD=2769) significantly 
higher than patients treated with THROMB and PCI (M=4911, SD 2125), p = 0.024. 
Moreover, Tukey post-hoc tests revealed that patients treated with PPCI have mean 
stepping time (M=1.74, SD=0.64) significantly higher than patients treated with 
THROMB and PCI (M=1.15, SD 0.45), p = 0.002. 
 
Table 5.25 
 Physical Activity and Clinical Data Variables at Time 1 
 BMI  Diagnosis date of 
CHD 
 
r p r p  Analysis Test 
Step count -0.264*  0.012 -0.377* 0.001 Pearson 
correlation 
Stepping time -0.230*  0.030 -0.368* 0.001 Pearson 
correlation 
Standing time -0.091 0.395 -0.078 
 
 0.465 Pearson 
correlation 
Upright time -0.144 0.177 -0.175 0.100 Pearson 
correlation 
Sitting/lying time 0.146 0.171 0.174 0.101 Pearson 
correlation 
* Correlation significant at <0.05 level (2-tailed) 
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Table 5.26 The Difference in PA Level at Time 1 According to AMI Treatment  
  df Sum of 
squares 
Mean 
square 
F p 
Step count  Between group  2 88128180 44064090 6.105 0.003* 
 Within group  87 627941454 7217717   
 Total  89 716069635    
Stepping time   Between group  2 4.4 2.2 6.226 0.003* 
 Within group  87 34 0.357   
 Total  89 35    
Standing time  
 
Between group  2 7.8 3.9 1.454 0.239 
 Within group  87 234 2.7   
 Total  89 242    
Upright time  Between group  2 22.6 11.3 2.755 0.069 
 Within group  87 357 4.1   
 Total  89 380    
Sedentary time  Between group 2 22 11.2 2.727 0.071 
 Within group 87 358 4.1   
 Total 89 380    
 
At Time 2, Pearson correlation showed negative correlations between BMI and step 
count (r = -0.378, p ˂0.001), and between BMI and stepping time (r = -0.344, p 
˂0.001). The diagnosis date of CHD alone has no correlation with PA level at Time 2, 
(Table 5.27). In addition, one-way ANOVA showed there were no significant 
differences in PA level among types of AMI treatment groups at Time 2 (Table 5.28). 
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Table 5.27  
Physical Activity and Clinical Data Variables at Time 2 
 BMI  Diagnosis date of 
CHD 
 
r p r p  Analysis Test 
Step count -0.378** 0.001 -0.220 0.373 Pearson 
correlation 
Stepping time 
-0.344** 0.001 -0.077 0.480 Pearson 
correlation 
Standing time -0.088 0.425 -0.072 0.512 Pearson 
correlation 
Upright time -0.153 0.164 -0.015 0.895 Pearson 
correlation 
Sitting/lying time -0.154 0.162 0.015 0.894 Pearson 
correlation 
**Correlation significant at <0.05 level (2-tailed) 
5.7 Self-efficacy Relationship with Physical Activity 
The study examined the correlations between global self-efficacy and its subscale 
and PA at Time 1 and Time 2. Pearson correlation tests found no correlations 
between self-efficacy and its subscales and PA level parameters including step count, 
stepping time, standing time, upright time and sedentary time at baseline, Time 1 and 
Time 2. The exceptions were just two correlations between step count and stepping 
time at Time 1 with the control symptoms subscale at Time 2 (Table 5.29).  
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Table 5.28  
The Difference in PA Level at Time 2 According to AMI Treatment 
  df Sum of 
squares 
Mean 
square  
F  p  
Step count  Between group 2 9295212 4647606 0.693 0.503 
 Within group 81 543461999 6709407   
 Total 83 552757211    
Stepping time   Between group 2 0.560 0.280 0.933 0.397 
 Within group 81 24.3 0.300   
 Total 83 24.8    
Standing time  
 
Between group 2 1.5 0.7 0.353 0.704 
 Within group 81 173.9 20.   
 Total 83 175    
Upright time  Between group 2 3 1.5 0.492 0.613 
 Within group 81 250 3   
 Total 83 253    
Sedentary time  Between group 2 3 4.5 0.494 0.612 
 Within group 81 250 3   
 Total 83 253    
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Table 5.29  
The Relationships between Self-Efficacy and Physical Activity  
 
Baseline  Time 1  Time 2  
 
Global 
CSEQ 
 
Control 
symptoms 
 
 
Maintain 
function 
Healthy 
lifestyle 
 
 
Global 
CSEQ 
 
Control 
symptoms 
 
 
Maintain 
function 
Healthy 
lifestyle 
 
 
Global 
CSEQ 
 
Control 
symptoms 
 
 
Maintain 
function 
Healthy 
lifestyle 
 
T
im
e
 1
  
Sedentary 
time  
r=-.151 
p=.156 
r=-.066 
p=.534 
r=-.174 
p=.102 
r=-.182 
p=.087 
r=-.131 
p=.220 
r=-.155 
p=.144 
r=-.097 
p=.363 
r=-.060 
p=.573 
r=-.102 
p=.356 
r=.144 
p=.193 
r=-.027 
p=.808 
r=.080 
p=.470 
Standing 
time 
r=.164 
p=.123 
r=-.084 
p=.432 
r=.186 
p=.079 
r=.186 
p=.080 
r=.10 
p=.349 
r=.136 
p=.20 
r=.064 
p=.549 
r=.020 
p=.850 
r=-.064 
p=.562 
r=.101 
p=.361 
r=.022 
p=.842 
r=-.030 
p=.785 
Stepping 
time 
r=.070 
p=.514 
r=.006 
p=.957 
r=-.081 
p=.448 
r=.113 
p=.289 
r=.180 
p=.089 
r=.166 
p=.118 
r=.164 
p=.124 
r=.151 
p=.155 
r=.178 
p=.106 
r=-.222* 
p=.042 
r=-.039 
p=.728 
r=-.184 
p=.094 
Upright 
time 
r=.152 
p=.153 
r=-.068 
p=.525 
r=.174 
p=.102 
r=.183 
p=.085 
r=.133 
p=.211 
r=.158 
p=.138 
r=.099 
p=.351 
r=.062 
p=.564 
r=.104 
p=.346 
r=.146 
p=.184 
r=.028 
p=.798 
r=.080 
p=.468 
Step count 
r=-.062 
p=.559 
r=-.004 
p=.970 
r=.081 
p=.449 
r=-.092 
p=.390 
r=.149 
p=.162 
r=.138 
p.195 
r=.130 
p=.223 
r=.130 
p=.222 
r=.186 
p=.089 
r=.227* 
p=.038 
r=.052 
p=.636 
r=.194 
p=.077 
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T
im
e
 2
  
Sedentary 
time  
r=-.017 
p=.878 
r=.046 
p=.675 
r=-.054 
p=.628 
r=-.048 
p=.664 
r=.031 
p=.777 
r=.032 
p=.774 
r=-.064 
p=.563 
r=-.115 
p=.296 
r=.045 
p=.686 
r=.012 
p=.916 
r=.128 
p=.245 
r=.032 
p=.772 
Standing 
time 
r=-.025 
p=.824 
r=-.031 
p=.782 
r=-.068 
p=.538 
r=-.028 
p=.797 
r=-.025 
p=.824 
r=-.031 
p=.781 
r=-.041 
p=.713 
r=.118 
p=.284 
r=-.052 
p=.639 
r=-.003 
p=.977 
r=-.105 
p=.343 
r=-.060 
p=.590 
Stepping 
time 
r=.037 
p=.740 
r=-.022 
p=.743 
r=.039 
p=.725 
r=.103 
p=.350 
r=-.006 
p=.953 
r=-.060 
p=.586 
r=.060 
p=.588 
r=-.027 
p=.807 
r=.020 
p=.857 
r=.040 
p=.719 
r=-.063 
p=.570 
r=-.076 
p=.494 
Upright 
time 
r=.016 
p=.885 
r=-.047 
p=.669 
r=.053 
p=.635 
 
r=.048 
p=.666 
r=.031 
p=.779 
r=-.032 
p=.771 
r=.064 
p=.563 
r=.115 
p=.297 
r=-.046 
p=.679 
r=.010 
p=.962 
r=-.128 
p=.244 
r=-.033 
p=767 
Step count 
r=.038 
p=.731 
r=.002 
p=.985 
r=.026 
p=.812 
r=.087 
p=.432 
r=-.009 
p=.935 
r=-.056 
p=.614 
r=.050 
p=.652 
r=.020 
p=.855 
r=.027 
p=.810 
r=.020 
p=.859 
r=-.028 
p=.800 
r=.100 
p=.365 
* Correlation significant at <0.05 level (2-tailed) 
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5.8 Summary of the Results  
The examination of self-efficacy and its subscales among patients with AMI in the 
early recovery phase showed there were significant differences in global CSEQ and 
its subscales between baseline, Time 1 and Time 2. The trends in the self-efficacy 
subscales showed increases between baseline and Time 1 similar to self-efficacy 
level increasing between Time 1 and Time 2. However, the increase in the healthy 
lifestyle subscale between Time 1 and Time 2 was less. The findings of the clinical 
data found there were few significant correlations between diagnosis date of CHD 
and global self-efficacy and control symptoms subscale at Time 1 only, with no 
significant correlations at baseline and at Time 2. BMI had no correlations with self-
efficacy and its subscales at baseline, Time 1 and Time 2. The findings showed A few 
significant differences among types of AMI treatment groups at baseline, but these 
differences disappeared at Time 1 and Time 2.  
Assessment of the PA data revealed no significant changes in PA parameters 
including, step count, stepping time, standing time, upright time and sedentary time 
between Time 1 and Time 2. Moreover, there were no significant changes in PA 
patterns between Time 1 and Time 2, that is, in upright and sedentary events. In 
addition, the study found significant negative relationships between CHD diagnosis 
date and step count and stepping time at Time 1, but this correlation disappeared at 
Time 2. BMI only had significant correlations with step count and stepping time at 
Time 1 and Time 2. The findings showed a few significant differences in steps count 
and stepping time among types of AMI treatment groups at Time 1, but these 
differences disappeared at Time 2. The study revealed that there were very few and 
small correlations between PA level and self-efficacy and its subscales, which were 
between step count and stepping time at Time 1 with control symptoms at Time 2. 
However, these few significant results did not follow a pattern.  
In addition, the study assessed the PA volume and pattern and revealed the following 
findings: PA showed low PA volume, namely step count, stepping time, standing time 
and upright time at Time 1 and Time 2. In addition to this, there was prolonged 
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sedentary time at Time 1 and Time 2. The findings showed a similar PA volume at 
Time 1 and Time 2 among patients with AMI in the early recovery phase. 
The mean step count per day was 6,981 steps ± (2,800) per day at Time 1 and 7,149 
± (2,575) steps per day at Time 2. The highest recorded mean number of steps per 
day was on Monday and Tuesday and the lowest recorded mean step count was on 
Friday at Time 1 and Time 2. The mean number of steps per day according to hour 
showed that steps count increased sharply from the morning to midday and 
decreased gradually in the afternoon and evening, with the highest recorded step 
count at 13:00 for both Time 1 and Time 2.  
The mean stepping time per day at Time 1 for all participants was 94.2 minutes per 
day, whereas the mean stepping time per day at Time 2 for all participants was 97.2 
minutes per day. The mean stepping time per day according to day was similar 
between Time 1 and Time 2, with the highest recorded mean daily stepping time on 
Monday and Tuesday and the lowest mean daily stepping time occurring on Friday. 
The mean stepping time per day according to hour increased sharply from the 
morning to midday, decreasing gradually in the afternoon, and evening, with the 
highest recorded step count at 13:00 for both Time 1 and Time 2. 
The mean standing time per day was 238.8 minutes at Time 1 and the mean standing 
time per day was 231.6 minutes at Time 2. The mean standing time per day 
according to day was similar at Time 1 and at Time 2. Tuesday had the greatest 
mean standing time per day at both Time 1 and Time 2. Moreover, Friday had the 
lowest mean standing time per day for both Time 1 and Time 2. The mean standing 
time was similar at Time 1 and Time 2. The greatest mean standing time per day 
according to hour was in the afternoon, particularly at 13:00 at Time 1 and Time 2. 
The lowest mean standing time per day was during the night-time.  
The mean upright time per day was 333 minutes at Time 1 and 327.6 minutes at 
Time 2. The mean upright time per day according to day was similar at both Time 1 
and Time 2. Tuesday had the greatest mean upright time per day, and Friday showed 
the least mean upright time per day for both Time 1 and Time 2. The mean upright 
time per day according to hour was similar for both Time 1 and Time 2, with the 
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highest mean upright time per day being during the afternoon and the lowest mean 
upright time per day being during the night-time for both Time 1 and Time 2.  
The mean sedentary time per day was 1,107 minutes (18.45 hours) at Time 1 and the 
mean sedentary time per day was 1,112 minutes (18.53 hours) at Time 2. The mean 
sedentary time per day according to day was similar at both Time 1 and Time 2. The 
highest recorded mean sedentary time per day was on Friday and Saturday and the 
lowest on Tuesday for both Time 1 and Time 2. The mean sedentary time decreased 
during the afternoon and increased during the night-time at Time 1 and Time 2.  
The PA pattern for upright events and sedentary events was similar at Time 1 and 
Time 2. Approximately, 75% of the upright events consisted of less than 33 minutes 
for both Time 1 and Time 2. However, there were no significant changes found 
between upright events at Time 1 and Time 2. Moreover, sedentary events were 
similar for all participants at Time 1 and Time 2, and approximately 75 % of the 
sedentary events consisted of less than 5.2 hours at both Time 1 and Time 2. 
However, there were no significant changes found between sedentary events at Time 
1 and Time 2.  
5.9 Conclusion 
The analysis of the findings has showed significant changes in global self-efficacy 
and its subscales between baseline, Time 1 and Time 2. Further, clinical variables 
occasionally showed a few significant results in self-efficacy level across the 
measurement times. These few significant results did not follow a pattern. The 
analysis of PA findings revealed decreased PA level in terms of step count, stepping 
time, standing time, and upright time. In addition to this, the participants spent 
prolonged periods in sedentary time at Time 1 and Time 2. Moreover, the study 
revealed no significant changes in PA levels and PA patterns between Time 1 and 
Time 2. 
The highest PA activity occurred in the afternoon and decreased in the night and 
morning. In addition to this, there was a decrease in PA levels during the weekends 
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at Time 1 and Time 2. Clinical data variables showed few significant differences and 
correlations with PA level. However, these few significant differences did not follow a 
pattern. The exception is that BMI has negative correlations with step count and 
stepping time at Time 1 and Time 2. Furthermore, the study findings found no 
correlations between self-efficacy and its subscales and PA levels at Time 1 and 
Time 2, which indicates that increased self-efficacy, did not influence PA levels 
among participants.  
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Chapter Six: Discussion 
6.1 Introduction  
This chapter explains the findings from two phases of the study alongside the small 
body of existing literature, to develop a better offering of the study. The findings of the 
study have supported some of its hypotheses. The researcher used the study 
objectives to structure the discussion of the study findings to provide more clarity that 
for research questions addressed. Four pertinent key points arise from the study 
findings that warrant discussion: 
 Translation and cross-cultural adaptation of the CSEQ 
 Self-efficacy level and changes in the early recovery phase  
 PA levels, patterns and changes in the early recovery phase 
 The relationship between self-efficacy level and PA level 
6.2 Translation and Cross-Cultural Adaptation of the Cardiac Self-Efficacy 
Questionnaire 
To the best of the researcher’s knowledge, this is the first study aiming to translate 
and cross-culturally adapt the CSEQ into Arabic. In addition, there is no Arabic 
version of the CSEQ at present ready for use. The Arabic version of the CSEQ has 
demonstrated good reliability and validity outcomes for use in Arabic-speaking 
countries, including test and re-test reliability (internal consistency= 84.6 and ICC= 
92.9). The original CSEQ is in English. The study translated and cross-cultural 
adapted all items in the CSEQ accurately into Arabic after  application of the WHO 
process of questionnaire  translation and cross-cultural adaptation (WHO, 2014).  
The translation and cross-cultural adaptation of the CSEQ for use in Arabic-speaking 
countries followed a standardised process recommended by the WHO. The input 
from the expert panel members resulted in translation and cross-cultural adoption that 
reflected a simple, clear and easy to use Arabic version of the CSEQ. Further 
suggestions from the participants who were involved in face validity as recommended 
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by Beaton et al. (2000) added an excellent user acceptability and comprehension to 
the Arabic CSEQ.  
Using the WHO process of translation and cross-cultural adaptation process closely 
linked contextual meaning to the target language. Without the careful translation of 
items, participants may have misunderstood their correct meaning. In addition, using 
Modern Standard Arabic (Fusha) is recommended during the translation and cross-
cultural adaptation process (Khalaila, 2013), for the purpose of making the CSEQ 
more broadly applicable for a range of cardiac patients in Middle Eastern countries.  
The social and cultural differences between Western and Arabic countries are a 
cause for concern, particularly reflected in discussions around sexual relationships in 
the original CSEQ as stated in item number 12. The question asks about maintaining 
sexual relationship with spouse. The laws, regulations and religious rules do not 
support any sexual relationship outside the marital relationship context in Arabic 
countries. In addition, the people do not discuss that topic frankly in Arabic-speaking 
countries. However, the translation of the CSEQ adopted this question and presented 
the question in the marital relationship context only. Further, the researcher assured 
the participants that their data were confidential, their privacy was highly regarded, 
and the objective of this question was only for research purposes. Therefore, the 
WHO process of translation and cross-cultural adaptation of questionnaires was 
crucial to ensure accurate conceptual understanding of items. 
The implementation of the pre-test and cognitive interviewing stage showed there 
were no missing items and the completion time for the CSEQ was relatively short, 
typically 10–15 minutes, which indicated that the user acceptability of the Arabic 
version of the CSEQ among the participants was excellent. There were no particular 
problems in the questionnaire translation process, with no items considered confusing 
or disturbing.  
Assessment of the validity and test- retest reliability of the Arabic CSEQ 
demonstrates good outcomes that confirmed the Arabic version of the CSEQ 
questionnaire’s ability to produce consistent results, including face validity testing, 
which showed that the appearance of the CSEQ, the writing style, format and 
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language of items were all clear. The content validity revealed that there was 
excellent content relevance of the CSEQ. This is consistent with the original CSEQ of 
Sullivan et al. (1998) and  those of previous studies (Fors et al., 2014; Saengsiri et 
al., 2013).  
The internal consistency of the translated version is good. The three CSEQ subscales: 
control symptoms, maintain function, and healthy lifestyle, have close internal 
consistency with each other, 0.841, 0.715 and 0.711 respectively. The test and re-test 
reliability was acceptable for all the CSEQ’s subscales in this study, demonstrating 
good stability for the CSEQ over time. In addition, all CSEQ items’ internal 
consistency was greater than 0.70, which reflects good stability for all items with time. 
These results are similar to findings in studies completed in other languages under 
similar circumstances (Fors et al., 2014; Saengsiri et al., 2013). For example, the 
Cronbach’s alpha for the Swedish version of the CSEQ  was 0.89 (Fors et al., 2014), 
and for the Thai version of the CSEQ it was 0.92 (Saengsiri et al., 2013). Furthermore,  
the Cronbach’s alpha in the original study was  0.90 for the control of symptoms 
subscale, and 0.87 for the maintenance of function subscale (Sullivan et al., 1998). In 
general, the Arabic version of the CSEQ revealed similar reliability and validity scores 
to the original version. 
There are three limitations related to the translation and cross-cultural adoption of the 
CSEQ. First: the WHO process mentioned that the English language should be 
involved in the back- translation process. However, there were no available 
translators at that time whose main language was English. The main language of the 
expert panel and translation members of was the Arabic language, but they are 
familiar with English. Second: the alternative options were so close to each other as 
to make the choice between the answers not easy. Therefore, the expert panel added 
score under each alternative score, which made the Arabic version of the CSEQ is 
easier to answer. Third: there was a limited time to test the CSEQ and carry out the 
data collection procedure, thus, the sample size used in the study for testing validity 
and test-reliability was relatively low, which might affect the findings of the CSEQ 
reliability.  
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6.3 Self-Efficacy Levels and Changes  
In Chapter three, the study outlined the importance of self-efficacy as a psychological 
construct that improves adherence to self-management skills (Sol et al., 2011), 
predicts re-hospitalisation and CVD complications (O’Neil et al., 2013), in addition to 
mortality (Sarkar et al., 2009), among patients with CHD and heart failure. It is a 
construct that is potentially increase in order to improve patient’s health outcomes. In 
the study, the researcher collected self-reported CSEQ data from a sample of 
patients with AMI recruited from a single centre in Jordan. The participants in this 
study did not have access to cardiac rehabilitation programmes or receive any health 
intervention that could affect self-efficacy during the collection period.  
This study assessed levels and changes in self-efficacy among patients with AMI in 
the early recovery phase. Self-efficacy referred to the individual’s confidence in 
carrying out specific health behaviours to achieve a desired goal. This is the first 
study to focus on changes in self-efficacy level in the early recovery phase among 
patients with AMI. There were very few published studies available, which measured 
self-efficacy levels during early recovery for patients with AMI not involved in cardiac 
rehabilitation with which to compare it. Therefore, the researcher compared study’s 
results with previous studies that measured self-efficacy level of patients with CHD 
after receiving treatment and patients after involvement in cardiac rehabilitation 
programmes. 
6.3.1 Self-Efficacy Levels and Changes at Baseline, Time 1 and Time 2 
The study found that patients have a significantly increased self-efficacy level in 
global self-efficacy and its three subscales from baseline to Time 1 and from Time 1 
to Time 2. The global self-efficacy subscale showed significant increase at baseline, 
Time 1 and Time 2. The trend of changes in global self-efficacy subscale level was 
stable and similar between baseline and Time 1, and between Time 1 and Time 2. 
The self-efficacy level was similar to other previous studies in Iran (Boroumand et al., 
2015; Jalilian, Mostafavi, & Sharifirad, 2013). The control symptoms and maintain 
function subscales showed significant increase at baseline, Time 1 and Time 2. The 
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changes in the observed trends of ‘control symptoms’ and ‘maintain function’ 
subscales level were stable and similar between baseline and Time 1, and between 
Time 1 and Time 2. Finally, the healthy lifestyle subscale showed significant increase 
at baseline, Time 1 and Time 2. The trend of changes in the healthy lifestyle subscale 
level was unstable and dissimilar between baseline and Time 1, and between Time 1 
and Time 2. The healthy lifestyle subscale changed relatively less than the other self-
efficacy subscales at Time 2. This subscale includes items regarding changes in CVD 
risk factors, and this indicated that the intention and motivation of patient with AMI to 
change their unhealthy behaviours decreased. This is consistent with the 
recommended guideline for patients with AMI to be involved in a cardiac rehabilitation 
programme within ten days after hospital discharge (NHS, 2016; NICE, 2013d).   
According to similar studies in the literature, these results of self-efficacy agree with 
the researcher’s expectations. In comparing self-efficacy level in this study with that 
found in the previous study that used CSEQ in Iran (Boroumand et al., 2015; Jalilian 
et al., 2013), the self-efficacy level was similar. The study’s results were consistent 
with many previous studies in the literature that showed patients with CHD had 
increased self-efficacy levels after being involved in cardiac rehabilitation 
programmes (Howarter et al., 2014; Maddison et al., 2014). In addition, this result in 
general is consistent with Blanchard et al. (2006), which showed that self-efficacy 
level increased from baseline (2 months) to 6 months in CHD patients not involved in 
cardiac rehabilitation. Blanchard et al. (2006) used different self-efficacy measures 
and the participants’ self-efficacy increased without them being involved in cardiac 
rehabilitation programmes. However, another previous study among patient with CHD 
treated by coronary artery angioplasty within six months by Salari et al. (2016) in Iran 
showed contradictory results as against Boroumand et al. (2015), the study showed 
that patients had low self-efficacy after coronary artery angioplasty (Salari et al., 
2016), this study measures self-efficacy once without follow up measurements for 
self-efficacy level or even investigating other variables that can affect self-efficacy 
level. Salari et al. (2016) did not provide possible reasons to explain low self-efficacy 
level among patients with CHD in Iran. 
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There are a number of possible reasons might explain increased self-efficacy among 
patients with AMI in the early recovery phase: according to the self-efficacy theory of 
Bandura (1997), physiological and affective states are one of the four resources that 
contribute to self-efficacy, which help us to explain the findings. Chest pain is a 
physiological symptom and one of the most common AMI symptoms. Chest pain can 
affect lifestyle change in the following ways. First: physiological and affective states 
are one of the four sources of self-efficacy, as individuals usually rely on their somatic 
and emotional condition when judging their capabilities. Therefore, when the patient 
feels chest pain, the patient will decide to decrease his/her capability to achieve a 
given task. Second: feeling chest pain related to AMI experience and increased 
symptoms burden in turn affect self-efficacy level (Sarkar et al., 2007). In this study, a 
daily diary chest pain showed that patients did not experience chest pain during the 
early recovery period. Chest pain occurs. This will indicate that there is a coronary re-
stenosis. Consequently, patients need to re-admit to the hospital. However, there 
were no patients re-hospitalised during the collection of the data in the study. Over 
and above this, affective states, such as anxiety, depression and quality of life, 
influence self-efficacy level (Allahverdipour et al., 2013; Joekes, Van Elderen, & 
Schreurs, 2007; Sarkar et al., 2007). This study did not measure these variables. 
Thus, the study cannot determine the role of physiological and affective states in 
improving self-efficacy level. 
Other factors that may affect the self-efficacy level are age and verbal persuasion (for 
example social support). The mean age of the participants in the study is young. 
There is an inverse relationship between age and cardiac self-efficacy, and age is 
one of the determinants of self-efficacy level among patients with CHD according to 
(Boroumand et al., 2015). (Boroumand et al., 2015) found that age, gender and 
functional capability are the determinants of self-efficacy. Thus, in addition, the 
expectation is for self-efficacy to be at a high level in this sample as their mean age is 
young. They do not have any disability that prevents their physical capability based 
on the exclusion criteria of the study. Therefore, self-efficacy level increases gradually 
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across baseline, Time 1 and Time 2, which is consistent with (Boroumand et al. 
(2015); Jalilian et al., 2013). Verbal persuasion is such as that received from a 
spouse, which might affect self-efficacy levels (Maeda et al., 2013). Jalilian et al. 
(2013) showed that there is a relationship between perceived social support and self-
efficacy among patients with CVD. According to Bandura’s self-efficacy theory, verbal 
persuasion is the second source of self-efficacy. The sample of the study included 
approximately two-thirds of participants who were married. Consequently, for patients 
with AMI, health care professionals could provide support, as well as encouraging 
each patient’s spouse to provide support to them in order to improve self-efficacy 
level.  
6.3.2 Self-efficacy level and Clinical Variables 
The study revealed that there was no relationship between self-efficacy and its 
subscales and BMI at baseline, Time 1 and Time 2. These results are inconsistent 
with the literature, which found that improving BMI correlated with improving self-
efficacy level among CHD patients (Kang & Yang, 2013; Sol et al., 2011). However, 
this relationship between self-efficacy and BMI is weak, as reported by Kim, McEwen, 
Kieffer, Herman, and Piette (2008). Further, abdominal obesity, and not BMI, 
correlated to the risk factors of patients with AMI in the Middle East (Gehani et al., 
2014) . 
There was no relationship between self-efficacy and its subscales and diagnosis date 
of CHD. In addition, AMI types of treatment showed there was no difference self-
efficacy and its subscales score at baseline, Time 1 and Time 2. There is no research 
in the literature showing whether there is a relationship between self-efficacy and 
CHD diagnosis date or disease duration and whether the AMI types of treatment have 
influence on self-efficacy level. 
There are various possible reasons, which may show why there was no significant 
association between self-efficacy and its three subscales and clinical variables. First: 
there is an absence of structured health education or cardiac rehabilitation 
programmes in Jordan. Accordingly, a patient with AMI is not aware of the AMI 
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treatment modalities that have been used for them (Eshah, 2011). Therefore, the 
CHD patients do not have enough information about their disease, AMI types of 
treatment and related information. Second: the recording of BMI was once at baseline 
and measurements of self-efficacy levels were at baseline, two and six weeks after 
hospitalisation. This could indicate that more BMI in-depth follow-up (BMI changes) 
might be necessary; particularly for BMI measures that need a longer time to detect 
changes. Third: the researcher used a disease-specific self-efficacy questionnaire. 
The research results could have been different if the researcher used another type of 
self-efficacy questionnaire, such as a general self-efficacy questionnaire or phase-
specific self-efficacy (task or self-regulatory self-efficacy). 
In summary, the discussion has offered reasons for the improvement in self-efficacy 
results improved significantly across baseline, Time 1 and Time 2. Self-efficacy can 
play an important role in the patients’ health promotion along with disease 
complication prevention and symptom recurrence. In addition, thorough assessment 
of self-efficacy of patients with AMI during the early recovery phase will enable 
greater understanding of changes in self-efficacy levels in the early recovery period. 
This is useful and provides an overview of self-efficacy, and identifies changes 
between baseline, Time 1 and Time 2 among patients with AMI. For this, healthcare 
professionals could use these findings in the clinical context to facilitate discussion of 
self-efficacy and tailoring of interventions to improve self-management skills based on 
the needs of patient with AMI. This result is expected and consistent with the previous 
studies (Blanchard et al., 2006; Howarter et al., 2014; Maddison et al., 2014). The 
study findings showed similar self-efficacy scores compared to previous study 
(Boroumand et al. (2015); Jalilian et al., 2013). Consequently, the findings confirmed 
the first hypothesis, noting improvements in self-efficacy levels in the early recovery 
phase among treated patients with AMI. 
6.4 Physical Activity Behaviours  
The previous section presented a detailed explanation of findings related to self-
efficacy and its subscales. This section explains changes in PA levels and patterns 
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for patients at Time 1 (week 2) and Time 2 (week 6). Following this, the researcher 
linked the findings to the related study context. To the best of the researcher’s 
knowledge, this study provides the first descriptive data on objectively measured PA 
levels among patients with AMI. In order to realise this aim, the study assessed PA 
levels and patterns among the AMI population in the early recovery phase in Middle 
Eastern countries.   
This study provides new information on PA during the day and the week in the early 
recovery phase for a representative sample of patients with AMI. The researcher 
used the activPAL3™ monitor to measure the PA level and pattern as well as, over a 
period of seven consecutive days, among patients with AMI. The activPAL3™ 
monitor is a valid and reliable activity monitor for PA measurement (Ryan et al., 2006) 
that can be used with older adults (Grant et al., 2008). No participants had access to 
a cardiac rehabilitation programme or disease self-management programme in the 
study.   
The study assessed the primary outcome measure of PA volume. For this, five 
parameters of PA volume were measured, namely: step count, stepping time, 
standing time, upright time (a combination of stepping and standing time) and 
sedentary time (lying/sitting time), and these have been shown to discriminate PA 
volume between Time 1 and Time 2. Time spent in these behaviours reflects the 
mean daily time after hospitalisation during free-living PA. 
The study implemented further investigations to determine PA pattern: upright and 
sedentary events, in order to obtain comprehensive information regarding PA 
behaviours. The section divides the discussion of this matter into four points: PA level 
and changes, PA pattern and changes, PA level and clinical variables, and the 
relationship between PA level and self-efficacy. 
6.4.1 Physical Activity Level and Changes   
The study investigated several aspects of PA behaviour. Its results revealed 
important findings. These results revealed low levels of PA in comparison with 
healthy populations in other studies (Bassett Jr et al., 2014; Fitzsimons et al. (2013)),  
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and prolonged periods of sedentary behaviour at both Time 1 and Time 2 (Colley et 
al., 2011; Matthews et al., 2008). In addition, patients with AMI demonstrated step 
count below those recommended by Tudor-Locke et al. (2011). The findings showed 
there was no significant change regarding five parameters of PA volume among 
patients with AMI between Time 1 and Time 2, according to the five parameters 
discussed in this section. These results of PA disagree with the researcher’s 
expectations.    
6.4.1.1 Step Count  
The study showed that the mean step count per day for patients with AMI was low at 
both Time 1 and Time 2. There is clear evidence that 5,000 steps per day is 
considered inactive or sedentary  (Tudor-Locke et al., 2012). Tudor-Locke et al. 
(2011) showed that 8,000 steps per/day was representative of the physical activity 
guideline of special populations such as CHD. For healthy older adults the guidelines 
are 7,000-10,000 steps per/day. Therefore, it is apparent that the population in this 
study was towards the less active end of the range. These results consistent with 
(Barghouti, AbuRmaileh, Jallad, & Abd-Qudah, 2015), in which PA was measured by 
self-reported PA questionnaire, showed that the Jordanian healthy adult population 
had a low level of PA.  
There are no previous studies specifically investigating the step count during the early 
recovery phase among the CHD population or any other population. Carrying out a 
comparison step count with other similar studies is feasible, because previous studies 
expressed PA level through measuring step count among patients with CHD (Houle 
et al., 2011; Izawa et al., 2006). The mean step count per day is similar to the findings 
from other studies among ACS and patients with AMI (Houle et al., 2011; Izawa et al., 
2006), which showed patients with AMI 3-6 months on from cardiac rehabilitation had 
approximately 5,845-6,097 steps per day. Moreover, despite assertions in the 
literature that PA levels of patients with AMI improve after hospitalisation and 
participation in cardiac rehabilitation (Houle et al., 2011; Izawa et al., 2006), this study 
found no differences between mean step count per day in Time 1 and Time 2 among 
patients with AMI in the early recovery phase (p=0.503).  
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                                 Highly active    ≥12,500 steps 
≥10,000 steps 
   7,500–9,999 steps 
    5,000–7,499 steps 
                               Sedentary life    ≤5,000 steps                     
Figure 6.1 Step count preliminary indices for healthy adults adopted from (Tudor-
Locke et al., 2012)  
 
The change in step count per day is inconsistent with Houle and colleagues (2011), 
who reported that there was an increase in step count after 3 months in the 
experimental group and in the control group (Houle et al., 2011). The change in step 
count per day is also inconsistent with the study results of Blanchard et al. (2006), 
who showed improved step count (measured by PA questionnaire) from 2-6 months 
among CHD patients not attending a cardiac rehabilitation programme. Change in 
step count per day is consistent with Izawa et al. (2006), who found step count 
among patients with AMI after cardiac rehabilitation to be 6,565 ± 1,115 in the 
experimental group and 6,283 ± 1,986 in the control group. However, there was a 
significant increase in step count after 12 months: 10,459 ± 3,310 in the experimental 
group and 6,923 ± 3,193 in the control group (Izawa et al., 2006). In addition, the 
study revealed similar findings to previous studies among the heart failure population 
conducted by Cowie et al. (2011). The study showed no significant changes in PA in 
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either home- or hospital- based exercise training for eight weeks at baseline or 8 
weeks in terms of step count, bouts (steps per day), and cadence (steps per minute), 
except for extra-long and long walking in the hospital based group. However, upright 
duration for the home group significantly improved six months after cessation of 
training.  
Therefore, the fact that mean step count per day did not improve during the early 
recovery phase among patients with AMI may be disappointing, as the patients 
received treatment. This indicates the need for cardiac rehabilitation programmes or 
education sessions for the patients with AMI. In conclusion, the improvement in step 
count in previous studies occurred after 3 to 12 months after involvement in cardiac 
rehabilitation programmes or receipt of intervention. However, the two measurement 
times of the study was short and thus cannot detect the changes in step count.  
The data analysis showed mean step count across weekdays is consistent. However, 
there was an overall drop in mean step count at weekends for both Time 1 and Time 
2. This is due to the weekly holiday (Friday and Saturday) in the Middle East, which 
means that usually there is no work or business at the weekend and social gatherings 
usually happen in the patient’s home as one of the cultural traditions and Islamic rules 
in Arab countries. The trend in step count was dissimilar across weekdays and 
weekends, which suggest the patients with AMI, did not modify their PA behaviour, 
even on their holidays. This drop in step count at the weekend is inconsistent with 
previous studies, which showed that there was no difference in step count between 
weekdays and weekends among office-based workers (Smith et al., 2015). 
The trends in mean step count showed there was a slight improvement in step count 
between weekends and weekdays at Time 2. The expectation was that PA would be 
higher on weekdays than weekends. Many reasons could explain these results, such 
as the healing process beginning to return to normal within 3 months after AMI, and 
the sociodemographic data showed that the employment represented two-thirds of 
the sample. In addition, governmental institutions are not working during the 
weekends. Therefore, they accomplish their business and related activities on 
weekdays.  
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This is the first study that has assessed and compared hourly step count, over 24 
hours, in free-living PA, in the early recovery phase among patients with AMI. Data 
analysis showed that PA for both Time 1 and Time 2 was very closely resembled the 
mean steps per hour.  
Mean step count per hour is consistent with a previous study among office-based 
workers in the UK (Smith et al., 2015), which showed that the lowest PA level 
occurred in afternoons and evenings. Copeland and Esliger (2009) reported most 
long bouts of activity in older participants took place before mid-day. However, 
Copeland and Esliger noted that the participants were more likely to undertake 
moderate-to-vigorous activity in the afternoon. 
This trend of step count from 07:00 to 20:00 is in concordance with the period for 
performing prayer time for the Muslim population, and this period is a convenient time 
for performing their daily life activities. The findings showed the large variations 
during the daytime and these variations in hourly time across the day as 
consequences of diurnal variations. Consequently, when promoting PA in older 
adults, an understanding of the distribution of activity throughout both the day and 
week may be helpful in scheduling activity programmes.  
6.4.1.2 Stepping Time  
The study found no significant difference in stepping time per day between Time 1 
and Time 2, which indicated that participants’ PA level was consistent after 
hospitalisation. There were no studies showing stepping time in a cardiac population 
with which to compare these results. However, the stepping time among patients with 
AMI was lower than healthy adults in the US – 114 minutes (Bassett Jr et al., 2014) - 
and older adults in UK – 105 (Fitzsimons et al., 2013) – see Table 6.1. Although the 
stepping time is important for health outcomes, the study found the stepping time to 
be below the recommended level. A previous European study for cardiac patients in 
2015 by Healy, Winkler, Owen, Anuradha, and Dunstan (2015) showed that each 
hour reallocated from sedentary time to stepping or standing will decrease metabolic 
risk factors. Further, each additional 2 hours per day of stepping was significantly 
associated with cardio-metabolic biomarkers such as lower BMI, total and High-
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Density Lipoprotein- Cholesterol ratio, triglycerides, waist circumference, and 2-hour 
plasma glucose and higher High-Density Lipoprotein-Cholesterol ratio. Stepping and 
standing time is one of the sitting-reduction strategies.  
The mean stepping time per day showed a consistent level across the week at Time 
1 and Time 2. However, there was a drop in stepping time at the weekend, 
particularly on Friday. Stepping time coincides with step count in the previous section, 
with increased stepping time and step count on weekdays and a drop in stepping time 
and step count at weekends. This could be due to Jordan lacking the open spaces 
and parks that are preferred among the people over sports facilities (Barghouti et al., 
2015). Moreover, cultural norms and a conservative tradition could be major barriers 
to stepping time, especially among females in Saudi Arabia, as reported by (Amin et 
al., 2012). However, in Jordan, the culture and traditions are less restrictive than in 
Saudi Arabia. In addition, the climate and temperature for most of the year are 
appropriate for performing outdoor activities in Jordan. 
Another explanation is due to the lifestyle in Jordan, where there is lack of electronic 
services such as payment of energy bills, governmental organisations and bank 
services, whereby Jordanians have to physically visit the related institution site when 
they need to deal with public services during the working hours in the week 
(Mohammad, Almarabeh, & Ali, 2009). Therefore, when the governmental 
organisation and bank services are open, stepping time will increase. This style of 
living increases the stepping time during weekdays. In addition, when the 
governmental organisations and banking sector are closed, the stepping time will 
decrease. 
This is the first study to describe hourly stepping time over 24 hours among an AMI 
population in the early recovery phase. The data showed that participants spent the 
majority of their stepping time in the late morning and afternoon. The lowest stepping 
time occurred at night-time for both at Time 1 and Time 2. These findings are 
consistent with Copeland and Esliger (2009), who showed that 65% of the activity 
occurred between late morning and afternoon. This may be due to the lifestyle in 
Jordan, such as opening hours for governmental departments, the bank sector, and 
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the transportation system in Jordan. Buses are the main means of inter-city transport 
in Jordan, and operate between cities. There are no fixed pick-up or set-down points 
for buses or “servis” (shared taxi) (Land Transport Regulatory Commission, 2016). 
6.4.1.3 Standing Time  
There was no significant change in mean daily standing time between Time 1 and 
Time 2, which indicated that participants’ standing time was consistent after 
hospitalisation. The overall mean standing time of participants was lower than healthy 
adults in the US – 360 minutes (Bassett Jr et al., 2014) - and older adults in UK – 251 
(Fitzsimons et al., 2013) -  see Table 6.1. In addition, a previous study showed that 
office-based workers spent 246 minutes per day of their day standing (Smith et al., 
2015). Standing time had a dose-response association with all-cause mortality in 
adults, and increasing standing may alleviate the health risks of prolonged sitting (van 
der Ploeg et al., 2014). However, the findings show there was a decrease in standing 
time at Time 2 of approximately 3% from the overall standing time at Time 1 due to 
lack of awareness of the benefits of a standing position and absence of  structured 
education for patients with AMI in Jordan (Eshah, 2011).  
There are three possible reasons that could explain this decrease in standing time. 
First, there is absence of structured health education programmes. Consequently, the 
cultural views on illness-recovery lead AMI patients to spend as much time as they 
can in a lying position during the day and avoid strenuous activities in order to control 
their condition by themselves. This is patients perception in addition to one of the 
local traditions, especially in Middle Eastern countries (Mosleh & Almalik, 2016). 
Second, Muslims pray five times per day, and they perform most of the prayers in 
standing positions, but according to Islam’s rules, Muslims can perform the prayer in 
a sitting position when the patients are not able to do them in a standing position. 
Third, according to Islam’s rules are recommendations, Muslims have not to drink or 
eat in a standing position. Fourth, there are issues with availability of personal and 
public transportation: there are no designated stops for public transportation, but the 
passenger can ask the driver at any point in the bus lane. Furthermore, a Jordanian 
Central Traffic Department study showed that the number of private cars in Jordan 
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has doubled over the past decade, with an annual increase of 8.4%. There are 1.43 
million vehicles registered in Jordan, meaning that compared to 1971, when there 
was one vehicle for every 58 residents, one in every five Jordanians now owns a car 
(The Jordan Times, 2014). The fuel price is 0.77$ US per litre in Jordan (Fuel price 
Jordan, 2016), compared to 1.44$ US per litre in the UK (Petrol prices UK, 2016),  
which encourages the Jordanian population to buy a car due to the affordable running 
costs.  
The mean standing time per day showed a consistent level across the week. 
However, there was a drop in standing time at weekends (Fridays and Saturdays) at 
Time 1 and at Time 2. This pattern of standing time is in agreement with the step 
count and stepping time in the previous sections. In this context, the consistent level 
of standing time is due to unawareness of the importance of standing time among 
patients with AMI due to the absence of structured education programme, in addition 
to lifestyle in Jordan such as eating habits and the transportation system.   
The trend in standing time according to day was not similar between Time 1 and Time 
2. In comparison, the standing time according to day at Time 2 was less than at Time 
1 on weekdays by 19.1 minutes, and the difference of standing time between Time 1 
and Time 2 at weekends increased by 14.7 minutes. Hence, the findings of the study 
showed unstable and reduced standing time among the patients with AMI at Time 2.   
This is the first study to describe hourly standing time over 24 hours among an AMI 
population in the early recovery phase. The data show that participants spent the 
majority of their standing time in the afternoon. The lowest standing time occurred at 
night-time at Time 1 and at Time 2. Although standing is the healthier alternative 
position to replace excessive periods of sitting (Katzmarzyk, 2014), the mean hourly 
standing time tended to be lower at Time 2. However, there were relatively low levels 
of mean hourly standing time throughout the day at both times. This reduced standing 
time could be due to the site of PCI catheter insertion after the femoral PCI 
procedure, in which patients with AMI feel uncomfortable for a few days and perhaps 
weeks if there is bruising. Therefore, health care professionals advise patients with 
AMI to avoid heavy lifting and to increase their PA gradually.  
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6.4.1.4 Upright Time  
There was no significant improvement in upright time found between Time 1 and 
Time 2. The decrease in upright time at Time 2 is due to a decrease in standing time 
at Time 2. Therefore, the standing time affected the upright time and the sedentary 
time increased accordingly. This finding of the study is consistent with Cowie et al. 
(2012), which showed that daily upright duration for the home group was not 
significantly improved at baseline or at 8 weeks, but only significantly improved six 
months after the end of training. 
The mean upright time per day is low, representing less than 25% of their day, with 
the remaining time, more than 75%, being sedentary time. There is no similar 
population in the literature to compare with the upright time of this study. A study of a 
healthy population in a previous study among older adults in UK found that 356 
minutes of their day was upright time (Fitzsimons et al., 2013). In addition, another 
study among healthy adults in the US found upright time was 474 minutes (Bassett Jr 
et al., 2014) (Table 6.1).   
Upright time is a good indicator of PA as the energy costs of standing and particularly 
stepping are considerably higher than sitting (Ainsworth et al., 2000). Increased 
upright time or standing and stepping times improve cardio-metabolic health. Sitting-
to-stepping reallocations per 2 hours / day were related to approximately 11% lower 
BMI, 7.5cm lower waist circumference, 11% lower 2-hour plasma glucose, 14% lower 
triglycerides, and 0.10 mmol/L higher High-Density Lipoprotein- Cholesterol ratio, 
while standing-to-stepping reallocations were related to 10% lower BMI, 7cm lower 
waist circumference, and 11% lower plasma glucose (Healy et al., 2015). Therefore, it 
is necessary to encourage patients with AMI to increase their upright time.  
The mean upright time per day showed a consistent level across weekdays. However, 
there was a drop in upright time at weekends at Time 1 and Time 2. This pattern of 
upright time is in harmony with their stepping and standing times in the previous 
section. Therefore, the participants in this study demonstrated low levels of upright 
time not only at weekends, but also on weekdays. 
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The trends of upright time showed there was decrease in the upright time according 
to day at Time 2 compared to Time 1 on weekdays of 9.1 minutes, and the upright 
time between Time 1 and Time 2 at weekends increased by 26.1 minutes. There 
were two reasons for this, first: decreased in patients’ awareness of the importance of 
upright time and absence of an effective education programme for patients with AMI 
in Jordan. Second: the healing process is still in progress and needs more time for 
reasons such as discomfort at the catheterisation site. Therefore, there should be a 
focus on increasing the upright time gradually on all days, particularly, during 
weekends. 
This is the first study that describes hourly upright time over 24 hours among an AMI 
population in the early recovery phase. The data showed that participants’ upright 
behaviour was similar at Time 1 and Time 2. Participants spent the majority of their 
upright time in the morning and the afternoon. The lowest upright time occurred at 
night-time at Time 1 and at Time 2. This pattern of upright time is congruent with the 
five prayer times among the Muslim population. Where the Muslims pray is in a 
mosque, if they are physically able to do so. If they cannot pray in the mosque and in 
a standing position, they can conduct the prayer in a sitting position in their home. 
Another explanation could be due to family responsibility in the local community, 
caring for children or older people (Barghouti et al., 2015). In addition, the retirement 
age is 65 years but early retirement is possible when the individual’s age reaches 50 
years. Further explanation for  the study findings is that rural residents are more 
physically active than urban residents, as Jordan lacks open spaces and parks 
(Barghouti et al., 2015) and most of the participants in the study were living in Amman 
or nearby. In addition, married people are less active due to social responsibility and 
in this study’s sample, 62% of the participants are married. Moreover, publicity and 
promotion of exercise are not formally approached in the country and there is a lack 
of information on approaches, interventions, community-wide campaigns, mass 
media campaigns or even health education classes (Barghouti et al., 2015; Eshah, 
2013).  
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6.4.1.5 Sedentary Time  
There was no significant change in mean daily sedentary time between Time 1 and 
Time 2, which indicated that participants’ sedentary time was consistent after 
hospitalisation. The data show that the patients spent prolonged time in sedentary 
(sitting/lying time) at Time 1 and Time 2, which represented 76.8% and 77.2% of their 
measurement time respectively. There is no similar study for comparison from the 
same population. Therefore, the study revealed that the sedentary time among 
patients with AMI was higher than in other healthy populations. In comparison with 
the healthy adult population in US, the participants spent 966 minutes of their day in 
sedentary time (Bassett Jr et al., 2014). Older adults spent 1,083 minutes of their time 
in sedentary time (Fitzsimons et al., 2013), as shown in Table 6.1. In general, the 
average objective measurement of sedentary time during waking time ranges from 
55–69% (Colley et al., 2011; Matthews et al., 2008). This finding is consistent with a 
previous survey implemented among healthy adults in Jordan, which revealed that 
only 12.5% of Jordanians were physically active while over 50% were aware of the 
recommended PA level (Barghouti et al., 2015).  
 
 
 
 
 
 
 
 
 
 212 
 
Table 6.1  
Comparison of Physical Activity Level among Patients with AMI, Healthy Adult and 
Elderly Populations 
Physical Activity 
parameters 
Healthy Adult 
(Bassett Jr et al., 
2014) 
Patients with 
AMI 
Older Adult 
(Fitzsimons et 
al., 2013) 
Step count (step per day) ------- 6,819 8,493 
Stepping time (mins)  114  94  105 
Standing time (mins) 360 239 251 
Upright time (mins) 474  333 356 
Sedentary time (mins) 966 1107 1083 
 
The data show that the participants spent the majority of their sedentary time at 
weekends and this decreased during weekdays, which is a mirror image of upright 
time at Time 1 and Time 2. There was a small variation between days but the 
greatest mean sedentary time per day at both Time 1 and Time 2 was at the 
weekends. The lowest mean sedentary time occurred on Mondays and Tuesdays, 
which are working weekdays in Middle Eastern countries, and the pattern of greatest 
mean sedentary time per day was similar between Time 1 and Time 2.  The 
participants had the greatest mean sedentary time on Fridays and Saturdays at Time 
1 and Time 2.  
In addition, the sedentary time represented 76.4% of their time on weekdays and 
79.2% on weekends at Time 1, whereas the sedentary time represented 76.5% and 
78.3% on weekdays and weekends respectively at Time 2. Thus, there was 
consistent sedentary time on working days and weekends at both Time 1 and Time 2, 
but sedentary time was higher during the weekends. Thus, health care professionals 
would recommend that the patients with AMI reduce sedentary time.   
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The mean hourly sedentary time was greater at Time 2 through all hours of the day. 
Comparing standard deviation, the data showed a large standard deviation in the 
afternoon more than the morning and night-time in both Time 1 and Time 2, which 
indicates considerable variation in sedentary time in the afternoon. However, there 
were relatively prolonged periods of sedentary time throughout the day at both times. 
This study revealed the same findings from relevant studies in Middle Eastern 
countries, such as  Barghouti et al. (2015), who found that PA is low among healthy 
adults in Jordan as a result of knowledge and sociodemographic determinants. 
(Barghouti et al., 2015) raised several concerns about knowledge and 
sociodemographic determinants, such as the conservative tradition and cultural 
norms being one of the PA barriers in Arab countries (Amin et al., 2012). Recently, a 
study conducted in the Middle East found that the majority of the adult population’s 
time was sedentary or spent at reduced activity levels and hence, there were barriers 
to PA as well as social, cultural, and environmental factors (Sayegh et al., 2016). 
There are various possible reasons explaining the prolonged sedentary time among 
patients with AMI. First, the pain and discomfort at the catheterisation site where the 
femoral or radial punctures could limit the patients’ mobility and increase their 
sedentary time. Second, the measurement time for the participants was during their 
sick leave period after hospitalisation, and most of the participants had not returned to 
work. Third, the absence of any education programme or rehabilitation programme to 
influence the cultural and religious beliefs, which may contribute to increase the 
sedentary time, considering that about 90% of Jordan’s population are Muslim and 
they pray five times each day, and every prayer consists of movements in both 
standing and sitting positions. However, according to Islamic religious rules, if the 
patients cannot perform prayer in a standing position, they can perform all the 
prayers’ movements in a sitting position.    
The study findings indicated that PA in patients with AMI was less than in the healthy 
population and below the recommended level. These findings are consistent with the 
literature, which shows that Middle Eastern countries have the highest physical 
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inactivity levels (Barghouti et al., 2015; Sayegh et al., 2016) and high prevalence of 
CVD risk factors (WHO, 2015b). 
To summarise, the discussion points out various possible reasons for the absence of 
significant differences between Time 1 and Time 2 in terms of PA volume. First, the 
study measured the data from patients with AMI after 2 and 6 weeks of 
hospitalisation, whereas in the literature, PA improvement occurred 3 to 6 months 
after cardiac rehabilitation. This indicates that more in-depth follow-up might be 
necessary, particularly for measures that require more time to detect changes. 
Second, the inconsistency between our study results and the results of other 
researchers (Houle et al., 2011; Izawa et al., 2006; Matthews et al., 2008; Tudor-
Locke, Burton, & Brown, 2009) may also be due to differences in the monitoring 
methodology used in these studies, such as different populations, varying 
measurement times, and focusing only on step count. The aforementioned studies 
used a PA monitoring system to measure AMI in patients with ACS or CHD after 
cardiac rehabilitation, rather than a healthy population under free-living conditions. 
Third, physiological factor: the healing of the site of catheterisation procedure is still in 
progress and needs more time. Fourth, unfortunately there is a lack of infrastructure 
and legislation in Jordan, such as a lack of open areas for walking, bicycle lanes and 
a national strategy to improve PA levels. In addition, lack of cardiac rehabilitation 
programmes in Jordan (Eshah, 2011) and this might limit the behavioural change 
opportunities of patients with AMI in the study. Fifth, a previous study, conducted in 
Jordan, showed that patients with ACS lacked knowledge about lifestyle changes 
after hospitalisation (Eshah, 2011). In addition, social and cultural factors influences 
such as conservative norms, traditions, and lifestyle do not support an individual in 
demonstrating the recommended PA level. Advice and information given by the 
healthcare team are important factors in increasing patients’ knowledge for 
behavioural change (Luszczynska et al., 2007). Sixth, the study did not include data 
related to levels of PA before hospitalisation and the co-morbidity of patients with 
AMI. These are considered one of the determinants of PA after hospitalisation for 
patients with CHD (Reid et al., 2006).  
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For these reasons, the results of this study highlight the need to enhance behavioural 
change strategy and reduce the sedentary time through the establishment of cardiac 
rehabilitation programmes among Jordanian patients with AMI. Consequently, the 
findings did not confirm the second hypothesis, which predicts improvements in PA 
levels in the early recovery phase among treated patients with AMI. 
6.4.2 Physical Activity Pattern and Changes 
This is the first study aimed at assessing PA pattern in the early recovery phase 
among patients with AMI. In order to meet this objective, further analysis was 
conducted to assess PA pattern for all participants to show the distribution of duration 
of the PA events, particularly upright and sedentary events, through plotting the 
proportion of total time spent in the event against the length of the event. 
Upright events were similar in frequency at Time 1 and Time 2. There were no 
significant differences in event accumulation regarding upright events. Approximately, 
50 % of accumulated upright time was in instalments of less than 10 minutes for both 
Time 1 and Time 2. This gives an insight into the accumulation of upright events in 
AMI populations. 
There was a similar frequency of sedentary events at Time 1 and Time 2. There were 
no differences in event accumulation regarding sedentary events. The results showed 
limited changes in PA pattern regarding upright time and sedentary time at Time 1 
and Time 2. Approximately, 75 % of accumulated sedentary time was in instalments 
of less than 5.2 hours for both Time 1 and Time 2. Therefore, there were no 
significant differences in event accumulation regarding sedentary events.  
These findings are consistent with a previous study, which showed neither home nor 
hospital training had any immediate effect on PA level (Cowie et al., 2011). In addition, 
it found no significant differences in PA levels in the long-term for both home and 
hospital training groups with heart failure. There were only significantly increased 
steps taken per day during ‘extra-long’ and ‘long’ walks in hospital-based training 
(Cowie et al., 2011).  
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6.4.3 PA level and Clinical Variables 
This is the first study that examined the relationship between clinical variables, such 
as BMI, CHD diagnosis date and AMI type of treatment with PA volume, namely: step 
count, stepping time, standing time, upright time, and sedentary time. The study 
found there were no significant relationships between clinical variables and PA level 
except that there were significant relationships between BMI and both step count and 
stepping time at Time 1 and Time 2, which is consistent with a previous study that 
showed a relationship between BMI and PA (Li et al., 2014). In addition, BMI is one of 
the PA determinants as reported by (Britton, Brunner, Kivimaki, & Shipley, 2011; 
Oliveira et al., 2014). Therefore, optimising BMI is very important to increase stepping 
time and step count among patients with AMI.   
There was no relationship between diagnosis date of CHD and PA level. In addition, 
there were no differences in PA level among type of AMI treatment groups at Time 1 
and Time 2. This is due to the lack of an education programme from health 
professionals and the impact of culture on day-to-day activity (Sriskantharajah & Kai, 
2007). Consequently, the patients lack knowledge about their disease and AMI 
treatment modalities.   
6.5 Association between Self-Efficacy and Physical Activity 
This study aimed to explore associations between self-efficacy and PA among the 
AMI population. Despite self-efficacy having been identified as one of the important 
predictors for a number of health behaviours including PA (Poortaghi et al., 2013; Sol 
et al., 2011), this study found that among patients with AMI, there was no statistically 
significant association between self-efficacy, and its three subscales, and PA in the 
early recovery phase.  
Application of Bandura’s self-efficacy theory showed that self-efficacy is an important 
component of behavioural change, that self-efficacy has been used widely among 
patients with CHD, and that CHD patients with higher self-efficacy levels have greater 
self-management skills (Katch, 2010; Poortaghi et al., 2013; Sol et al., 2011). The 
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findings of the study are inconsistent with Bandura’s self-efficacy theory and the 
literature as reported by (Blanchard et al., 2006; Izawa et al., 2006; Luszczynska & 
Sutton, 2006), who found a relationship between self-efficacy and PA level. However, 
this study examined the association between self-efficacy and PA outside the cardiac 
rehabilitation context, in addition to which the study did not investigate other relevant 
variables, such as anxiety and depression.  
A few studies found no association between self-efficacy and PA, such as a recent 
study among a rheumatoid arthritis population, in which self-efficacy was assessed by 
using the rheumatoid arthritis self-efficacy questionnaire and PA was measured by 
using the Yale PA Survey (Larkin, Gallagher, Fraser, & Kennedy, 2016). Another 
study found that self-efficacy can explain only 7.6% of PA level (Yates et al., 2003). 
This indicates that the association between self-efficacy and PA is more complex. In 
addition, self-efficacy alone cannot determine PA level of patients with AMI in the 
early recovery phase outside the cardiac rehabilitation context.  
One of the possible factors affecting the association between self-efficacy and PA 
was the use of the CSEQ. This occurred when the study measured the association 
between the confidence of patients in their ability to do such tasks related to their 
cardiac disease and PA behaviour. The study considered both self-efficacy and PA 
level as part of their overall cardiac disease self-management behaviour. Interestingly, 
the results did not demonstrate a significant association between self-efficacy and PA 
levels among the AMI population as reported in the literature. It might be due to the 
CSEQ measures self-efficacy for CVD self-management skills and not their 
confidence in ability to involve themselves in PA behaviour. Thus, the findings relating 
to assessing cardiac self-efficacy as part of CVD patients’ self-management could not 
guarantee the existence of association with PA level. Hence, using a tool to assess 
self-efficacy for PA would be more appropriate in order to identify the association with 
PA behaviour.    
CSEQ is a task self-efficacy questionnaire. Generally, studies related to cardiac 
rehabilitation programmes have frequently used task self-efficacy questionnaires. 
However, a few studies have used maintain, coping and scheduling self-efficacy 
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questionnaires for actions that facilitate adherence to secondary prevention. With little 
attention to the use of long-term maintenance self-efficacy questionnaires as 
systemically reviewed by Woodgate and Brawley (2008). This is consistent with 
another study by Luszczynska and Sutton (2006), who showed that different types of 
self-efficacy such as maintenance and recovery of self-efficacy (phase-specific self-
efficacy) after cardiac rehabilitation should be considered to predict PA. The 
association between self-efficacy and PA can vary according to the action asked for 
in the questionnaire, the context under which exposure to activity is experienced and 
the temporal nature of the exercise exposure (McAuley et al. (2011).  
In the literature, association between self-efficacy and PA has clearly been examined 
in the cardiac rehabilitation context (Woodgate & Brawley, 2008). However, some 
studies found that there was no association between self-efficacy and PA among 
rheumatoid arthritis patients (Larkin et al., 2016). Therefore, using self-efficacy in 
different contexts would have an effective influence on self-efficacy, as reported by 
(McAuley, Jerome, Marquez, Elavsky, & Blissmer, 2003), which reveals that social 
context significantly influences self-efficacy.  
Another possible reason for the lack of association between self-efficacy and PA is 
the fact that self-efficacy measures the belief in an individual’s ability to do a task but 
does not measure their motivation and intentions, such as their willingness to do it. 
The study found that increased self-efficacy did not increase PA level. This may be 
due to the participants overestimating their confidence, while their actual performance 
in PA was low. Further, it might be there was a lack of motivation among the 
participants to increase their PA level. This discrepancy raises the question of 
considering the mismatch between self-efficacy in a specific task and actual ability 
related to that task.  
The implementation of this study in Jordan, where there was no cardiac rehabilitation. 
It is important to highlight the social and cultural influence context on the study results, 
as this is clearly linked to affect the four sources of self-efficacy and free living PA, 
and in turn, to the association between self-efficacy and PA. McAuley et al. (2003) 
showed social support and affective states can also influence self-efficacy. These 
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factors are considered to influence self-efficacy and that need to be considered when 
developing health  interventions  (McAuley et al., 2003). For example, a socially 
supportive group has high self-efficacy level in home-based activity programmes 
(McAuley & Blissmer, 2000). 
Certain key factors have been found in understanding PA among cardiac patients, 
such as personal factors, and health barriers such as symptom distress and negative 
well-being (Yates et al., 2003). In addition, other factors that may influence PA of 
patients with AMI are lack of infrastructure such as open spaces and parks, and 
legislation, transportation systems and the conservative culture and traditions of 
Jordan.  
PA barriers and self-efficacy barriers such as, individuals having high confidence in 
their ability to partake in PA but being unaware of importance of PA, feelings of pain, 
and adverse weather, have been found to affect the association between self-efficacy 
and PA(Blanchard et al., 2007). The study has not investigated these barriers. 
Moreover, data on PA was not measured at the prior hospitalisation point, and this 
information could have been valuable, as a previous study found self-efficacy levels 
to be related to a patient’s pre-hospitalisation PA level (LaPier et al., 2009). 
Furthermore, the early recovery period is a short period after hospitalisation. Given 
this relatively short period of study, a longer follow-up could be beneficial, particularly 
for the study of self-efficacy and PA measures that require a longer time to detect 
changes. 
This study has revealed that the associations between self-efficacy and PA level 
results are more complex. Previous  studies have investigated the effectiveness of 
behaviour change techniques in changing self-efficacy for enhancing PA among 
different populations of older adults (Ashford et al., 2010), among obese people 
(Olander et al., 2013), and among elderly people (French et al., 2014). The findings of 
these studies showed that effective interventions for changing PA self-efficacy in 
healthy adults are not the same in older adults and the obese population. In addition, 
each patient population has different self-efficacy mechanisms that are more effective 
in enhancing PA levels.  
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The study aims to measure self-efficacy to determine PA behaviour. However, 
behavioural  change is a complex process to achieve, with many factors that can 
interact and influence it (Michie, Atkins, & West, 2014). The Behaviour Change Wheel 
by Michie, van Stralen, and West (2011) shows several factors such as training, 
education, and persuasion. In addition, health policy, legislation and guidelines are 
fundamental components in the Behaviour Change Wheel, which could help 
individuals to change their lifestyles. Therefore, patients with AMI should have 
enough belief in their capabilities and motivation and goal-setting are among the 
strongest variables associated with PA maintenance (Amireault, Godin, & Vézina-Im, 
2013). 
Nonetheless, this lack of association between self-efficacy and PA is an important 
finding, indicating that other mechanisms could influence the association between 
self-efficacy and PA, such as socio-cultural context. In addition, Bandura’s self-
efficacy theory provided inadequate explanation of the association between self-
efficacy and PA level among patients with AMI not attending cardiac rehabilitation. 
Consequently, the study findings did not confirm the third hypothesis, which predicted 
association between self-efficacy and PA level among treated patients with AMI in the 
early recovery phase.   
6.6 Conclusion 
This chapter has provided a discussion of the study findings, alongside existing 
evidence. Further, the chapter considers the meaning of the study’s findings, 
concerning PA levels of patients with AMI. The chapter structured the discussion by 
using the study’s questions to demonstrate the extent to which the study answered 
each question.  
The study showed following WHO guidelines in order to translate and cross-culturally 
adapt the CSEQ was successful, and the CSEQ demonstrated good reliability and 
validity outcomes for use in Arabic-speaking countries. The study found that self-
efficacy level increased after treatment. However, increased self-efficacy level did not 
influence PA levels in the early recovery phase. PA levels and patterns remained 
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steady during the early recovery phase, but did not meet the internationally 
recommended PA level. 
The study found no association between self-efficacy measured using the CSEQ 
measure and PA. It is therefore possible to conclude that, although self-efficacy has 
association with PA in the cardiac rehabilitation context, but this association does not 
occur in outside cardiac rehabilitation context. The study’s findings were inconsistent 
with the literature, which could be a result of both using a task self-efficacy 
questionnaire and other mechanisms such as social and cultural factors. These might 
influence the association between self-efficacy and PA outside of a cardiac 
rehabilitation setting. These finding have added new knowledge regarding the AMI 
patient population in the early recovery phase.  
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Chapter Seven: Conclusion and Recommendations 
7.1 Introduction   
The research reported here developed an Arabic version of the CSEQ, assessed, 
explored, and identified the relevant information of patients concerning AMI patients’ 
self-efficacy and PA levels and patterns, and more importantly, gathered evidence 
revealing that Jordanian patients with AMI have low PA and increased self-efficacy 
levels. The study found no relationship between self-efficacy and PA level among 
patients with AMI in the early recovery phase. This chapter outlines the contribution 
the research has made to existing knowledge. Then, the chapter identifies and 
discusses the limitations of the research. Following that, it outlines the implications for 
clinical practice, policy and future research. Finally, this chapter presents the study’s 
conclusion. 
The aim of the study was to use the WHO guidance (WHO, 2014) to inform the 
translation and adaptation of the CSEQ measure to Arabic. In addition, changes in 
self-efficacy and PA level and pattern among patients with AMI in the early recovery 
phase were assessed and associations between self-efficacy and PA explored. The 
study had four objectives. 
The first objective was the translation and cross-cultural adaptation of the CSEQ to 
Arabic, and testing of the validity and reliability of the Arabic version. The Arabic 
CSEQ was translated and demonstrated good validity and reliability outcomes. The 
Arabic version of the CSEQ would be beneficial for the healthcare profession, through 
using the CSEQ in any study with different health interventions, which aims to 
measure self-efficacy as a health intervention outcome in order to improve self-
management skills.  
The second objective of the study was to assess the changes in self-efficacy at 
baseline, two weeks and six weeks by using the self-reported Arabic CSEQ among 
patients with AMI following hospitalisation. The study found statistically significant 
changes in self-efficacy levels and its subscales at baseline, two weeks and six 
 223 
 
weeks after hospital discharge. Therefore, there is an increase in self-efficacy 
occurred after receiving treatment in the early recovery period.  
The third objective of the study was to determine changes in PA level and pattern. 
The study found no significant changes in PA among patients with AMI at two weeks 
and at six weeks following hospitalisation. In conclusion, many factors can influence 
PA level and pattern. Consequently, patients with AMI need to be involved in such 
programmes that aim to increase their PA levels to meet the internationally 
recommended level of PA.   
The fourth objective was to explore whether there was an association between self-
efficacy and PA level. Although self-efficacy is a prominent predictor for PA in the 
literature, there were no associations found between self-efficacy and its subscales 
and PA level. It seems that the relationship between self-efficacy and PA is complex 
and requires further investigation. In conclusion, other mechanisms can affect PA 
behaviour among patients with AMI after treatment in Jordan, such as socio-cultural 
factors.  
7.2 Contribution to Existing Knowledge 
The study has successfully translated and cross-cultural adapted of the CSEQ into 
Arabic. The CSEQ demonstrated good reliability and validity outcomes for use in 
Arabic-speaking countries. Changes in self-efficacy levels increased significantly. PA 
levels did not change; Increase in self-efficacy did not influence PA levels among 
patients with AMI. These study findings contribute new knowledge in the following 
ways: 
1- This study translated and cross-culturally adapted the CESQ to Arabic and created 
a valid and reliable tool measuring self-efficacy, available in the Arabic language. In 
addition, this will enable future researchers to use this questionnaire in Arabic-
speaking countries for patients with AMI, confident in the knowledge that it is a 
reliable and valid tool.  
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2- To the researcher’s knowledge, this is the first study to seek to assess the changes 
in self-efficacy and its subscales and PA level and pattern in the early recovery phase 
after treatment for AMI. 
3- This study showed that there a need for further research to investigate the 
relationship between self-efficacy and PA level among patients with AMI not involved 
in a cardiac rehabilitation programme in the early recovery phase. 
4- This is the first study that focuses solely on the early recovery phase for patients 
with AMI after receiving treatment and considers those who have no access to 
cardiac rehabilitation or disease self-management programmes.   
5- This is the first study to measure PA level and pattern among patients with AMI 
after receiving treatment in Middle Eastern countries, through using body-worn 
activity monitors. The use of body-worn activity monitors adds an accurate, specific 
and sensitive measurement, sufficient to meet the study’s objectives. This is of 
particular relevance when conducting a PA measurement at two time points, 
preferred over using self-administered PA recall questionnaires, which are subject to 
bias and overestimation.  
6- This study contributes to enhancing secondary prevention practice, establishing 
cardiac rehabilitation programmes and promoting PA behaviour among patients 
experiencing AMI in Jordan through addressing the changes in PA levels and 
patterns among patients with AMI after treatment in the early recovery phase.   
7- To researcher’s knowledge, this is first study in this field related to secondary 
prevention in the Middle East to use new research tools such as an Arabic CSEQ and 
body-worn activity monitors among AMI populations.  
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7.3 Limitations of the Study 
The following limitations should be borne in mind when considering the results of the 
research: 
 The implementation of the study was in one setting, a cardiac centre only. This 
limits the generalisability of the study findings among the Jordanian population, 
even though the JUH receives patients with AMI from throughout the country.  
 Although the translation and cross-cultural adaptation of the CSEQ into Arabic 
was successful, the validity and reliability test was in small sample sizes of 
patients with CHD. In addition, further validity and reliability tests are required 
to test the Arabic version of the CSEQ. 
 Using a disease-specific self-efficacy questionnaire in a specific and short 
period of measurement may have affected the study findings. With this in mind, 
a different phase-specific self-efficacy questionnaire, such as a recovery, 
maintain or coping self-efficacy questionnaire, might be recommended for 
future research. 
 There are many factors able to influence self-efficacy level. The study did not 
measure psychological factors such as health beliefs, anxiety and depression, 
which could affect self-efficacy level (Allahverdipour et al., 2013; Joekes, Van 
Elderen, & Schreurs, 2007; Sarkar et al., 2007).  
 The study sample was recruited from a convenient group of patients with AMI 
admitted to JUH, and more than 50% of screened patients with AMI were 
ineligible, such as patients with AMI with heart failure or previous AMI, or those 
that could not read and write. In addition, there was the exclusion of patients 
with AMI treated by CABG. Furthermore, about 30% of eligible patients with 
AMI refused to participate and 62% were male.  
 The study setting was in Jordan where there are no formal cardiac 
rehabilitation programmes or structured health education programmes in 
hospitals. This may have had an impact on the study findings. In other 
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countries where patients with AMI have access to cardiac rehabilitation 
programmes, patients might have more motivation and a greater 
understanding of the nature of their illness and the ways to change their 
behaviour. 
 The collection of study’s data was after patients’ hospitalisation over a short 
period (up to six weeks), so a longer follow-up time for measurements such as 
six or twelve months might have revealed further changes in patients’ self-
efficacy levels and in PA volume and pattern.   
 The recording of PA measurement for patients with AMI was during the early 
recovery phase, when most of the patients had not returned to work. 
Therefore, it should be borne in mind that PA level might have changed had 
they returned to their work. 
7.4 Recommendations 
This research has explored several crucial findings regarding translation and cross-
cultural adaptation of an Arabic CSEQ and using the CSEQ to measure self-efficacy 
level among CHD patients. The study findings showed no improvement in PA levels 
among patients with AMI in the early recovery phase. The following section identified 
a number of recommendations from this research. The researcher has made a 
dissemination plan to publish these recommendations, (Appendix AA).    
7.4.1 Implications for Practice 
Previous studies have shown the importance of cardiac rehabilitation programmes for 
patients with AMI (Dalal et al., 2015; Giannuzzi et al., 2008). Cardiac rehabilitation 
has been shown to increase patients’ awareness and knowledge of coronary risk 
factors, specifically PA level, and self-efficacy (Dalal et al., 2015). However, patients 
with AMI in Jordan do not have access to structured education programmes or 
cardiac rehabilitation centres (Eshah, 2011). Despite this, using the Arabic version of 
the CSEQ should be useful in the assessment of self-efficacy when developing health 
interventions for patients with AMI.   
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Patients’ PA levels did not meet international recommendations. Reducing sedentary 
time leads to clinically important reductions in CVD risk factors in the AMI population. 
Therefore, the healthcare professional should consider developing effective 
intervention in order to help patients with AMI increase PA levels and decrease 
sedentary time. 
The study findings highlight the importance of a sedentary time reduction strategy for 
patients with AMI, through promoting PA by placing more emphasis on awareness of 
the importance of PA, optimising BMI, and a healthy and active lifestyle. Patients with 
AMI must be encouraged to understand that lifestyle changes are not optional, but a 
necessary part of the recovery process that can contribute to improved health 
outcomes. In addition, patients with AMI should be encouraged to increase their 
awareness of benefits and outcomes of secondary prevention practice.  
Healthcare professionals play a key role in promoting a sedentary reduction strategy 
and improving upright time among AMI populations. One suggested strategy is to 
replace sitting events with standing events during daily activities. In addition, 
scheduling more PA during the weekends and in the morning and evening is 
important, as these are the times when the AMI population was less active.   
The study found that PA level in Jordan is below the international recommendations. 
Therefore, the health intervention developers have to establish a suitable and 
effective health intervention that helps patients with AMI improve their PA levels. 
There is now the necessary health intervention to motivate patients with AMI to 
increase adherence to secondary prevention strategies, such as cardiac rehabilitation 
programmes or disease self-management programmes for Jordanian patients with 
AMI. Using health technology such as text messaging, Internet, and mobile phones is 
now feasible and widely accessed by individuals. For this reason, health technology 
provides an ideal opportunity to deliver health interventions and cardiac rehabilitation 
programmes to increase physical activity levels. For the short term, there is an 
essential need for more effort to establish such educational activities at the hospital.  
 228 
 
7.4.2 Implications for Health Policy   
In order to keep up to date with wider changes along with health concerns, the health 
policy makers have to update secondary prevention policies regularly and check them 
frequently, in order to ascertain the importance of a secondary prevention strategic 
plan within the healthcare setting. This could draw upon the Ministry of Health in 
Jordan, which should update its strategies regularly. Health policy makers in Jordan 
have to develop a new healthcare policy, national health plan, and legislation to 
improve PA behaviour at two levels: community and individual. In addition, they need 
to produce a national PA report to monitor the PA status in Jordan annually.  
The health policy makers have to focus more and pay special attention to health 
education programmes by considering AMI populations’ needs. These national health 
policies act as a framework for all healthcare sectors and hospitals and should be 
evaluated and updated frequently in order to accomplish their aims. More attention 
and special care is required to determine the suitable environmental factors and 
managerial support that will enhance the process of health education, including 
educational materials.  
Health policymakers have to make greater efforts to ensure the continuity of health 
care provided to patients with AMI after their discharge from the hospital. The health 
policymakers should consider involving patients with AMI in education programmes 
after hospitalisation that improve their skills and enhance their adherence to the 
treatment – such as establishing cardiac rehabilitation programmes – in order to 
ensure that patients with AMI obtain appropriate secondary prevention.  
Finally, the researcher strongly advise the Jordanian government to develop 
strategies that focus on promoting PA and act in a supporting role in reducing 
sedentary behaviours in different settings such as healthcare settings, workplaces, 
schools and transport systems, making the active choice the easy choice. In addition, 
health policymakers should aim to promote PA among people in their daily activity. 
Furthermore, in order to achieve its endeavour to improve PA levels, the Jordanian 
government should establish infrastructure such as cycle lanes, tracks, paths and 
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parks at a local level to promote walking and cycling, this can replace many car trips 
and increase PA behaviours.   
7.4.3 Implications for Future Research 
The successful application of the WHO process of translation and cross-cultural 
adaptation of the Arabic version of the CSEQ leads to good findings of validity and 
reliability. However, more psychometric property evaluations are highly 
recommended, such as construct validity and confirmatory factors analysis on a more 
representative sample size. It would also be valuable to test using the Arabic version 
of the CSEQ in different Arabic-speaking countries. 
Usage of other types of self-efficacy questionnaires such as general self-efficacy 
questionnaire or phase-specific self-efficacy scale, to assess self-efficacy levels in 
specific periods, could improve the research. Further, assessment psychological 
factors such as anxiety and depression is required when measuring self-efficacy level. 
In addition, Bandura’s self-efficacy theory is widely used in much research to explain 
the relationships between variables. However, using Bandura self-efficacy theory 
would be more applicable in investigating self-efficacy level among patients in the 
cardiac rehabilitation context rather than measuring self-efficacy in socio-cultural 
context, where many factors may influence self-efficacy level. 
Measurement of PA level is now feasible through using objective devices. The 
researcher strongly recommends that this study be replicated using different research 
methods. Further, the researcher recommends implementing the study in many 
Arabic-speaking countries, especially in those with established cardiac rehabilitation 
programmes. In addition, subsequent studies should test different cardiac populations, 
add further variables, and have a longer follow-up times such as up to six or twelve 
months.  
There is a need to implement further research to explore the determinants of PA 
behaviours and PA barriers in the future, in order to gain a better understanding of PA 
behaviours among Jordanian patients with AMI, and the role of nurses in supporting 
and providing health education for patients with AMI and improving the environment 
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and health education sessions. In addition, it is desirable to develop further 
methodological approaches such as qualitative studies to explore AMI patients’ 
beliefs, attitudes and knowledge about different methods of education styles, 
including the use of mobile smart phones and outside resources. Further, the 
investigation of other variables and relevant CVD risk factors in the future, such as 
quality of life, smoking cessation, diet, blood pressure and blood lipids control, would 
be beneficial.  Consequently, these studies could reveal related results that might 
support a secondary prevention strategy.  
7.5 Conclusion  
This study extends the knowledge of secondary prevention for the AMI population. 
The study has revealed many new findings. The CSEQ is available now in Arabic. It 
would be beneficial for the healthcare profession, to use the CSEQ in any study with 
different health interventions that aims to measure self-efficacy as an outcome in 
order to improve self-management skills.  
The researcher recommends further qualitative and quantitative studies to investigate 
self-efficacy constructs among patients with AMI in Jordan, with consideration of the 
use of generic and phase-specific self-efficacy tools. This study showed the feasibility 
of measuring PA after AMI accurately, and indicated PA levels below the 
recommended level. Therefore, there is a need for further qualitative studies to 
explore the barriers and enablers of PA among patients with AMI. In addition, there is 
a need for a wider national strategy, an updated health policy, effective health 
intervention and a health campaign in Jordan to improve PA behaviour for patients 
with AMI.  
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from 6 to 12 
months 
significantly 
related to a 
decrease in 
health-related 
benefits and PA 
intentions and an 
increase in time 
and health-related 
barriers. Finally, 
the increase in PA 
from baseline to 
12 months 
significantly 
related to an 
increase in health-
related benefits 
and intentions and 
a decrease in 
health-related 
barriers. 
To 
determine 
whether 
changes 
in self-
efficacy, 
PA 
intension, 
perceived 
severity 
and 
susceptibi
lity and 
PA 
benefits/ 
barriers 
were 
associate
d with PA 
in 
hospital,6 
and 12 
months 
Longitudin
al study / 
(N=555 
CHD) not 
attending 
cardiac 
rehabilitati
on / 
Approved 
from 
ethical 
committee 
 
Patients 
were 
compared 
to changes 
in self-
efficacy; 
PA 
intention, 
perceived 
severity 
and 
susceptibili
ty, and PA 
benefits/ba
rriers were 
associated 
with 
changes in 
PA at 
baseline, 6 
and 12 
months 
 
Self-reported PA 
questionnaire, PA 
intentions 
questionnaire and 
self-efficacy 
questionnaire 
Data were 
collected by 
distributing 
the 
Questionnai
re and after 
hospitalizati
on and 
follow up 6 
months 
 
 
Data was 
analysed by 
Statistical 
analyses 
were 
performed 
with SPSS 
Changes in PA 
levels over a 12-
month period 
were associated 
with changes in 
various 
theoretical 
variables. and, 
the associations 
among these 
variables with 
PA varied as a 
function of time 
after 
hospitalization 
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PA After Cardiac 
Rehabilitation: 
Evidence That 
Different Types of 
Self-Efficacy Are 
Important in 
Maintainers and 
Relapsers 
Maintenance self-
efficacy predicted 
PA in a subgroup 
of participants 
who maintained 
regular activity at 
8 months after MI, 
and recovery self-
efficacy predicted 
PA Among 
participants who 
had relapsed by 8 
months after MI 
 
 
 
 
 
 
To test 
whether 
maintena
nce self-
efficacy 
predicts 
PA 
among 
individual
s who 
maintain 
an active 
lifestyle 
and 
whether 
recovery 
self-
efficacy 
predicts 
PA 
among 
those 
who 
relapse to 
a less 
active 
lifestyle 
Longitudin
al study / 
n=114) MI 
patients 
after 
cardiac 
rehabilitati
on / 
Nothing 
mentione
d 
about the 
Ethics at 
all 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patients 
were 
compared 
to   self-
efficacy; 
PA at 2 
and 8 
months 
after MI/ 
Maintenance and 
recovery Self-
efficacy 
questionnaire  and 
PA  scale 
Data were 
collected in 
hospital by 
questionnai
re, and PA 
was 
measured 
by asking 
questions 
and the 
response 
scale from 
0 -10. 
 
Nothing 
about the 
Application 
that used in 
data 
analysis 
Patients who 
conduct 
interventions 
among cardiac 
rehabilitation 
patients should 
aim to increase 
recovery self-
efficacy among 
those patients 
who are at risk 
for relapse and 
to increase 
maintenance 
self-efficacy 
among those 
patients who are 
likely to maintain 
their level of PA 
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Barrier Self-
Efficacy and PA 
Over a 12-Month 
Period in Men and 
Women Who Do 
and Do Not 
Attend Cardiac 
Rehabilitation 
 
Significant 
declines in PA 
over time, which 
especially among 
women 
, the association 
between barrier 
self-efficacy and 
PA became 
significantly 
weaker over time, 
especially for 
women. This 
trend was similar 
for participants 
who did and did 
not attend cardiac 
rehabilitation 
To 
examine 
(a) 
changes 
in PA in 
2, 6 and 
12-month 
period in 
people 
living with 
cardiac 
disease 
who did 
not attend 
cardiac 
rehabilitat
ion, and 
(b) the 
role of 
barrier 
self-
efficacy in 
explaining 
these 
changes 
from a 
gender 
perspecti
ve.  A 
secondar
y 
objective 
was to 
examine 
whether 
attending 
cardiac 
rehabilitat
ion (or 
not) 
moderate
d the 
gender– 
barrier 
self-
efficacy 
relationsh
ip with PA 
Longitudin
al study / 
(N=801) 
(n=247) 
patients 
attended 
cardiac 
rehabilitati
on 
(n=554) 
not 
attending 
cardiac 
rehabilitati
on / 
Approval 
of the 
study 
procedure
s was 
obtained 
from the 
Research 
Ethics 
Committe
e in 
Ottawa 
and 
Kingston, 
Canada 
 
Two 
groups, 
one group 
who 
attended 
cardiac 
rehabilitatio
n and the 
second 
group who 
didn’t 
attend 
cardiac 
rehabilitatio
n 
 
Barrier self-
efficacy was 
measured with a 
five-item scale 
developed by 
Plotnikoff and 
Higginbotham  
 
Assessment of 
pre-hospitalization 
PA by the leisure 
score index (LSI) 
of the Godin 
Leisure-Time 
Exercise 
Questionnaire 
(Godin & 
Shephard, 1985)  
 
The frequency of 
PA at each 
intensity level 
multiplied by its 
metabolic 
equivalent based 
in fixed formula. 
Follow-up 
assessment of PA 
after 
hospitalization 
using a telephone- 
administered PA 
recall interview. 
 
Data 
collection 
was at 
baseline in 
hospital and 
follow up 
data by 
telephone 
and mail. 
 
 
Nothing 
about the 
Application 
that used in 
data 
analysis 
Interventions 
that focus on 
increasing 
barrier self-
efficacy in 
people living 
with heart 
disease after 
hospitalization 
will likely equally 
benefit men and 
women in the 
short term but 
may 
disproportionatel
y benefit men in 
the longer term 
regardless of 
participation in 
cardiac 
rehabilitation. 
 
Self-
reporte
d 
questio
nnaire 
were 
used in 
both 
self-
efficacy 
and PA 
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The long-term 
benefits of cardiac 
rehabilitation on 
depression, 
anxiety, PA and 
quality of life 
The total energy 
expenditure 
between baseline 
values and all 
subsequent 
measures over 
time 
 
PA was 
significantly 
higher for men 
compared to 
women 
To 
investigat
e the 
long-term 
benefits 
of a six-
week 
comprehe
nsive 
cardiac 
rehabilitat
ion 
program
me on PA 
 
Repeater 
measures 
at 
baseline, 
6 and 12 
months 
after 
cardiac 
rehabilitati
on / 
(n=105) 
MI 
patents / 
Approved 
by the 
local 
ethics 
committee 
 
 
 
No group Patients 
completed the PA 
energy 
expenditure 
(seven-day recall 
activity) measured 
by self-
administered 
questionnaire, 
MacNew Heart 
Disease Health- 
Related Quality of 
Life (MacNew) 
and Hospital 
Anxiety and 
Depression scale 
at baseline, six 
weeks, six and 
12 months 
 
All 
questionnai
res were 
administere
d via the 
hospital 
postal 
service and 
mailed to 
the patient’s 
home 
address 
with a 
prepaid 
envelope 
 
All data 
were 
analysed by 
SPSS 16 
 
 
 
 
 
 
 
A six-week 
cardiac 
rehabilitation 
programme is 
beneficial in 
improving 
quality of life, PA 
status, 
Anxiety and 
depression 
  
These benefits 
maintained at 12 
months. 
Elevated levels 
of depression 
were associated 
with 
Impaired quality 
of life 
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Innovative 
program to 
increase PA 
following an acute 
coronary 
syndrome: 
Randomized 
controlled trial 
 
 
At baseline, 
averages 
steps/day were 
similar between 
groups (5845 
±3246 vs. 6097 
±3055 steps/day; 
p = 0.812). At 3-
month follow-up, 
both groups 
increased their 
averages 
steps/day (p < 
0.05). This 
increase was 
higher in the 
experimental 
group (3388 ± 844 
vs. 1934 ±889 
steps/day; p < 
0.001). At 12-
month, interaction 
effects (group 
×time) in PA and 
waist 
circumference 
were different 
between groups 
(p < 0.05), 
whereas self-
efficacy 
expectation 
increased in both 
groups similarly (p 
< 0.05). 
 
To 
evaluate 
the 
impact of 
a socio-
cognitive 
interventi
on 
associate
d with a 
pedomete
r-based 
program 
on PA, 
CVDs risk 
factors 
and self-
efficacy 
expectati
on during 
one year 
following 
ACS 
 
RCT / 
(n=65) 
ACS /  
 
Approved 
by the 
research 
ethics 
committee
s of 
Quebec 
 
Patients 
were 
compared 
to steps 
count 
in the 
experiment
al group 
and 
patients in 
the usual 
care group 
 
Pedometers with a 
7-day memory  
distributing 
the 
pedometer 
for ACS 
patients 
after 
hospitalizati
on 
 
Data was 
analysed by 
SAS 
Version 9.2  
 
 
The intervention 
is useful to 
improve average 
steps/day and 
waist 
circumference 
during the first 
year following 
an acute 
coronary 
syndrome. This 
study supports 
development of 
the home-based 
cardiac 
rehabilitation 
program using 
socio-cognitive 
intervention 
associated with 
a pedometer 
after an acute 
coronary 
syndrome. 
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Using an 
individualised 
consultation and 
activPAL™ 
feedback to 
reduce sedentary 
time in older 
Scottish adults: 
Results of a 
feasibility and pilot 
study 
 
There was 
reduction in total 
time spent 
sitting/lying was 
24 min/day. Total 
time spent in 
stepping activities, 
such as walking 
increased by 13 
min/day. Self-
report data 
suggested 
participants 
achieved 
behaviour change 
by reducing time 
spent using 
motorised 
transport and/or 
watching 
television. 
 
To 
explore 
an 
individuali
sed 
interventi
on 
strategy 
aimed at 
reducing 
sedentary 
behaviour
s in older 
Scottish 
adults 
 
a pre-
experime
ntal (one 
group pre-
test–post-
test) 
 
24 healthy 
older 
adults 
 
Nothing 
mentione
d about 
the Ethics 
at all 
No 
comparativ
e groups  
Sedentary 
behaviour was 
measured 
objectively using 
the activPAL™ 
monitor. 
Sedentary 
behaviour was 
measured 
subjectively using 
the Sedentary 
Behaviour 
Questionnaire 
 
SPSS 
version 19 
 
Paired t 
tests or 
Wilcoxon 
Signed 
Rank Test 
were used 
to compare 
objectively 
measured 
 
Study suggested 
a consultation 
approach might 
help individuals 
reduce time 
spent in 
sedentary 
behaviours. A 
larger, RCT is 
warranted with a 
diverse sample 
to increase 
generalisability. 
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The HEART 
mobile phone trial: 
the partial 
mediating effects 
of self-efficacy on 
PA among cardiac 
patients 
 
Change in self-
efficacy at 
24weeks 
significantly 
mediated the 
treatment effect 
on leisure-time PA 
by 13%, but only 
partially mediated 
the effect on 
walking by 4% at 
24weeks. 
 
 
 
To 
evaluate 
the 
mediating 
effect of 
self-
efficacy 
on PA 
levels in 
an 
mHealth 
delivered 
exercise 
cardiac 
rehabilitat
ion 
program 
RCT (n= 
171) / 
CHD were 
randomly 
assigned 
to either 
receive 
the 
HEART 
mobile 
Health 
interventio
n (n=85) 
in addition 
to usual 
cardiac 
services 
(n = 86) 
within the 
previous 
3–
24month 
/  
nothing 
mentione
d about 
the ethical 
approval 
 
PVO2 was 
determined 
using 
respiratory 
gas 
analysis 
during a 
standardiz
ed 
treadmill 
exercise 
testing 
protocol. 
Self-
reported 
PA levels 
were 
assessed 
using the 
inter- 
national PA 
questionnai
re long 
form 
(IPAQ-LF) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Self-reported Self-
efficacy and PA 
questionnaires 
All 
outcomes 
were 
measured 
at baseline 
and 
24weeks 
 
All 
statistical 
analyses 
were 
performed 
using SAS 
version 9.3  
 
 
Mobile Health 
intervention 
involving text 
messaging and 
Internet support 
had a positive 
treatment effect 
on leisure-time 
PA and walking 
at 24weeks, and  
changes in self-
efficacy  
mediated this 
effect  
There 
was no 
informa
tion 
about 
RCT 
registra
tion 
and 
ethical 
approv
al. 
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Exercise Self-
efficacy and 
Symptoms of 
Depression after 
Cardiac 
Rehabilitation 
  
Predicting 
Changes over 
Time Using a 
Piecewise Growth 
Curve Analysis 
Self-efficacy 
levels were 
highest at the 
beginning of 
cardiac 
rehabilitation, 
significantly 
declined 6 months 
after cardiac 
rehabilitation, and 
levelled off over 
the next 18 
months. 
To 
assess 
temporal 
pattern of  
patients’ 
exercise 
self-
efficacy 
after 
cardiac 
rehabilitat
ion 
program 
completio
n 
Repeated 
measures 
(n=133) / 
All study 
procedure
s were 
approved 
by 
appropriat
e hospital 
and 
university 
institution
al review 
boards. 
 
No groups Data were 
collected by 
Cardiac Exercise 
Self-Efficacy 
Instrument at 
baseline the 6 
months’ interval 
until 2 years 
 
Data were 
collected by 
mail 
 
Analysis of 
data by 
using SPSS 
19.0 
 
 
That patients 
show unrealistic 
optimism 
surrounding the 
ease of initiating 
and maintaining 
an exercise 
program and 
that integrating 
efficacy-building 
activities into 
cardiac 
rehabilitation, 
especially for 
patients who 
show signs of 
distress, is 
advisable 
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Weekday and 
weekend patterns 
of objectively 
measured sitting, 
standing, and 
stepping in a 
sample of office-
based workers: 
the active 
buildings study. 
 
 
Total 
sitting/standing 
time was similar 
on weekdays 
(10.6/4.1 hours) 
and weekends 
(10.6/4.3 hours). 
Total step count 
was also similar 
over weekdays 
(9682 ± 3872) and 
weekends 
(9518 ± 4615). 
The highest PA 
levels during 
weekdays 
accrued at 0700 
to 0900, 1200 to 
1400, and 1700 to 
1900; and during 
the weekend at 
1000 to 1700. 
During the 
weekday, the 
greatest amount 
of sitting accrued 
at 0900 to 1200, 
1400 to 1700, and 
2000 to 2300, and 
on the weekend 
between 1800 
and 2300. During 
the weekday, the 
greatest amount 
of standing 
accrued between 
0700-1000 and 
1700-2100, and 
on the weekend 
between1000-
1800. On the 
Understa
nding the 
total 
amount 
and 
patterns 
of sitting, 
standing 
and 
stepping 
in office-
based 
workers 
 
Cross 
section 
study  
 
Ethical 
approval 
was 
obtained 
through 
the 
University 
College 
London 
Research 
Ethics 
Committe
e 
 
There were 
no groups, 
a sample 
of 164 
office-
based 
workers 
 
Measurements of 
PA were for 24 
hours a day for 
five consecutive 
days, always 
including Saturday 
and Sunday and 
during bathing. 
Daily amounts and 
patterns of time 
spent sitting, 
standing, stepping 
and step counts 
and frequency of 
sit/stand 
transitions 
 
Office 
workers  
 
SPSS , 
descriptive 
statistics 
and t-test  
Office based-
workers 
demonstrate 
high levels of 
sitting during 
both the working 
week and 
weekend. 
Interventions 
that target the 
working day and 
the evenings 
(weekday and 
weekend) to 
displace sitting 
with activity may 
offer most 
promise for 
reducing 
population levels 
of sedentary 
behaviour and 
increasing PA 
levels, in office-
based workers 
residing in 
England. 
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Behavioural 
intervention to 
increase PA in 
adults with 
coronary heart 
disease in Jordan 
 
 
 
Moderate PA 
significantly 
increased in the 
intervention group 
compared with 
control group 
(mean change 
(SD) of frequency: 
0.23 (0.87) 
days/week versus 
-.06 (0.40); 
duration: 15.53 
(90.15) 
minutes/week 
versus −3.67 
(22.60) 
minutes/week; 
intensity: 31.05 
(105.98) METs 
versus 14.68 
(90.40) METs). 
Walking 
significantly 
increased in the 
intervention group 
compared with 
control group 
(mean change 
(SD) of frequency: 
3.15 (2.75) 
days/week versus 
0.37 (1.83) 
days/week; 
duration: 150.90 
(124.47) 
minutes/week 
versus 24.05 
(195.93) 
minutes/week; 
intensity: 495. 12 
(413.74) METs 
versus14.62 
(265.06) METs). 
Intervention 
participants had 
To 
assess 
the 
efficacy of 
a 
behaviour
al 
interventi
on to 
increase 
PA in 
patients 
with 
coronary 
heart 
disease 
not 
attending 
structured 
cardiac 
rehabilitat
ion 
program
mes 
 
Parallel 
randomis
ed 
controlled 
trial 
comparin
g 6-month 
multi-
compone
nt 
behaviour
al change 
interventio
n 
 
Ethical 
approval 
for the 
study was 
granted in 
the UK by 
the local 
institution
al review 
board, 
and in 
Jordan by 
the 
institution
al review 
boards at 
both 
participati
ng 
hospital 
sites 
(Jordan 
University 
Hospital 
and King 
Abdullah 
University 
Hospital) 
Jordanian 
outpatients 
with CHD, 
group 1 
received 
usual care 
from their 
physicians, 
which 
consisted 
of general 
(rather 
than 
tailored) 
advice 
about the 
benefits of 
PA and 
instructions 
to engage 
in 
moderate-
intensity 
PA, such 
as brisk 
walking. 
Group 2 
received 
usual care, 
plus a six-
month 
behavioura
l 
interventio
n delivered 
by a 
cardiac 
nurse 
 
PA, blood 
pressure, body 
mass index, 
Exercise self-
efficacy and 
health-related 
quality of life at 6 
months after 
hospitalisation. 
 
Outcome 
data were 
collected at 
two time 
points: 
baseline 
(immediatel
y after 
recruitment) 
and 
immediately 
post-
intervention 
(6 months 
after 
randomisati
on). The 
researcher 
collected 
questionnai
re 
measures 
via 
structured 
interview, 
and at the 
same 
appointmen
t, collected 
physiologic
al and body 
composition 
measures. 
Three 
months 
after the 
end of the 
intervention 
(9 months 
after 
randomisati
on), 
participants 
in the 
intervention 
group were 
invited to 
complete a 
questionnai
re survey to 
assess their 
perceptions 
of the 
 
Multi-component 
behavioural 
intervention 
increases PA, 
and improves 
body 
composition, 
physiological 
and 
psychological 
outcomes in 
CHD patients 
not attending 
structured 
rehabilitation 
programmes. 
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Appendix B: Permission to use from the author of cardiac self-efficacy questionnaire 
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 مقياس مستوى الثقة لمرضى القلب
 
  : على الإجابة المناسبة أو اختيار أقرب أجابه ممكنة ×الرجاء الإجابة على الأسئلة التالية بوضع علامة 
 
 
 واثق تماما
 
 4
 
واثق الى 
 حد كبير
 3 
 
ثقة 
 متوسطة
 2 
 
واثق إلى 
 حد ما
 1
 
لا ثقة على 
 الإطلاق
 0
 
 السؤال
 
 
      
  :لديك بقدرتك على  الثقةدرجة  ما مدى
 
 
      
  نشاطك البدني تغيير مستوىطريق  الصدر عنالتحكم بألم 
 
 1
      
  نشاطك البدني تغيير مستوىالتحكم  بضيق التنفس عن طريق 
 
 2
      
  طريق أخذ الأدوية الخاصة بك الصدر عنالتحكم بألم 
 
 3
      
  كالتحكم بضيق التنفس عن طريق أخذ الأدوية الخاصة ب
 
 4
      
 الاتصال أو زيارة طبيب القلب عند الضرورة 
 
 5
      
 امكانية شرح مخاوفك حول مرض القلب الى طبيبك
 
 6
      
  تناول الأدوية الخاصة بك لعلاج مرض القلب 
 
 7
      
  صحتك لما له من فوائد على ممارسة النشاط البدني 
 
 8
      
  لمعتادةالمحافظة على أنشطتك الاجتماعية ا
 
 9
  072
 
 
  
 
    
 المحافظة على أنشطتك المعتادة في البيت مع أسرتك
 
 01
      
 المحافظة على أنشطتك المعتادة في العمل
 
 11
 
 
      
 المحافظة على علاقتك الجنسية مع زوجك
 
 21
      
التمرين حتى التعرق ( بانتظامممارسة التمارين الرياضية 
  )وزيادة معدل نبضات القلب
 
 31
      
  إذا كنت بدينا(انقاص وزنك  (
 
 41
      
  )إذا كنت مدخنا(التوقف عن التدخين 
 
 51
      
  )إذا أوصى الطبيب بذلك(تغيير النظام الغذائي الخاص بك  
 
 61
 
 
 شكرا لك على المشاركة
 
 
 
 
 
 
 
 
 271 
 
Appendix D: Sociodemographic data sheet 
 
Measurement of PA Levels and Self-Efficacy during Early Recovery after Acute 
Myocardial Infarction: 
ةساردلا ناونع :  
 كولس سايقل ىدملا ةليوط ةسارد ةلحرم يف بلقلا ةلضع ءاشتحا ىضرم نيب سفنلاب ةقثلا ىوتسمو يندبلا طاشنلا
ندرلاا يف ركبملا ءافشلا 
  Socio-demographic variables:    please put × in appropriate box 
ةيعامتجلاا لماوعلا : ةملاع عض ×بسانملا عبرملا يف  
1. Sex                                                                                              سنجلا          1    
 Male                                     ركد                                 
 Female                      ىثنأ                                            
 
2.             Age                                                                  ةيرمعلا ةلحرملا             2 
 
3. Educational level                                                          يميلعتلا ىوتسملا         3         
 Secondary school or less                                       لقأوأ ةيوناث ةداهش  
 Higher Diploma or less                                          لقأوأ يلاع مولبد  
 Bachelor degree                                              رثكأ وأ ةيعماج ةجرد  
 Higher education                                      هاروتكدلا وا ريتسجاملا ةجرد    
  
4. Marital Status        4                                                                           ةيعامتجلاا ةلاحلا
                                  
 Single/ widow                                 لمرأ وا   بزعأ  
 Married                                                     جوزتم  
 Divorced                                                                      قلطم 
 
5. Occupation 5                                                                   ةيفيظولا ةلاحلا                     
                            
 Employed                                                                  فظوم  
 Un employed                                                           فظوم ريغ  
 Retired                                                                            دعاقتم 
 Self-employed                                                 صاخلا هباسحل فظوم 
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Appendix E: Diary daily record for chest pain 
 
Study Title: 
Measurement of PA Levels and Self-Efficacy during Early Recovery after Acute 
Myocardial Infarction: 
 
Have you felt any chest pain in last week?     Yes                    No  
 
If yes, please fill the question from 1 to question 4. 
 
1. What days ___________________________________ 
2. What is the chest pain level?  
The Lowest                                                                                      the Highest   
 
                                                                                                                                                   
1 2 3 4 5 6 7 8 9 10 
 
3. What is the duration of chest pain?  
----------------------------------------------- 
4. What is frequency of the pain?  
  4, or more, times  
   per day   
1-3 times per  
day   
3 or more times per   
week, but not every  
day                
 
College of Health & Social Care                                                   Date of application: 4
th
 of Dec 2014 
Name of Researcher: Abedalmajeed Shajrawi                           Version: 3   Ethics application HSCR14/120
 273 
 
 
 
Appendix F: activPAL3™ using instruction  
 
 
 activPAL3™   is PA monitor to determine inclination of one or more body segment. 
The activPAL3™ is worn on the midpoint of the anterior side of the thigh as shown in 
the Figure below; it is lightweight about 20 gm and small size.  
 
activPAL3™ is safe monitor and has been used in more than 300 scientific 
researches since 2001.  activPAL3™ is attached to the skin by using dual layer 
hydrogel adhesive pad. In addition, it is reusable and long lasting gel. If you will 
remove activPAL3™ monitor for any period, just placed it on clean and dry plastic 
surface   
 
Participants will wear the activPAL3™ monitor for seven full days, 24 hours a day 
including sleeping period. activPAL3™ is not waterproof. In case of exposure to water, 
you can only remove the monitor when, swimming or before any water-based 
activities. You will notice green flashlight on the activPAL3™ every 3 seconds that is 
indicating recording on progress. After completing a full 7 days, the researcher will 
contact you to collect the activPAL3™ monitor. If you would like to know your record 
result, please contact the researcher after three working days from the collecting date. 
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Do not hesitate to call me on my mobile or, submit an email, if you need any help or 
query please contact on my details below: 
 
Abedalmajeed Shajrawi                 Mobile number:  +962-789615640      
Email:    a.m.shajrawi@edu.saldford.ac.uk  
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Appendix G: Participants information sheet 
 
Study Title: Measurement of PA Levels and Self-Efficacy during Early Recovery 
after Acute Myocardial Infarction: 
 
Invitation paragraph 
I would like to invite you to take part in this study, which will explore the confidence 
levels and PA levels of heart attack patients following hospitalization in Jordan. 
Purpose of the study 
The main aim of the study is to measure the changes in confidence levels and PA 
behaviours at 2 & 6 weeks following hospitalization for a heart attack  
  
Why I have been invited? 
You have been invited to participate in this study because you have recently suffered 
a heart attack and been treated in Jordan University Hospital.  
 
Do I have to take part? 
Participation in this study is optional. You are free to refuse to participate or 
discontinue at any time. If you decide not to participate in the study, your participation 
will not affect future treatment and care.  
 
What will happen to me if I take part? 
If you agree to participate in this study, you should sign a consent form. The nursing 
staff will then contact me so I can arrange to meet with you. Then the research will 
ask you to complete a questionnaire whilst in hospital. Your role in the study will then 
consists of two phases: The first time, 2 weeks after hospital discharge. The 
researcher will meet with you 30 minutes before you follow up appointment in cardiac 
patients’ clinic in Out Patients Department (OPD and give you all the information 
needed). You will complete a questionnaire such as how much confidence you have 
to do some tasks. In addition, you will attach a PA monitor on the mid-thigh of your 
right leg for 7 days as per enclosed written instructions.  After 7 days, the researcher 
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will contact you to collect the activity monitor from your home address. A Jordanian 
driver will visit your house to collect the questionnaire and monitor. The researcher 
will give you details about the driver and his car. The second time: at 6 weeks 
following hospitalization, the researcher will repeat the same steps.  
 
Expenses and payments No payment is required for your participation in this study; 
all participants will participate for free.  
 
What will I have to do? 
The study has two parts: in the first part, the researcher will meet with you in the OPD, 
2-weeks following hospitalization. During this meeting, the researcher will ask you to 
complete a questionnaire and I will attach an activity monitor to your thigh, which you 
will need to wear for the following 7 days. At the end of the 7 days, the researcher will 
contact you and arrange for collection of the activity monitor.  
In the second part, the researcher will meet you again at 6 weeks following 
hospitalization, and repeat the same process as in part one.  For more information 
about activity monitor, please see the activity monitor using instructions. 
  
What are the possible disadvantages and risk of taking part? 
There are no disadvantages or any risk to you in this study.  
 
What are the possible benefits of taking part? 
There are no individual benefits associated with your participation in this study. 
However, this study may help the researcher to understand the confidence levels and 
PA behaviours among heart attack patients following hospitalization in Jordan, which 
in turn may help us improve care of patients after a heart attack.  
 
What if there is a problem? 
If you have questions or wish to report a research-related problem, you may contact: 
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Dr. Ian Jones 
Senior Lecturer in Cardiovascular Nursing  
School of Nursing, Midwifery, Social Work & Social Sciences 
Room MS230, Mary Seacole Building, University of Salford, Salford M5 4WT 
Telephone: +44 (0) 1612957278   | Mobile: +44 (0)7725910761 
Email: i.jones@salford.ac.uk 
 
 Will my taking part in the study be kept confidential? 
The researcher will strictly maintain your privacy of your records and identity. 
Identifying information appears only on consent forms, which the researcher will lock 
it in a secure locker, after completion of study, the researcher will keep the 
anonymous records for 3 years for further analysis, and then the researcher will 
discard them. To keep the privacy of the data, each person will get a random secret 
number to keep track of data produced. Results of the study in any presentation or 
magazine will include only group results, and the researcher will not ever use 
identifying information. In addition, the researcher will handle all collected data 
according to Data Protection Act 1998 UK.  
 
Involvement of the General Practitioner/Family Doctor (GP) 
There is no need to involve your doctor during or after the study.  
 
What will happen to the results of the research study? 
The researcher will use all data from the questions and activity monitor for analysis. 
The data will be protected and remain anonymous.  It will be analysed only by the 
researcher and his supervisor. In addition, the researcher will keep the data during 
the study in locked lockers or in a password-protected computer, which only the 
researcher can gain access. After completion of the study, the data will remain 
anonymized but the researcher will keep them for 3 years for further analysis. At the 
end of the 3 years, the researcher will erase all data. Each participant can receive a 
copy of his/ her result by contacting the researcher three working days after the 
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collection date. At the end of the study, the researcher will give an executive 
summary of the study to the Jordan University Hospital administration.   
 
Who is organizing or sponsoring the research? 
The researcher organises this study by himself, under the supervision of an academic 
team from University of Salford / at Manchester / UK.  
 
Further information and contact details 
Abedalmajeed Shajrawi, 
Mobile number: +962- 789615640     
Email: a.m.shajrawi@edu.salford.ac.uk 
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Appendix H: Participant’s consent form 
 
Please read the sentences below and put your initial in the small boxes below if 
you agree.  
 
 I confirm that I have read and understood the information sheet for the above 
study (version (3) x 4th of Dec 2014) and what my contribution will be.  
  
        
 I have been given the opportunity to ask questions (face to face, via telephone 
and e-mail). 
  
 
 I agree to take part in the study completing the questionnaires and attaching 
the PA monitor 2 weeks and 6 weeks after hospital discharge.    
 
 I understand that my participation is voluntary and that I can withdraw from the 
research at any time without giving any reason.  
 
 I understand how the researcher will use my responses, who will see them and 
how the data will be stored. 
 
 I agree to take part in both parts of the study (questionnaires and PA monitor) 
In the case of a participant withdrawing all his/her related data will be erased. 
 
 I am aware that I can withdraw from the study at any time. In case I withdraw, 
my data will not form any part of the study.  
 
 I have read the above, and I agree to take part in the study.  
 
 
Name of participant 
 
…………………………………………………………………………… 
 
Signature 
 
 
…………………………………………………………………… 
 
Date ………………………………. 
 
Name of the researcher who collect the consent: 
 
Signature:                                                               Date  
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Appendix I: Participants invitation letter 
 
Dear Participant 
     I am writing to you to invite you to take part in a study. I am a PhD student at the 
University of Salford, Manchester/ UK. This study is part of my PhD programme. I am 
interested in how people manage their PA levels after a heart attack. 
This study is entitled: 
Measurement of PA Levels and Self-Efficacy during Early Recovery after Acute 
Myocardial Infarction: 
 
PA, such as walking, has significant benefits to an individual’s health. However, a 
persons’ confidence may influence such activity. I would like to gain a better 
understanding of people’s activity levels after heart attack. In addition, how confident 
they feel to become more active.  
 
     If you agree to take part in the study, your role   would consist of two parts: the first 
part, the researcher will meet with you 2 weeks after hospital discharge. The second 
part, the researcher will meet with you again 6 weeks after hospitalization. The 
researcher will give you all the information needed and dates at the time of enrolment.  
 
      The ethical committees from University of Salford / UK and Jordan University 
Hospital/ Jordan have approved this study.   
 
Your willingness to participate in the study will be highly appreciated 
Further information and contact details: 
Abedalmajeed Shajrawi 
Mobile number:  +962- 789615640                  Email: a.m.shajrawi@edu.salford.ac.uk 
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Appendix J: The University of Salford ethical approval 
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Appendix K: JUH ethical approval 
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Appendix L: Mean steps count according to day at Time 1 and Time 2 
Mean steps count according to day at Time 1  
Day Mean step 
count T1 (Step) 
SD (Step) Minimum 
(Step) 
Maximum(Step) 
 
Range(Step) 
Sunday 7,069.89 3,402.34 1062 15964 14902 
Monday 7,382.00 3,838.02 1514 17266 15752 
Tuesday 7,505.10 3,702.34 1192 16784 15592 
Wednesday 7,269.23 3,599.01 788 14476 13688 
Thursday 6,965.10 3,373.01 1096 15654 14558 
Friday 5,661.19 3,109.47 680 18916 18236 
Saturday 6,135.40 3,047.79 478 18144 17666 
 
Mean steps count according to day at Time 2 
Day Mean step 
count T2 (Step) 
SD 
(Step) 
Minimum 
(Step) 
Maximum (Step) Range (Step) 
Sunday 7,474.1 3,495.41 1750 15154 13404 
Monday 7,804.63 3,624.53 472 14126 13654 
Tuesday 7,791.87 4,062.07 1780 19804 18024 
Wednesday 6,570.87 3,134.34 214 14014 13800 
Thursday 7,632.91 3,623.89 2144 16976 14832 
Friday 5,965.95 2,538.35 2190 12432 10242 
Saturday 6,597.02 3,320.06 2118 14964 12846 
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Appendix M: Mean steps count according to hour at Time1 
Hour Mean steps 
count (step) 
Median 
(Step) 
SD 
(step) 
Range 
(step) 
Minimum 
(step) 
Maximum 
(step) 
 
Interquartile 
range 
(step) 
1 94.10 47.67 138.58 819.00 0.00 819.00 115.2 
2 48.07 9.17 102.10 584.40 0.00 584.40 47.89 
3 23.50 4.57 71.63 525.33 0.00 525.33 17.69 
4 12.90 0.43 34.81 254.00 0.00 254.00 14.58 
5 33.51 2.67 65.00 299.33 0.00 299.33 38.14 
6 95.93 27.14 144.17 747.60 0.00 747.60 150.84 
7 155.89 78.33 193.53 1026.29 0.00 1026.29 232.68 
8 277.91 158.71 301.47 1415.50 0.00 1415.50 403.45 
9 345.70 279.67 327.68 1602.00 0.00 1602.00 389.07 
10 434.04 336.67 381.42 2128.00 0.00 2128.00 420.41 
11 455.84 418.57 313.00 1291.67 0.00 1291.67 476.48 
12 481.95 424.86 329.41 1534.86 0.00 1534.86 446.03 
13 534.80 504.29 320.91 1364.29 0.00 1364.29 474.64 
14 532.56 454.29 352.09 1452.00 5.00 1457.00 450.38 
15 442.50 403.67 284.11 1253.17 3.50 1256.67 442.62 
16 336.78 263.00 275.10 1803.60 0.00 1803.60 332.06 
17 393.09 345.14 312.87 1881.60 0.00 1881.60 406.98 
18 339.53 256.29 248.64 1316.67 0.00 1316.67 325.74 
19 378.91 304.00 326.06 1716.53 14.33 1730.86 289.23 
20 417.37 300.00 351.06 1862.04 27.67 1889.71 391.96 
21 293.74 209.71 238.73 1472.00 10.00 1482.00 260.95 
22 264.93 210.00 249.09 1892.33 0.00 1892.33 244.82 
23 203.90 180.00 183.08 1192.06 3.14 1195.20 207.39 
24 143.98 113.43 153.07 761.25 0.00 761.25 128.31 
 
 
 
 285 
 
Appendix N: Mean steps count according to hour at Time 2 
Hour Mean steps 
count (step) 
Median 
(Step) 
SD 
(step) 
Range 
(step) 
Minimum 
(step) 
Maximum 
(step) 
 
Interquartile 
range 
(step) 
1 95.33 56.29 112.33 634.00 0.00 634.00 110 
2 56.82 15.36 124.12 943.14 0.00 943.14 67.5 
3 27.32 0.29 101.04 762.86 0.00 762.86 9.62 
4 35.53 0.00 114.20 557.43 0.00 557.43 9 
5 48.78 0.00 134.47 697.14 0.00 697.14 16.29 
6 108.03 18.77 255.04 1976.86 0.00 1976.86 79.07 
7 170.67 130.80 190.99 883.71 0.00 883.71 240.07 
8 299.62 196.43 287.98 1333.14 0.00 1333.14 469.21 
9 307.34 274.77 247.82 1237.00 0.00 1237.00 299.22 
10 368.98 325.83 280.44 1396.86 0.00 1396.86 390.22 
11 505.91 454.29 355.57 1584.67 7.33 1592.00 504.06 
12 552.36 564.57 283.13 1353.43 47.71 1401.14 369.29 
13 660.81 669.43 346.54 1658.00 0.00 1658.00 464.15 
14 615.25 604.74 353.67 1668.50 0.00 1668.50 483.32 
15 472.51 430.41 279.10 1079.71 0.00 1079.71 441.66 
16 338.71 300.00 225.01 1051.86 0.00 1051.86 331.32 
17 379.77 338.57 299.39 1876.67 0.00 1876.67 271.14 
18 322.35 299.43 203.48 1338.79 13.71 1352.50 253.14 
19 330.56 273.71 210.78 1100.85 48.86 1149.71 199.14 
20 338.23 279.77 228.92 1309.72 41.71 1351.43 250.96 
21 320.55 251.00 239.52 1079.71 4.29 1084.00 228.14 
22 274.76 232.02 202.80 1364.57 0.00 1364.57 200.86 
23 228.35 201.43 143.60 810.29 0.00 810.29 137.92 
24 161.30 129.48 136.06 808.86 0.00 808.86 149.29 
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Appendix O: Mean stepping time according to day at Time 1 and Time 2 
Mean stepping time according to day at Time 1 
Day Mean stepping time 
at T1 (mins) 
SD 
(mins) 
Minimum 
(mins) 
Maximum 
(mins) 
Range 
(mins) 
Sunday 98.57 45.12 13.8 234.6 220.8 
Monday 100.03 49.6 0 234.6 234.6 
Tuesday 100.73 49.15 0 266.4 266.4 
Wednesday 98.29 46.65 12 218.4 206.4 
Thursday 94.84 43.42 17.4 216.6 199.2 
Friday 80.69 42.19 9.6 257.4 247.8 
Saturday 87.3 39.24 7.2 220.2 213 
 
Mean stepping time according to day at Time 2 
Day Mean stepping 
time at T2 (mins) 
SD 
(mins) 
Minimum 
(mins) 
Maximum 
(mins) 
Range 
(mins) 
Sunday 100.8 43.33 27.6 201 173.4 
Monday 105.91 44.16 7.8 194.4 186.6 
Tuesday 106.12 48.49 31.2 232.2 201 
Wednesday 91.54 39.76 3 213 210 
Thursday 102.95 43.79 36 213.6 177.6 
Friday 86.39 32.9 34.8 205.8 171 
Saturday 92.99 41.42 36 209.4 173.4 
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Appendix P: Mean stepping time according to hour at Time 1 
Hour Mean stepping time 
at Time 1 (mins) 
Median 
(mins) 
SD 
(mins) 
Range 
(mins) 
Minimum 
(mins) 
Maximum 
(mins) 
 
Interquartile 
range (mins) 
1 1.55 0.6 2.28 12 0 12 2.4 
2 0.74 0 1.64 9 0 9 0.6 
3 0.28 0 0.77 4.8 0 4.8 0.6 
4 0.19 0 0.54 3.6 0 3.6 0 
5 0.52 0 1.06 5.4 0 5.4 0.6 
6 1.44 0.6 2.16 9 0 9 2.4 
7 2.29 1.2 2.81 14.4 0 14.4 3.6 
8 3.73 2.4 3.89 18 0 18 5.4 
9 4.70 3.9 4.20 19.8 0 19.8 5.4 
10 5.83 4.8 4.58 23.4 0 23.4 6 
11 6.25 5.4 4.14 18 0 18 6.6 
12 6.60 6 4.22 24 0 24 6 
13 7.32 6.9 4.16 22.8 0 22.8 6 
14 7.18 6.6 4.21 16.2 0 16.2 6 
15 6.10 5.7 3.55 15.6 0 15.6 6 
16 4.76 3.9 3.36 16.8 0 16.8 4.2 
17 5.35 4.8 3.63 18 0 18 4.8 
18 5.02 3.9 3.41 17.4 0 17.4 4.8 
19 5.40 4.8 3.79 16.8 0.6 17.4 4.8 
20 5.86 4.8 4.27 21.6 0.6 22.2 4.8 
21 4.21 3.6 3.08 19.2 0 19.2 4.8 
22 3.97 3 3.29 21.6 0 21.6 3.6 
23 3.12 3 2.59 13.8 0 13.8 3.6 
24 2.22 1.8 2.32 10.8 0 10.8 2.4 
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Appendix Q: Mean stepping time according to hour at Time 2 
Hour Mean stepping time at 
T 2 (mins) 
Median 
(mins) 
SD 
(mins) 
Range 
(mins) 
Minimum 
(mins) 
Maximum 
(mins) 
 
Interquartile 
range 
(mins) 
1 1.51 1.20 1.70 9.60 0.00 9.60 1.8 
2 0.81 0.00 1.64 12.00 0.00 12.00 1.2 
3 0.36 0.00 1.34 9.60 0.00 9.60 0 
4 0.50 0.00 1.64 9.00 0.00 9.00 0 
5 0.68 0.00 1.87 10.80 0.00 10.80 0 
6 1.45 0.30 3.03 21.00 0.00 21.00 1.2 
7 2.50 1.80 2.82 14.40 0.00 14.40 3.6 
8 3.92 3.00 3.57 18.00 0.00 18.00 5.4 
9 4.04 3.60 3.00 13.20 0.00 13.20 4.2 
10 4.88 4.80 3.51 15.60 0.00 15.60 4.8 
11 6.74 6.30 4.40 18.00 0.00 18.00 7.2 
12 7.47 7.80 3.35 15.00 0.60 15.60 4.8 
13 8.59 8.70 3.88 17.40 0.00 17.40 4.8 
14 7.96 7.80 3.97 17.40 0.00 17.40 6 
15 6.52 6.60 3.56 15.60 0.00 15.60 4.8 
16 4.74 4.80 2.91 16.80 0.00 16.80 3.6 
17 5.20 4.80 3.40 18.00 0.00 18.00 4.2 
18 4.86 4.80 2.76 15.60 0.00 15.60 3 
19 5.13 4.50 2.91 13.20 0.60 13.80 3 
20 4.96 4.20 2.94 15.60 0.60 16.20 3 
21 4.61 3.90 2.86 13.20 0.00 13.20 3 
22 4.14 3.60 2.54 15.60 0.00 15.60 3 
23 3.58 3.60 2.10 10.80 0.00 10.80 1.8 
24 2.44 1.80 2.03 12.60 0.00 12.60 2.4 
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Appendix R: Mean standing time according to day at Time 1 and Time 2  
 Mean standing time according to day at Time 1 
Day Mean standing time 
according to day at T1 
(mins) 
SD 
(mins) 
Minimum 
(mins) 
Maximum 
(mins) 
Range 
(mins) 
 
Sunday 232.40 106.18 70.80 577.80 507.00 
Monday 235.46 124.03 68.40 609.60 541.20 
Tuesday 249.64 130.62 25.20 724.20 699.00 
Wednesday 244.33 110.18 37.80 600.60 562.80 
Thursday 247.73 140.81 58.20 986.40 928.20 
Friday 199.82 109.40 51.60 500.40 448.80 
Saturday 230.11 106.24 51.00 484.20 433.20 
 
Mean standing time according to day at Time 2 
Day Mean standing time 
according to day at T2 
(mins) 
SD 
(mins) 
Minimum 
(mins) 
Maximum 
(mins) 
Range 
(mins) 
 
Sunday 227.54 114.47 36.60 701.40 664.80 
Monday 250.31 128.96 37.80 819.60 781.80 
Tuesday 257.36 120.95 52.20 673.20 621.00 
Wednesday 226.47 105.50 5.40 497.40 492.00 
Thursday 228.86 97.61 49.80 472.80 423.00 
Friday 217.47 96.19 36.00 463.80 427.80 
Saturday 227.12 115.46 61.80 697.20 635.40 
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Appendix S: Mean standing time according to hour at Time 1 
Hour Mean standing 
time according 
to hour at T1 
(mins) 
Median 
(mins) 
SD 
(mins) 
Range 
(mins) 
Minimum 
(mins) 
Maximum 
(mins) 
 
Interquartile 
range (mins) 
1 3.85 0.18 5.28 26.4 0 26.4 4.8 
2 2.36 0.06 4.40 20.4 0 20.4 3 
3 1.60 0 3.83 21.6 0 21.6 1.2 
4 1.54 0 3.76 22.8 0 22.8 0.6 
5 3.02 0.03 4.85 19.8 0 19.8 4.2 
6 6.20 0.24 7.89 27 0 27 9.6 
7 6.88 0.54 7.15 29.4 0 29.4 10.8 
8 8.94 0.63 8.58 37.2 0 37.2 12.6 
9 12.24 0.96 9.08 40.8 0 40.8 13.8 
10 14.21 1.23 10.37 40.2 0 40.2 13.2 
11 15.72 1.41 10.59 38.4 0 38.4 16.8 
12 15.67 1.5 9.28 41.4 0 41.4 14.4 
13 17.10 1.74 9.01 35.4 0 35.4 15 
14 15.66 1.5 8.39 42 0 42 9.6 
15 14.14 1.29 7.97 34.8 0 34.8 10.8 
16 12.22 1.05 7.91 33.6 0 33.6 9 
17 12.77 1.14 8.36 39 0 39 10.8 
18 12.97 1.17 8.43 45.6 0 45.6 11.4 
19 12.67 1.2 7.26 40.8 0.6 41.4 8.4 
20 13.15 1.08 7.79 34.8 0.6 35.4 9.6 
21 11.35 0.9 8.23 49.2 1.2 50.4 10.2 
22 10.03 0.9 7.55 30.6 0 30.6 10.8 
23 8.62 0.78 6.68 30.6 0 30.6 9 
24 6.14 0.42 6.31 33 0 33 7.8 
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Appendix T: Mean standing time according to hour at Time 2 
Hour Mean standing time 
according to hour 
at T2 (mins) 
Median 
(mins) 
SD 
(mins) 
Range 
(mins) 
Minimum 
(mins) 
Maximu
m (mins) 
 
Interquartile 
range 
(mins) 
1 3.25 1.8 3.302 14.4 0 14.4 4.2 
2 2.35 0.6 3.95 19.8 0 19.8 3 
3 1.71 0 4.46 27 0 27 1.2 
4 2.61 0 5.99 30 0 30 1.2 
5 3.07 0 6.12 33.6 0 33.6 2.4 
6 5.31 1.8 7.82 42.6 0 42.6 7.8 
7 6.82 4.8 6.59 33.6 0 33.6 9.6 
8 8.46 6.9 7.37 26.4 0 26.4 12 
9 10.76 7.8 9.04 30.6 0 30.6 15.6 
10 13.01 11.7 10.01 41.4 0 41.4 15.6 
11 16.60 16.2 9.85 37.8 0.6 38.4 18 
12 17.53 16.2 8.31 34.8 0.6 35.4 12 
13 17.97 17.4 8.30 41.4 0 41.4 12 
14 15.28 14.7 7.37 36.6 0 36.6 9.6 
15 14.14 12.6 7.62 38.4 0 38.4 7.8 
16 10.15 9.9 6.40 37.8 0 37.8 7.2 
17 11.17 9.6 6.41 27 0 27 7.2 
18 12.3 11.1 6.82 27.6 1.2 28.8 10.2 
19 12 11.4 6.48 29.4 2.4 31.8 7.2 
20 11.31 10.5 6.57 31.8 1.2 33 7.2 
21 10.84 9.6 6.37 37.2 0.6 37.8 7.2 
22 10.41 9.6 5.92 28.2 0 28.2 6.6 
23 8.39 7.8 4.64 19.8 0 19.8 6.6 
24 5.26 4.8 4.10 19.2 0 19.2 4.8 
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Appendix U: Mean upright time according to day at Time 1 and Time 2  
Mean upright time according to day at Time 1 
Day Mean upright time 
according to day at T1 
(mins) 
SD 
(mins) 
Minimum 
(mins) 
Maximum 
(mins) 
Range 
(mins) 
 
Sunday 326.15 127.24 137.40 765.60 628.20 
Monday 334.40 154.51 70.20 791.40 721.20 
Tuesday 354.86 166.47 25.20 816.60 791.40 
Wednesday 342.61 138.26 49.80 669.00 619.20 
Thursday 342.57 169.51 78.60 1117.80 1039.20 
Friday 280.51 139.79 85.20 634.20 549.00 
Saturday 317.42 130.02 87.00 600.60 513.60 
 
Mean upright time according to day at Time 2 
Day Mean upright time 
according to day at 
T 2 (mins) 
SD 
(mins) 
Minimum 
(mins) 
Maximum 
(mins) 
Range 
(mins) 
 
Sunday 328.34 136.37 108.60 767.40 658.80 
Monday 349.90 140.49 61.20 709.20 648.00 
Tuesday 363.47 146.72 96.00 813.00 717.00 
Wednesday 318.01 131.07 8.40 604.20 595.80 
Thursday 331.82 130.31 98.40 652.20 553.80 
Friday 303.86 117.49 70.80 627.60 556.80 
Saturday 320.11 142.18 108.60 796.80 688.20 
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Appendix V: Mean upright time according to hour at Time 1 
Hour Mean 
(mins) 
Median 
(mins) 
SD 
(mins) 
Range 
(mins) 
Minimum 
(mins) 
Maximum 
(mins) 
 
Interquartile 
range 
(mins) 
1 5.41 3.00 7.19 38.40 0.00 38.40 7.65 
2 3.14 0.60 5.44 23.40 0.00 23.40 3 
3 1.93 0.30 4.37 22.20 0.00 22.20 1.8 
4 1.74 0.00 3.97 23.40 0.00 23.40 1.2 
5 3.53 0.60 5.52 19.80 0.00 19.80 5.4 
6 7.64 3.00 9.71 34.80 0.00 34.80 11.1 
7 9.18 6.90 9.52 37.80 0.00 37.80 14.25 
8 12.63 9.60 11.58 46.20 0.00 46.20 17.25 
9 16.99 13.80 12.03 53.40 0.00 53.40 20.85 
10 20.02 17.70 13.51 54.00 0.00 54.00 21.75 
11 21.95 21.60 13.55 50.40 0.00 50.40 23.85 
12 22.24 21.60 12.10 49.80 0.00 49.80 18.9 
13 24.41 24.90 11.40 46.80 0.00 46.80 20.55 
14 22.82 21.30 10.85 48.00 0.60 48.60 16.2 
15 20.22 19.20 10.56 44.40 0.00 44.40 16.2 
16 16.95 15.60 10.07 43.80 0.00 43.80 12 
17 18.09 17.10 10.90 49.20 0.00 49.20 14.85 
18 18.00 16.20 10.61 57.00 0.00 57.00 15.3 
19 18.04 17.40 9.40 48.00 1.20 49.20 11.4 
20 19.03 15.90 10.69 44.40 1.20 45.60 16.8 
21 15.53 12.00 10.26 55.80 1.80 57.60 13.5 
22 13.97 12.30 9.92 41.40 0.00 41.40 12.9 
23 11.70 10.80 8.53 36.00 0.00 36.00 12.45 
24 8.34 6.30 8.13 36.00 0.00 36.00 10.65 
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Appendix W: Mean upright time according to hour at Time 2 
Hour Mean 
(mins) 
Median 
(mins) 
SD 
(mins) 
Range 
(mins) 
Minimum 
(mins) 
Maximum 
(mins) 
 
Interquartile 
range 
(mins) 
1 4.71 3.00 4.84 24.00 0.00 24.00 5.4 
2 3.17 1.20 5.06 31.20 0.00 31.20 4.05 
3 2.10 0.00 5.61 33.00 0.00 33.00 1.2 
4 3.12 0.00 7.27 39.00 0.00 39.00 1.8 
5 3.78 0.00 7.79 44.40 0.00 44.40 3 
6 6.79 2.40 10.21 54.60 0.00 54.60 9.6 
7 9.29 7.20 9.12 45.00 0.00 45.00 13.2 
8 12.36 10.20 10.34 44.40 0.00 44.40 18.75 
9 14.81 12.60 11.21 38.40 0.00 38.40 20.25 
10 17.81 15.90 12.58 48.60 0.00 48.60 21.15 
11 23.39 23.10 13.10 50.40 0.60 51.00 23.1 
12 25.00 24.60 10.31 45.00 1.80 46.80 14.7 
13 26.50 27.00 10.12 50.40 0.00 50.40 14.85 
14 23.19 23.10 10.00 46.20 0.00 46.20 14.25 
15 20.66 19.50 10.30 48.60 0.00 48.60 12.45 
16 14.84 13.20 8.59 48.00 0.00 48.00 9.3 
17 16.38 13.80 8.94 37.80 0.00 37.80 12.15 
18 17.17 15.00 8.96 39.00 1.20 40.20 13.65 
19 17.11 16.20 8.61 40.80 3.60 44.40 10.8 
20 16.29 15.30 8.58 40.20 2.40 42.60 10.2 
21 15.44 14.10 8.23 43.20 0.60 43.80 10.2 
22 14.54 13.50 7.58 36.00 0.00 36.00 9.45 
23 11.93 10.80 6.33 30.00 0.00 30.00 8.4 
24 7.76 6.60 5.90 31.80 0.00 31.80 7.05 
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Appendix X: Mean sedentary time according to day at Time 1 and Time 2 
Mean sedentary time according to day at Time 1 
Day Mean sedentary time 
according to day at T1 
(mins) 
SD 
(mins) 
Minimum 
(mins) 
Maximum 
(mins) 
Range 
(mins) 
 
Sunday 1,112.09 132.53 673.20 1302.00 628.80 
Monday 1,103.91 154.31 648.60 1368.60 720.00 
Tuesday 1,089.70 163.14 623.40 1414.80 791.40 
Wednesday 1,097.35 138.35 769.80 1390.20 620.40 
Thursday 1,097.21 169.60 320.40 1362.60 1042.20 
Friday 1,159.39 139.88 807.60 1353.60 546.00 
Saturday 1,122.57 129.65 839.40 1353.00 513.60 
 
Mean sedentary time according to day at Time 2 
Day Mean sedentary time 
according to day at T 2 
(mins) 
SD 
(mins) 
Minimum 
(mins) 
Maximum 
(mins) 
Range 
(mins) 
 
Sunday 1,111.42 136.28 672.00 1330.80 658.80 
Monday 1,089.85 140.33 731.40 1378.20 646.80 
Tuesday 1,076.32 146.52 627.60 1343.40 715.80 
Wednesday 1,122.02 131.06 835.80 1431.60 595.80 
Thursday 1,108.06 130.34 787.80 1341.00 553.20 
Friday 1,136.35 117.50 812.40 1369.80 557.40 
Saturday 1,119.84 141.92 644.40 1330.80 686.40 
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Appendix Y: Mean sedentary time according to hour at Time 1 
Hour Mean Sedentary 
time according 
to hour at T1 
Median SD Range minimum maximum Interquartile 
range 
1 54.61 57.00 7.27 38.40 21.60 60.00 7.20 
2 56.98 59.40 5.33 23.40 36.60 60.00 3.00 
3 58.15 60.00 4.23 22.20 37.80 60.00 1.80 
4 58.31 60.00 3.86 23.40 36.60 60.00 1.20 
5 56.54 59.40 5.44 19.80 40.20 60.00 4.80 
6 52.40 57.00 9.67 34.80 25.20 60.00 10.20 
7 50.83 53.10 9.57 37.80 22.20 60.00 13.20 
8 47.36 50.40 11.58 46.20 13.80 60.00 17.40 
9 43.03 46.20 12.04 54.00 6.00 60.00 19.80 
10 40.08 42.30 13.58 54.00 6.00 60.00 21.60 
11 38.06 38.10 13.55 50.40 9.60 60.00 23.40 
12 37.75 38.40 12.11 50.40 9.60 60.00 19.20 
13 35.60 35.40 11.43 46.80 13.20 60.00 19.20 
14 37.22 38.70 10.86 48.00 11.40 59.40 15.60 
15 39.84 40.80 10.58 44.40 15.60 60.00 16.20 
16 43.12 44.40 10.07 43.80 16.20 60.00 12.60 
17 41.99 42.90 10.89 48.60 11.40 60.00 15.00 
18 42.04 43.80 10.62 57.00 3.00 60.00 16.20 
19 41.98 42.60 9.40 48.00 10.80 58.80 11.40 
20 41.05 44.40 10.69 44.40 14.40 58.80 15.00 
21 44.51 48.00 10.31 55.80 2.40 58.20 12.60 
22 46.09 47.40 9.87 41.40 18.60 60.00 13.20 
23 48.32 49.20 8.50 36.00 24.00 60.00 12.00 
24 51.66 54.00 8.18 36.00 24.00 60.00 10.20 
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Appendix Z: Mean sedentary time according hour at Time 2 
Hour Mean sedentary 
time according to 
hour at T 2 (mins) 
Median 
(mins) 
SD 
(mins) 
Range 
(mins) 
Minimum 
(mins) 
Maximum 
(mins) 
Interquartile 
Range (mins) 
1 55.30 57.00 4.79 23.40 36.60 60.00 5.40 
2 56.83 58.80 5.06 31.20 28.80 60.00 4.20 
3 57.91 60.00 5.66 33.00 27.00 60.00 1.20 
4 56.89 60.00 7.28 39.00 21.00 60.00 1.80 
5 56.23 60.00 7.79 44.40 15.60 60.00 3.00 
6 53.22 57.60 10.27 54.60 5.40 60.00 9.60 
7 50.74 52.20 9.10 45.00 15.00 60.00 13.20 
8 47.62 49.80 10.37 44.40 15.60 60.00 19.20 
9 45.18 47.40 11.20 38.40 21.60 60.00 20.40 
10 42.22 44.40 12.57 48.60 11.40 60.00 21.60 
11 36.60 37.20 13.11 50.40 9.00 59.40 23.40 
12 35.07 35.40 10.26 45.00 13.20 58.20 15.00 
13 33.49 33.00 10.13 50.40 9.60 60.00 15.00 
14 36.78 37.20 9.98 46.20 13.80 60.00 14.40 
15 39.35 40.20 10.30 48.60 11.40 60.00 13.20 
16 45.20 46.80 8.56 48.00 12.00 60.00 9.00 
17 43.66 46.20 8.94 37.80 22.20 60.00 12.60 
18 42.89 43.80 8.91 38.40 20.40 58.80 13.20 
19 42.91 43.80 8.58 40.80 15.60 56.40 10.80 
20 43.72 45.00 8.54 40.20 17.40 57.60 10.20 
21 44.52 45.60 8.21 43.20 16.20 59.40 9.60 
22 45.52 46.80 7.59 36.00 24.00 60.00 9.60 
23 48.08 49.20 6.34 30.00 30.00 60.00 8.40 
24 52.33 53.40 5.90 31.80 28.20 60.00 6.60 
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Appendix AA:  Dissemination Plan of Findings 
The findings of the study will be disseminated to all involved departments, for 
example health policymakers such as hospital administrators, nurses’ managers, 
medical staff and nurse educators to promote changes to nursing practice and nurse 
education to promote a secondary prevention strategy. One way to begin such 
strategic development is to ensure dissemination of the findings from this study 
widely, through presentations and peer-reviewed publications. Therefore, envisaging 
of the following plan to facilitate such a process: 
 The researcher will publish two peer-reviewed papers. Presenting the findings 
of the study and raising awareness in Jordan of coronary risk factors. In 
addition, publishing the findings of this study in various international journals: 
firstly, publishing the CSEQ translation and cross-cultural adaptation chapter in 
the peer-reviewed journal and secondly, self-efficacy and PA will be a poster 
presentation in the fifth International Conference on Ambulatory Monitoring of 
physical activity and Movement (ICAMPAM) then published in peer-reviewed 
journal. 
 Presentations of the findings on a local, national and international platform will 
be necessary to raise awareness for nurses, managers, educators and 
medical staff and to put the topic on the agenda of the nursing and medical 
professions and healthcare organisations. 
 A working paper could be developed and presented to the Jordanian Nursing 
and Midwifery Council; this would be a discussion paper to suggest a review 
and adaptation of the code of nursing ethics to ensure that nurses have a 
structured, organised role in increasing AMI populations’ awareness of PA and 
secondary prevention.  
 The researcher will submit a translated report regarding study findings to 
concerned institutions such as MoH, JUH and the WHO office in Amman, 
Jordan. 
 The findings will be available on the University of Salford website. 
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Appendix BB: Research Development 
 
Exploring this critical topic was challenging and informing healthcare policymakers of 
the study results are vital. Given the prolonged data collection period of the study, I 
was concerned that a number of patients with AMI would not participate. Although 
some participants changed their mind and declined participation as the study 
progressed, the deeper underlying influences of Jordanian culture and the 
understanding of the issues regarding this topic became more apparent to me as a 
researcher and as a CCU nurse.  
As a researcher living in Jordan, I believe now that starts activating an improved 
lifestyle and the importance of secondary prevention among the patient with AMI 
population. Patients with AMI have to demonstrate secondary prevention practices 
with regard to treating CHD, and cultural health misinterpretation needs to be rectified. 
It is necessary that researchers are made more aware that cardiac disease self-
management programmes should be available, these programmes need to be visible 
and accessible to all patients with AMI, whatever their economic status or position in 
the community.  
The PhD study journey and the invaluable support of my supervisors have improved 
my skills in problem solving, managing research, and communication. These skills 
are highly valuable for my future independent work in research in Jordan to produce 
high quality research and improve professional nursing education and practice in this 
country. 
Research training offered by the University of Salford has also supported my efforts, 
and developed my knowledge and skills to carry out research. The training included 
short one or two-day seminars alongside longer modules that have improved my 
research and technical skills. These courses included sessions on a research 
methods training module, referencing, interview skills as well as qualitative and 
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quantitative data analysis. Shorter seminars of high value included: applying for 
ethics, preparing and delivering successful conference presentations. I think I will be 
having a vital role as an academic and a research to consolidate these skills within 
student seminars and conferences within the university and European conferences. 
  
 
 
